Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal eye physiology (HP:0012373)help
Parent Node:
expand
Abnormality of vision (HP:0000504)help
..Starting node
..expand
Visual impairment (HP:0000505)help
Term ID: 505
Name: Visual impairment
Synonym: Impaired vision; Loss of eyesight; Poor vision; Visual impairment
Definition: Visual impairment (or vision impairment) is vision loss (of a person) to such a degree as to qualify as an additional support need through a significant limitation of visual capability resulting from either disease, trauma, or congenital or degenerative conditions that cannot be corrected by conventional means, such as refractive correction, medication, or surgery.
Comments:
Reference: HP:0000505
Genes and Diseases:
 
       Child Nodes:
........expandBlindness (HP:0000618) help
................... HP:0007875 Congenital blindness
........expandSevere visual impairment (HP:0001141) help
........expandCongenital visual impairment (HP:0007758) help
........expandModerate visual impairment (HP:0030515) help
........expandCortical visual impairment (HP:0100704) help

 Sister Nodes: 
..expandAbnormality of binocular vision (HP:0011514) help
..expandAmaurosis fugax (HP:0100576) help
..expandBlurred vision (HP:0000622) help
..expandBradyopsia (HP:0030511) help
..expandColor vision defect (HP:0000551) help
..expandDifficulty adjusting to changes in luminance (HP:0030512) help
..expandHemeralopia (HP:0012047) help
..expandMetamorphopsia (HP:0012508) help
..expandNyctalopia (HP:0000662) help
..expandPhotophobia (HP:0000613) help
..expandPhotopsia (HP:0030786) help
..expandPoor visual behavior for age (HP:0025152) help
..expandReduced visual acuity (HP:0007663) help
..expandVisual field defect (HP:0001123) help
..expandVisual loss (HP:0000572) help
..expandVitreous floaters (HP:0100832) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000505HP:0000505Visual impairment0AAAS CL E G H808613666ORPHA:869Triple A syndromeHP:0040282 - Frequent57
HP:0000505HP:0000505Visual impairment0AARS1 CL E G H1620OMIM:619661LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2
HP:0000505HP:0000505Visual impairment0ABCA1 CL E G H1929OMIM:205400Tangier disease.191
HP:0000505HP:0000505Visual impairment0ABCA4 CL E G H2434ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional826
HP:0000505HP:0000505Visual impairment0ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0000505Visual impairment0ABCA4 CL E G H2434ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent826
HP:0000505HP:0000505Visual impairment0ABCA4 CL E G H2434OMIM:601718Retinitis pigmentosa 19826
HP:0000505HP:0000505Visual impairment0ABCA4 CL E G H2434ORPHA:827Stargardt disease826
HP:0000505HP:0000505Visual impairment0ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional415
HP:0000505HP:0000505Visual impairment0ABCC6 CL E G H36857OMIM:177850Pseudoxanthoma elasticum, forme fruste.415
HP:0000505HP:0000505Visual impairment0ABCC6 CL E G H36857OMIM:264800PSEUDOXANTHOMA ELASTICUM; PXE415
HP:0000505HP:0000505Visual impairment0ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy135
HP:0000505HP:0000505Visual impairment0ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophy135
HP:0000505HP:0000505Visual impairment0ACO2 CL E G H50118OMIM:616289Optic atrophy 9.60
HP:0000505HP:0000505Visual impairment0ACTB CL E G H60132ORPHA:79107Developmental malformations-deafness-dystonia syndrome72
HP:0000505HP:0000505Visual impairment0ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasia178
HP:0000505HP:0000505Visual impairment0ADA2 CL E G H518161839ORPHA:820Sneddon syndrome22
HP:0000505HP:0000505Visual impairment0ADAM9 CL E G H8754216ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional41
HP:0000505HP:0000505Visual impairment0ADAM9 CL E G H8754216OMIM:612775Cone-Rod dystrophy 9.HP:0011463 - Childhood onset41
HP:0000505HP:0000505Visual impairment0ADAMTS10 CL E G H8179413201ORPHA:3449Weill-Marchesani syndrome63
HP:0000505HP:0000505Visual impairment0ADAMTS10 CL E G H8179413201OMIM:277600Weill-Marchesani syndrome 163
HP:0000505HP:0000505Visual impairment0ADAMTSL4 CL E G H5450719706ORPHA:1885Isolated ectopia lentisHP:0040283 - Occasional84
HP:0000505HP:0000505Visual impairment0ADARB1 CL E G H104226OMIM:618862NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS1
HP:0000505HP:0000505Visual impairment0ADGRV1 CL E G H8405917416ORPHA:231178Usher syndrome type 2530
HP:0000505HP:0000505Visual impairment0ADNP CL E G H2339415766ORPHA:404448ADNP syndrome47
HP:0000505HP:0000505Visual impairment0ADNP CL E G H2339415766OMIM:615873Helsmoortel-van der Aa syndrome.47
HP:0000505HP:0000505Visual impairment0AFF3 CL E G H38996473OMIM:619297KINSSHIP SYNDROME; KINS1
HP:0000505HP:0000505Visual impairment0AFF4 CL E G H2712517869ORPHA:444077Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome6
HP:0000505HP:0000505Visual impairment0AFG3L2 CL E G H10939315OMIM:618977OPTIC ATROPHY 12; OPA1286
HP:0000505HP:0000505Visual impairment0AGBL1 CL E G H12362426504ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000505HP:0000505Visual impairment0AGBL5 CL E G H6050926147ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent2
HP:0000505HP:0000505Visual impairment0AGBL5 CL E G H6050926147OMIM:617023Retinitis pigmentosa 752
HP:0000505HP:0000505Visual impairment0AGO2 CL E G H271613263OMIM:619149LESSEL-KREIENKAMP SYNDROME; LESKRES
HP:0000505HP:0000505Visual impairment0AGTPBP1 CL E G H2328717258ORPHA:2254Pontocerebellar hypoplasia type 11
HP:0000505HP:0000505Visual impairment0AHDC1 CL E G H2724525230ORPHA:412069AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome36
HP:0000505HP:0000505Visual impairment0AHI1 CL E G H5480621575OMIM:608629Joubert syndrome 3.175
HP:0000505HP:0000505Visual impairment0AHI1 CL E G H5480621575ORPHA:220493Joubert syndrome with ocular defect175
HP:0000505HP:0000505Visual impairment0AHI1 CL E G H5480621575ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent175
HP:0000505HP:0000505Visual impairment0AHR CL E G H196348ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent2
HP:0000505HP:0000505Visual impairment0AHR CL E G H196348OMIM:618345RETINITIS PIGMENTOSA 85; RP852
HP:0000505HP:0000505Visual impairment0AIFM1 CL E G H91318768ORPHA:83629Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndromeHP:0040282 - Frequent60
HP:0000505HP:0000505Visual impairment0AIMP1 CL E G H925510648OMIM:260600Leukodystrophy, hypomyelinating, 3.4
HP:0000505HP:0000505Visual impairment0AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0000505HP:0000505Visual impairment0AIPL1 CL E G H23746359ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional114
HP:0000505HP:0000505Visual impairment0AIPL1 CL E G H23746359ORPHA:65Leber congenital amaurosis114
HP:0000505HP:0000505Visual impairment0AIPL1 CL E G H23746359OMIM:604393Leber congenital amaurosis 4114
HP:0000505HP:0000505Visual impairment0AIPL1 CL E G H23746359OMIM:268000Retinitis pigmentosa114
HP:0000505HP:0000505Visual impairment0AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0000505HP:0000505Visual impairment0AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0000505HP:0000505Visual impairment0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0000505Visual impairment0AKT3 CL E G H10000393ORPHA:99802Hemimegalencephaly19
HP:0000505HP:0000505Visual impairment0ALDH3A2 CL E G H224403OMIM:270200Sjogren-Larsson syndrome87
HP:0000505HP:0000505Visual impairment0ALG2 CL E G H8536523159OMIM:607906Congenital disorder of glycosylation, type Ii.46
HP:0000505HP:0000505Visual impairment0ALG3 CL E G H1019523056OMIM:601110Congenital disorder of glycosylation, type Id37
HP:0000505HP:0000505Visual impairment0ALMS1 CL E G H7840428ORPHA:64Alström syndrome404
HP:0000505HP:0000505Visual impairment0ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome404
HP:0000505HP:0000505Visual impairment0ALPK1 CL E G H8021620917OMIM:614979Splenomegaly, cytopenia, and vision loss
HP:0000505HP:0000505Visual impairment0AMACR CL E G H23600451OMIM:614307Alpha-methylacyl-CoA racemase deficiency.44
HP:0000505HP:0000505Visual impairment0AMACR CL E G H23600451ORPHA:79095Congenital bile acid synthesis defect type 444
HP:0000505HP:0000505Visual impairment0AMPD2 CL E G H271469OMIM:615809Pontocerebellar hypoplasia, type 921
HP:0000505HP:0000505Visual impairment0ANGPTL6 CL E G H8385423140ORPHA:231160Familial cerebral saccular aneurysm
HP:0000505HP:0000505Visual impairment0ANKH CL E G H5617215492ORPHA:1522Craniometaphyseal dysplasiaHP:0040283 - Occasional164
HP:0000505HP:0000505Visual impairment0ANKRD11 CL E G H2912321316ORPHA:26125016q24.3 microdeletion syndromeHP:0040283 - Occasional102
HP:0000505HP:0000505Visual impairment0ANKRD55 CL E G H7972225681ORPHA:85410Oligoarticular juvenile idiopathic arthritis
HP:0000505HP:0000505Visual impairment0ANOS1 CL E G H37306211ORPHA:478Kallmann syndromeHP:0040283 - Occasional65
HP:0000505HP:0000505Visual impairment0ANTXR1 CL E G H8416821014ORPHA:2067GAPO syndromeHP:0040282 - Frequent8
HP:0000505HP:0000505Visual impairment0AP1G1 CL E G H164555OMIM:619467USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD
HP:0000505HP:0000505Visual impairment0AP3B1 CL E G H8546566OMIM:608233Hermansky-Pudlak syndrome 283
HP:0000505HP:0000505Visual impairment0AP3D1 CL E G H8943568ORPHA:1000Ocular albinism with late-onset sensorineural deafnessHP:0040281 - Very frequent1
HP:0000505HP:0000505Visual impairment0AP3D1 CL E G H8943568ORPHA:54X-linked recessive ocular albinismHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0AP4B1 CL E G H10717572ORPHA:280763Severe intellectual disability and progressive spastic paraplegia49
HP:0000505HP:0000505Visual impairment0AP4E1 CL E G H23431573ORPHA:280763Severe intellectual disability and progressive spastic paraplegia48
HP:0000505HP:0000505Visual impairment0AP4M1 CL E G H9179574ORPHA:280763Severe intellectual disability and progressive spastic paraplegia41
HP:0000505HP:0000505Visual impairment0AP4S1 CL E G H11154575ORPHA:280763Severe intellectual disability and progressive spastic paraplegia18
HP:0000505HP:0000505Visual impairment0APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040283 - Occasional3179
HP:0000505HP:0000505Visual impairment0APOE CL E G H348613OMIM:603075Macular degeneration, age-related, 139
HP:0000505HP:0000505Visual impairment0ARHGDIA CL E G H396678OMIM:615244Nephrotic syndrome, type 83
HP:0000505HP:0000505Visual impairment0ARHGEF18 CL E G H2337017090ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent6
HP:0000505HP:0000505Visual impairment0ARHGEF18 CL E G H2337017090OMIM:617433Retinitis pigmentosa 786
HP:0000505HP:0000505Visual impairment0ARHGEF2 CL E G H9181682OMIM:617523Neurodevelopmental disorder with midbrain and hindbrain malformations1
HP:0000505HP:0000505Visual impairment0ARID1A CL E G H828911110ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent88
HP:0000505HP:0000505Visual impairment0ARID1A CL E G H828911110OMIM:614607Coffin-Siris syndrome 2.88
HP:0000505HP:0000505Visual impairment0ARID1B CL E G H5749218040ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent219
HP:0000505HP:0000505Visual impairment0ARID1B CL E G H5749218040OMIM:135900Coffin-Siris syndrome 1.219
HP:0000505HP:0000505Visual impairment0ARID2 CL E G H19652818037ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent25
HP:0000505HP:0000505Visual impairment0ARL2 CL E G H402693OMIM:619082MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1; MRCS1
HP:0000505HP:0000505Visual impairment0ARL2BP CL E G H2356817146ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent3
HP:0000505HP:0000505Visual impairment0ARL2BP CL E G H2356817146OMIM:615434Retinitis pigmentosa with or without situs inversus3
HP:0000505HP:0000505Visual impairment0ARL3 CL E G H403694OMIM:618161JOUBERT SYNDROME 35; JBTS351
HP:0000505HP:0000505Visual impairment0ARL3 CL E G H403694ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent1
HP:0000505HP:0000505Visual impairment0ARL3 CL E G H403694OMIM:618173RETINITIS PIGMENTOSA 83; RP831
HP:0000505HP:0000505Visual impairment0ARL6 CL E G H8410013210OMIM:209900Bardet-Biedl syndrome 129
HP:0000505HP:0000505Visual impairment0ARL6 CL E G H8410013210OMIM:600151Bardet-Biedl syndrome 329
HP:0000505HP:0000505Visual impairment0ARL6 CL E G H8410013210ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent29
HP:0000505HP:0000505Visual impairment0ARL6 CL E G H8410013210OMIM:268000Retinitis pigmentosa29
HP:0000505HP:0000505Visual impairment0ARMC9 CL E G H8021020730OMIM:617622JOUBERT SYNDROME 30; JBTS30
HP:0000505HP:0000505Visual impairment0ARNT2 CL E G H991516876ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0ARNT2 CL E G H991516876OMIM:615926Webb-Dattani syndrome
HP:0000505HP:0000505Visual impairment0ARPC4 CL E G H10093707OMIM:620141
HP:0000505HP:0000505Visual impairment0ARSA CL E G H410713ORPHA:309271Metachromatic leukodystrophy, adult form253
HP:0000505HP:0000505Visual impairment0ARSA CL E G H410713ORPHA:309263Metachromatic leukodystrophy, juvenile form253
HP:0000505HP:0000505Visual impairment0ARSA CL E G H410713ORPHA:309256Metachromatic leukodystrophy, late infantile form253
HP:0000505HP:0000505Visual impairment0ARSG CL E G H2290124102ORPHA:231183Usher syndrome type 3
HP:0000505HP:0000505Visual impairment0ARSG CL E G H2290124102OMIM:618144USHER SYNDROME, TYPE IV; USH4
HP:0000505HP:0000505Visual impairment0ARX CL E G H17030218060OMIM:300004Corpus callosum, agenesis of, with abnormal genitalia.166
HP:0000505HP:0000505Visual impairment0ASB10 CL E G H13637117185OMIM:603383GLAUCOMA 1, OPEN ANGLE, F; GLC1F54
HP:0000505HP:0000505Visual impairment0ASNS CL E G H440753OMIM:615574Asparagine synthetase deficiency17
HP:0000505HP:0000505Visual impairment0ASPA CL E G H443756OMIM:271900Canavan disease48
HP:0000505HP:0000505Visual impairment0ASPA CL E G H443756ORPHA:314911Severe Canavan disease48
HP:0000505HP:0000505Visual impairment0ASPH CL E G H444757OMIM:601552Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs4
HP:0000505HP:0000505Visual impairment0ATF6 CL E G H22926791ORPHA:49382Achromatopsia10
HP:0000505HP:0000505Visual impairment0ATF6 CL E G H22926791OMIM:616517ACHROMATOPSIA 7; ACHM710
HP:0000505HP:0000505Visual impairment0ATF6 CL E G H22926791ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional10
HP:0000505HP:0000505Visual impairment0ATIC CL E G H471794ORPHA:250977AICA-ribosiduria4
HP:0000505HP:0000505Visual impairment0ATIC CL E G H471794OMIM:608688Aicar transformylase/imp cyclohydrolase deficiency4
HP:0000505HP:0000505Visual impairment0ATN1 CL E G H18223033OMIM:618494Congenital hypotonia, epilepsy, developmental delay, and digital anomalies16
HP:0000505HP:0000505Visual impairment0ATOH7 CL E G H22020213907ORPHA:91495Persistent hyperplastic primary vitreous4
HP:0000505HP:0000505Visual impairment0ATOH7 CL E G H22020213907OMIM:221900Persistent hyperplastic primary vitreous, autosomal recessive4
HP:0000505HP:0000505Visual impairment0ATP1A2 CL E G H477800ORPHA:569Familial or sporadic hemiplegic migraine239
HP:0000505HP:0000505Visual impairment0ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss150
HP:0000505HP:0000505Visual impairment0ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ATP6 CL E G H45087414OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ATP6 CL E G H45087414ORPHA:644NARP syndrome
HP:0000505HP:0000505Visual impairment0ATP6 CL E G H45087414OMIM:551500Neuropathy, ataxia, and retinitis pigmentosa
HP:0000505HP:0000505Visual impairment0ATP6V0A1 CL E G H535865OMIM:6199701
HP:0000505HP:0000505Visual impairment0ATRX CL E G H546886ORPHA:847Alpha-thalassemia-X-linked intellectual disability syndrome169
HP:0000505HP:0000505Visual impairment0ATRX CL E G H546886ORPHA:96253Cushing diseaseHP:0040283 - Occasional169
HP:0000505HP:0000505Visual impairment0ATXN7 CL E G H631410560OMIM:164500Spinocerebellar ataxia 7 opca III opca with retinal degeneration opca with macular degeneration and external ophthalmoplegia autosomal dominant cerebellar ataxia, type II adca, type II8
HP:0000505HP:0000505Visual impairment0ATXN7 CL E G H631410560ORPHA:94147Spinocerebellar ataxia type 78
HP:0000505HP:0000505Visual impairment0B3GALNT2 CL E G H14878928596ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent43
HP:0000505HP:0000505Visual impairment0B3GALNT2 CL E G H14878928596OMIM:615181MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1143
HP:0000505HP:0000505Visual impairment0B3GAT3 CL E G H26229923OMIM:245600Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects5
HP:0000505HP:0000505Visual impairment0B3GLCT CL E G H14517320207ORPHA:709Peters plus syndromeHP:0040283 - Occasional36
HP:0000505HP:0000505Visual impairment0B4GAT1 CL E G H1104115685OMIM:615287MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1317
HP:0000505HP:0000505Visual impairment0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0000505Visual impairment0BAP1 CL E G H8314950ORPHA:39044Uveal melanoma184
HP:0000505HP:0000505Visual impairment0BAZ1B CL E G H9031961ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0BBS1 CL E G H582966OMIM:209900Bardet-Biedl syndrome 1114
HP:0000505HP:0000505Visual impairment0BBS1 CL E G H582966ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent114
HP:0000505HP:0000505Visual impairment0BBS2 CL E G H583967ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent97
HP:0000505HP:0000505Visual impairment0BBS2 CL E G H583967OMIM:616562Retinitis pigmentosa 7497
HP:0000505HP:0000505Visual impairment0BBS5 CL E G H129880970OMIM:615983Bardet-Biedl syndrome 525
HP:0000505HP:0000505Visual impairment0BCL10 CL E G H8915989ORPHA:52417MALT lymphomaHP:0040283 - Occasional18
HP:0000505HP:0000505Visual impairment0BCL7B CL E G H92751005ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0BCOR CL E G H5488020893ORPHA:568Microphthalmia, Lenz typeHP:0040283 - Occasional101
HP:0000505HP:0000505Visual impairment0BCOR CL E G H5488020893OMIM:309800Microphthalmia, syndromic 1101
HP:0000505HP:0000505Visual impairment0BCOR CL E G H5488020893OMIM:300166Microphthalmia, syndromic 2101
HP:0000505HP:0000505Visual impairment0BDNF CL E G H6271033ORPHA:893WAGR syndromeHP:0040282 - Frequent5
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040281 - Very frequent182
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703ORPHA:1243Best vitelliform macular dystrophyHP:0040281 - Very frequent182
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703OMIM:611809BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB182
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703OMIM:153700Macular dystrophy, vitelliform, 2.182
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent182
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703OMIM:613194Retinitis pigmentosa-50182
HP:0000505HP:0000505Visual impairment0BEST1 CL E G H743912703OMIM:193220VITREORETINOCHOROIDOPATHY182
HP:0000505HP:0000505Visual impairment0BIRC3 CL E G H330591ORPHA:52417MALT lymphomaHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 8.42
HP:0000505HP:0000505Visual impairment0BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0000505HP:0000505Visual impairment0BMP4 CL E G H6521071OMIM:607932Microphthalmia, syndromic 638
HP:0000505HP:0000505Visual impairment0BMPR1A CL E G H6571076ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional385
HP:0000505HP:0000505Visual impairment0BOLA3 CL E G H38896224415OMIM:614299Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemiaHP:0040283 - Occasional14
HP:0000505HP:0000505Visual impairment0BRAF CL E G H6731097OMIM:115150Cardiofaciocutaneous syndrome 1276
HP:0000505HP:0000505Visual impairment0BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0000505Visual impairment0BRAF CL E G H6731097ORPHA:96253Cushing diseaseHP:0040283 - Occasional276
HP:0000505HP:0000505Visual impairment0BRAT1 CL E G H22192721701OMIM:618056Neurodevelopmental disorder with cerebellar atrophy and with or without seizuresHP:0040284 - Very rare20
HP:0000505HP:0000505Visual impairment0BRAT1 CL E G H22192721701OMIM:614498Rigidity and multifocal seizure syndrome, lethal neonatal20
HP:0000505HP:0000505Visual impairment0BRCA1 CL E G H6721100ORPHA:84Fanconi anemiaHP:0040283 - Occasional5769
HP:0000505HP:0000505Visual impairment0BRCA2 CL E G H6751101ORPHA:84Fanconi anemiaHP:0040283 - Occasional7642
HP:0000505HP:0000505Visual impairment0BRIP1 CL E G H8399020473ORPHA:84Fanconi anemiaHP:0040283 - Occasional1086
HP:0000505HP:0000505Visual impairment0BTD CL E G H6861122ORPHA:79241Biotinidase deficiency223
HP:0000505HP:0000505Visual impairment0BTD CL E G H6861122OMIM:253260Biotinidase deficiencymultiple carboxylase deficiency, late-onset223
HP:0000505HP:0000505Visual impairment0BTNL2 CL E G H562441142ORPHA:797Sarcoidosis1
HP:0000505HP:0000505Visual impairment0BUD23 CL E G H11404916405ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0C19ORF12 CL E G H8363625443OMIM:614298Neurodegeneration with brain iron accumulation 4114
HP:0000505HP:0000505Visual impairment0C1QBP CL E G H7081243OMIM:617713Combined oxidative phosphorylation deficiency 33
HP:0000505HP:0000505Visual impairment0C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration20
HP:0000505HP:0000505Visual impairment0C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degeneration20
HP:0000505HP:0000505Visual impairment0C4A CL E G H7201323ORPHA:117Behçet disease1
HP:0000505HP:0000505Visual impairment0CA2 CL E G H7601373OMIM:259730Osteopetrosis, autosomal recessive 3.29
HP:0000505HP:0000505Visual impairment0CA4 CL E G H7621375ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent23
HP:0000505HP:0000505Visual impairment0CABP4 CL E G H570101386OMIM:610427Cone-Rod synaptic disorder, congenital nonprogressive94
HP:0000505HP:0000505Visual impairment0CABP4 CL E G H570101386ORPHA:215Congenital stationary night blindness94
HP:0000505HP:0000505Visual impairment0CACNA1A CL E G H7731388ORPHA:569Familial or sporadic hemiplegic migraine449
HP:0000505HP:0000505Visual impairment0CACNA1B CL E G H7741389OMIM:618497Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements5
HP:0000505HP:0000505Visual impairment0CACNA1D CL E G H7761391OMIM:615474Primary aldosteronism, seizures, and neurologic abnormalities51
HP:0000505HP:0000505Visual impairment0CACNA1D CL E G H7761391ORPHA:369929Primary hyperaldosteronism-seizures-neurological abnormalities syndrome51
HP:0000505HP:0000505Visual impairment0CACNA1E CL E G H7771392OMIM:618285Developmental and epileptic encephalopathy 6911
HP:0000505HP:0000505Visual impairment0CACNA1F CL E G H7781393OMIM:300600Aland island eye disease58
HP:0000505HP:0000505Visual impairment0CACNA1F CL E G H7781393ORPHA:178333Ã…land Islands eye disease58
HP:0000505HP:0000505Visual impairment0CACNA1F CL E G H7781393ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional58
HP:0000505HP:0000505Visual impairment0CACNA1F CL E G H7781393OMIM:300476Cone-Rod dystrophy, X-linked, 358
HP:0000505HP:0000505Visual impairment0CACNA1F CL E G H7781393ORPHA:215Congenital stationary night blindness58
HP:0000505HP:0000505Visual impairment0CACNA1F CL E G H7781393OMIM:300071Night blindness, congenital stationary, type 2A.58
HP:0000505HP:0000505Visual impairment0CACNA2D4 CL E G H9358920202ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional129
HP:0000505HP:0000505Visual impairment0CACNA2D4 CL E G H9358920202ORPHA:215Congenital stationary night blindness129
HP:0000505HP:0000505Visual impairment0CACNA2D4 CL E G H9358920202OMIM:610478Retinal cone dystrophy 4129
HP:0000505HP:0000505Visual impairment0CAMK2B CL E G H8161461OMIM:617799Mental retardation, autosomal dominant 54.
HP:0000505HP:0000505Visual impairment0CAPN5 CL E G H7261482OMIM:193235Vitreoretinopathy, neovascular inflammatory6
HP:0000505HP:0000505Visual impairment0CARS2 CL E G H7958725695ORPHA:477774Combined oxidative phosphorylation defect type 2735
HP:0000505HP:0000505Visual impairment0CARS2 CL E G H7958725695OMIM:616672Combined oxidative phosphorylation deficiency 27.35
HP:0000505HP:0000505Visual impairment0CASK CL E G H85731497ORPHA:163937X-linked intellectual disability, Najm typeHP:0040282 - Frequent118
HP:0000505HP:0000505Visual impairment0CASZ1 CL E G H5489726002ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0CBS CL E G H8751550ORPHA:394Classic homocystinuria242
HP:0000505HP:0000505Visual impairment0CBS CL E G H8751550OMIM:236200Homocystinuria due to cystathionine beta-synthase deficiency242
HP:0000505HP:0000505Visual impairment0CC2D2A CL E G H5754529253OMIM:612285Joubert syndrome 9247
HP:0000505HP:0000505Visual impairment0CC2D2A CL E G H5754529253ORPHA:1454Joubert syndrome with hepatic defectHP:0040282 - Frequent247
HP:0000505HP:0000505Visual impairment0CC2D2A CL E G H5754529253ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent247
HP:0000505HP:0000505Visual impairment0CC2D2A CL E G H5754529253OMIM:619845RETINITIS PIGMENTOSA 93; RP93247
HP:0000505HP:0000505Visual impairment0CCDC141 CL E G H28502526821ORPHA:478Kallmann syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0CCDC28B CL E G H7914028163OMIM:209900Bardet-Biedl syndrome 14
HP:0000505HP:0000505Visual impairment0CCDC47 CL E G H5700324856OMIM:618268Trichohepatoneurodevelopmental syndrome
HP:0000505HP:0000505Visual impairment0CCND1 CL E G H5951582ORPHA:892Von Hippel-Lindau disease1
HP:0000505HP:0000505Visual impairment0CCR1 CL E G H12301602ORPHA:117Behçet disease
HP:0000505HP:0000505Visual impairment0CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopenia
HP:0000505HP:0000505Visual impairment0CD247 CL E G H9191677ORPHA:85410Oligoarticular juvenile idiopathic arthritis8
HP:0000505HP:0000505Visual impairment0CDC42 CL E G H9981736ORPHA:487796Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome6
HP:0000505HP:0000505Visual impairment0CDC42BPB CL E G H95781738OMIM:619841
HP:0000505HP:0000505Visual impairment0CDH23 CL E G H6407213733ORPHA:96253Cushing diseaseHP:0040283 - Occasional636
HP:0000505HP:0000505Visual impairment0CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0000505HP:0000505Visual impairment0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0000505HP:0000505Visual impairment0CDH23 CL E G H6407213733ORPHA:231169Usher syndrome type 1636
HP:0000505HP:0000505Visual impairment0CDH3 CL E G H10011762ORPHA:1573Hypotrichosis with juvenile macular degeneration87
HP:0000505HP:0000505Visual impairment0CDH3 CL E G H10011762OMIM:601553Hypotrichosis, congenital, with juvenile macular dystrophy87
HP:0000505HP:0000505Visual impairment0CDHR1 CL E G H9221114550ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional147
HP:0000505HP:0000505Visual impairment0CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000505HP:0000505Visual impairment0CDHR1 CL E G H9221114550ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent147
HP:0000505HP:0000505Visual impairment0CDK8 CL E G H10241779OMIM:618748INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES; IDDHBA
HP:0000505HP:0000505Visual impairment0CDKL5 CL E G H679211411OMIM:300672Developmental and epileptic encephalopathy 2405
HP:0000505HP:0000505Visual impairment0CDON CL E G H5093717104ORPHA:93925Alobar holoprosencephaly200
HP:0000505HP:0000505Visual impairment0CDON CL E G H5093717104ORPHA:93924Lobar holoprosencephaly200
HP:0000505HP:0000505Visual impairment0CDON CL E G H5093717104ORPHA:93926Midline interhemispheric variant of holoprosencephaly200
HP:0000505HP:0000505Visual impairment0CDON CL E G H5093717104ORPHA:220386Semilobar holoprosencephaly200
HP:0000505HP:0000505Visual impairment0CEP120 CL E G H15324126690ORPHA:220493Joubert syndrome with ocular defect7
HP:0000505HP:0000505Visual impairment0CEP164 CL E G H2289729182OMIM:614845Nephronophthisis 1534
HP:0000505HP:0000505Visual impairment0CEP164 CL E G H2289729182ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent34
HP:0000505HP:0000505Visual impairment0CEP250 CL E G H111901859OMIM:618358CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2
HP:0000505HP:0000505Visual impairment0CEP290 CL E G H8018429021OMIM:610188Joubert syndrome 5342
HP:0000505HP:0000505Visual impairment0CEP290 CL E G H8018429021ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent342
HP:0000505HP:0000505Visual impairment0CEP290 CL E G H8018429021ORPHA:65Leber congenital amaurosis342
HP:0000505HP:0000505Visual impairment0CEP290 CL E G H8018429021OMIM:611755Leber congenital amaurosis 10.HP:0003577 - Congenital onset342
HP:0000505HP:0000505Visual impairment0CEP290 CL E G H8018429021ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent342
HP:0000505HP:0000505Visual impairment0CEP290 CL E G H8018429021OMIM:610189Senior-Loken syndrome 6.342
HP:0000505HP:0000505Visual impairment0CEP41 CL E G H9568112370ORPHA:220493Joubert syndrome with ocular defect90
HP:0000505HP:0000505Visual impairment0CEP78 CL E G H8413125740OMIM:617236CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL9
HP:0000505HP:0000505Visual impairment0CEP78 CL E G H8413125740ORPHA:231183Usher syndrome type 39
HP:0000505HP:0000505Visual impairment0CEP85L CL E G H38711921638OMIM:618873LISSENCEPHALY 10; LIS101
HP:0000505HP:0000505Visual impairment0CEP85L CL E G H38711921638ORPHA:572013Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome1
HP:0000505HP:0000505Visual impairment0CERKL CL E G H37529821699ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent71
HP:0000505HP:0000505Visual impairment0CERKL CL E G H37529821699OMIM:608380Retinitis pigmentosa 2671
HP:0000505HP:0000505Visual impairment0CERT1 CL E G H100872205OMIM:616351Mental retardation, autosomal dominant 34
HP:0000505HP:0000505Visual impairment0CFAP410 CL E G H7551260ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0CFAP410 CL E G H7551260OMIM:617547Retinal dystrophy with or without macular staphyloma
HP:0000505HP:0000505Visual impairment0CFAP418 CL E G H15765727232OMIM:617406Bardet-Biedl syndrome 21
HP:0000505HP:0000505Visual impairment0CFAP418 CL E G H15765727232ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0CFAP418 CL E G H15765727232OMIM:614500Cone-Rod dystrophy 16
HP:0000505HP:0000505Visual impairment0CFAP418 CL E G H15765727232ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0CFAP418 CL E G H15765727232OMIM:268000Retinitis pigmentosa
HP:0000505HP:0000505Visual impairment0CFH CL E G H30754883OMIM:126700Basal laminar drusen86
HP:0000505HP:0000505Visual impairment0CFH CL E G H30754883ORPHA:75376Familial drusen86
HP:0000505HP:0000505Visual impairment0CFHR1 CL E G H30784888OMIM:603075Macular degeneration, age-related, 1
HP:0000505HP:0000505Visual impairment0CFHR3 CL E G H1087816980OMIM:603075Macular degeneration, age-related, 1
HP:0000505HP:0000505Visual impairment0CFI CL E G H34265394ORPHA:75376Familial drusen57
HP:0000505HP:0000505Visual impairment0CFI CL E G H34265394OMIM:615439Macular degeneration, age-related, 1357
HP:0000505HP:0000505Visual impairment0CHD3 CL E G H11071918OMIM:618205Snijders blok-campeau syndrome2
HP:0000505HP:0000505Visual impairment0CHD7 CL E G H5563620626ORPHA:478Kallmann syndromeHP:0040283 - Occasional515
HP:0000505HP:0000505Visual impairment0CHKA CL E G H11191937OMIM:620023
HP:0000505HP:0000505Visual impairment0CHM CL E G H11211940OMIM:303100CHOROIDEREMIA47
HP:0000505HP:0000505Visual impairment0CHM CL E G H11211940ORPHA:180ChoroideremiaHP:0040281 - Very frequent47
HP:0000505HP:0000505Visual impairment0CHMP1A CL E G H51198740OMIM:614961Pontocerebellar hypoplasia, type 819
HP:0000505HP:0000505Visual impairment0CHN1 CL E G H11231943ORPHA:233Duane retraction syndrome35
HP:0000505HP:0000505Visual impairment0CHN1 CL E G H11231943OMIM:604356DUANE RETRACTION SYNDROME 2; DURS235
HP:0000505HP:0000505Visual impairment0CHP1 CL E G H1126117433OMIM:618438Spastic ataxia 9, autosomal recessive
HP:0000505HP:0000505Visual impairment0CHRDL1 CL E G H9185129861OMIM:309300MEGALOCORNEA9
HP:0000505HP:0000505Visual impairment0CHST3 CL E G H94691971OMIM:245600Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects165
HP:0000505HP:0000505Visual impairment0CHST6 CL E G H41666938ORPHA:98969Macular corneal dystrophy129
HP:0000505HP:0000505Visual impairment0CIB2 CL E G H1051824579ORPHA:231169Usher syndrome type 115
HP:0000505HP:0000505Visual impairment0CKAP2L CL E G H15046826877OMIM:272440Filippi syndrome.7
HP:0000505HP:0000505Visual impairment0CLCC1 CL E G H2315529675OMIM:609913RETINITIS PIGMENTOSA 32; RP32
HP:0000505HP:0000505Visual impairment0CLCN2 CL E G H11812020OMIM:615651Leukoencephalopathy with ataxia44
HP:0000505HP:0000505Visual impairment0CLCN4 CL E G H11832022ORPHA:485350CLCN4-related X-linked intellectual disability syndrome45
HP:0000505HP:0000505Visual impairment0CLCN4 CL E G H11832022OMIM:300114Raynaud-Claes syndrome45
HP:0000505HP:0000505Visual impairment0CLCN6 CL E G H11852024OMIM:619173NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA
HP:0000505HP:0000505Visual impairment0CLCN7 CL E G H11862025ORPHA:53Albers-Schönberg osteopetrosisHP:0040282 - Frequent102
HP:0000505HP:0000505Visual impairment0CLCN7 CL E G H11862025ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent102
HP:0000505HP:0000505Visual impairment0CLCN7 CL E G H11862025OMIM:618541Hypopigmentation, organomegaly, and delayed myelination and development102
HP:0000505HP:0000505Visual impairment0CLCN7 CL E G H11862025ORPHA:210110Intermediate osteopetrosisHP:0040284 - Very rare102
HP:0000505HP:0000505Visual impairment0CLCN7 CL E G H11862025OMIM:166600Osteopetrosis, autosomal dominant 2102
HP:0000505HP:0000505Visual impairment0CLCN7 CL E G H11862025OMIM:611490Osteopetrosis, autosomal recessive 4.102
HP:0000505HP:0000505Visual impairment0CLEC3B CL E G H712311891OMIM:619977
HP:0000505HP:0000505Visual impairment0CLIP2 CL E G H74612586ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3216
HP:0000505HP:0000505Visual impairment0CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000505HP:0000505Visual impairment0CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5141
HP:0000505HP:0000505Visual impairment0CLN5 CL E G H12032076ORPHA:228360CLN5 diseaseHP:0040281 - Very frequent141
HP:0000505HP:0000505Visual impairment0CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6143
HP:0000505HP:0000505Visual impairment0CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8111
HP:0000505HP:0000505Visual impairment0CLN8 CL E G H20552079ORPHA:1947Progressive epilepsy-intellectual disability syndrome, Finnish typeHP:0040281 - Very frequent111
HP:0000505HP:0000505Visual impairment0CLP1 CL E G H1097816999ORPHA:411493Pontocerebellar hypoplasia type 10HP:0040284 - Very rare7
HP:0000505HP:0000505Visual impairment0CLRN1 CL E G H740112605OMIM:268000Retinitis pigmentosa60
HP:0000505HP:0000505Visual impairment0CLRN1 CL E G H740112605ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent60
HP:0000505HP:0000505Visual impairment0CLRN1 CL E G H740112605OMIM:614180Retinitis pigmentosa 6160
HP:0000505HP:0000505Visual impairment0CLRN1 CL E G H740112605ORPHA:231183Usher syndrome type 360
HP:0000505HP:0000505Visual impairment0CLRN1 CL E G H740112605OMIM:276902Usher syndrome, type IIIA60
HP:0000505HP:0000505Visual impairment0CLTC CL E G H12132092OMIM:617854Mental retardation, autosomal dominant 561
HP:0000505HP:0000505Visual impairment0CNGA1 CL E G H12592148OMIM:268000Retinitis pigmentosa44
HP:0000505HP:0000505Visual impairment0CNGA1 CL E G H12592148ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent44
HP:0000505HP:0000505Visual impairment0CNGA1 CL E G H12592148OMIM:613756RETINITIS PIGMENTOSA 49; RP4944
HP:0000505HP:0000505Visual impairment0CNGA3 CL E G H12612150ORPHA:49382Achromatopsia82
HP:0000505HP:0000505Visual impairment0CNGA3 CL E G H12612150OMIM:216900Achromatopsia 282
HP:0000505HP:0000505Visual impairment0CNGA3 CL E G H12612150ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional82
HP:0000505HP:0000505Visual impairment0CNGB1 CL E G H12582151ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent164
HP:0000505HP:0000505Visual impairment0CNGB1 CL E G H12582151OMIM:613767Retinitis pigmentosa 45164
HP:0000505HP:0000505Visual impairment0CNGB3 CL E G H547142153ORPHA:49382Achromatopsia194
HP:0000505HP:0000505Visual impairment0CNGB3 CL E G H547142153OMIM:262300Achromatopsia 3194
HP:0000505HP:0000505Visual impairment0CNGB3 CL E G H547142153ORPHA:1871Progressive cone dystrophyHP:0040281 - Very frequent194
HP:0000505HP:0000505Visual impairment0CNGB3 CL E G H547142153ORPHA:827Stargardt disease194
HP:0000505HP:0000505Visual impairment0CNNM4 CL E G H26504105OMIM:217080Jalili syndrome61
HP:0000505HP:0000505Visual impairment0CNNM4 CL E G H26504105ORPHA:1873Jalili syndromeHP:0040281 - Very frequent61
HP:0000505HP:0000505Visual impairment0CNTNAP1 CL E G H85068011OMIM:618186Neuropathy, congenital hypomyelinating, 3.9
HP:0000505HP:0000505Visual impairment0COG5 CL E G H1046614857ORPHA:263487COG5-CDG79
HP:0000505HP:0000505Visual impairment0COL11A1 CL E G H13012186ORPHA:250984Autosomal recessive Stickler syndrome215
HP:0000505HP:0000505Visual impairment0COL11A1 CL E G H13012186ORPHA:560Marshall syndromeHP:0040282 - Frequent215
HP:0000505HP:0000505Visual impairment0COL17A1 CL E G H13082194OMIM:122400Epithelial recurrent erosion dystrophy.129
HP:0000505HP:0000505Visual impairment0COL17A1 CL E G H13082194ORPHA:293381Epithelial recurrent erosion dystrophy129
HP:0000505HP:0000505Visual impairment0COL18A1 CL E G H807812195OMIM:618880GLAUCOMA, PRIMARY CLOSED-ANGLE; GLCC177
HP:0000505HP:0000505Visual impairment0COL18A1 CL E G H807812195ORPHA:1571Knobloch syndrome177
HP:0000505HP:0000505Visual impairment0COL18A1 CL E G H807812195OMIM:267750Knobloch syndrome 1177
HP:0000505HP:0000505Visual impairment0COL25A1 CL E G H8457018603ORPHA:91411Congenital ptosis3
HP:0000505HP:0000505Visual impairment0COL2A1 CL E G H12802200ORPHA:93315Spondylometaphyseal dysplasia, 'corner fracture' typeHP:0040283 - Occasional284
HP:0000505HP:0000505Visual impairment0COL2A1 CL E G H12802200ORPHA:90653Stickler syndrome type 1284
HP:0000505HP:0000505Visual impairment0COL2A1 CL E G H12802200OMIM:108300Stickler syndrome, type I284
HP:0000505HP:0000505Visual impairment0COL3A1 CL E G H12812201ORPHA:231160Familial cerebral saccular aneurysm749
HP:0000505HP:0000505Visual impairment0COL4A1 CL E G H12822202OMIM:175780Brain small vessel disease 1 with or without ocular anomalies193
HP:0000505HP:0000505Visual impairment0COL7A1 CL E G H12942214ORPHA:89842Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form263
HP:0000505HP:0000505Visual impairment0COL7A1 CL E G H12942214ORPHA:79408Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form263
HP:0000505HP:0000505Visual impairment0COL8A2 CL E G H12962216ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000505HP:0000505Visual impairment0COL8A2 CL E G H12962216ORPHA:98973Posterior polymorphous corneal dystrophy3
HP:0000505HP:0000505Visual impairment0COL9A1 CL E G H12972217ORPHA:250984Autosomal recessive Stickler syndrome110
HP:0000505HP:0000505Visual impairment0COL9A2 CL E G H12982218ORPHA:250984Autosomal recessive Stickler syndrome110
HP:0000505HP:0000505Visual impairment0COL9A3 CL E G H12992219ORPHA:250984Autosomal recessive Stickler syndrome137
HP:0000505HP:0000505Visual impairment0COPB2 CL E G H92762232OMIM:617800Microcephaly 19, primary, autosomal recessive
HP:0000505HP:0000505Visual impairment0COQ2 CL E G H2723525223OMIM:607426Coenzyme Q10 deficiency, primary, 154
HP:0000505HP:0000505Visual impairment0COQ2 CL E G H2723525223ORPHA:255249Leigh syndrome with nephrotic syndrome54
HP:0000505HP:0000505Visual impairment0COQ7 CL E G H102292244OMIM:616733Coenzyme Q10 deficiency, primary, 8.1
HP:0000505HP:0000505Visual impairment0COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0COX1 CL E G H45127419ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0COX1 CL E G H45127419OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0COX2 CL E G H45137421ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0COX2 CL E G H45137421OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0COX3 CL E G H45147422OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0COX3 CL E G H45147422ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0COX3 CL E G H45147422OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0COX6B1 CL E G H13402280OMIM:619051MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN710
HP:0000505HP:0000505Visual impairment0COX7B CL E G H13492291OMIM:300887Linear skin defects with multiple congenital anomalies 2HP:0040283 - Occasional6
HP:0000505HP:0000505Visual impairment0COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndrome6
HP:0000505HP:0000505Visual impairment0CPSF3 CL E G H516922326OMIM:619876
HP:0000505HP:0000505Visual impairment0CRB1 CL E G H234182343ORPHA:65Leber congenital amaurosis156
HP:0000505HP:0000505Visual impairment0CRB1 CL E G H234182343OMIM:613835Leber congenital amaurosis 8.HP:0011463 - Childhood onset156
HP:0000505HP:0000505Visual impairment0CRB1 CL E G H234182343ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent156
HP:0000505HP:0000505Visual impairment0CRB1 CL E G H234182343OMIM:600105Retinitis pigmentosa 12156
HP:0000505HP:0000505Visual impairment0CREBBP CL E G H13872348OMIM:618332MENKE-HENNEKAM SYNDROME 1; MKHK1291
HP:0000505HP:0000505Visual impairment0CRX CL E G H14062383ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional158
HP:0000505HP:0000505Visual impairment0CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2158
HP:0000505HP:0000505Visual impairment0CRX CL E G H14062383ORPHA:65Leber congenital amaurosis158
HP:0000505HP:0000505Visual impairment0CRX CL E G H14062383OMIM:613829Leber congenital amaurosis 7.158
HP:0000505HP:0000505Visual impairment0CRX CL E G H14062383OMIM:268000Retinitis pigmentosa158
HP:0000505HP:0000505Visual impairment0CRX CL E G H14062383ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent158
HP:0000505HP:0000505Visual impairment0CRYAA CL E G H14092388OMIM:604219Cataract 9, multiple types.33
HP:0000505HP:0000505Visual impairment0CRYBB1 CL E G H14142397OMIM:611544Cataract 17, multiple types18
HP:0000505HP:0000505Visual impairment0CRYGC CL E G H14202410OMIM:604307Cataract 2, multiple types.11
HP:0000505HP:0000505Visual impairment0CSF1R CL E G H14362433OMIM:618476Brain abnormalities, neurodegeneration, and dysosteosclerosisHP:0040284 - Very rare149
HP:0000505HP:0000505Visual impairment0CSPP1 CL E G H7984826193ORPHA:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophy57
HP:0000505HP:0000505Visual impairment0CTC1 CL E G H8016926169OMIM:612199Cerebroretinal microangiopathy with calcifications and cysts160
HP:0000505HP:0000505Visual impairment0CTLA4 CL E G H14932505ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional10
HP:0000505HP:0000505Visual impairment0CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0000505Visual impairment0CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathy88
HP:0000505HP:0000505Visual impairment0CTNS CL E G H14972518OMIM:219800Cystinosis, nephropathic178
HP:0000505HP:0000505Visual impairment0CTNS CL E G H14972518ORPHA:411641Ocular cystinosisHP:0040281 - Very frequent178
HP:0000505HP:0000505Visual impairment0CTSD CL E G H15092529OMIM:610127Ceroid lipofuscinosis, neuronal, 10159
HP:0000505HP:0000505Visual impairment0CWC27 CL E G H1028310664ORPHA:166035Brachydactyly-short stature-retinitis pigmentosa syndrome4
HP:0000505HP:0000505Visual impairment0CWC27 CL E G H1028310664OMIM:250410Retinitis pigmentosa with or without skeletal anomalies4
HP:0000505HP:0000505Visual impairment0CYP1B1 CL E G H15452597ORPHA:98976Congenital glaucoma101
HP:0000505HP:0000505Visual impairment0CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent101
HP:0000505HP:0000505Visual impairment0CYP27A1 CL E G H15932605ORPHA:909Cerebrotendinous xanthomatosisHP:0040281 - Very frequent114
HP:0000505HP:0000505Visual impairment0CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy126
HP:0000505HP:0000505Visual impairment0CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040282 - Frequent126
HP:0000505HP:0000505Visual impairment0CYSLTR2 CL E G H5710518274ORPHA:39044Uveal melanoma1
HP:0000505HP:0000505Visual impairment0CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0CYTB CL E G H45197427OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0CYTB CL E G H45197427OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0D2HGDH CL E G H72829428358OMIM:600721D-2-Hydroxyglutaric aciduria 1102
HP:0000505HP:0000505Visual impairment0DCC CL E G H16302701ORPHA:478Kallmann syndromeHP:0040283 - Occasional36
HP:0000505HP:0000505Visual impairment0DCN CL E G H16342705OMIM:610048Corneal dystrophy, congenital stromal31
HP:0000505HP:0000505Visual impairment0DCT CL E G H16382709OMIM:619165OCULOCUTANEOUS ALBINISM, TYPE VIII; OCA8
HP:0000505HP:0000505Visual impairment0DDR2 CL E G H49212731OMIM:618175WARBURG-CINOTTI SYNDROME; WRCN45
HP:0000505HP:0000505Visual impairment0DDX3X CL E G H16542745ORPHA:457260X-linked intellectual disability-hypotonia-movement disorder syndromeHP:0040283 - Occasional57
HP:0000505HP:0000505Visual impairment0DHDDS CL E G H7994720603ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent47
HP:0000505HP:0000505Visual impairment0DHDDS CL E G H7994720603OMIM:613861Retinitis pigmentosa 5947
HP:0000505HP:0000505Visual impairment0DHX37 CL E G H5764717210OMIM:618731NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC2
HP:0000505HP:0000505Visual impairment0DHX38 CL E G H978517211ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent1
HP:0000505HP:0000505Visual impairment0DIAPH1 CL E G H17292876OMIM:616632Seizures, cortical blindness, and microcephaly syndrome118
HP:0000505HP:0000505Visual impairment0DISP1 CL E G H8497619711ORPHA:93925Alobar holoprosencephaly22
HP:0000505HP:0000505Visual impairment0DISP1 CL E G H8497619711ORPHA:93924Lobar holoprosencephaly22
HP:0000505HP:0000505Visual impairment0DISP1 CL E G H8497619711ORPHA:93926Midline interhemispheric variant of holoprosencephaly22
HP:0000505HP:0000505Visual impairment0DISP1 CL E G H8497619711ORPHA:220386Semilobar holoprosencephaly22
HP:0000505HP:0000505Visual impairment0DLAT CL E G H17372896ORPHA:79244Pyruvate dehydrogenase E2 deficiency82
HP:0000505HP:0000505Visual impairment0DLD CL E G H17382898ORPHA:2394Pyruvate dehydrogenase E3 deficiency89
HP:0000505HP:0000505Visual impairment0DLL1 CL E G H285142908ORPHA:93925Alobar holoprosencephaly3
HP:0000505HP:0000505Visual impairment0DLL1 CL E G H285142908ORPHA:93924Lobar holoprosencephaly3
HP:0000505HP:0000505Visual impairment0DLL1 CL E G H285142908ORPHA:93926Midline interhemispheric variant of holoprosencephaly3
HP:0000505HP:0000505Visual impairment0DLL1 CL E G H285142908ORPHA:220386Semilobar holoprosencephaly3
HP:0000505HP:0000505Visual impairment0DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0000505HP:0000505Visual impairment0DNAJC30 CL E G H8427716410ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040281 - Very frequent94
HP:0000505HP:0000505Visual impairment0DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000505HP:0000505Visual impairment0DOCK7 CL E G H8544019190ORPHA:411986Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome11
HP:0000505HP:0000505Visual impairment0DOCK7 CL E G H8544019190OMIM:615859Epileptic encephalopathy, early infantile, 2311
HP:0000505HP:0000505Visual impairment0DOHH CL E G H8347528662OMIM:620066
HP:0000505HP:0000505Visual impairment0DOLK CL E G H2284523406ORPHA:91131DK1-CDG55
HP:0000505HP:0000505Visual impairment0DPF2 CL E G H59779964ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0DPM1 CL E G H88133005OMIM:608799Congenital disorder of glycosylation, type IE27
HP:0000505HP:0000505Visual impairment0DPM1 CL E G H88133005ORPHA:79322DPM1-CDG27
HP:0000505HP:0000505Visual impairment0DPP6 CL E G H18043010OMIM:616311MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD3318
HP:0000505HP:0000505Visual impairment0DRAM2 CL E G H12833828769ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional9
HP:0000505HP:0000505Visual impairment0DRAM2 CL E G H12833828769OMIM:616502Cone-Rod dystrophy 219
HP:0000505HP:0000505Visual impairment0DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 7.46
HP:0000505HP:0000505Visual impairment0DTYMK CL E G H18413061OMIM:619847
HP:0000505HP:0000505Visual impairment0DUSP6 CL E G H18483072ORPHA:478Kallmann syndromeHP:0040283 - Occasional4
HP:0000505HP:0000505Visual impairment0DYRK1A CL E G H18593091ORPHA:464311Intellectual disability syndrome due to a DYRK1A point mutation134
HP:0000505HP:0000505Visual impairment0EARS2 CL E G H12445429419OMIM:614924Combined oxidative phosphorylation deficiency 12.80
HP:0000505HP:0000505Visual impairment0EFEMP1 CL E G H22023218OMIM:126600Doyne honeycomb retinal dystrophy.54
HP:0000505HP:0000505Visual impairment0EFEMP1 CL E G H22023218ORPHA:75376Familial drusen54
HP:0000505HP:0000505Visual impairment0EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent54
HP:0000505HP:0000505Visual impairment0EIF2B1 CL E G H19673257OMIM:603896Leukoencephalopathy with vanishing white matter42
HP:0000505HP:0000505Visual impairment0EIF2B2 CL E G H88923258OMIM:603896Leukoencephalopathy with vanishing white matter24
HP:0000505HP:0000505Visual impairment0EIF2B3 CL E G H88913259OMIM:603896Leukoencephalopathy with vanishing white matter32
HP:0000505HP:0000505Visual impairment0EIF2B4 CL E G H88903260OMIM:603896Leukoencephalopathy with vanishing white matter38
HP:0000505HP:0000505Visual impairment0EIF2B5 CL E G H88933261OMIM:603896Leukoencephalopathy with vanishing white matter48
HP:0000505HP:0000505Visual impairment0EIF4H CL E G H745812741ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0ELMO2 CL E G H6391617233OMIM:606893Vascular malformation, primary intraosseous3
HP:0000505HP:0000505Visual impairment0ELN CL E G H20063327ORPHA:904Williams syndromeHP:0040282 - Frequent172
HP:0000505HP:0000505Visual impairment0ELN CL E G H20063327OMIM:194050Williams-Beuren syndrome172
HP:0000505HP:0000505Visual impairment0ELOVL1 CL E G H6483414418OMIM:618527Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features
HP:0000505HP:0000505Visual impairment0ELOVL4 CL E G H678514415ORPHA:827Stargardt disease62
HP:0000505HP:0000505Visual impairment0ELOVL4 CL E G H678514415OMIM:600110STARGARDT DISEASE 3; STGD362
HP:0000505HP:0000505Visual impairment0ELP4 CL E G H266101171OMIM:617141Aniridia 24
HP:0000505HP:0000505Visual impairment0EMC1 CL E G H2306528957OMIM:616875Cerebellar atrophy, visual impairment, and psychomotor retardation5
HP:0000505HP:0000505Visual impairment0EMC1 CL E G H2306528957ORPHA:480898Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome5
HP:0000505HP:0000505Visual impairment0ENG CL E G H20223349ORPHA:231160Familial cerebral saccular aneurysm186
HP:0000505HP:0000505Visual impairment0ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasia186
HP:0000505HP:0000505Visual impairment0ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional151
HP:0000505HP:0000505Visual impairment0EPCAM CL E G H407211529ORPHA:144Lynch syndromeHP:0040283 - Occasional170
HP:0000505HP:0000505Visual impairment0EPM2A CL E G H79573413OMIM:254780Myoclonic epilepsy of lafora83
HP:0000505HP:0000505Visual impairment0EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15
HP:0000505HP:0000505Visual impairment0ERAP1 CL E G H5175218173ORPHA:117Behçet disease1
HP:0000505HP:0000505Visual impairment0ERCC1 CL E G H20673433ORPHA:90322Cockayne syndrome type 2HP:0040283 - Occasional20
HP:0000505HP:0000505Visual impairment0ERCC1 CL E G H20673433ORPHA:1466COFS syndromeHP:0040282 - Frequent20
HP:0000505HP:0000505Visual impairment0ERCC2 CL E G H20683434ORPHA:1466COFS syndromeHP:0040282 - Frequent106
HP:0000505HP:0000505Visual impairment0ERCC4 CL E G H20723436ORPHA:90321Cockayne syndrome type 1HP:0040282 - Frequent158
HP:0000505HP:0000505Visual impairment0ERCC4 CL E G H20723436ORPHA:84Fanconi anemiaHP:0040283 - Occasional158
HP:0000505HP:0000505Visual impairment0ERCC4 CL E G H20723436OMIM:610965XFE progeroid syndrome.158
HP:0000505HP:0000505Visual impairment0ERCC5 CL E G H20733437ORPHA:1466COFS syndromeHP:0040282 - Frequent83
HP:0000505HP:0000505Visual impairment0ERCC6 CL E G H20743438ORPHA:90321Cockayne syndrome type 1HP:0040282 - Frequent199
HP:0000505HP:0000505Visual impairment0ERCC6 CL E G H20743438ORPHA:90322Cockayne syndrome type 2HP:0040283 - Occasional199
HP:0000505HP:0000505Visual impairment0ERCC6 CL E G H20743438ORPHA:1466COFS syndromeHP:0040282 - Frequent199
HP:0000505HP:0000505Visual impairment0ERCC8 CL E G H11613439ORPHA:90321Cockayne syndrome type 1HP:0040282 - Frequent55
HP:0000505HP:0000505Visual impairment0ERCC8 CL E G H11613439ORPHA:90322Cockayne syndrome type 2HP:0040283 - Occasional55
HP:0000505HP:0000505Visual impairment0ERF CL E G H20773444ORPHA:207Crouzon disease12
HP:0000505HP:0000505Visual impairment0ESPN CL E G H8371513281ORPHA:231169Usher syndrome type 133
HP:0000505HP:0000505Visual impairment0EXOSC3 CL E G H5101017944ORPHA:2254Pontocerebellar hypoplasia type 138
HP:0000505HP:0000505Visual impairment0EXOSC8 CL E G H1134017035ORPHA:2254Pontocerebellar hypoplasia type 14
HP:0000505HP:0000505Visual impairment0EXOSC8 CL E G H1134017035OMIM:616081Pontocerebellar hypoplasia, type 1C.4
HP:0000505HP:0000505Visual impairment0EXOSC9 CL E G H53939137ORPHA:2254Pontocerebellar hypoplasia type 1
HP:0000505HP:0000505Visual impairment0EYS CL E G H34600721555ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent209
HP:0000505HP:0000505Visual impairment0EYS CL E G H34600721555OMIM:602772Retinitis pigmentosa 25209
HP:0000505HP:0000505Visual impairment0FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegeneration76
HP:0000505HP:0000505Visual impairment0FAM161A CL E G H8414025808ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent56
HP:0000505HP:0000505Visual impairment0FAM161A CL E G H8414025808OMIM:606068RETINITIS PIGMENTOSA 28; RP2856
HP:0000505HP:0000505Visual impairment0FAN1 CL E G H2290929170ORPHA:144Lynch syndromeHP:0040283 - Occasional15
HP:0000505HP:0000505Visual impairment0FANCA CL E G H21753582ORPHA:84Fanconi anemiaHP:0040283 - Occasional340
HP:0000505HP:0000505Visual impairment0FANCB CL E G H21873583ORPHA:84Fanconi anemiaHP:0040283 - Occasional58
HP:0000505HP:0000505Visual impairment0FANCC CL E G H21763584ORPHA:84Fanconi anemiaHP:0040283 - Occasional410
HP:0000505HP:0000505Visual impairment0FANCD2 CL E G H21773585ORPHA:84Fanconi anemiaHP:0040283 - Occasional147
HP:0000505HP:0000505Visual impairment0FANCE CL E G H21783586ORPHA:84Fanconi anemiaHP:0040283 - Occasional73
HP:0000505HP:0000505Visual impairment0FANCF CL E G H21883587ORPHA:84Fanconi anemiaHP:0040283 - Occasional87
HP:0000505HP:0000505Visual impairment0FANCG CL E G H21893588ORPHA:84Fanconi anemiaHP:0040283 - Occasional73
HP:0000505HP:0000505Visual impairment0FANCI CL E G H5521525568ORPHA:84Fanconi anemiaHP:0040283 - Occasional157
HP:0000505HP:0000505Visual impairment0FANCL CL E G H5512020748ORPHA:84Fanconi anemiaHP:0040283 - Occasional53
HP:0000505HP:0000505Visual impairment0FANCM CL E G H5769723168ORPHA:84Fanconi anemiaHP:0040283 - Occasional107
HP:0000505HP:0000505Visual impairment0FARS2 CL E G H1066721062OMIM:614946Combined oxidative phosphorylation deficiency 14HP:0040283 - Occasional36
HP:0000505HP:0000505Visual impairment0FAS CL E G H35511920ORPHA:117Behçet disease59
HP:0000505HP:0000505Visual impairment0FAS CL E G H35511920ORPHA:3437Vogt-Koyanagi-Harada diseaseHP:0040282 - Frequent59
HP:0000505HP:0000505Visual impairment0FBN1 CL E G H22003603ORPHA:1885Isolated ectopia lentisHP:0040283 - Occasional1361
HP:0000505HP:0000505Visual impairment0FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0000505HP:0000505Visual impairment0FBN1 CL E G H22003603ORPHA:3449Weill-Marchesani syndrome1361
HP:0000505HP:0000505Visual impairment0FBN1 CL E G H22003603OMIM:608328Weill-Marchesani syndrome 2, dominant1361
HP:0000505HP:0000505Visual impairment0FBN2 CL E G H22013604OMIM:616118MACULAR DEGENERATION, EARLY-ONSET; EOMD655
HP:0000505HP:0000505Visual impairment0FBXW7 CL E G H5529416712OMIM:62001222
HP:0000505HP:0000505Visual impairment0FCSK CL E G H19725829500OMIM:618324Congenital disorder of glycosylation with defective fucosylation 2.
HP:0000505HP:0000505Visual impairment0FDFT1 CL E G H22223629OMIM:618156SQUALENE SYNTHASE DEFICIENCY; SQSD
HP:0000505HP:0000505Visual impairment0FDX2 CL E G H11281230546OMIM:251900Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathyHP:0040284 - Very rare
HP:0000505HP:0000505Visual impairment0FDXR CL E G H22323642OMIM:617717Auditory neuropathy and optic atrophy.
HP:0000505HP:0000505Visual impairment0FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0FEZF1 CL E G H38954922788ORPHA:478Kallmann syndromeHP:0040283 - Occasional2
HP:0000505HP:0000505Visual impairment0FGF12 CL E G H22573668OMIM:617166Epileptic encephalopathy, early infantile, 473
HP:0000505HP:0000505Visual impairment0FGF17 CL E G H88223673ORPHA:478Kallmann syndromeHP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0FGF8 CL E G H22533686ORPHA:93925Alobar holoprosencephaly17
HP:0000505HP:0000505Visual impairment0FGF8 CL E G H22533686ORPHA:478Kallmann syndromeHP:0040283 - Occasional17
HP:0000505HP:0000505Visual impairment0FGF8 CL E G H22533686ORPHA:93924Lobar holoprosencephaly17
HP:0000505HP:0000505Visual impairment0FGF8 CL E G H22533686ORPHA:93926Midline interhemispheric variant of holoprosencephaly17
HP:0000505HP:0000505Visual impairment0FGF8 CL E G H22533686ORPHA:220386Semilobar holoprosencephaly17
HP:0000505HP:0000505Visual impairment0FGFR1 CL E G H22603688ORPHA:478Kallmann syndromeHP:0040283 - Occasional172
HP:0000505HP:0000505Visual impairment0FGFR1 CL E G H22603688ORPHA:93924Lobar holoprosencephaly172
HP:0000505HP:0000505Visual impairment0FGFR1 CL E G H22603688ORPHA:220386Semilobar holoprosencephaly172
HP:0000505HP:0000505Visual impairment0FGFR1 CL E G H22603688ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent172
HP:0000505HP:0000505Visual impairment0FGFR2 CL E G H22633689ORPHA:87Apert syndromeHP:0040283 - Occasional175
HP:0000505HP:0000505Visual impairment0FGFR2 CL E G H22633689ORPHA:207Crouzon disease175
HP:0000505HP:0000505Visual impairment0FGFR2 CL E G H22633689OMIM:123500Crouzon syndrome.175
HP:0000505HP:0000505Visual impairment0FGFR2 CL E G H22633689ORPHA:93259Pfeiffer syndrome type 2175
HP:0000505HP:0000505Visual impairment0FGFR2 CL E G H22633689ORPHA:93260Pfeiffer syndrome type 3175
HP:0000505HP:0000505Visual impairment0FGFR2 CL E G H22633689ORPHA:794Saethre-Chotzen syndrome175
HP:0000505HP:0000505Visual impairment0FGFR3 CL E G H22613690ORPHA:93262Crouzon syndrome-acanthosis nigricans syndromeHP:0040283 - Occasional145
HP:0000505HP:0000505Visual impairment0FGFR3 CL E G H22613690OMIM:602849Muenke syndrome145
HP:0000505HP:0000505Visual impairment0FGFR3 CL E G H22613690ORPHA:794Saethre-Chotzen syndrome145
HP:0000505HP:0000505Visual impairment0FH CL E G H22713700OMIM:606812Fumarase deficiency.301
HP:0000505HP:0000505Visual impairment0FIG4 CL E G H989616873ORPHA:208441Bilateral parasagittal parieto-occipital polymicrogyriaHP:0040283 - Occasional111
HP:0000505HP:0000505Visual impairment0FKBP6 CL E G H84683722ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0FKRP CL E G H7914717997ORPHA:370959Congenital muscular dystrophy with cerebellar involvement157
HP:0000505HP:0000505Visual impairment0FKRP CL E G H7914717997ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent157
HP:0000505HP:0000505Visual impairment0FKRP CL E G H7914717997OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1157
HP:0000505HP:0000505Visual impairment0FKTN CL E G H22183622ORPHA:272Congenital muscular dystrophy, Fukuyama typeHP:0040283 - Occasional184
HP:0000505HP:0000505Visual impairment0FKTN CL E G H22183622ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent184
HP:0000505HP:0000505Visual impairment0FKTN CL E G H22183622OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1184
HP:0000505HP:0000505Visual impairment0FLNA CL E G H23163754ORPHA:1826Frontometaphyseal dysplasia493
HP:0000505HP:0000505Visual impairment0FLRT3 CL E G H237673762ORPHA:478Kallmann syndromeHP:0040283 - Occasional4
HP:0000505HP:0000505Visual impairment0FLVCR1 CL E G H2898224682OMIM:609033Ataxia, posterior column, with retinitis pigmentosa111
HP:0000505HP:0000505Visual impairment0FLVCR1 CL E G H2898224682ORPHA:88628Posterior column ataxia-retinitis pigmentosa syndrome111
HP:0000505HP:0000505Visual impairment0FN1 CL E G H23353778ORPHA:93315Spondylometaphyseal dysplasia, 'corner fracture' typeHP:0040283 - Occasional9
HP:0000505HP:0000505Visual impairment0FOXC1 CL E G H22963800ORPHA:250923Isolated aniridia63
HP:0000505HP:0000505Visual impairment0FOXE3 CL E G H23013808OMIM:610256Anterior segment dysgenesis 223
HP:0000505HP:0000505Visual impairment0FOXH1 CL E G H89283814ORPHA:93925Alobar holoprosencephaly48
HP:0000505HP:0000505Visual impairment0FOXH1 CL E G H89283814ORPHA:93924Lobar holoprosencephaly48
HP:0000505HP:0000505Visual impairment0FOXH1 CL E G H89283814ORPHA:93926Midline interhemispheric variant of holoprosencephaly48
HP:0000505HP:0000505Visual impairment0FOXH1 CL E G H89283814ORPHA:220386Semilobar holoprosencephaly48
HP:0000505HP:0000505Visual impairment0FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0000505HP:0000505Visual impairment0FOXP1 CL E G H270863823ORPHA:52417MALT lymphomaHP:0040283 - Occasional184
HP:0000505HP:0000505Visual impairment0FOXRED1 CL E G H5557226927ORPHA:2609Isolated complex I deficiency61
HP:0000505HP:0000505Visual impairment0FOXRED1 CL E G H5557226927OMIM:618241Mitochondrial complex I deficiency, nuclear type 1961
HP:0000505HP:0000505Visual impairment0FRAS1 CL E G H8014419185ORPHA:2052Fraser syndrome353
HP:0000505HP:0000505Visual impairment0FRAS1 CL E G H8014419185OMIM:219000Fraser syndrome353
HP:0000505HP:0000505Visual impairment0FREM2 CL E G H34164025396ORPHA:2052Fraser syndrome263
HP:0000505HP:0000505Visual impairment0FRMD7 CL E G H901678079OMIM:310700Nystagmus 1, congenital, X-linked38
HP:0000505HP:0000505Visual impairment0FSCN2 CL E G H257943960ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent26
HP:0000505HP:0000505Visual impairment0FSCN2 CL E G H257943960OMIM:607921RETINITIS PIGMENTOSA 30; RP3026
HP:0000505HP:0000505Visual impairment0FXN CL E G H23953951ORPHA:95Friedreich ataxia18
HP:0000505HP:0000505Visual impairment0FXN CL E G H23953951OMIM:229300Friedreich ataxia 1HP:0040283 - Occasional18
HP:0000505HP:0000505Visual impairment0FZD4 CL E G H83224042OMIM:133780Exudative vitreoretinopathy 1109
HP:0000505HP:0000505Visual impairment0FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathy109
HP:0000505HP:0000505Visual impairment0FZD4 CL E G H83224042ORPHA:91495Persistent hyperplastic primary vitreous109
HP:0000505HP:0000505Visual impairment0FZD4 CL E G H83224042ORPHA:90050Retinopathy of prematurity109
HP:0000505HP:0000505Visual impairment0GABRA2 CL E G H25554076OMIM:618557DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE784
HP:0000505HP:0000505Visual impairment0GABRB1 CL E G H25604081OMIM:617153Epileptic encephalopathy, early infantile, 453
HP:0000505HP:0000505Visual impairment0GABRB2 CL E G H25614082OMIM:617829Epileptic encephalopathy, infantile or early childhood, 244
HP:0000505HP:0000505Visual impairment0GABRD CL E G H25634084ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional10
HP:0000505HP:0000505Visual impairment0GALC CL E G H25814115ORPHA:206448Adult Krabbe disease160
HP:0000505HP:0000505Visual impairment0GALC CL E G H25814115ORPHA:206436Infantile Krabbe disease160
HP:0000505HP:0000505Visual impairment0GALC CL E G H25814115OMIM:245200Krabbe disease160
HP:0000505HP:0000505Visual impairment0GALC CL E G H25814115ORPHA:206443Late-infantile/juvenile Krabbe diseaseHP:0040283 - Occasional160
HP:0000505HP:0000505Visual impairment0GAS1 CL E G H26194165ORPHA:93925Alobar holoprosencephaly2
HP:0000505HP:0000505Visual impairment0GAS1 CL E G H26194165ORPHA:93924Lobar holoprosencephaly2
HP:0000505HP:0000505Visual impairment0GAS1 CL E G H26194165ORPHA:93926Midline interhemispheric variant of holoprosencephaly2
HP:0000505HP:0000505Visual impairment0GAS1 CL E G H26194165ORPHA:220386Semilobar holoprosencephaly2
HP:0000505HP:0000505Visual impairment0GATA1 CL E G H26234170ORPHA:79277Congenital erythropoietic porphyria29
HP:0000505HP:0000505Visual impairment0GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndrome137
HP:0000505HP:0000505Visual impairment0GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasia8
HP:0000505HP:0000505Visual impairment0GDF3 CL E G H95734218OMIM:613703MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB67
HP:0000505HP:0000505Visual impairment0GDF6 CL E G H3922554221ORPHA:65Leber congenital amaurosis64
HP:0000505HP:0000505Visual impairment0GDF6 CL E G H3922554221OMIM:615360LEBER CONGENITAL AMAUROSIS 17; LCA1764
HP:0000505HP:0000505Visual impairment0GDF6 CL E G H3922554221OMIM:613703MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB664
HP:0000505HP:0000505Visual impairment0GJA1 CL E G H26974274ORPHA:1522Craniometaphyseal dysplasiaHP:0040283 - Occasional68
HP:0000505HP:0000505Visual impairment0GJA1 CL E G H26974274ORPHA:2710Oculodentodigital dysplasiaHP:0040282 - Frequent68
HP:0000505HP:0000505Visual impairment0GJB2 CL E G H27064284OMIM:148210Keratitis-Ichthyosis-Deafness syndrome, autosomal dominant199
HP:0000505HP:0000505Visual impairment0GJB2 CL E G H27064284ORPHA:477KID syndromeHP:0040281 - Very frequent199
HP:0000505HP:0000505Visual impairment0GJB6 CL E G H108044288ORPHA:477KID syndromeHP:0040281 - Very frequent56
HP:0000505HP:0000505Visual impairment0GLB1 CL E G H27204298ORPHA:79255GM1 gangliosidosis type 1120
HP:0000505HP:0000505Visual impairment0GLI2 CL E G H27364318ORPHA:93925Alobar holoprosencephaly173
HP:0000505HP:0000505Visual impairment0GLI2 CL E G H27364318ORPHA:93924Lobar holoprosencephaly173
HP:0000505HP:0000505Visual impairment0GLI2 CL E G H27364318ORPHA:93926Midline interhemispheric variant of holoprosencephaly173
HP:0000505HP:0000505Visual impairment0GLI2 CL E G H27364318ORPHA:220386Semilobar holoprosencephaly173
HP:0000505HP:0000505Visual impairment0GLRX5 CL E G H5121820134ORPHA:401866Childhood-onset spasticity with hyperglycinemiaHP:0040282 - Frequent17
HP:0000505HP:0000505Visual impairment0GLRX5 CL E G H5121820134OMIM:616859Spasticity, childhood-onset, with hyperglycinemia.17
HP:0000505HP:0000505Visual impairment0GLYCTK CL E G H13215824247ORPHA:941D-glyceric aciduria6
HP:0000505HP:0000505Visual impairment0GM2A CL E G H27604367OMIM:272750Gm2-Gangliosidosis, ab variant69
HP:0000505HP:0000505Visual impairment0GMPPA CL E G H2992622923ORPHA:869Triple A syndromeHP:0040282 - Frequent24
HP:0000505HP:0000505Visual impairment0GMPPB CL E G H2992522932ORPHA:370959Congenital muscular dystrophy with cerebellar involvement34
HP:0000505HP:0000505Visual impairment0GMPPB CL E G H2992522932ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent34
HP:0000505HP:0000505Visual impairment0GNA11 CL E G H27674379ORPHA:39044Uveal melanoma16
HP:0000505HP:0000505Visual impairment0GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndrome7
HP:0000505HP:0000505Visual impairment0GNAQ CL E G H27764390ORPHA:39044Uveal melanoma7
HP:0000505HP:0000505Visual impairment0GNAS CL E G H27784392ORPHA:562McCune-Albright syndrome101
HP:0000505HP:0000505Visual impairment0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic101
HP:0000505HP:0000505Visual impairment0GNAT1 CL E G H27794393ORPHA:215Congenital stationary night blindness39
HP:0000505HP:0000505Visual impairment0GNAT1 CL E G H27794393OMIM:610444Night blindness, congenital stationary, autosomal dominant 339
HP:0000505HP:0000505Visual impairment0GNAT1 CL E G H27794393OMIM:616389Night blindness, congenital stationary, type 1G39
HP:0000505HP:0000505Visual impairment0GNAT2 CL E G H27804394ORPHA:49382Achromatopsia19
HP:0000505HP:0000505Visual impairment0GNAT2 CL E G H27804394OMIM:613856ACHROMATOPSIA 4; ACHM419
HP:0000505HP:0000505Visual impairment0GNAT2 CL E G H27804394ORPHA:1871Progressive cone dystrophyHP:0040281 - Very frequent19
HP:0000505HP:0000505Visual impairment0GNB1 CL E G H27824396ORPHA:488613Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome12
HP:0000505HP:0000505Visual impairment0GNB1 CL E G H27824396OMIM:616973Mental retardation, autosomal dominant 4212
HP:0000505HP:0000505Visual impairment0GNB3 CL E G H27844400ORPHA:215Congenital stationary night blindness5
HP:0000505HP:0000505Visual impairment0GNS CL E G H27994422OMIM:252940Mucopolysaccharidosis, type IIID69
HP:0000505HP:0000505Visual impairment0GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopenia23
HP:0000505HP:0000505Visual impairment0GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopenia8
HP:0000505HP:0000505Visual impairment0GPAA1 CL E G H87334446OMIM:617810GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15
HP:0000505HP:0000505Visual impairment0GPAA1 CL E G H87334446ORPHA:529665Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndromeHP:0040284 - Very rare
HP:0000505HP:0000505Visual impairment0GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0000505HP:0000505Visual impairment0GPR143 CL E G H493520145OMIM:300500Albinism, ocular, type I.64
HP:0000505HP:0000505Visual impairment0GPR143 CL E G H493520145OMIM:300814Nystagmus 6, congenital, X-linked64
HP:0000505HP:0000505Visual impairment0GPR143 CL E G H493520145ORPHA:54X-linked recessive ocular albinismHP:0040283 - Occasional64
HP:0000505HP:0000505Visual impairment0GPR179 CL E G H44043531371ORPHA:215Congenital stationary night blindness124
HP:0000505HP:0000505Visual impairment0GPR179 CL E G H44043531371OMIM:614565Night blindness, congenital stationary, type 1E.124
HP:0000505HP:0000505Visual impairment0GRHL2 CL E G H799772799OMIM:618031Corneal dystrophy, posterior polymorphous, 433
HP:0000505HP:0000505Visual impairment0GRHL2 CL E G H799772799ORPHA:98973Posterior polymorphous corneal dystrophy33
HP:0000505HP:0000505Visual impairment0GRIK2 CL E G H28984580OMIM:619580NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS32
HP:0000505HP:0000505Visual impairment0GRIN1 CL E G H29024584ORPHA:208447Bilateral generalized polymicrogyria108
HP:0000505HP:0000505Visual impairment0GRIN1 CL E G H29024584OMIM:614254Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant108
HP:0000505HP:0000505Visual impairment0GRIN2D CL E G H29064588OMIM:617162Epileptic encephalopathy, early infantile, 462
HP:0000505HP:0000505Visual impairment0GRIP1 CL E G H2342618708ORPHA:2052Fraser syndrome80
HP:0000505HP:0000505Visual impairment0GRK1 CL E G H601110013ORPHA:215Congenital stationary night blindness4
HP:0000505HP:0000505Visual impairment0GRK1 CL E G H601110013ORPHA:75382Oguchi diseaseHP:0040284 - Very rare4
HP:0000505HP:0000505Visual impairment0GRM6 CL E G H29164598ORPHA:215Congenital stationary night blindness63
HP:0000505HP:0000505Visual impairment0GRM7 CL E G H29174599OMIM:618922NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA5
HP:0000505HP:0000505Visual impairment0GRN CL E G H28964601OMIM:614706Ceroid lipofuscinosis, neuronal, 11.126
HP:0000505HP:0000505Visual impairment0GSN CL E G H29344620ORPHA:85448AGel amyloidosisHP:0040282 - Frequent53
HP:0000505HP:0000505Visual impairment0GTF2I CL E G H29694659ORPHA:904Williams syndromeHP:0040282 - Frequent1
HP:0000505HP:0000505Visual impairment0GTF2IRD1 CL E G H95694661ORPHA:904Williams syndromeHP:0040282 - Frequent1
HP:0000505HP:0000505Visual impairment0GTF2IRD2 CL E G H8416330775ORPHA:904Williams syndromeHP:0040282 - Frequent1
HP:0000505HP:0000505Visual impairment0GTPBP2 CL E G H546764670OMIM:617988Jaberi-Elahi syndrome.
HP:0000505HP:0000505Visual impairment0GTPBP3 CL E G H8470514880ORPHA:444013Combined oxidative phosphorylation defect type 23HP:0040283 - Occasional30
HP:0000505HP:0000505Visual impairment0GTPBP3 CL E G H8470514880OMIM:616198Combined oxidative phosphorylation deficiency 23HP:0040283 - Occasional30
HP:0000505HP:0000505Visual impairment0GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent24
HP:0000505HP:0000505Visual impairment0GUCA1A CL E G H29784678OMIM:602093Cone dystrophy 324
HP:0000505HP:0000505Visual impairment0GUCA1A CL E G H29784678ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional24
HP:0000505HP:0000505Visual impairment0GUCA1A CL E G H29784678ORPHA:1871Progressive cone dystrophyHP:0040281 - Very frequent24
HP:0000505HP:0000505Visual impairment0GUCA1B CL E G H29794679ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent36
HP:0000505HP:0000505Visual impairment0GUCA1B CL E G H29794679OMIM:613827RETINITIS PIGMENTOSA 48; RP4836
HP:0000505HP:0000505Visual impairment0GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent124
HP:0000505HP:0000505Visual impairment0GUCY2D CL E G H30004689ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional124
HP:0000505HP:0000505Visual impairment0GUCY2D CL E G H30004689OMIM:601777Cone-Rod dystrophy 6124
HP:0000505HP:0000505Visual impairment0GUCY2D CL E G H30004689ORPHA:65Leber congenital amaurosis124
HP:0000505HP:0000505Visual impairment0GUCY2D CL E G H30004689OMIM:204000Leber congenital amaurosis, type I124
HP:0000505HP:0000505Visual impairment0GUSB CL E G H29904696OMIM:253220Mucopolysaccharidosis, type VII54
HP:0000505HP:0000505Visual impairment0H1-4 CL E G H30084718OMIM:617537Rahman syndrome
HP:0000505HP:0000505Visual impairment0H3-3A CL E G H30204764OMIM:619720BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1
HP:0000505HP:0000505Visual impairment0H4C3 CL E G H83644787OMIM:619758TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1
HP:0000505HP:0000505Visual impairment0H4C9 CL E G H82944793OMIM:619951
HP:0000505HP:0000505Visual impairment0HADHA CL E G H30304801ORPHA:5Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency99
HP:0000505HP:0000505Visual impairment0HARS1 CL E G H30354816ORPHA:231183Usher syndrome type 3
HP:0000505HP:0000505Visual impairment0HARS1 CL E G H30354816OMIM:614504Usher syndrome, type IIIB.
HP:0000505HP:0000505Visual impairment0HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndrome11
HP:0000505HP:0000505Visual impairment0HDAC4 CL E G H975914063OMIM:619797NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES; NEDCHF33
HP:0000505HP:0000505Visual impairment0HECW2 CL E G H5752029853OMIM:617268Neurodevelopmental disorder with hypotonia, seizures, and absent language11
HP:0000505HP:0000505Visual impairment0HESX1 CL E G H88204877ORPHA:478Kallmann syndromeHP:0040283 - Occasional21
HP:0000505HP:0000505Visual impairment0HESX1 CL E G H88204877ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent21
HP:0000505HP:0000505Visual impairment0HEXB CL E G H30744879OMIM:268800Sandhoff disease80
HP:0000505HP:0000505Visual impairment0HGSNAT CL E G H13805026527ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent86
HP:0000505HP:0000505Visual impairment0HGSNAT CL E G H13805026527OMIM:616544Retinitis pigmentosa 7386
HP:0000505HP:0000505Visual impairment0HIKESHI CL E G H5150126938OMIM:616881Leukodystrophy, hypomyelinating, 13HP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0HK1 CL E G H30984922OMIM:618547NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA11
HP:0000505HP:0000505Visual impairment0HK1 CL E G H30984922OMIM:617460Retinitis pigmentosa 7911
HP:0000505HP:0000505Visual impairment0HKDC1 CL E G H8020123302OMIM:619614RETINITIS PIGMENTOSA 92; RP922
HP:0000505HP:0000505Visual impairment0HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathy4
HP:0000505HP:0000505Visual impairment0HLA-B CL E G H31064932ORPHA:117Behçet disease4
HP:0000505HP:0000505Visual impairment0HLA-B CL E G H31064932ORPHA:397Giant cell arteritisHP:0040282 - Frequent4
HP:0000505HP:0000505Visual impairment0HLA-B CL E G H31064932ORPHA:36426Stevens-Johnson syndromeHP:0040283 - Occasional4
HP:0000505HP:0000505Visual impairment0HLA-DPA1 CL E G H31134938ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0HLA-DPB1 CL E G H31154940ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0HLA-DQB1 CL E G H31194944OMIM:123400Creutzfeldt-Jakob disease.
HP:0000505HP:0000505Visual impairment0HLA-DRB1 CL E G H31234948ORPHA:397Giant cell arteritisHP:0040282 - Frequent2
HP:0000505HP:0000505Visual impairment0HLA-DRB1 CL E G H31234948ORPHA:797Sarcoidosis2
HP:0000505HP:0000505Visual impairment0HMCN1 CL E G H8387219194OMIM:603075Macular degeneration, age-related, 1262
HP:0000505HP:0000505Visual impairment0HMX1 CL E G H31665017OMIM:612109Oculoauricular syndrome2
HP:0000505HP:0000505Visual impairment0HPDL CL E G H8484228242OMIM:619026NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE SPASTICITY AND BRAIN WHITE MATTER ABNORMALITIES; NEDSWMA
HP:0000505HP:0000505Visual impairment0HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0000505HP:0000505Visual impairment0HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 367
HP:0000505HP:0000505Visual impairment0HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4123
HP:0000505HP:0000505Visual impairment0HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5105
HP:0000505HP:0000505Visual impairment0HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0000505HP:0000505Visual impairment0HS6ST1 CL E G H93945201ORPHA:478Kallmann syndromeHP:0040283 - Occasional8
HP:0000505HP:0000505Visual impairment0HSD17B10 CL E G H30284800ORPHA:391428HSD10 disease, infantile type19
HP:0000505HP:0000505Visual impairment0HSD17B10 CL E G H30284800OMIM:300438HSD10 mitochondrial disease19
HP:0000505HP:0000505Visual impairment0HSD17B4 CL E G H32955213OMIM:261515D-bifunctional protein deficiency98
HP:0000505HP:0000505Visual impairment0HSPG2 CL E G H33395273ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional345
HP:0000505HP:0000505Visual impairment0HSPG2 CL E G H33395273ORPHA:800Schwartz-Jampel syndromeHP:0040281 - Very frequent345
HP:0000505HP:0000505Visual impairment0IBA57 CL E G H20020527302ORPHA:468661Autosomal recessive spastic paraplegia type 74HP:0040282 - Frequent16
HP:0000505HP:0000505Visual impairment0IBA57 CL E G H20020527302OMIM:615330Multiple mitochondrial dysfunctions syndrome 3.16
HP:0000505HP:0000505Visual impairment0IBA57 CL E G H20020527302OMIM:616451Spastic paraplegia 74, autosomal recessive.16
HP:0000505HP:0000505Visual impairment0IDH3A CL E G H34195384ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0IDH3A CL E G H34195384OMIM:619007RETINITIS PIGMENTOSA 90; RP90
HP:0000505HP:0000505Visual impairment0IDH3B CL E G H34205385ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent30
HP:0000505HP:0000505Visual impairment0IDH3B CL E G H34205385OMIM:612572RETINITIS PIGMENTOSA 46; RP4630
HP:0000505HP:0000505Visual impairment0IDS CL E G H34235389ORPHA:217093Mucopolysaccharidosis type 2, attenuated formHP:0040282 - Frequent86
HP:0000505HP:0000505Visual impairment0IDS CL E G H34235389ORPHA:217085Mucopolysaccharidosis type 2, severe formHP:0040282 - Frequent86
HP:0000505HP:0000505Visual impairment0IFNGR1 CL E G H34595439ORPHA:117Behçet disease60
HP:0000505HP:0000505Visual impairment0IFT140 CL E G H974229077ORPHA:65Leber congenital amaurosis148
HP:0000505HP:0000505Visual impairment0IFT140 CL E G H974229077ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent148
HP:0000505HP:0000505Visual impairment0IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80148
HP:0000505HP:0000505Visual impairment0IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly148
HP:0000505HP:0000505Visual impairment0IFT172 CL E G H2616030391OMIM:619471BARDET-BIEDL SYNDROME 20; BBS2048
HP:0000505HP:0000505Visual impairment0IFT172 CL E G H2616030391ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent48
HP:0000505HP:0000505Visual impairment0IFT74 CL E G H8017321424OMIM:617119BARDET-BIEDL SYNDROME 20; BBS203
HP:0000505HP:0000505Visual impairment0IFT88 CL E G H810020606ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent3
HP:0000505HP:0000505Visual impairment0IGBP1 CL E G H34765461OMIM:300472CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA, AND MICROGNATHIA5
HP:0000505HP:0000505Visual impairment0IGH CL E G H34925477ORPHA:52417MALT lymphomaHP:0040283 - Occasional7
HP:0000505HP:0000505Visual impairment0IKBKG CL E G H85175961ORPHA:464Incontinentia pigmentiHP:0040282 - Frequent52
HP:0000505HP:0000505Visual impairment0IKZF1 CL E G H1032013176ORPHA:36426Stevens-Johnson syndromeHP:0040283 - Occasional8
HP:0000505HP:0000505Visual impairment0IL10 CL E G H35865962ORPHA:117Behçet disease2
HP:0000505HP:0000505Visual impairment0IL12A CL E G H35925969ORPHA:117Behçet disease
HP:0000505HP:0000505Visual impairment0IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet disease
HP:0000505HP:0000505Visual impairment0IL17RD CL E G H5475617616ORPHA:478Kallmann syndromeHP:0040283 - Occasional9
HP:0000505HP:0000505Visual impairment0IL23R CL E G H14923319100ORPHA:117Behçet disease1
HP:0000505HP:0000505Visual impairment0IL2RA CL E G H35596008ORPHA:85410Oligoarticular juvenile idiopathic arthritis65
HP:0000505HP:0000505Visual impairment0IL2RB CL E G H35606009ORPHA:85410Oligoarticular juvenile idiopathic arthritis
HP:0000505HP:0000505Visual impairment0IMPDH1 CL E G H36146052ORPHA:65Leber congenital amaurosis52
HP:0000505HP:0000505Visual impairment0IMPDH1 CL E G H36146052OMIM:613837Leber congenital amaurosis 1152
HP:0000505HP:0000505Visual impairment0IMPDH1 CL E G H36146052ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent52
HP:0000505HP:0000505Visual impairment0IMPDH1 CL E G H36146052OMIM:180105Retinitis pigmentosa 1052
HP:0000505HP:0000505Visual impairment0IMPG1 CL E G H36176055ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040281 - Very frequent4
HP:0000505HP:0000505Visual impairment0IMPG1 CL E G H36176055OMIM:616151Macular dystrophy, vitelliform, 44
HP:0000505HP:0000505Visual impairment0IMPG1 CL E G H36176055ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent4
HP:0000505HP:0000505Visual impairment0IMPG2 CL E G H5093918362ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040281 - Very frequent120
HP:0000505HP:0000505Visual impairment0IMPG2 CL E G H5093918362OMIM:616152Macular dystrophy, vitelliform, 5120
HP:0000505HP:0000505Visual impairment0IMPG2 CL E G H5093918362ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent120
HP:0000505HP:0000505Visual impairment0IMPG2 CL E G H5093918362OMIM:613581RETINITIS PIGMENTOSA 56; RP56120
HP:0000505HP:0000505Visual impairment0INPP5E CL E G H5662321474ORPHA:1454Joubert syndrome with hepatic defectHP:0040282 - Frequent111
HP:0000505HP:0000505Visual impairment0INPP5E CL E G H5662321474ORPHA:220493Joubert syndrome with ocular defect111
HP:0000505HP:0000505Visual impairment0INPP5E CL E G H5662321474OMIM:610156Mental retardation, truncal obesity, retinal dystrophy, and micropenis syndrome.111
HP:0000505HP:0000505Visual impairment0INPP5E CL E G H5662321474ORPHA:75858MORM syndromeHP:0040281 - Very frequent111
HP:0000505HP:0000505Visual impairment0INVS CL E G H2713017870ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent106
HP:0000505HP:0000505Visual impairment0IQCB1 CL E G H965728949ORPHA:65Leber congenital amaurosis61
HP:0000505HP:0000505Visual impairment0IQCB1 CL E G H965728949ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent61
HP:0000505HP:0000505Visual impairment0IQSEC1 CL E G H992229112OMIM:618687INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA
HP:0000505HP:0000505Visual impairment0ISCA2 CL E G H12296119857OMIM:616370Multiple mitochondrial dysfunctions syndrome 4.7
HP:0000505HP:0000505Visual impairment0ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopenia119
HP:0000505HP:0000505Visual impairment0ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopenia69
HP:0000505HP:0000505Visual impairment0ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopenia80
HP:0000505HP:0000505Visual impairment0ITM2B CL E G H94456174OMIM:616079Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities3
HP:0000505HP:0000505Visual impairment0ITPR1 CL E G H37086180OMIM:206700Gillespie syndrome.177
HP:0000505HP:0000505Visual impairment0JAK2 CL E G H37176192ORPHA:71493Familial thrombocytosis57
HP:0000505HP:0000505Visual impairment0KANSL1 CL E G H28405824565ORPHA:36395817q21.31 microdeletion syndromeHP:0040282 - Frequent283
HP:0000505HP:0000505Visual impairment0KANSL1 CL E G H28405824565ORPHA:363965Koolen-De Vries syndrome due to a point mutationHP:0040282 - Frequent283
HP:0000505HP:0000505Visual impairment0KARS1 CL E G H37356215OMIM:619196DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
HP:0000505HP:0000505Visual impairment0KAT6A CL E G H799413013OMIM:616268Arboleda-Tham syndrome34
HP:0000505HP:0000505Visual impairment0KAT6A CL E G H799413013ORPHA:457193Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome34
HP:0000505HP:0000505Visual impairment0KCNAB2 CL E G H85146229ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0KCNJ13 CL E G H37696259ORPHA:65Leber congenital amaurosis42
HP:0000505HP:0000505Visual impairment0KCNJ13 CL E G H37696259OMIM:614186Leber congenital amaurosis 16.42
HP:0000505HP:0000505Visual impairment0KCNN2 CL E G H37816291OMIM:619724DYSTONIA 34, MYOCLONIC; DYT34
HP:0000505HP:0000505Visual impairment0KCNV2 CL E G H16952219698OMIM:610356Retinal cone dystrophy 3B73
HP:0000505HP:0000505Visual impairment0KCTD7 CL E G H15488121957OMIM:611726Epilepsy, progressive myoclonic 3, with or without intracellular inclusions106
HP:0000505HP:0000505Visual impairment0KERA CL E G H110816309OMIM:217300Cornea plana 28
HP:0000505HP:0000505Visual impairment0KIAA0586 CL E G H978619960ORPHA:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophy24
HP:0000505HP:0000505Visual impairment0KIAA1549 CL E G H5767022219ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0KIAA1549 CL E G H5767022219OMIM:618613RETINITIS PIGMENTOSA 86; RP86
HP:0000505HP:0000505Visual impairment0KIDINS220 CL E G H5749829508OMIM:617296SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO4
HP:0000505HP:0000505Visual impairment0KIF11 CL E G H38326388OMIM:152950Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation46
HP:0000505HP:0000505Visual impairment0KIF11 CL E G H38326388ORPHA:2526Microcephaly-lymphedema-chorioretinopathy syndrome46
HP:0000505HP:0000505Visual impairment0KIF14 CL E G H992819181OMIM:617914Microcephaly 20, primary, autosomal recessive9
HP:0000505HP:0000505Visual impairment0KIF1A CL E G H547888OMIM:614255Mental retardation, autosomal dominant 9276
HP:0000505HP:0000505Visual impairment0KIF1A CL E G H547888ORPHA:2836PEHO syndrome276
HP:0000505HP:0000505Visual impairment0KIF1C CL E G H107496317ORPHA:397946Autosomal spastic paraplegia type 5838
HP:0000505HP:0000505Visual impairment0KIF3B CL E G H93716320OMIM:618955RETINITIS PIGMENTOSA 89; RP89
HP:0000505HP:0000505Visual impairment0KIF5A CL E G H37986323OMIM:617235Myoclonus, intractable, neonatal93
HP:0000505HP:0000505Visual impairment0KIZ CL E G H5585715865ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent3
HP:0000505HP:0000505Visual impairment0KIZ CL E G H5585715865OMIM:615780Retinitis pigmentosa 693
HP:0000505HP:0000505Visual impairment0KLHL7 CL E G H5597515646ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent42
HP:0000505HP:0000505Visual impairment0KLRC4 CL E G H83026377ORPHA:117Behçet disease
HP:0000505HP:0000505Visual impairment0KMT2B CL E G H975715840OMIM:61993411
HP:0000505HP:0000505Visual impairment0KRAS CL E G H38456407ORPHA:144Lynch syndromeHP:0040283 - Occasional196
HP:0000505HP:0000505Visual impairment0KRT12 CL E G H38596414OMIM:122100Meesmann corneal dystrophy 122
HP:0000505HP:0000505Visual impairment0LAMA1 CL E G H2842176481ORPHA:370022Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome35
HP:0000505HP:0000505Visual impairment0LAMA1 CL E G H2842176481OMIM:615960Poretti-Boltshauser syndrome35
HP:0000505HP:0000505Visual impairment0LAMB2 CL E G H39136487OMIM:609049Pierson syndrome92
HP:0000505HP:0000505Visual impairment0LAMC3 CL E G H103196494OMIM:614115Cortical malformations, occipital114
HP:0000505HP:0000505Visual impairment0LAMP2 CL E G H39206501OMIM:300257Danon disease.211
HP:0000505HP:0000505Visual impairment0LARGE1 CL E G H92156511ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent136
HP:0000505HP:0000505Visual impairment0LARGE1 CL E G H92156511OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1136
HP:0000505HP:0000505Visual impairment0LCA5 CL E G H16769131923ORPHA:65Leber congenital amaurosis70
HP:0000505HP:0000505Visual impairment0LCA5 CL E G H16769131923OMIM:604537Leber congenital amaurosis 570
HP:0000505HP:0000505Visual impairment0LCA5 CL E G H16769131923ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent70
HP:0000505HP:0000505Visual impairment0LCAT CL E G H39316522ORPHA:79292Fish-eye diseaseHP:0040283 - Occasional26
HP:0000505HP:0000505Visual impairment0LEMD3 CL E G H2359228887ORPHA:1306Buschke-Ollendorff syndromeHP:0040283 - Occasional68
HP:0000505HP:0000505Visual impairment0LETM1 CL E G H39546556OMIM:6200892
HP:0000505HP:0000505Visual impairment0LIM2 CL E G H39826610OMIM:615277Cataract 19, multiple types16
HP:0000505HP:0000505Visual impairment0LIMK1 CL E G H39846613ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0LMBRD2 CL E G H9225525287OMIM:619694DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES; DENBA
HP:0000505HP:0000505Visual impairment0LMNB1 CL E G H40016637OMIM:619179MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH2644
HP:0000505HP:0000505Visual impairment0LOC111365204 CL E G H111365204OMIM:600790Chorioretinal atrophy, progressive bifocal.
HP:0000505HP:0000505Visual impairment0LOC111365204 CL E G H111365204OMIM:136550Macular dystrophy, retinal, 1, north Carolina type
HP:0000505HP:0000505Visual impairment0LONP1 CL E G H93619479ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiency8
HP:0000505HP:0000505Visual impairment0LOXL3 CL E G H8469513869ORPHA:250984Autosomal recessive Stickler syndrome4
HP:0000505HP:0000505Visual impairment0LRAT CL E G H92276685ORPHA:65Leber congenital amaurosis62
HP:0000505HP:0000505Visual impairment0LRAT CL E G H92276685OMIM:613341Leber congenital amaurosis 1462
HP:0000505HP:0000505Visual impairment0LRAT CL E G H92276685ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent62
HP:0000505HP:0000505Visual impairment0LRAT CL E G H92276685OMIM:268000Retinitis pigmentosa62
HP:0000505HP:0000505Visual impairment0LRAT CL E G H92276685ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent62
HP:0000505HP:0000505Visual impairment0LRIT3 CL E G H34519324783ORPHA:215Congenital stationary night blindness54
HP:0000505HP:0000505Visual impairment0LRP2 CL E G H40366694OMIM:222448Donnai-Barrow syndrome289
HP:0000505HP:0000505Visual impairment0LRP2 CL E G H40366694ORPHA:2143Donnai-Barrow syndrome289
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697OMIM:133780Exudative vitreoretinopathy 1125
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697OMIM:601813Exudative vitreoretinopathy 4125
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathy125
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndrome125
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697OMIM:259770Osteoporosis-Pseudoglioma syndrome125
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697ORPHA:178377Osteosclerosis-developmental delay-craniosynostosis syndromeHP:0040283 - Occasional125
HP:0000505HP:0000505Visual impairment0LRP5 CL E G H40416697ORPHA:90050Retinopathy of prematurity125
HP:0000505HP:0000505Visual impairment0LRPAP1 CL E G H40436701OMIM:615431Myopia 23, autosomal recessive4
HP:0000505HP:0000505Visual impairment0LSS CL E G H40476708OMIM:616509Cataract 442
HP:0000505HP:0000505Visual impairment0LTBP2 CL E G H40536715ORPHA:98976Congenital glaucoma123
HP:0000505HP:0000505Visual impairment0LTBP2 CL E G H40536715ORPHA:3449Weill-Marchesani syndrome123
HP:0000505HP:0000505Visual impairment0LUZP1 CL E G H779814985ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0LYRM7 CL E G H9062428072OMIM:615838Mitochondrial complex III deficiency, nuclear type 810
HP:0000505HP:0000505Visual impairment0LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndrome239
HP:0000505HP:0000505Visual impairment0LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0000505HP:0000505Visual impairment0LZTFL1 CL E G H545856741OMIM:615994BARDET-BIEDL SYNDROME 17; BBS174
HP:0000505HP:0000505Visual impairment0MAB21L1 CL E G H40816757OMIM:618479Cerebellar, ocular, craniofacial, and genital syndrome.
HP:0000505HP:0000505Visual impairment0MACF1 CL E G H2349913664OMIM:618325Lissencephaly 9 with complex brainstem malformation2
HP:0000505HP:0000505Visual impairment0MACF1 CL E G H2349913664ORPHA:572013Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome2
HP:0000505HP:0000505Visual impairment0MAD2L2 CL E G H104596764ORPHA:84Fanconi anemiaHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0MAF CL E G H40946776ORPHA:1272Aymé-Gripp syndromeHP:0040282 - Frequent21
HP:0000505HP:0000505Visual impairment0MAFB CL E G H99356408ORPHA:233Duane retraction syndrome63
HP:0000505HP:0000505Visual impairment0MAG CL E G H40996783OMIM:616680Spastic paraplegia 75, autosomal recessive4
HP:0000505HP:0000505Visual impairment0MAK CL E G H41176816ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent53
HP:0000505HP:0000505Visual impairment0MAK CL E G H41176816OMIM:614181Retinitis pigmentosa 6253
HP:0000505HP:0000505Visual impairment0MALT1 CL E G H108926819ORPHA:52417MALT lymphomaHP:0040283 - Occasional6
HP:0000505HP:0000505Visual impairment0MAP3K7 CL E G H68856859ORPHA:1826Frontometaphyseal dysplasia11
HP:0000505HP:0000505Visual impairment0MAPK8IP3 CL E G H231626884OMIM:618443Neurodevelopmental disorder with or without variable brain abnormalities
HP:0000505HP:0000505Visual impairment0MAPKAPK3 CL E G H78676888OMIM:617111Macular dystrophy, patterned, 31
HP:0000505HP:0000505Visual impairment0MARK3 CL E G H41406897OMIM:618283Visual impairment and progressive phthisis bulbi
HP:0000505HP:0000505Visual impairment0MBD5 CL E G H5577720444OMIM:156200Mental retardation, autosomal dominant 1.252
HP:0000505HP:0000505Visual impairment0MC1R CL E G H41576929OMIM:203200Albinism, oculocutaneous, type II.124
HP:0000505HP:0000505Visual impairment0MC1R CL E G H41576929ORPHA:79432Oculocutaneous albinism type 2124
HP:0000505HP:0000505Visual impairment0MCOLN1 CL E G H5719213356OMIM:252650Mucolipidosis IV78
HP:0000505HP:0000505Visual impairment0MECR CL E G H5110219691OMIM:617282Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities.6
HP:0000505HP:0000505Visual impairment0MECR CL E G H5110219691ORPHA:508093MEPAN syndrome6
HP:0000505HP:0000505Visual impairment0MED25 CL E G H8185728845ORPHA:464738Basel-Vanagaite-Smirin-Yosef syndrome43
HP:0000505HP:0000505Visual impairment0MEFV CL E G H42106998ORPHA:117Behçet disease281
HP:0000505HP:0000505Visual impairment0MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0000505HP:0000505Visual impairment0MERTK CL E G H104617027ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent75
HP:0000505HP:0000505Visual impairment0MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 3875
HP:0000505HP:0000505Visual impairment0METTL27 CL E G H15536819068ORPHA:904Williams syndromeHP:0040282 - Frequent1
HP:0000505HP:0000505Visual impairment0MFF CL E G H5694724858OMIM:617086Encephalopathy due to defective mitochondrial and peroxisomal fission 2.17
HP:0000505HP:0000505Visual impairment0MFF CL E G H5694724858ORPHA:485421MFF-related encephalopathy due to mitochondrial and peroxisomal fission defectHP:0040282 - Frequent17
HP:0000505HP:0000505Visual impairment0MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000505HP:0000505Visual impairment0MFRP CL E G H8355218121OMIM:611040Microphthalmia, isolated 5.26
HP:0000505HP:0000505Visual impairment0MFSD8 CL E G H25647128486OMIM:610951Ceroid lipofuscinosis, neuronal, 7120
HP:0000505HP:0000505Visual impairment0MFSD8 CL E G H25647128486OMIM:616170Macular dystrophy with central cone involvement.120
HP:0000505HP:0000505Visual impairment0MICOS13 CL E G H12598833702ORPHA:670473-methylglutaconic aciduria type 3HP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0MICOS13 CL E G H12598833702OMIM:618329COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37
HP:0000505HP:0000505Visual impairment0MICU1 CL E G H103671530OMIM:615673Myopathy with extrapyramidal signs14
HP:0000505HP:0000505Visual impairment0MIR184 CL E G H40696031555OMIM:614303Edict syndrome.1
HP:0000505HP:0000505Visual impairment0MIR204 CL E G H40698731582OMIM:616722Retinal dystrophy and iris coloboma with or without congenital cataract1
HP:0000505HP:0000505Visual impairment0MKS1 CL E G H549037121ORPHA:220493Joubert syndrome with ocular defect127
HP:0000505HP:0000505Visual impairment0MLH1 CL E G H42927127ORPHA:144Lynch syndromeHP:0040283 - Occasional1819
HP:0000505HP:0000505Visual impairment0MLH3 CL E G H270307128ORPHA:144Lynch syndromeHP:0040283 - Occasional131
HP:0000505HP:0000505Visual impairment0MLXIPL CL E G H5108512744ORPHA:904Williams syndromeHP:0040282 - Frequent1
HP:0000505HP:0000505Visual impairment0MLXIPL CL E G H5108512744OMIM:194050Williams-Beuren syndrome1
HP:0000505HP:0000505Visual impairment0MMACHC CL E G H2597424525ORPHA:79282Methylmalonic acidemia with homocystinuria, type cblCHP:0040282 - Frequent101
HP:0000505HP:0000505Visual impairment0MMACHC CL E G H2597424525OMIM:277400Methylmalonic aciduria and homocystinuria, Cblc type.101
HP:0000505HP:0000505Visual impairment0MMP1 CL E G H43127155ORPHA:79408Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form6
HP:0000505HP:0000505Visual impairment0MMP19 CL E G H43277165OMIM:611543Cavitary optic disc anomalies2
HP:0000505HP:0000505Visual impairment0MMP23B CL E G H85107171ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0MPL CL E G H43527217ORPHA:71493Familial thrombocytosis97
HP:0000505HP:0000505Visual impairment0MSH2 CL E G H44367325ORPHA:144Lynch syndromeHP:0040283 - Occasional2162
HP:0000505HP:0000505Visual impairment0MSH6 CL E G H29567329ORPHA:144Lynch syndromeHP:0040283 - Occasional2232
HP:0000505HP:0000505Visual impairment0MSX2 CL E G H44887392OMIM:604757Craniosynostosis 245
HP:0000505HP:0000505Visual impairment0MTFMT CL E G H12326329666OMIM:614947Combined oxidative phosphorylation deficiency 15HP:0040283 - Occasional29
HP:0000505HP:0000505Visual impairment0MTHFS CL E G H105887437OMIM:618367Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination
HP:0000505HP:0000505Visual impairment0MTOR CL E G H24753942ORPHA:99802Hemimegalencephaly68
HP:0000505HP:0000505Visual impairment0MTR CL E G H45487468OMIM:250940Homocystinuria-megaloblastic anemia, cblg Complementation type217
HP:0000505HP:0000505Visual impairment0MTRFR CL E G H9157426784ORPHA:320375Autosomal recessive spastic paraplegia type 55
HP:0000505HP:0000505Visual impairment0MTRFR CL E G H9157426784ORPHA:254930Combined oxidative phosphorylation defect type 7HP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0MTRFR CL E G H9157426784OMIM:613559Combined oxidative phosphorylation deficiency 7.
HP:0000505HP:0000505Visual impairment0MTRFR CL E G H9157426784OMIM:615035Spastic paraplegia 55, autosomal recessive.
HP:0000505HP:0000505Visual impairment0MTRR CL E G H45527473OMIM:236270Homocystinuria-megaloblastic anemia, cbl E type88
HP:0000505HP:0000505Visual impairment0MTRR CL E G H45527473ORPHA:2169Methylcobalamin deficiency type cblEHP:0040283 - Occasional88
HP:0000505HP:0000505Visual impairment0MTTP CL E G H45477467ORPHA:14Abetalipoproteinemia81
HP:0000505HP:0000505Visual impairment0MYO7A CL E G H46477606ORPHA:231169Usher syndrome type 1516
HP:0000505HP:0000505Visual impairment0MYO7A CL E G H46477606ORPHA:231178Usher syndrome type 2516
HP:0000505HP:0000505Visual impairment0MYO7A CL E G H46477606OMIM:276900Usher syndrome, type I516
HP:0000505HP:0000505Visual impairment0MYOC CL E G H46537610ORPHA:98976Congenital glaucoma47
HP:0000505HP:0000505Visual impairment0MYOC CL E G H46537610ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent47
HP:0000505HP:0000505Visual impairment0NAA10 CL E G H826018704ORPHA:568Microphthalmia, Lenz typeHP:0040283 - Occasional23
HP:0000505HP:0000505Visual impairment0NAA10 CL E G H826018704OMIM:309800Microphthalmia, syndromic 123
HP:0000505HP:0000505Visual impairment0NADK2 CL E G H13368626404OMIM:6160342,4-Dienoyl-Coa reductase deficiency14
HP:0000505HP:0000505Visual impairment0NADK2 CL E G H13368626404ORPHA:431361Progressive encephalopathy with leukodystrophy due to DECR deficiency14
HP:0000505HP:0000505Visual impairment0NAGA CL E G H46687631ORPHA:79279Alpha-N-acetylgalactosaminidase deficiency type 147
HP:0000505HP:0000505Visual impairment0NAGA CL E G H46687631OMIM:609241Schindler disease, type I47
HP:0000505HP:0000505Visual impairment0NAPB CL E G H6390815751OMIM:6200332
HP:0000505HP:0000505Visual impairment0NARS2 CL E G H7973126274OMIM:616239Combined oxidative phosphorylation deficiency 2434
HP:0000505HP:0000505Visual impairment0NBAS CL E G H5159415625OMIM:614800Short stature, optic nerve atrophy, and pelger-huet anomaly25
HP:0000505HP:0000505Visual impairment0NCAPG2 CL E G H5489221904OMIM:618460Khan-Khan-Katsanis syndrome.2
HP:0000505HP:0000505Visual impairment0NCF1 CL E G H6533617660ORPHA:904Williams syndromeHP:0040282 - Frequent13
HP:0000505HP:0000505Visual impairment0ND1 CL E G H45357455ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000505Visual impairment0ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ND1 CL E G H45357455OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ND1 CL E G H45357455ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0ND1 CL E G H45357455OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0ND2 CL E G H45367456ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000505Visual impairment0ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ND2 CL E G H45367456OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ND3 CL E G H45377458ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000505Visual impairment0ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ND4 CL E G H45387459OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ND4 CL E G H45387459ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ND4L CL E G H45397460OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ND5 CL E G H45407461OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ND5 CL E G H45407461ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0ND5 CL E G H45407461OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000505Visual impairment0ND6 CL E G H45417462OMIM:535000Leber optic atrophy
HP:0000505HP:0000505Visual impairment0ND6 CL E G H45417462ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0ND6 CL E G H45417462OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0NDE1 CL E G H5482017619ORPHA:2177Hydranencephaly96
HP:0000505HP:0000505Visual impairment0NDNF CL E G H7962526256ORPHA:478Kallmann syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0NDP CL E G H46937678OMIM:305390Exudative vitreoretinopathy 2, X-linked39
HP:0000505HP:0000505Visual impairment0NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathy39
HP:0000505HP:0000505Visual impairment0NDP CL E G H46937678OMIM:310600Norrie disease39
HP:0000505HP:0000505Visual impairment0NDP CL E G H46937678ORPHA:649Norrie disease39
HP:0000505HP:0000505Visual impairment0NDP CL E G H46937678ORPHA:91495Persistent hyperplastic primary vitreous39
HP:0000505HP:0000505Visual impairment0NDP CL E G H46937678ORPHA:90050Retinopathy of prematurity39
HP:0000505HP:0000505Visual impairment0NDUFA1 CL E G H46947683ORPHA:2609Isolated complex I deficiency7
HP:0000505HP:0000505Visual impairment0NDUFA11 CL E G H12632820371ORPHA:2609Isolated complex I deficiency32
HP:0000505HP:0000505Visual impairment0NDUFA6 CL E G H47007690ORPHA:2609Isolated complex I deficiency1
HP:0000505HP:0000505Visual impairment0NDUFAF1 CL E G H5110318828ORPHA:2609Isolated complex I deficiency40
HP:0000505HP:0000505Visual impairment0NDUFAF2 CL E G H9194228086ORPHA:2609Isolated complex I deficiency26
HP:0000505HP:0000505Visual impairment0NDUFAF3 CL E G H2591529918ORPHA:2609Isolated complex I deficiency31
HP:0000505HP:0000505Visual impairment0NDUFAF3 CL E G H2591529918ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional31
HP:0000505HP:0000505Visual impairment0NDUFAF4 CL E G H2907821034ORPHA:2609Isolated complex I deficiency50
HP:0000505HP:0000505Visual impairment0NDUFAF5 CL E G H7913315899ORPHA:2609Isolated complex I deficiency34
HP:0000505HP:0000505Visual impairment0NDUFAF8 CL E G H28418433551ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000505Visual impairment0NDUFB10 CL E G H47167696ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000505Visual impairment0NDUFB11 CL E G H5453920372ORPHA:2609Isolated complex I deficiency3
HP:0000505HP:0000505Visual impairment0NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndrome3
HP:0000505HP:0000505Visual impairment0NDUFB3 CL E G H47097698ORPHA:2609Isolated complex I deficiency9
HP:0000505HP:0000505Visual impairment0NDUFB8 CL E G H47147703ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0NDUFB9 CL E G H47157704ORPHA:2609Isolated complex I deficiency16
HP:0000505HP:0000505Visual impairment0NDUFS1 CL E G H47197707ORPHA:2609Isolated complex I deficiency81
HP:0000505HP:0000505Visual impairment0NDUFS2 CL E G H47207708ORPHA:2609Isolated complex I deficiency65
HP:0000505HP:0000505Visual impairment0NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000505HP:0000505Visual impairment0NDUFS2 CL E G H47207708ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional65
HP:0000505HP:0000505Visual impairment0NDUFS3 CL E G H47227710ORPHA:2609Isolated complex I deficiency22
HP:0000505HP:0000505Visual impairment0NDUFS4 CL E G H47247711ORPHA:2609Isolated complex I deficiency27
HP:0000505HP:0000505Visual impairment0NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0000505HP:0000505Visual impairment0NDUFS6 CL E G H47267713ORPHA:2609Isolated complex I deficiency21
HP:0000505HP:0000505Visual impairment0NDUFS7 CL E G H3742917714ORPHA:2609Isolated complex I deficiency38
HP:0000505HP:0000505Visual impairment0NDUFS8 CL E G H47287715ORPHA:2609Isolated complex I deficiency42
HP:0000505HP:0000505Visual impairment0NDUFV1 CL E G H47237716ORPHA:2609Isolated complex I deficiency74
HP:0000505HP:0000505Visual impairment0NDUFV1 CL E G H47237716OMIM:618225Mitochondrial complex I deficiency, nuclear type 474
HP:0000505HP:0000505Visual impairment0NDUFV2 CL E G H47297717ORPHA:2609Isolated complex I deficiency27
HP:0000505HP:0000505Visual impairment0NEK2 CL E G H47517745ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent5
HP:0000505HP:0000505Visual impairment0NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 243
HP:0000505HP:0000505Visual impairment0NEU1 CL E G H47587758ORPHA:93399Juvenile sialidosis type 243
HP:0000505HP:0000505Visual impairment0NEU1 CL E G H47587758OMIM:256550Neuraminidase deficiency43
HP:0000505HP:0000505Visual impairment0NEU1 CL E G H47587758ORPHA:812Sialidosis type 1HP:0040281 - Very frequent43
HP:0000505HP:0000505Visual impairment0NEUROD2 CL E G H47617763OMIM:618374Epileptic encephalopathy, early infantile, 72
HP:0000505HP:0000505Visual impairment0NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndrome1952
HP:0000505HP:0000505Visual impairment0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0000505Visual impairment0NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2220
HP:0000505HP:0000505Visual impairment0NFIX CL E G H47847788ORPHA:44798019p13.3 microduplication syndrome40
HP:0000505HP:0000505Visual impairment0NHLRC1 CL E G H37888421576OMIM:254780Myoclonic epilepsy of lafora77
HP:0000505HP:0000505Visual impairment0NHLRC2 CL E G H37435424731OMIM:618278Fibrosis, neurodegeneration, and cerebral angiomatosis
HP:0000505HP:0000505Visual impairment0NHS CL E G H48107820OMIM:302200Cataract, congenital total, with posterior sutural opacities in heterozygotes88
HP:0000505HP:0000505Visual impairment0NHS CL E G H48107820OMIM:302350Nance-Horan syndrome88
HP:0000505HP:0000505Visual impairment0NHS CL E G H48107820ORPHA:627Nance-Horan syndromeHP:0040281 - Very frequent88
HP:0000505HP:0000505Visual impairment0NLRP3 CL E G H11454816400ORPHA:1451CINCA syndromeHP:0040282 - Frequent217
HP:0000505HP:0000505Visual impairment0NMNAT1 CL E G H6480217877ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional15
HP:0000505HP:0000505Visual impairment0NMNAT1 CL E G H6480217877ORPHA:65Leber congenital amaurosis15
HP:0000505HP:0000505Visual impairment0NMNAT1 CL E G H6480217877OMIM:608553Leber congenital amaurosis 915
HP:0000505HP:0000505Visual impairment0NMNAT1 CL E G H6480217877OMIM:619260SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS; SHILCA15
HP:0000505HP:0000505Visual impairment0NOD2 CL E G H641275331ORPHA:90340Blau syndrome187
HP:0000505HP:0000505Visual impairment0NODAL CL E G H48387865ORPHA:93925Alobar holoprosencephaly45
HP:0000505HP:0000505Visual impairment0NODAL CL E G H48387865ORPHA:93924Lobar holoprosencephaly45
HP:0000505HP:0000505Visual impairment0NODAL CL E G H48387865ORPHA:93926Midline interhemispheric variant of holoprosencephaly45
HP:0000505HP:0000505Visual impairment0NODAL CL E G H48387865ORPHA:220386Semilobar holoprosencephaly45
HP:0000505HP:0000505Visual impairment0NOG CL E G H92417866OMIM:186500Multiple synostoses syndrome 122
HP:0000505HP:0000505Visual impairment0NOTCH3 CL E G H48547883OMIM:125310Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathy144
HP:0000505HP:0000505Visual impairment0NPHP1 CL E G H48677905ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent85
HP:0000505HP:0000505Visual impairment0NPHP3 CL E G H270317907ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent157
HP:0000505HP:0000505Visual impairment0NPHP4 CL E G H26173419104ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent220
HP:0000505HP:0000505Visual impairment0NPHP4 CL E G H26173419104OMIM:606996Senior-Loken syndrome 4220
HP:0000505HP:0000505Visual impairment0NR2E3 CL E G H100027974ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent58
HP:0000505HP:0000505Visual impairment0NR2F1 CL E G H70257975OMIM:615722Bosch-Boonstra-Schaaf optic atrophy syndrome.37
HP:0000505HP:0000505Visual impairment0NR2F1 CL E G H70257975ORPHA:401777Optic atrophy-intellectual disability syndrome37
HP:0000505HP:0000505Visual impairment0NR3C1 CL E G H29087978ORPHA:96253Cushing diseaseHP:0040283 - Occasional79
HP:0000505HP:0000505Visual impairment0NRL CL E G H49018002ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent30
HP:0000505HP:0000505Visual impairment0NRL CL E G H49018002OMIM:613750Retinitis pigmentosa 27.30
HP:0000505HP:0000505Visual impairment0NSMCE2 CL E G H28605326513ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndrome2
HP:0000505HP:0000505Visual impairment0NTRK2 CL E G H49158032OMIM:617830EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE588
HP:0000505HP:0000505Visual impairment0NUBPL CL E G H8022420278ORPHA:2609Isolated complex I deficiency89
HP:0000505HP:0000505Visual impairment0NUS1 CL E G H11615021042OMIM:617082Congenital disorder of glycosylation, type IAA.1
HP:0000505HP:0000505Visual impairment0NYX CL E G H605068082ORPHA:215Congenital stationary night blindness42
HP:0000505HP:0000505Visual impairment0OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retina94
HP:0000505HP:0000505Visual impairment0OAT CL E G H49428091OMIM:258870Ornithine aminotransferase deficiency94
HP:0000505HP:0000505Visual impairment0OCA2 CL E G H49488101OMIM:203200Albinism, oculocutaneous, type II.121
HP:0000505HP:0000505Visual impairment0OCA2 CL E G H49488101ORPHA:79432Oculocutaneous albinism type 2121
HP:0000505HP:0000505Visual impairment0OCRL CL E G H49528108OMIM:309000Lowe syndrome.88
HP:0000505HP:0000505Visual impairment0OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of Lowe88
HP:0000505HP:0000505Visual impairment0OFD1 CL E G H84812567ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent201
HP:0000505HP:0000505Visual impairment0OFD1 CL E G H84812567OMIM:300424Retinitis pigmentosa 23201
HP:0000505HP:0000505Visual impairment0OGDHL CL E G H5575325590OMIM:619701YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN3
HP:0000505HP:0000505Visual impairment0OGT CL E G H84738127OMIM:300997Mental retardation, X-linked 1064
HP:0000505HP:0000505Visual impairment0OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndrome214
HP:0000505HP:0000505Visual impairment0OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040281 - Very frequent214
HP:0000505HP:0000505Visual impairment0OPA1 CL E G H49768140OMIM:210000Behr syndrome214
HP:0000505HP:0000505Visual impairment0OPA1 CL E G H49768140OMIM:165500Optic atrophy 1.214
HP:0000505HP:0000505Visual impairment0OPA1 CL E G H49768140OMIM:125250Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy.214
HP:0000505HP:0000505Visual impairment0OPA3 CL E G H802078142ORPHA:670473-methylglutaconic aciduria type 3HP:0040281 - Very frequent163
HP:0000505HP:0000505Visual impairment0OPA3 CL E G H802078142OMIM:2585013-methylglutaconic aciduria, type III.163
HP:0000505HP:0000505Visual impairment0OPA3 CL E G H802078142ORPHA:67036Autosomal dominant optic atrophy and cataractHP:0040280 - Obligate163
HP:0000505HP:0000505Visual impairment0OPA3 CL E G H802078142OMIM:165300OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3163
HP:0000505HP:0000505Visual impairment0OPN1LW CL E G H59569936OMIM:303700Blue cone monochromacy.7
HP:0000505HP:0000505Visual impairment0OPN1LW CL E G H59569936ORPHA:16Blue cone monochromatismHP:0040283 - Occasional7
HP:0000505HP:0000505Visual impairment0OPN1LW CL E G H59569936ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional7
HP:0000505HP:0000505Visual impairment0OPN1MW CL E G H26524206OMIM:303700Blue cone monochromacy.5
HP:0000505HP:0000505Visual impairment0OPN1MW CL E G H26524206ORPHA:16Blue cone monochromatismHP:0040283 - Occasional5
HP:0000505HP:0000505Visual impairment0OPN1MW CL E G H26524206ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional5
HP:0000505HP:0000505Visual impairment0OPN1SW CL E G H6111012ORPHA:88629Tritanopia3
HP:0000505HP:0000505Visual impairment0OSGEP CL E G H5564418028OMIM:617729Galloway-Mowat syndrome 3.
HP:0000505HP:0000505Visual impairment0OSTM1 CL E G H2896221652OMIM:259720Osteopetrosis, autosomal recessive 5.73
HP:0000505HP:0000505Visual impairment0OTX2 CL E G H50158522ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent41
HP:0000505HP:0000505Visual impairment0OVOL2 CL E G H5849515804ORPHA:98973Posterior polymorphous corneal dystrophy4
HP:0000505HP:0000505Visual impairment0P3H2 CL E G H5521419317OMIM:614292Myopia, high, with cataract and vitreoretinal degeneration5
HP:0000505HP:0000505Visual impairment0P4HA2 CL E G H89748547ORPHA:397Giant cell arteritisHP:0040282 - Frequent3
HP:0000505HP:0000505Visual impairment0P4HTM CL E G H5468128858OMIM:618493Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities
HP:0000505HP:0000505Visual impairment0PAK2 CL E G H50628591ORPHA:1571Knobloch syndrome
HP:0000505HP:0000505Visual impairment0PALB2 CL E G H7972826144ORPHA:84Fanconi anemiaHP:0040283 - Occasional1349
HP:0000505HP:0000505Visual impairment0PANK2 CL E G H8002515894ORPHA:216873Atypical pantothenate kinase-associated neurodegeneration55
HP:0000505HP:0000505Visual impairment0PANK2 CL E G H8002515894ORPHA:216866Classic pantothenate kinase-associated neurodegeneration55
HP:0000505HP:0000505Visual impairment0PANK4 CL E G H5522919366OMIM:619593CATARACT 49; CTRCT49
HP:0000505HP:0000505Visual impairment0PARS2 CL E G H2597330563OMIM:618437Epileptic encephalopathy, early infantile, 7514
HP:0000505HP:0000505Visual impairment0PAX2 CL E G H50768616OMIM:120330Papillorenal syndrome39
HP:0000505HP:0000505Visual impairment0PAX2 CL E G H50768616ORPHA:1475Renal coloboma syndromeHP:0040282 - Frequent39
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620OMIM:604229Anterior segment dysgenesis 5, multiple subtypes194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620ORPHA:2334Autosomal dominant keratitis194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620OMIM:120200COLOBOMA, OCULAR, AUTOSOMAL DOMINANT194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620OMIM:136520Foveal hypoplasia and presenile cataract syndromefoveal hypoplasia, isolated, included.194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620ORPHA:250923Isolated aniridia194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620ORPHA:137902Isolated optic nerve hypoplasia/aplasia194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620ORPHA:35737Morning glory disc anomaly194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620OMIM:165550OPTIC NERVE HYPOPLASIA, BILATERAL194
HP:0000505HP:0000505Visual impairment0PAX6 CL E G H50808620ORPHA:893WAGR syndromeHP:0040282 - Frequent194
HP:0000505HP:0000505Visual impairment0PCARE CL E G H38893934383ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0PCARE CL E G H38893934383OMIM:613428Retinitis pigmentosa 54
HP:0000505HP:0000505Visual impairment0PCDH12 CL E G H512948657OMIM:251280Microcephaly, seizures, spasticity, and brain calcifications.
HP:0000505HP:0000505Visual impairment0PCDH15 CL E G H6521714674ORPHA:231169Usher syndrome type 1352
HP:0000505HP:0000505Visual impairment0PCYT1A CL E G H51308754ORPHA:65Leber congenital amaurosis11
HP:0000505HP:0000505Visual impairment0PCYT1A CL E G H51308754OMIM:608940Spondylometaphyseal dysplasia with cone-rod dystrophy11
HP:0000505HP:0000505Visual impairment0PCYT1A CL E G H51308754ORPHA:85167Spondylometaphyseal dysplasia-cone-rod dystrophy syndromeHP:0040281 - Very frequent11
HP:0000505HP:0000505Visual impairment0PCYT2 CL E G H58338756OMIM:618770SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82
HP:0000505HP:0000505Visual impairment0PDE4D CL E G H51448783ORPHA:439822PDE4D haploinsufficiency syndromeHP:0040283 - Occasional113
HP:0000505HP:0000505Visual impairment0PDE6A CL E G H51458785ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent116
HP:0000505HP:0000505Visual impairment0PDE6A CL E G H51458785OMIM:613810RETINITIS PIGMENTOSA 43; RP43116
HP:0000505HP:0000505Visual impairment0PDE6B CL E G H51588786ORPHA:215Congenital stationary night blindness126
HP:0000505HP:0000505Visual impairment0PDE6B CL E G H51588786ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent126
HP:0000505HP:0000505Visual impairment0PDE6C CL E G H51468787ORPHA:49382Achromatopsia80
HP:0000505HP:0000505Visual impairment0PDE6C CL E G H51468787OMIM:613093Cone dystrophy 4.80
HP:0000505HP:0000505Visual impairment0PDE6C CL E G H51468787ORPHA:1871Progressive cone dystrophyHP:0040281 - Very frequent80
HP:0000505HP:0000505Visual impairment0PDE6G CL E G H51488789OMIM:268000Retinitis pigmentosa18
HP:0000505HP:0000505Visual impairment0PDE6G CL E G H51488789ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent18
HP:0000505HP:0000505Visual impairment0PDE6G CL E G H51488789OMIM:613582Retinitis pigmentosa 5718
HP:0000505HP:0000505Visual impairment0PDE6H CL E G H51498790ORPHA:49382Achromatopsia14
HP:0000505HP:0000505Visual impairment0PDE6H CL E G H51498790OMIM:610024Retinal cone dystrophy 3A14
HP:0000505HP:0000505Visual impairment0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0000505Visual impairment0PDHA1 CL E G H51608806ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiency88
HP:0000505HP:0000505Visual impairment0PDPN CL E G H1063029602ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0PDSS2 CL E G H5710723041OMIM:614652Coenzyme Q10 deficiency, primary, 354
HP:0000505HP:0000505Visual impairment0PDSS2 CL E G H5710723041ORPHA:255249Leigh syndrome with nephrotic syndrome54
HP:0000505HP:0000505Visual impairment0PDXK CL E G H85668819OMIM:618511Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy.
HP:0000505HP:0000505Visual impairment0PDZD7 CL E G H7995526257ORPHA:231178Usher syndrome type 240
HP:0000505HP:0000505Visual impairment0PDZD8 CL E G H11898726974OMIM:620021
HP:0000505HP:0000505Visual impairment0PEPD CL E G H51848840ORPHA:742Prolidase deficiencyHP:0040282 - Frequent66
HP:0000505HP:0000505Visual impairment0PET100 CL E G H10013180140038OMIM:619055MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN126
HP:0000505HP:0000505Visual impairment0PEX1 CL E G H51898850ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent169
HP:0000505HP:0000505Visual impairment0PEX1 CL E G H51898850ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent169
HP:0000505HP:0000505Visual impairment0PEX1 CL E G H51898850ORPHA:912Zellweger syndromeHP:0040282 - Frequent169
HP:0000505HP:0000505Visual impairment0PEX10 CL E G H51928851ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent75
HP:0000505HP:0000505Visual impairment0PEX10 CL E G H51928851ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent75
HP:0000505HP:0000505Visual impairment0PEX10 CL E G H51928851OMIM:614871Peroxisome biogenesis disorder 6B.75
HP:0000505HP:0000505Visual impairment0PEX10 CL E G H51928851ORPHA:912Zellweger syndromeHP:0040282 - Frequent75
HP:0000505HP:0000505Visual impairment0PEX11B CL E G H87998853ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent4
HP:0000505HP:0000505Visual impairment0PEX11B CL E G H87998853ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent4
HP:0000505HP:0000505Visual impairment0PEX11B CL E G H87998853ORPHA:912Zellweger syndromeHP:0040282 - Frequent4
HP:0000505HP:0000505Visual impairment0PEX12 CL E G H51938854ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent65
HP:0000505HP:0000505Visual impairment0PEX12 CL E G H51938854ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent65
HP:0000505HP:0000505Visual impairment0PEX12 CL E G H51938854ORPHA:912Zellweger syndromeHP:0040282 - Frequent65
HP:0000505HP:0000505Visual impairment0PEX13 CL E G H51948855ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent66
HP:0000505HP:0000505Visual impairment0PEX13 CL E G H51948855ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent66
HP:0000505HP:0000505Visual impairment0PEX13 CL E G H51948855OMIM:614885Peroxisome biogenesis disorder 11B66
HP:0000505HP:0000505Visual impairment0PEX13 CL E G H51948855ORPHA:912Zellweger syndromeHP:0040282 - Frequent66
HP:0000505HP:0000505Visual impairment0PEX14 CL E G H51958856ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent46
HP:0000505HP:0000505Visual impairment0PEX14 CL E G H51958856ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent46
HP:0000505HP:0000505Visual impairment0PEX14 CL E G H51958856ORPHA:912Zellweger syndromeHP:0040282 - Frequent46
HP:0000505HP:0000505Visual impairment0PEX16 CL E G H94098857ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent59
HP:0000505HP:0000505Visual impairment0PEX16 CL E G H94098857ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent59
HP:0000505HP:0000505Visual impairment0PEX16 CL E G H94098857OMIM:614877Peroxisome biogenesis disorder 8B.59
HP:0000505HP:0000505Visual impairment0PEX16 CL E G H94098857ORPHA:912Zellweger syndromeHP:0040282 - Frequent59
HP:0000505HP:0000505Visual impairment0PEX19 CL E G H58249713ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent62
HP:0000505HP:0000505Visual impairment0PEX19 CL E G H58249713ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent62
HP:0000505HP:0000505Visual impairment0PEX19 CL E G H58249713ORPHA:912Zellweger syndromeHP:0040282 - Frequent62
HP:0000505HP:0000505Visual impairment0PEX2 CL E G H58289717ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent82
HP:0000505HP:0000505Visual impairment0PEX2 CL E G H58289717ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent82
HP:0000505HP:0000505Visual impairment0PEX2 CL E G H58289717OMIM:614867Peroxisome biogenesis disorder 5B.82
HP:0000505HP:0000505Visual impairment0PEX2 CL E G H58289717ORPHA:912Zellweger syndromeHP:0040282 - Frequent82
HP:0000505HP:0000505Visual impairment0PEX26 CL E G H5567022965ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent106
HP:0000505HP:0000505Visual impairment0PEX26 CL E G H5567022965ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent106
HP:0000505HP:0000505Visual impairment0PEX26 CL E G H5567022965OMIM:614873Peroxisome biogenesis disorder 7B.106
HP:0000505HP:0000505Visual impairment0PEX26 CL E G H5567022965ORPHA:912Zellweger syndromeHP:0040282 - Frequent106
HP:0000505HP:0000505Visual impairment0PEX3 CL E G H85048858ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent47
HP:0000505HP:0000505Visual impairment0PEX3 CL E G H85048858ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent47
HP:0000505HP:0000505Visual impairment0PEX3 CL E G H85048858ORPHA:912Zellweger syndromeHP:0040282 - Frequent47
HP:0000505HP:0000505Visual impairment0PEX5 CL E G H58309719ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent99
HP:0000505HP:0000505Visual impairment0PEX5 CL E G H58309719ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent99
HP:0000505HP:0000505Visual impairment0PEX5 CL E G H58309719ORPHA:912Zellweger syndromeHP:0040282 - Frequent99
HP:0000505HP:0000505Visual impairment0PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome98
HP:0000505HP:0000505Visual impairment0PEX6 CL E G H51908859ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent98
HP:0000505HP:0000505Visual impairment0PEX6 CL E G H51908859ORPHA:44Neonatal adrenoleukodystrophyHP:0040282 - Frequent98
HP:0000505HP:0000505Visual impairment0PEX6 CL E G H51908859OMIM:614863Peroxisome biogenesis disorder 4B.98
HP:0000505HP:0000505Visual impairment0PEX6 CL E G H51908859ORPHA:912Zellweger syndromeHP:0040282 - Frequent98
HP:0000505HP:0000505Visual impairment0PEX7 CL E G H51918860ORPHA:773Refsum diseaseHP:0040282 - Frequent72
HP:0000505HP:0000505Visual impairment0PGAP1 CL E G H8005525712OMIM:615802MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT4220
HP:0000505HP:0000505Visual impairment0PGK1 CL E G H52308896ORPHA:713Glycogen storage disease due to phosphoglycerate kinase 1 deficiency21
HP:0000505HP:0000505Visual impairment0PGK1 CL E G H52308896OMIM:300653Phosphoglycerate kinase 1 deficiency21
HP:0000505HP:0000505Visual impairment0PHF6 CL E G H8429518145OMIM:301900Borjeson-Forssman-Lehmann syndrome.29
HP:0000505HP:0000505Visual impairment0PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form37
HP:0000505HP:0000505Visual impairment0PHOX2A CL E G H401691OMIM:602078Fibrosis of extraocular muscles, congenital, 2.6
HP:0000505HP:0000505Visual impairment0PHYH CL E G H52648940ORPHA:773Refsum diseaseHP:0040282 - Frequent45
HP:0000505HP:0000505Visual impairment0PI4KA CL E G H52978983OMIM:619708GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2; GIDID211
HP:0000505HP:0000505Visual impairment0PIEZO2 CL E G H6389526270ORPHA:1154Arthrogryposis-oculomotor limitation-electroretinal anomalies syndromeHP:0040282 - Frequent77
HP:0000505HP:0000505Visual impairment0PIGA CL E G H52778957OMIM:300868Multiple congenital anomalies-hypotonia-seizures syndrome 246
HP:0000505HP:0000505Visual impairment0PIGA CL E G H52778957OMIM:301072NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH46
HP:0000505HP:0000505Visual impairment0PIGB CL E G H94888959OMIM:618580DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80; DEE80
HP:0000505HP:0000505Visual impairment0PIGN CL E G H235568967ORPHA:280633Multiple congenital anomalies-hypotonia-seizures syndrome37
HP:0000505HP:0000505Visual impairment0PIGN CL E G H235568967OMIM:614080Multiple congenital anomalies-hypotonia-seizures syndrome 137
HP:0000505HP:0000505Visual impairment0PIGP CL E G H512273046OMIM:617599Epileptic encephalopathy, early infantile, 552
HP:0000505HP:0000505Visual impairment0PIGQ CL E G H909114135OMIM:618548MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4; MCAHS43
HP:0000505HP:0000505Visual impairment0PIGS CL E G H9400514937OMIM:618143GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18
HP:0000505HP:0000505Visual impairment0PIGT CL E G H5160414938ORPHA:369837Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome12
HP:0000505HP:0000505Visual impairment0PIGT CL E G H5160414938OMIM:615398Multiple congenital anomalies-hypotonia-seizures syndrome 3.12
HP:0000505HP:0000505Visual impairment0PIGU CL E G H12886915791OMIM:618590NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS
HP:0000505HP:0000505Visual impairment0PIGY CL E G H8499228213OMIM:616809Hyperphosphatasia with mental retardation syndrome 62
HP:0000505HP:0000505Visual impairment0PIK3CA CL E G H52908975ORPHA:99802Hemimegalencephaly162
HP:0000505HP:0000505Visual impairment0PIK3CA CL E G H52908975ORPHA:144Lynch syndromeHP:0040283 - Occasional162
HP:0000505HP:0000505Visual impairment0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0000505Visual impairment0PIK3R2 CL E G H52968980OMIM:603387Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome12
HP:0000505HP:0000505Visual impairment0PITPNM3 CL E G H8339421043ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional135
HP:0000505HP:0000505Visual impairment0PITPNM3 CL E G H8339421043OMIM:600977Cone-Rod dystrophy 5135
HP:0000505HP:0000505Visual impairment0PITX2 CL E G H53089005OMIM:180550Ring dermoid of cornea51
HP:0000505HP:0000505Visual impairment0PITX3 CL E G H53099006OMIM:610623Cataract 11, multiple types6
HP:0000505HP:0000505Visual impairment0PLA2G6 CL E G H83989039ORPHA:35069Infantile neuroaxonal dystrophy133
HP:0000505HP:0000505Visual impairment0PLA2G6 CL E G H83989039OMIM:256600Neurodegeneration with brain iron accumulation 2A133
HP:0000505HP:0000505Visual impairment0PLCH1 CL E G H2300729185ORPHA:93925Alobar holoprosencephaly
HP:0000505HP:0000505Visual impairment0PLEKHM1 CL E G H984229017ORPHA:210110Intermediate osteopetrosisHP:0040284 - Very rare2
HP:0000505HP:0000505Visual impairment0PLG CL E G H53409071OMIM:217090Plasminogen deficiency, type iligneous conjunctivitis, included11
HP:0000505HP:0000505Visual impairment0PLK4 CL E G H1073311397ORPHA:2518Autosomal recessive chorioretinopathy-microcephaly syndromeHP:0040282 - Frequent11
HP:0000505HP:0000505Visual impairment0PLK4 CL E G H1073311397OMIM:616171Microcephaly and chorioretinopathy, autosomal recessive, 2.11
HP:0000505HP:0000505Visual impairment0PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1105
HP:0000505HP:0000505Visual impairment0PLXND1 CL E G H231299107ORPHA:570Moebius syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0PMPCB CL E G H95129119OMIM:617954Multiple mitochondrial dysfunctions syndrome 6
HP:0000505HP:0000505Visual impairment0PMS1 CL E G H53789121ORPHA:144Lynch syndromeHP:0040283 - Occasional56
HP:0000505HP:0000505Visual impairment0PMS2 CL E G H53959122ORPHA:144Lynch syndromeHP:0040283 - Occasional1121
HP:0000505HP:0000505Visual impairment0PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0000505HP:0000505Visual impairment0PNPT1 CL E G H8717823166OMIM:608703Spinocerebellar ataxia 25.60
HP:0000505HP:0000505Visual impairment0PNPT1 CL E G H8717823166ORPHA:101111Spinocerebellar ataxia type 2560
HP:0000505HP:0000505Visual impairment0POC1B CL E G H28280930836ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0POC1B CL E G H28280930836OMIM:615973Cone-Rod dystrophy 20.3
HP:0000505HP:0000505Visual impairment0POGZ CL E G H2312618801ORPHA:468678White-Sutton syndromeHP:0040282 - Frequent35
HP:0000505HP:0000505Visual impairment0POGZ CL E G H2312618801OMIM:616364White-Sutton syndrome35
HP:0000505HP:0000505Visual impairment0POLA1 CL E G H54229173OMIM:301220PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR2
HP:0000505HP:0000505Visual impairment0POLG CL E G H54289179ORPHA:726Alpers-Huttenlocher syndrome464
HP:0000505HP:0000505Visual impairment0POLG CL E G H54289179ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040283 - Occasional464
HP:0000505HP:0000505Visual impairment0POLG CL E G H54289179ORPHA:254886Autosomal recessive progressive external ophthalmoplegiaHP:0040283 - Occasional464
HP:0000505HP:0000505Visual impairment0POLG CL E G H54289179OMIM:203700Mitochondrial DNA depletion syndrome 4A (Alpers type)464
HP:0000505HP:0000505Visual impairment0POLG CL E G H54289179OMIM:258450Progressive external ophthalmoplegia with mitochondrial DNA deletions,autosomal recessiveHP:0040283 - Occasional464
HP:0000505HP:0000505Visual impairment0POLG2 CL E G H112329180ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040283 - Occasional45
HP:0000505HP:0000505Visual impairment0POLG2 CL E G H112329180OMIM:619425MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE); MTDPS16B45
HP:0000505HP:0000505Visual impairment0POLG2 CL E G H112329180OMIM:610131Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 445
HP:0000505HP:0000505Visual impairment0POLR1B CL E G H8417220454ORPHA:861Treacher-Collins syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0POLR1C CL E G H953320194ORPHA:861Treacher-Collins syndromeHP:0040282 - Frequent38
HP:0000505HP:0000505Visual impairment0POLR1D CL E G H5108220422ORPHA:861Treacher-Collins syndromeHP:0040282 - Frequent31
HP:0000505HP:0000505Visual impairment0POLR2A CL E G H54309187OMIM:618603NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB
HP:0000505HP:0000505Visual impairment0POLR3GL CL E G H8426528466OMIM:619234SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM
HP:0000505HP:0000505Visual impairment0POMGNT1 CL E G H5562419139ORPHA:370959Congenital muscular dystrophy with cerebellar involvement180
HP:0000505HP:0000505Visual impairment0POMGNT1 CL E G H5562419139ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent180
HP:0000505HP:0000505Visual impairment0POMGNT1 CL E G H5562419139ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent180
HP:0000505HP:0000505Visual impairment0POMGNT1 CL E G H5562419139OMIM:617123RETINITIS PIGMENTOSA 76; RP76180
HP:0000505HP:0000505Visual impairment0POMK CL E G H8419726267ORPHA:370959Congenital muscular dystrophy with cerebellar involvement18
HP:0000505HP:0000505Visual impairment0POMK CL E G H8419726267OMIM:615249MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12.18
HP:0000505HP:0000505Visual impairment0POMT1 CL E G H105859202ORPHA:370959Congenital muscular dystrophy with cerebellar involvement213
HP:0000505HP:0000505Visual impairment0POMT1 CL E G H105859202ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent213
HP:0000505HP:0000505Visual impairment0POMT1 CL E G H105859202OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1213
HP:0000505HP:0000505Visual impairment0POMT2 CL E G H2995419743ORPHA:370959Congenital muscular dystrophy with cerebellar involvement221
HP:0000505HP:0000505Visual impairment0POMT2 CL E G H2995419743ORPHA:588Muscle-eye-brain diseaseHP:0040281 - Very frequent221
HP:0000505HP:0000505Visual impairment0POMT2 CL E G H2995419743OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1221
HP:0000505HP:0000505Visual impairment0PORCN CL E G H6484017652OMIM:305600Focal dermal hypoplasia.20
HP:0000505HP:0000505Visual impairment0POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndrome40
HP:0000505HP:0000505Visual impairment0PPP1R12A CL E G H46597618OMIM:618820GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS
HP:0000505HP:0000505Visual impairment0PPP2CA CL E G H55159299OMIM:618354Neurodevelopmental disorder and language delay with or without structural brain abnormalities.2
HP:0000505HP:0000505Visual impairment0PPP2R1A CL E G H55189302OMIM:616362Mental retardation, autosomal dominant 3613
HP:0000505HP:0000505Visual impairment0PPP2R1A CL E G H55189302ORPHA:457284Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome13
HP:0000505HP:0000505Visual impairment0PPP3CA CL E G H55309314OMIM:617711Epileptic encephalopathy, infantile or early childhood, 12
HP:0000505HP:0000505Visual impairment0PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1172
HP:0000505HP:0000505Visual impairment0PQBP1 CL E G H100849330OMIM:309500Renpenning syndrome28
HP:0000505HP:0000505Visual impairment0PRCD CL E G H76820632528ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent39
HP:0000505HP:0000505Visual impairment0PRDM16 CL E G H6397614000ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional148
HP:0000505HP:0000505Visual impairment0PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndrome58
HP:0000505HP:0000505Visual impairment0PRDX1 CL E G H50529352OMIM:277400Methylmalonic aciduria and homocystinuria, Cblc type.
HP:0000505HP:0000505Visual impairment0PRIMPOL CL E G H20197326575OMIM:615420Myopia 22, autosomal dominant.1
HP:0000505HP:0000505Visual impairment0PRKCZ CL E G H55909412ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0PRKDC CL E G H55919413OMIM:615966Immunodeficiency 26 with or without neurologic abnormalitiesHP:0040283 - Occasional42
HP:0000505HP:0000505Visual impairment0PRNP CL E G H56219449OMIM:123400Creutzfeldt-Jakob disease.69
HP:0000505HP:0000505Visual impairment0PROK2 CL E G H6067518455ORPHA:478Kallmann syndromeHP:0040283 - Occasional9
HP:0000505HP:0000505Visual impairment0PROKR2 CL E G H12867415836ORPHA:478Kallmann syndromeHP:0040283 - Occasional34
HP:0000505HP:0000505Visual impairment0PROKR2 CL E G H12867415836ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent34
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional110
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454OMIM:612657CONE-ROD DYSTROPHY 12; CORD12110
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454OMIM:608051Macular dystrophy, retinal, 2110
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent110
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454ORPHA:827Stargardt disease110
HP:0000505HP:0000505Visual impairment0PROM1 CL E G H88429454OMIM:603786Stargardt disease 4110
HP:0000505HP:0000505Visual impairment0PRORP CL E G H969219958OMIM:619737COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54; COXPD54
HP:0000505HP:0000505Visual impairment0PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive75
HP:0000505HP:0000505Visual impairment0PRPF3 CL E G H912917348ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent28
HP:0000505HP:0000505Visual impairment0PRPF3 CL E G H912917348OMIM:601414Retinitis pigmentosa 1828
HP:0000505HP:0000505Visual impairment0PRPF31 CL E G H2612115446ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent70
HP:0000505HP:0000505Visual impairment0PRPF31 CL E G H2612115446OMIM:600138Retinitis pigmentosa 1170
HP:0000505HP:0000505Visual impairment0PRPF4 CL E G H912817349ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent2
HP:0000505HP:0000505Visual impairment0PRPF6 CL E G H2414815860ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent51
HP:0000505HP:0000505Visual impairment0PRPF6 CL E G H2414815860OMIM:613983Retinitis pigmentosa 60.51
HP:0000505HP:0000505Visual impairment0PRPF8 CL E G H1059417340ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent94
HP:0000505HP:0000505Visual impairment0PRPF8 CL E G H1059417340OMIM:600059Retinitis pigmentosa 1394
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040281 - Very frequent159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942OMIM:608161Macular dystrophy, vitelliform, 3.HP:0003581 - Adult onset159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942OMIM:608133Retinitis pigmentosa 7159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescens159
HP:0000505HP:0000505Visual impairment0PRPH2 CL E G H59619942ORPHA:827Stargardt disease159
HP:0000505HP:0000505Visual impairment0PRPS1 CL E G H56319462OMIM:301835Arts syndrome49
HP:0000505HP:0000505Visual impairment0PRPS1 CL E G H56319462OMIM:311070Charcot-Marie-Tooth disease, X-linked recessive, 549
HP:0000505HP:0000505Visual impairment0PRPS1 CL E G H56319462ORPHA:1187Lethal ataxia with deafness and optic atrophyHP:0040281 - Very frequent49
HP:0000505HP:0000505Visual impairment0PRR12 CL E G H5747929217OMIM:619539NEUROOCULAR SYNDROME; NOC1
HP:0000505HP:0000505Visual impairment0PRRT2 CL E G H11247630500ORPHA:569Familial or sporadic hemiplegic migraine94
HP:0000505HP:0000505Visual impairment0PRTN3 CL E G H56579495ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0PRUNE1 CL E G H5849713420ORPHA:544469PRUNE1-related neurological syndrome8
HP:0000505HP:0000505Visual impairment0PSAP CL E G H56609498ORPHA:206436Infantile Krabbe disease81
HP:0000505HP:0000505Visual impairment0PSAP CL E G H56609498ORPHA:309271Metachromatic leukodystrophy, adult form81
HP:0000505HP:0000505Visual impairment0PSAP CL E G H56609498ORPHA:309263Metachromatic leukodystrophy, juvenile form81
HP:0000505HP:0000505Visual impairment0PSAP CL E G H56609498ORPHA:309256Metachromatic leukodystrophy, late infantile form81
HP:0000505HP:0000505Visual impairment0PSMD12 CL E G H57189557OMIM:617516Stankiewicz-Isidor syndrome4
HP:0000505HP:0000505Visual impairment0PTCH1 CL E G H57279585ORPHA:93925Alobar holoprosencephaly665
HP:0000505HP:0000505Visual impairment0PTCH1 CL E G H57279585ORPHA:93924Lobar holoprosencephaly665
HP:0000505HP:0000505Visual impairment0PTCH1 CL E G H57279585ORPHA:93926Midline interhemispheric variant of holoprosencephaly665
HP:0000505HP:0000505Visual impairment0PTCH1 CL E G H57279585ORPHA:220386Semilobar holoprosencephaly665
HP:0000505HP:0000505Visual impairment0PTPN2 CL E G H57719650ORPHA:85410Oligoarticular juvenile idiopathic arthritis
HP:0000505HP:0000505Visual impairment0PTPN22 CL E G H261919652ORPHA:397Giant cell arteritisHP:0040282 - Frequent3
HP:0000505HP:0000505Visual impairment0PTPN22 CL E G H261919652ORPHA:900Granulomatosis with polyangiitisHP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0PTPN22 CL E G H261919652ORPHA:85410Oligoarticular juvenile idiopathic arthritis3
HP:0000505HP:0000505Visual impairment0PTPN22 CL E G H261919652ORPHA:3437Vogt-Koyanagi-Harada diseaseHP:0040282 - Frequent3
HP:0000505HP:0000505Visual impairment0PUF60 CL E G H2282717042ORPHA:5084888q24.3 microdeletion syndrome19
HP:0000505HP:0000505Visual impairment0PUF60 CL E G H2282717042ORPHA:508498Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome19
HP:0000505HP:0000505Visual impairment0PUS3 CL E G H8348025461ORPHA:488627Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndromeHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0PXDN CL E G H783714966OMIM:269400Corneal opacification with other ocular anomalies22
HP:0000505HP:0000505Visual impairment0PYCR2 CL E G H2992030262ORPHA:481152PYCR2-related microcephaly-progressive leukoencephalopathy11
HP:0000505HP:0000505Visual impairment0RAB11B CL E G H92309761OMIM:617807Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter.
HP:0000505HP:0000505Visual impairment0RAB18 CL E G H2293114244ORPHA:2510Micro syndrome85
HP:0000505HP:0000505Visual impairment0RAB18 CL E G H2293114244OMIM:614222Warburg micro syndrome 385
HP:0000505HP:0000505Visual impairment0RAB28 CL E G H93649768ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional6
HP:0000505HP:0000505Visual impairment0RAB28 CL E G H93649768OMIM:615374Cone-Rod dystrophy 186
HP:0000505HP:0000505Visual impairment0RAB3GAP1 CL E G H2293017063ORPHA:2510Micro syndrome90
HP:0000505HP:0000505Visual impairment0RAB3GAP2 CL E G H2578217168ORPHA:2510Micro syndrome135
HP:0000505HP:0000505Visual impairment0RAC1 CL E G H58799801ORPHA:500159Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom3
HP:0000505HP:0000505Visual impairment0RAD51 CL E G H58889817ORPHA:84Fanconi anemiaHP:0040283 - Occasional9
HP:0000505HP:0000505Visual impairment0RAD51C CL E G H58899820ORPHA:84Fanconi anemiaHP:0040283 - Occasional391
HP:0000505HP:0000505Visual impairment0RALGAPA1 CL E G H25395917770OMIM:618797NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT1
HP:0000505HP:0000505Visual impairment0RAX2 CL E G H8483918286OMIM:62010252
HP:0000505HP:0000505Visual impairment0RAX2 CL E G H8483918286ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional52
HP:0000505HP:0000505Visual impairment0RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 1152
HP:0000505HP:0000505Visual impairment0RBP3 CL E G H59499921ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent108
HP:0000505HP:0000505Visual impairment0RBP3 CL E G H59499921OMIM:268000Retinitis pigmentosa108
HP:0000505HP:0000505Visual impairment0RBP3 CL E G H59499921OMIM:615233Retinitis pigmentosa 66.108
HP:0000505HP:0000505Visual impairment0RBP4 CL E G H59509922OMIM:615147Retinal dystrophy, iris coloboma, and comedogenic acne syndrome.8
HP:0000505HP:0000505Visual impairment0RCBTB1 CL E G H5521318243OMIM:617175RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA8
HP:0000505HP:0000505Visual impairment0RD3 CL E G H34303519689ORPHA:65Leber congenital amaurosis95
HP:0000505HP:0000505Visual impairment0RD3 CL E G H34303519689OMIM:610612Leber congenital amaurosis 1295
HP:0000505HP:0000505Visual impairment0RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome2
HP:0000505HP:0000505Visual impairment0RDH12 CL E G H14522619977ORPHA:65Leber congenital amaurosis45
HP:0000505HP:0000505Visual impairment0RDH12 CL E G H14522619977OMIM:612712Leber congenital amaurosis 1345
HP:0000505HP:0000505Visual impairment0RDH12 CL E G H14522619977ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent45
HP:0000505HP:0000505Visual impairment0RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescens32
HP:0000505HP:0000505Visual impairment0REEP6 CL E G H9284030078ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent5
HP:0000505HP:0000505Visual impairment0REEP6 CL E G H9284030078OMIM:617304Retinitis pigmentosa 775
HP:0000505HP:0000505Visual impairment0RERE CL E G H4739965ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional16
HP:0000505HP:0000505Visual impairment0RERE CL E G H4739965ORPHA:494344RERE-related neurodevelopmental syndrome16
HP:0000505HP:0000505Visual impairment0REV3L CL E G H59809968ORPHA:570Moebius syndromeHP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0RFC2 CL E G H59829970ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0RFT1 CL E G H9186930220OMIM:612015Congenital disorder of glycosylation, type IN92
HP:0000505HP:0000505Visual impairment0RFT1 CL E G H9186930220ORPHA:244310RFT1-CDGHP:0040282 - Frequent92
HP:0000505HP:0000505Visual impairment0RFWD3 CL E G H5515925539ORPHA:84Fanconi anemiaHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0RGR CL E G H59959990ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent28
HP:0000505HP:0000505Visual impairment0RGR CL E G H59959990OMIM:613769RETINITIS PIGMENTOSA 44; RP4428
HP:0000505HP:0000505Visual impairment0RGS9 CL E G H878710004ORPHA:75374BradyopsiaHP:0040281 - Very frequent9
HP:0000505HP:0000505Visual impairment0RGS9BP CL E G H38853130304ORPHA:75374BradyopsiaHP:0040281 - Very frequent6
HP:0000505HP:0000505Visual impairment0RHO CL E G H601010012ORPHA:215Congenital stationary night blindness107
HP:0000505HP:0000505Visual impairment0RHO CL E G H601010012OMIM:610445Night blindness, congenital stationary, autosomal dominant 1107
HP:0000505HP:0000505Visual impairment0RHO CL E G H601010012ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent107
HP:0000505HP:0000505Visual impairment0RHO CL E G H601010012OMIM:613731Retinitis pigmentosa 4107
HP:0000505HP:0000505Visual impairment0RHO CL E G H601010012ORPHA:52427Retinitis punctata albescens107
HP:0000505HP:0000505Visual impairment0RHOA CL E G H387667OMIM:618727ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES; EDFAOB8
HP:0000505HP:0000505Visual impairment0RIC1 CL E G H5758917686OMIM:618761CATIFA SYNDROME; CATIFA
HP:0000505HP:0000505Visual impairment0RIMS1 CL E G H2299917282ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional102
HP:0000505HP:0000505Visual impairment0RIMS1 CL E G H2299917282OMIM:603649CONE-ROD DYSTROPHY 7; CORD7102
HP:0000505HP:0000505Visual impairment0RIMS2 CL E G H969917283OMIM:618970CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE; CRSDS2
HP:0000505HP:0000505Visual impairment0RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophy47
HP:0000505HP:0000505Visual impairment0RLBP1 CL E G H601710024OMIM:607476NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD47
HP:0000505HP:0000505Visual impairment0RLBP1 CL E G H601710024ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent47
HP:0000505HP:0000505Visual impairment0RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescens47
HP:0000505HP:0000505Visual impairment0RMRP CL E G H602310031ORPHA:175Cartilage-hair hypoplasiaHP:0040281 - Very frequent37
HP:0000505HP:0000505Visual impairment0RNF13 CL E G H1134210057OMIM:618379DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73; DEE73
HP:0000505HP:0000505Visual impairment0RNF13 CL E G H1134210057ORPHA:544503RNF13-related severe early-onset epileptic encephalopathy
HP:0000505HP:0000505Visual impairment0RNU4ATAC CL E G H10015168334016OMIM:226960EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS15
HP:0000505HP:0000505Visual impairment0RNU4ATAC CL E G H10015168334016ORPHA:1824Lowry-Wood syndromeHP:0040283 - Occasional15
HP:0000505HP:0000505Visual impairment0ROM1 CL E G H609410254OMIM:268000Retinitis pigmentosa38
HP:0000505HP:0000505Visual impairment0ROM1 CL E G H609410254ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent38
HP:0000505HP:0000505Visual impairment0ROM1 CL E G H609410254OMIM:608133Retinitis pigmentosa 738
HP:0000505HP:0000505Visual impairment0RORA CL E G H609510258OMIM:618060INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA1
HP:0000505HP:0000505Visual impairment0RP1 CL E G H610110263ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent111
HP:0000505HP:0000505Visual impairment0RP1 CL E G H610110263OMIM:180100Retinitis pigmentosa 1111
HP:0000505HP:0000505Visual impairment0RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000505HP:0000505Visual impairment0RP1L1 CL E G H9413715946ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent284
HP:0000505HP:0000505Visual impairment0RP1L1 CL E G H9413715946OMIM:618826RETINITIS PIGMENTOSA 88; RP88284
HP:0000505HP:0000505Visual impairment0RP2 CL E G H610210274ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent45
HP:0000505HP:0000505Visual impairment0RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked45
HP:0000505HP:0000505Visual impairment0RP9 CL E G H610010288ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent14
HP:0000505HP:0000505Visual impairment0RP9 CL E G H610010288OMIM:180104Retinitis pigmentosa 914
HP:0000505HP:0000505Visual impairment0RPE65 CL E G H612110294ORPHA:65Leber congenital amaurosis129
HP:0000505HP:0000505Visual impairment0RPE65 CL E G H612110294OMIM:204100Leber congenital amaurosis, type II129
HP:0000505HP:0000505Visual impairment0RPE65 CL E G H612110294ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent129
HP:0000505HP:0000505Visual impairment0RPE65 CL E G H612110294OMIM:613794Retinitis pigmentosa 20.129
HP:0000505HP:0000505Visual impairment0RPE65 CL E G H612110294OMIM:618697RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87129
HP:0000505HP:0000505Visual impairment0RPE65 CL E G H612110294ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent129
HP:0000505HP:0000505Visual impairment0RPGR CL E G H610310295ORPHA:49382Achromatopsia200
HP:0000505HP:0000505Visual impairment0RPGR CL E G H610310295ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional200
HP:0000505HP:0000505Visual impairment0RPGR CL E G H610310295OMIM:304020Cone-rod dystrophy, X-linked, 1200
HP:0000505HP:0000505Visual impairment0RPGR CL E G H610310295OMIM:300834MACULAR DEGENERATION, X-LINKED ATROPHIC200
HP:0000505HP:0000505Visual impairment0RPGR CL E G H610310295ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent200
HP:0000505HP:0000505Visual impairment0RPGR CL E G H610310295OMIM:300029Retinitis pigmentosa 3200
HP:0000505HP:0000505Visual impairment0RPGRIP1 CL E G H5709613436ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional109
HP:0000505HP:0000505Visual impairment0RPGRIP1 CL E G H5709613436OMIM:608194CONE-ROD DYSTROPHY 13; CORD13109
HP:0000505HP:0000505Visual impairment0RPGRIP1 CL E G H5709613436ORPHA:65Leber congenital amaurosis109
HP:0000505HP:0000505Visual impairment0RPGRIP1 CL E G H5709613436OMIM:613826Leber congenital amaurosis 6109
HP:0000505HP:0000505Visual impairment0RPGRIP1L CL E G H2332229168ORPHA:1454Joubert syndrome with hepatic defectHP:0040282 - Frequent167
HP:0000505HP:0000505Visual impairment0RPS20 CL E G H622410405ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0RRAS2 CL E G H2280017271OMIM:618624NOONAN SYNDROME 12; NS121
HP:0000505HP:0000505Visual impairment0RRM2B CL E G H5048417296ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040283 - Occasional125
HP:0000505HP:0000505Visual impairment0RRM2B CL E G H5048417296OMIM:268315ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION125
HP:0000505HP:0000505Visual impairment0RS1 CL E G H624710457OMIM:312700Retinoschisis 1, X-linked, juvenile148
HP:0000505HP:0000505Visual impairment0RTN4IP1 CL E G H8481618647OMIM:616732OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA102
HP:0000505HP:0000505Visual impairment0SAG CL E G H629510521ORPHA:215Congenital stationary night blindness32
HP:0000505HP:0000505Visual impairment0SAG CL E G H629510521ORPHA:75382Oguchi diseaseHP:0040284 - Very rare32
HP:0000505HP:0000505Visual impairment0SAG CL E G H629510521ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent32
HP:0000505HP:0000505Visual impairment0SAG CL E G H629510521OMIM:613758RETINITIS PIGMENTOSA 47; RP4732
HP:0000505HP:0000505Visual impairment0SALL2 CL E G H629710526OMIM:216820COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE1
HP:0000505HP:0000505Visual impairment0SALL4 CL E G H5716715924ORPHA:959Acro-renal-ocular syndromeHP:0040282 - Frequent86
HP:0000505HP:0000505Visual impairment0SALL4 CL E G H5716715924ORPHA:233Duane retraction syndrome86
HP:0000505HP:0000505Visual impairment0SAR1B CL E G H5112810535ORPHA:71Chylomicron retention diseaseHP:0040283 - Occasional8
HP:0000505HP:0000505Visual impairment0SARDH CL E G H175710536ORPHA:3129Sarcosinemia4
HP:0000505HP:0000505Visual impairment0SCAPER CL E G H4985513081OMIM:618195Intellectual developmental disorder and retinitis pigmentosa
HP:0000505HP:0000505Visual impairment0SCAPER CL E G H4985513081ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000505Visual impairment0SCN1A CL E G H632310585OMIM:607208Epileptic encephalopathy, early infantile, 6 (Dravet syndrome)1053
HP:0000505HP:0000505Visual impairment0SCN1A CL E G H632310585ORPHA:569Familial or sporadic hemiplegic migraine1053
HP:0000505HP:0000505Visual impairment0SCN1A CL E G H632310585OMIM:609634Migraine, familial hemiplegic, 31053
HP:0000505HP:0000505Visual impairment0SCN3A CL E G H632810590OMIM:617938EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE6270
HP:0000505HP:0000505Visual impairment0SCN8A CL E G H633410596OMIM:614306Cognitive impairment with or without cerebellar ataxia357
HP:0000505HP:0000505Visual impairment0SCO2 CL E G H999710604ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional40
HP:0000505HP:0000505Visual impairment0SDCCAG8 CL E G H1080610671ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent61
HP:0000505HP:0000505Visual impairment0SDHA CL E G H638910680ORPHA:3208Isolated succinate-CoQ reductase deficiency304
HP:0000505HP:0000505Visual impairment0SDHA CL E G H638910680OMIM:252011Mitochondrial complex II deficiency.304
HP:0000505HP:0000505Visual impairment0SDHA CL E G H638910680OMIM:619259NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA304
HP:0000505HP:0000505Visual impairment0SDHAF1 CL E G H64409633867ORPHA:3208Isolated succinate-CoQ reductase deficiency16
HP:0000505HP:0000505Visual impairment0SDHB CL E G H639010681ORPHA:3208Isolated succinate-CoQ reductase deficiency237
HP:0000505HP:0000505Visual impairment0SDHD CL E G H639210683ORPHA:3208Isolated succinate-CoQ reductase deficiency129
HP:0000505HP:0000505Visual impairment0SDHD CL E G H639210683OMIM:619167MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; MC2DN3129
HP:0000505HP:0000505Visual impairment0SELENOI CL E G H8546529361ORPHA:506353Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction
HP:0000505HP:0000505Visual impairment0SELENOI CL E G H8546529361OMIM:618768SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81
HP:0000505HP:0000505Visual impairment0SEMA3A CL E G H1037110723ORPHA:478Kallmann syndromeHP:0040283 - Occasional14
HP:0000505HP:0000505Visual impairment0SEMA4A CL E G H6421810729ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional48
HP:0000505HP:0000505Visual impairment0SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 1048
HP:0000505HP:0000505Visual impairment0SEMA4A CL E G H6421810729ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional48
HP:0000505HP:0000505Visual impairment0SEMA4A CL E G H6421810729ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent48
HP:0000505HP:0000505Visual impairment0SEMA4A CL E G H6421810729OMIM:610282Retinitis pigmentosa 3548
HP:0000505HP:0000505Visual impairment0SEPSECS CL E G H5109130605ORPHA:2524Pontocerebellar hypoplasia type 266
HP:0000505HP:0000505Visual impairment0SETBP1 CL E G H2604015573OMIM:616078Mental retardation, autosomal dominant 29143
HP:0000505HP:0000505Visual impairment0SETBP1 CL E G H2604015573ORPHA:798Schinzel-Giedion syndromeHP:0040282 - Frequent143
HP:0000505HP:0000505Visual impairment0SETD1A CL E G H973929010OMIM:619056NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES; NEDSID6
HP:0000505HP:0000505Visual impairment0SETD5 CL E G H5520925566ORPHA:404440Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency43
HP:0000505HP:0000505Visual impairment0SF3B1 CL E G H2345110768ORPHA:39044Uveal melanoma19
HP:0000505HP:0000505Visual impairment0SF3B2 CL E G H1099210769OMIM:164210Hemifacial microsomia2
HP:0000505HP:0000505Visual impairment0SFXN4 CL E G H11955916088OMIM:615578Combined oxidative phosphorylation deficiency 18.17
HP:0000505HP:0000505Visual impairment0SH3BP2 CL E G H645210825ORPHA:184CherubismHP:0040283 - Occasional177
HP:0000505HP:0000505Visual impairment0SH3BP2 CL E G H645210825OMIM:118400Cherubism177
HP:0000505HP:0000505Visual impairment0SH3TC2 CL E G H7962829427ORPHA:99949Charcot-Marie-Tooth disease type 4C493
HP:0000505HP:0000505Visual impairment0SHANK3 CL E G H8535814294OMIM:606232Phelan-Mcdermid syndrome53
HP:0000505HP:0000505Visual impairment0SHH CL E G H646910848ORPHA:93925Alobar holoprosencephaly67
HP:0000505HP:0000505Visual impairment0SHH CL E G H646910848ORPHA:93924Lobar holoprosencephaly67
HP:0000505HP:0000505Visual impairment0SHH CL E G H646910848ORPHA:93926Midline interhemispheric variant of holoprosencephaly67
HP:0000505HP:0000505Visual impairment0SHH CL E G H646910848ORPHA:220386Semilobar holoprosencephaly67
HP:0000505HP:0000505Visual impairment0SIX3 CL E G H649610889ORPHA:93925Alobar holoprosencephaly32
HP:0000505HP:0000505Visual impairment0SIX3 CL E G H649610889ORPHA:93924Lobar holoprosencephaly32
HP:0000505HP:0000505Visual impairment0SIX3 CL E G H649610889ORPHA:93926Midline interhemispheric variant of holoprosencephaly32
HP:0000505HP:0000505Visual impairment0SIX3 CL E G H649610889ORPHA:220386Semilobar holoprosencephaly32
HP:0000505HP:0000505Visual impairment0SKI CL E G H649710896ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional150
HP:0000505HP:0000505Visual impairment0SLC19A2 CL E G H1056010938ORPHA:49827Thiamine-responsive megaloblastic anemia syndrome55
HP:0000505HP:0000505Visual impairment0SLC19A2 CL E G H1056010938OMIM:249270Thiamine-Responsive megaloblastic anemia syndrome55
HP:0000505HP:0000505Visual impairment0SLC1A3 CL E G H650710941ORPHA:209967Episodic ataxia type 663
HP:0000505HP:0000505Visual impairment0SLC24A1 CL E G H918710975ORPHA:215Congenital stationary night blindness66
HP:0000505HP:0000505Visual impairment0SLC24A1 CL E G H918710975OMIM:613830Night blindness, congenital stationary, type 1D66
HP:0000505HP:0000505Visual impairment0SLC24A5 CL E G H28365220611OMIM:113750Albinism, oculocutaneous, type VI.12
HP:0000505HP:0000505Visual impairment0SLC24A5 CL E G H28365220611ORPHA:370097Oculocutaneous albinism type 612
HP:0000505HP:0000505Visual impairment0SLC25A1 CL E G H657610979OMIM:615182Combined d-2- and l-2-hydroxyglutaric aciduria28
HP:0000505HP:0000505Visual impairment0SLC25A4 CL E G H29110990ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040283 - Occasional68
HP:0000505HP:0000505Visual impairment0SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0000505HP:0000505Visual impairment0SLC25A46 CL E G H9113725198ORPHA:2254Pontocerebellar hypoplasia type 114
HP:0000505HP:0000505Visual impairment0SLC35A2 CL E G H735511022ORPHA:356961SLC35A2-CDG27
HP:0000505HP:0000505Visual impairment0SLC38A3 CL E G H1099118044OMIM:619881
HP:0000505HP:0000505Visual impairment0SLC38A8 CL E G H14616732434OMIM:609218Foveal hypoplasia 2.13
HP:0000505HP:0000505Visual impairment0SLC39A14 CL E G H2351620858OMIM:144755Hyperostosis cranialis interna5
HP:0000505HP:0000505Visual impairment0SLC39A4 CL E G H5563017129ORPHA:37Acrodermatitis enteropathicaHP:0040283 - Occasional55
HP:0000505HP:0000505Visual impairment0SLC45A2 CL E G H5115116472OMIM:606574ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA442
HP:0000505HP:0000505Visual impairment0SLC45A2 CL E G H5115116472ORPHA:79435Oculocutaneous albinism type 442
HP:0000505HP:0000505Visual impairment0SLC4A11 CL E G H8395916438ORPHA:293603Congenital hereditary endothelial dystrophy type II66
HP:0000505HP:0000505Visual impairment0SLC4A11 CL E G H8395916438OMIM:613268CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD466
HP:0000505HP:0000505Visual impairment0SLC4A11 CL E G H8395916438ORPHA:1490Corneal dystrophy-perceptive deafness syndromeHP:0040281 - Very frequent66
HP:0000505HP:0000505Visual impairment0SLC4A11 CL E G H8395916438OMIM:217400Corneal endothelial dystrophy and perceptive deafness66
HP:0000505HP:0000505Visual impairment0SLC4A11 CL E G H8395916438ORPHA:98974Fuchs endothelial corneal dystrophy66
HP:0000505HP:0000505Visual impairment0SLC52A2 CL E G H7958130224OMIM:614707Brown-Vialetto-Van laere syndrome 247
HP:0000505HP:0000505Visual impairment0SLC6A6 CL E G H653311052OMIM:145350Hypotaurinemic retinal degeneration and cardiomyopathy
HP:0000505HP:0000505Visual impairment0SLC7A14 CL E G H5770929326ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent4
HP:0000505HP:0000505Visual impairment0SLC7A14 CL E G H5770929326OMIM:615725Retinitis pigmentosa 684
HP:0000505HP:0000505Visual impairment0SLX4 CL E G H8446423845ORPHA:84Fanconi anemiaHP:0040283 - Occasional274
HP:0000505HP:0000505Visual impairment0SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasia504
HP:0000505HP:0000505Visual impairment0SMARCA2 CL E G H659511098ORPHA:2728Blepharophimosis-intellectual disability syndrome, Ohdo type146
HP:0000505HP:0000505Visual impairment0SMARCA4 CL E G H659711100ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent617
HP:0000505HP:0000505Visual impairment0SMARCA4 CL E G H659711100OMIM:614609Coffin-Siris syndrome 4617
HP:0000505HP:0000505Visual impairment0SMARCB1 CL E G H659811103ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent87
HP:0000505HP:0000505Visual impairment0SMARCB1 CL E G H659811103OMIM:614608Coffin-Siris syndrome 3.87
HP:0000505HP:0000505Visual impairment0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0000505Visual impairment0SMARCC2 CL E G H660111105ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent1
HP:0000505HP:0000505Visual impairment0SMARCD1 CL E G H660211106ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0SMARCE1 CL E G H660511109ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent47
HP:0000505HP:0000505Visual impairment0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0000505Visual impairment0SMC1A CL E G H824311111ORPHA:220386Semilobar holoprosencephaly135
HP:0000505HP:0000505Visual impairment0SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome174
HP:0000505HP:0000505Visual impairment0SMG9 CL E G H5600625763OMIM:616920Heart and brain malformation syndrome.2
HP:0000505HP:0000505Visual impairment0SMO CL E G H660811119OMIM:601707Curry-Jones syndrome22
HP:0000505HP:0000505Visual impairment0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0000505Visual impairment0SNRNP200 CL E G H2302030859ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent83
HP:0000505HP:0000505Visual impairment0SNRNP200 CL E G H2302030859OMIM:610359Retinitis pigmentosa 3383
HP:0000505HP:0000505Visual impairment0SNRPN CL E G H663811164ORPHA:177907Prader-Willi syndrome due to translocation37
HP:0000505HP:0000505Visual impairment0SNX10 CL E G H2988714974ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent2
HP:0000505HP:0000505Visual impairment0SOBP CL E G H5508429256OMIM:613671Mental retardation, anterior maxillary protrusion, and strabismusHP:0040283 - Occasional29
HP:0000505HP:0000505Visual impairment0SON CL E G H665111183ORPHA:500150Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome12
HP:0000505HP:0000505Visual impairment0SON CL E G H665111183OMIM:617140Zttk syndrome12
HP:0000505HP:0000505Visual impairment0SOST CL E G H5096413771OMIM:122860Craniodiaphyseal dysplasia, autosomal dominant26
HP:0000505HP:0000505Visual impairment0SOST CL E G H5096413771OMIM:269500Sclerosteosis 126
HP:0000505HP:0000505Visual impairment0SOX10 CL E G H666311190ORPHA:478Kallmann syndromeHP:0040283 - Occasional61
HP:0000505HP:0000505Visual impairment0SOX11 CL E G H666411191ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent14
HP:0000505HP:0000505Visual impairment0SOX2 CL E G H665711195ORPHA:77298Anophthalmia/microphthalmia-esophageal atresia syndrome33
HP:0000505HP:0000505Visual impairment0SOX2 CL E G H665711195ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent33
HP:0000505HP:0000505Visual impairment0SOX3 CL E G H665811199ORPHA:3157Septo-optic dysplasia spectrumHP:0040281 - Very frequent24
HP:0000505HP:0000505Visual impairment0SOX4 CL E G H665911200ORPHA:1465Coffin-Siris syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0SPATA5 CL E G H16637818119OMIM:616577Epilepsy, hearing loss, and mental retardation syndrome.19
HP:0000505HP:0000505Visual impairment0SPATA5 CL E G H16637818119ORPHA:457351Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndromeHP:0040281 - Very frequent19
HP:0000505HP:0000505Visual impairment0SPATA5L1 CL E G H7902928762OMIM:619616NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS
HP:0000505HP:0000505Visual impairment0SPATA7 CL E G H5581220423ORPHA:65Leber congenital amaurosis48
HP:0000505HP:0000505Visual impairment0SPATA7 CL E G H5581220423OMIM:604232LEBER CONGENITAL AMAUROSIS 3; LCA348
HP:0000505HP:0000505Visual impairment0SPATA7 CL E G H5581220423ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent48
HP:0000505HP:0000505Visual impairment0SPATA7 CL E G H5581220423ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent48
HP:0000505HP:0000505Visual impairment0SPEN CL E G H2301317575ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional4
HP:0000505HP:0000505Visual impairment0SPG11 CL E G H8020811226ORPHA:2822Autosomal recessive spastic paraplegia type 11HP:0040283 - Occasional287
HP:0000505HP:0000505Visual impairment0SPG11 CL E G H8020811226OMIM:604360Spastic paraplegia 11, autosomal recessive.HP:0003581 - Adult onset287
HP:0000505HP:0000505Visual impairment0SPRY4 CL E G H8184815533ORPHA:478Kallmann syndromeHP:0040283 - Occasional5
HP:0000505HP:0000505Visual impairment0SPTBN1 CL E G H671111275OMIM:619475DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA
HP:0000505HP:0000505Visual impairment0SPTBN4 CL E G H5773114896OMIM:617519Neurodevelopmental disorder with hypotonia, neuropathy, and deafness3
HP:0000505HP:0000505Visual impairment0SRD5A3 CL E G H7964425812OMIM:612379Congenital disorder of glycosylation, type IQ80
HP:0000505HP:0000505Visual impairment0SRD5A3 CL E G H7964425812ORPHA:324737SRD5A3-CDG80
HP:0000505HP:0000505Visual impairment0SREBF1 CL E G H672011289OMIM:158310Mucoepithelial dysplasia, hereditary1
HP:0000505HP:0000505Visual impairment0SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesisHP:0040283 - Occasional23
HP:0000505HP:0000505Visual impairment0ST3GAL5 CL E G H886910872OMIM:609056Salt and pepper developmental regression syndrome47
HP:0000505HP:0000505Visual impairment0STAG2 CL E G H1073511355ORPHA:93925Alobar holoprosencephaly1
HP:0000505HP:0000505Visual impairment0STAG2 CL E G H1073511355ORPHA:220386Semilobar holoprosencephaly1
HP:0000505HP:0000505Visual impairment0STAT4 CL E G H677511365ORPHA:117Behçet disease2
HP:0000505HP:0000505Visual impairment0STAT4 CL E G H677511365ORPHA:85410Oligoarticular juvenile idiopathic arthritis2
HP:0000505HP:0000505Visual impairment0STIL CL E G H649110879ORPHA:93925Alobar holoprosencephaly99
HP:0000505HP:0000505Visual impairment0STIL CL E G H649110879ORPHA:93924Lobar holoprosencephaly99
HP:0000505HP:0000505Visual impairment0STIL CL E G H649110879ORPHA:93926Midline interhemispheric variant of holoprosencephaly99
HP:0000505HP:0000505Visual impairment0STIL CL E G H649110879ORPHA:220386Semilobar holoprosencephaly99
HP:0000505HP:0000505Visual impairment0STX1A CL E G H680411433ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0STX3 CL E G H680911438OMIM:619446RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE; RDMVID1
HP:0000505HP:0000505Visual impairment0SUCLA2 CL E G H880311448ORPHA:1933Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduriaHP:0040281 - Very frequent66
HP:0000505HP:0000505Visual impairment0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0000505Visual impairment0SUMF1 CL E G H28536220376ORPHA:585Multiple sulfatase deficiencyHP:0040281 - Very frequent80
HP:0000505HP:0000505Visual impairment0SUOX CL E G H682111460OMIM:272300SULFOCYSTEINURIA40
HP:0000505HP:0000505Visual impairment0SURF1 CL E G H683411474ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional73
HP:0000505HP:0000505Visual impairment0SYNJ1 CL E G H886711503OMIM:617389Epileptic encephalopathy, early infantile, 53.9
HP:0000505HP:0000505Visual impairment0SYT1 CL E G H685711509OMIM:618218Baker-Gordon syndrome.1
HP:0000505HP:0000505Visual impairment0TACR3 CL E G H687011528ORPHA:478Kallmann syndromeHP:0040283 - Occasional34
HP:0000505HP:0000505Visual impairment0TACSTD2 CL E G H407011530OMIM:204870Corneal dystrophy, gelatinous drop-like.42
HP:0000505HP:0000505Visual impairment0TANGO2 CL E G H12898925439ORPHA:480864Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome12
HP:0000505HP:0000505Visual impairment0TAOK1 CL E G H5755129259OMIM:619575DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES; DDIB
HP:0000505HP:0000505Visual impairment0TASP1 CL E G H5561715859OMIM:618950SULEIMAN-EL-HATTAB SYNDROME; SULEHS
HP:0000505HP:0000505Visual impairment0TAT CL E G H689811573ORPHA:28378Tyrosinemia type 243
HP:0000505HP:0000505Visual impairment0TBC1D20 CL E G H12863716133ORPHA:2510Micro syndrome15
HP:0000505HP:0000505Visual impairment0TBC1D20 CL E G H12863716133OMIM:615663Warburg micro syndrome 415
HP:0000505HP:0000505Visual impairment0TBC1D24 CL E G H5746529203OMIM:220500Doors syndrome271
HP:0000505HP:0000505Visual impairment0TBC1D24 CL E G H5746529203OMIM:615338Epileptic encephalopathy, early infantile, 16271
HP:0000505HP:0000505Visual impairment0TBC1D2B CL E G H2310229183ORPHA:397973Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome
HP:0000505HP:0000505Visual impairment0TBCK CL E G H9362728261OMIM:616900Hypotonia, infantile, with psychomotor retardation and characteristic facies 313
HP:0000505HP:0000505Visual impairment0TBL2 CL E G H2660811586ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0TBX1 CL E G H689911592OMIM:188400Digeorge syndrome32
HP:0000505HP:0000505Visual impairment0TCF4 CL E G H692511634ORPHA:98974Fuchs endothelial corneal dystrophy241
HP:0000505HP:0000505Visual impairment0TCIRG1 CL E G H1031211647ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent82
HP:0000505HP:0000505Visual impairment0TCIRG1 CL E G H1031211647ORPHA:210110Intermediate osteopetrosisHP:0040284 - Very rare82
HP:0000505HP:0000505Visual impairment0TCIRG1 CL E G H1031211647OMIM:259700Osteopetrosis, autosomal recessive 182
HP:0000505HP:0000505Visual impairment0TCOF1 CL E G H694911654OMIM:154500Treacher collins-franceschetti syndrome140
HP:0000505HP:0000505Visual impairment0TCOF1 CL E G H694911654ORPHA:861Treacher-Collins syndromeHP:0040282 - Frequent140
HP:0000505HP:0000505Visual impairment0TDGF1 CL E G H699711701ORPHA:93925Alobar holoprosencephaly1
HP:0000505HP:0000505Visual impairment0TDGF1 CL E G H699711701ORPHA:93924Lobar holoprosencephaly1
HP:0000505HP:0000505Visual impairment0TDGF1 CL E G H699711701ORPHA:93926Midline interhemispheric variant of holoprosencephaly1
HP:0000505HP:0000505Visual impairment0TDGF1 CL E G H699711701ORPHA:220386Semilobar holoprosencephaly1
HP:0000505HP:0000505Visual impairment0TEK CL E G H701011724ORPHA:98976Congenital glaucoma78
HP:0000505HP:0000505Visual impairment0TELO2 CL E G H989429099ORPHA:488642TELO2-related intellectual disability-neurodevelopmental disorder12
HP:0000505HP:0000505Visual impairment0TELO2 CL E G H989429099OMIM:616954You-Hoover-Fong syndrome12
HP:0000505HP:0000505Visual impairment0TENM3 CL E G H5571429944OMIM:615145Microphthalmia, isolated, with coloboma 9.12
HP:0000505HP:0000505Visual impairment0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0000505Visual impairment0TFE3 CL E G H703011752OMIM:301066INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES; MRXSPF
HP:0000505HP:0000505Visual impairment0TFG CL E G H1034211758OMIM:615658Spastic paraplegia 57, autosomal recessive18
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771OMIM:607541Corneal dystrophy, Avellino type.58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771OMIM:121820Corneal dystrophy, epithelial basement membrane58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771OMIM:122200Corneal dystrophy, lattice type I58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771OMIM:608471Corneal dystrophy, lattice type IIIA.58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771OMIM:608470Corneal dystrophy, Reis-Bucklers type58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771ORPHA:98962Granular corneal dystrophy type I58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771ORPHA:98963Granular corneal dystrophy type II58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type I58
HP:0000505HP:0000505Visual impairment0TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophy58
HP:0000505HP:0000505Visual impairment0TGFBR2 CL E G H704811773ORPHA:144Lynch syndromeHP:0040283 - Occasional253
HP:0000505HP:0000505Visual impairment0TGFBR3 CL E G H704911774ORPHA:231160Familial cerebral saccular aneurysm1
HP:0000505HP:0000505Visual impairment0TGIF1 CL E G H705011776ORPHA:93925Alobar holoprosencephaly32
HP:0000505HP:0000505Visual impairment0TGIF1 CL E G H705011776ORPHA:93924Lobar holoprosencephaly32
HP:0000505HP:0000505Visual impairment0TGIF1 CL E G H705011776ORPHA:93926Midline interhemispheric variant of holoprosencephaly32
HP:0000505HP:0000505Visual impairment0TGIF1 CL E G H705011776ORPHA:220386Semilobar holoprosencephaly32
HP:0000505HP:0000505Visual impairment0THOC2 CL E G H5718719073OMIM:300957Mental retardation, X-linked 12/355
HP:0000505HP:0000505Visual impairment0THPO CL E G H706611795ORPHA:71493Familial thrombocytosis23
HP:0000505HP:0000505Visual impairment0THSD1 CL E G H5590117754ORPHA:231160Familial cerebral saccular aneurysm2
HP:0000505HP:0000505Visual impairment0TIMM8A CL E G H167811817OMIM:304700Mohr-Tranebjaerg syndrome.15
HP:0000505HP:0000505Visual impairment0TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndromeHP:0040282 - Frequent15
HP:0000505HP:0000505Visual impairment0TIMMDC1 CL E G H513001321ORPHA:2609Isolated complex I deficiency1
HP:0000505HP:0000505Visual impairment0TIMP3 CL E G H707811822OMIM:136900Sorsby fundus dystrophy95
HP:0000505HP:0000505Visual impairment0TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophy95
HP:0000505HP:0000505Visual impairment0TK2 CL E G H708411831ORPHA:254886Autosomal recessive progressive external ophthalmoplegiaHP:0040283 - Occasional103
HP:0000505HP:0000505Visual impairment0TLCD3B CL E G H8372325295ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0TLCD3B CL E G H8372325295OMIM:619531CONE-ROD DYSTROPHY 22; CORD22
HP:0000505HP:0000505Visual impairment0TLR4 CL E G H709911850ORPHA:117Behçet disease3
HP:0000505HP:0000505Visual impairment0TMEM126A CL E G H8423325382OMIM:612989Optic atrophy 7 with or without auditory neuropathy23
HP:0000505HP:0000505Visual impairment0TMEM126B CL E G H5586330883ORPHA:2609Isolated complex I deficiency4
HP:0000505HP:0000505Visual impairment0TMEM138 CL E G H5152426944ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent39
HP:0000505HP:0000505Visual impairment0TMEM216 CL E G H5125925018OMIM:608091Joubert syndrome 2.45
HP:0000505HP:0000505Visual impairment0TMEM216 CL E G H5125925018ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent45
HP:0000505HP:0000505Visual impairment0TMEM231 CL E G H7958337234ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent33
HP:0000505HP:0000505Visual impairment0TMEM237 CL E G H6506214432ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent82
HP:0000505HP:0000505Visual impairment0TMEM270 CL E G H13588623018ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0TMEM53 CL E G H7963926186OMIM:619727CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE; CTDI
HP:0000505HP:0000505Visual impairment0TMEM67 CL E G H9114728396OMIM:610688Joubert syndrome 6166
HP:0000505HP:0000505Visual impairment0TMEM67 CL E G H9114728396ORPHA:1454Joubert syndrome with hepatic defectHP:0040282 - Frequent166
HP:0000505HP:0000505Visual impairment0TMEM98 CL E G H2602224529OMIM:615972Nanophthalmos 4HP:0040283 - Occasional3
HP:0000505HP:0000505Visual impairment0TNFRSF11A CL E G H879211908OMIM:612301OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB772
HP:0000505HP:0000505Visual impairment0TNFSF11 CL E G H860011926ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent44
HP:0000505HP:0000505Visual impairment0TNFSF11 CL E G H860011926OMIM:259710Osteopetrosis, autosomal recessive 244
HP:0000505HP:0000505Visual impairment0TOPORS CL E G H1021021653ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent61
HP:0000505HP:0000505Visual impairment0TOPORS CL E G H1021021653OMIM:609923Retinitis pigmentosa 3161
HP:0000505HP:0000505Visual impairment0TP53 CL E G H715711998ORPHA:96253Cushing diseaseHP:0040283 - Occasional911
HP:0000505HP:0000505Visual impairment0TP53 CL E G H715711998ORPHA:2807Papilloma of choroid plexusHP:0040283 - Occasional911
HP:0000505HP:0000505Visual impairment0TP53RK CL E G H11285816197OMIM:617730Galloway-Mowat syndrome 4.
HP:0000505HP:0000505Visual impairment0TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2203
HP:0000505HP:0000505Visual impairment0TRAF3IP1 CL E G H2614617861ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent6
HP:0000505HP:0000505Visual impairment0TRAF7 CL E G H8423120456OMIM:618164Cardiac, facial, and digital anomalies with developmental delay
HP:0000505HP:0000505Visual impairment0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0000505Visual impairment0TRAPPC11 CL E G H6068425751ORPHA:869Triple A syndromeHP:0040282 - Frequent27
HP:0000505HP:0000505Visual impairment0TRAPPC12 CL E G H5111224284ORPHA:500144Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome2
HP:0000505HP:0000505Visual impairment0TRAPPC12 CL E G H5111224284OMIM:617669Encephalopathy, progressive, early-onset, with brain atrophy and spasticity2
HP:0000505HP:0000505Visual impairment0TRAPPC2L CL E G H5169330887OMIM:618331Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis
HP:0000505HP:0000505Visual impairment0TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations56
HP:0000505HP:0000505Visual impairment0TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0000505HP:0000505Visual impairment0TRIM44 CL E G H5476519016OMIM:617142Aniridia 31
HP:0000505HP:0000505Visual impairment0TRIM44 CL E G H5476519016ORPHA:250923Isolated aniridia1
HP:0000505HP:0000505Visual impairment0TRIO CL E G H720412303ORPHA:476126Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome8
HP:0000505HP:0000505Visual impairment0TRNC CL E G H45117477OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNE CL E G H45567479ORPHA:225Maternally-inherited diabetes and deafnessHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0TRNF CL E G H45587481ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNF CL E G H45587481OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNH CL E G H45647487ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNK CL E G H45667489ORPHA:225Maternally-inherited diabetes and deafnessHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0TRNK CL E G H45667489OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNL1 CL E G H45677490ORPHA:225Maternally-inherited diabetes and deafnessHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0TRNL1 CL E G H45677490ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNL1 CL E G H45677490OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNQ CL E G H45727495ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNQ CL E G H45727495OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNS1 CL E G H45747497ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNS1 CL E G H45747497OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNS2 CL E G H45757498ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNS2 CL E G H45757498OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNS2 CL E G H45757498ORPHA:231183Usher syndrome type 3
HP:0000505HP:0000505Visual impairment0TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28
HP:0000505HP:0000505Visual impairment0TRNV CL E G H45777500OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRNW CL E G H45787501ORPHA:550MELAS
HP:0000505HP:0000505Visual impairment0TRNW CL E G H45787501OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000505Visual impairment0TRPM1 CL E G H43087146ORPHA:215Congenital stationary night blindness104
HP:0000505HP:0000505Visual impairment0TRPM1 CL E G H43087146OMIM:613216NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C104
HP:0000505HP:0000505Visual impairment0TRRAP CL E G H829512347OMIM:618454Developmental delay with or without dysmorphic facies and autism.2
HP:0000505HP:0000505Visual impairment0TSEN15 CL E G H11646116791ORPHA:2524Pontocerebellar hypoplasia type 23
HP:0000505HP:0000505Visual impairment0TSEN2 CL E G H8074628422ORPHA:2524Pontocerebellar hypoplasia type 284
HP:0000505HP:0000505Visual impairment0TSEN2 CL E G H8074628422OMIM:612389Pontocerebellar hypoplasia, type 2B.84
HP:0000505HP:0000505Visual impairment0TSEN34 CL E G H7904215506ORPHA:2524Pontocerebellar hypoplasia type 257
HP:0000505HP:0000505Visual impairment0TSEN34 CL E G H7904215506OMIM:612390PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C57
HP:0000505HP:0000505Visual impairment0TSEN54 CL E G H28398927561ORPHA:2524Pontocerebellar hypoplasia type 2102
HP:0000505HP:0000505Visual impairment0TSEN54 CL E G H28398927561OMIM:277470Pontocerebellar hypoplasia, type 2A.102
HP:0000505HP:0000505Visual impairment0TSFM CL E G H1010212367OMIM:610505Combined oxidative phosphorylation deficiency 3.43
HP:0000505HP:0000505Visual impairment0TSPAN12 CL E G H2355421641OMIM:613310Exudative vitreoretinopathy 5HP:0040283 - Occasional39
HP:0000505HP:0000505Visual impairment0TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathy39
HP:0000505HP:0000505Visual impairment0TTC8 CL E G H12301620087ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent41
HP:0000505HP:0000505Visual impairment0TTC8 CL E G H12301620087OMIM:613464Retinitis pigmentosa 51.41
HP:0000505HP:0000505Visual impairment0TTLL5 CL E G H2309319963ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional9
HP:0000505HP:0000505Visual impairment0TTLL5 CL E G H2309319963OMIM:615860Cone-Rod dystrophy 199
HP:0000505HP:0000505Visual impairment0TTPA CL E G H727412404ORPHA:96Ataxia with vitamin E deficiencyHP:0040283 - Occasional62
HP:0000505HP:0000505Visual impairment0TTR CL E G H727612405OMIM:105210Amyloidosis, hereditary, transthyretin-related.107
HP:0000505HP:0000505Visual impairment0TUB CL E G H727512406OMIM:616188Retinal dystrophy and obesity.1
HP:0000505HP:0000505Visual impairment0TUB CL E G H727512406ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent1
HP:0000505HP:0000505Visual impairment0TUBA3D CL E G H11345724071OMIM:617928Keratoconus 9
HP:0000505HP:0000505Visual impairment0TUBB2B CL E G H34773330829ORPHA:300573Polymicrogyria due to TUBB2B mutation39
HP:0000505HP:0000505Visual impairment0TUBB3 CL E G H1038120772ORPHA:300570Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation64
HP:0000505HP:0000505Visual impairment0TUBB3 CL E G H1038120772OMIM:600638Fibrosis of extraocular muscles, congenital, 3A, with or without extraocularinvolvement64
HP:0000505HP:0000505Visual impairment0TUBB4A CL E G H1038220774OMIM:612438Leukodystrophy, hypomyelinating, 6.66
HP:0000505HP:0000505Visual impairment0TUBB4B CL E G H1038320771ORPHA:65Leber congenital amaurosis
HP:0000505HP:0000505Visual impairment0TUBB4B CL E G H1038320771OMIM:617879Leber congenital amaurosis with early-onset deafness
HP:0000505HP:0000505Visual impairment0TUBGCP2 CL E G H1084418599OMIM:618737PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS
HP:0000505HP:0000505Visual impairment0TUBGCP4 CL E G H2722916691ORPHA:2518Autosomal recessive chorioretinopathy-microcephaly syndromeHP:0040282 - Frequent14
HP:0000505HP:0000505Visual impairment0TUBGCP4 CL E G H2722916691OMIM:616335Microcephaly and chorioretinopathy, autosomal recessive, 3.14
HP:0000505HP:0000505Visual impairment0TUBGCP6 CL E G H8537818127ORPHA:2518Autosomal recessive chorioretinopathy-microcephaly syndromeHP:0040282 - Frequent61
HP:0000505HP:0000505Visual impairment0TUBGCP6 CL E G H8537818127OMIM:251270Microcephaly and chorioretinopathy, autosomal recessive, 1.61
HP:0000505HP:0000505Visual impairment0TULP1 CL E G H728712423ORPHA:65Leber congenital amaurosis66
HP:0000505HP:0000505Visual impairment0TULP1 CL E G H728712423OMIM:613843Leber congenital amaurosis 15.66
HP:0000505HP:0000505Visual impairment0TULP1 CL E G H728712423ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent66
HP:0000505HP:0000505Visual impairment0TULP1 CL E G H728712423OMIM:600132RETINITIS PIGMENTOSA 14; RP1466
HP:0000505HP:0000505Visual impairment0TWIST1 CL E G H729112428ORPHA:794Saethre-Chotzen syndrome18
HP:0000505HP:0000505Visual impairment0TWIST2 CL E G H11758120670ORPHA:920Ablepharon macrostomia syndromeHP:0040282 - Frequent7
HP:0000505HP:0000505Visual impairment0TWNK CL E G H566521160ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040283 - Occasional113
HP:0000505HP:0000505Visual impairment0TYR CL E G H729912442OMIM:203100Albinism, oculocutaneous, type IA.146
HP:0000505HP:0000505Visual impairment0TYR CL E G H729912442OMIM:606952Albinism, oculocutaneous, type IB.146
HP:0000505HP:0000505Visual impairment0TYR CL E G H729912442ORPHA:79431Oculocutaneous albinism type 1AHP:0040282 - Frequent146
HP:0000505HP:0000505Visual impairment0TYR CL E G H729912442ORPHA:79434Oculocutaneous albinism type 1BHP:0040282 - Frequent146
HP:0000505HP:0000505Visual impairment0UBAC2 CL E G H33786720486ORPHA:117Behçet disease
HP:0000505HP:0000505Visual impairment0UBE2T CL E G H2908925009ORPHA:84Fanconi anemiaHP:0040283 - Occasional2
HP:0000505HP:0000505Visual impairment0UBE4B CL E G H1027712500ORPHA:16061p36 deletion syndromeHP:0040283 - Occasional
HP:0000505HP:0000505Visual impairment0UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive21
HP:0000505HP:0000505Visual impairment0UFM1 CL E G H5156920597OMIM:617899Leukodystrophy, hypomyelinating, 14
HP:0000505HP:0000505Visual impairment0UNC119 CL E G H909412565ORPHA:1872Cone rod dystrophyHP:0040283 - Occasional30
HP:0000505HP:0000505Visual impairment0UROD CL E G H738912591ORPHA:95159Hepatoerythropoietic porphyria31
HP:0000505HP:0000505Visual impairment0UROS CL E G H739012592ORPHA:79277Congenital erythropoietic porphyria41
HP:0000505HP:0000505Visual impairment0USH1C CL E G H1008312597ORPHA:231169Usher syndrome type 1173
HP:0000505HP:0000505Visual impairment0USH1C CL E G H1008312597OMIM:276900Usher syndrome, type I173
HP:0000505HP:0000505Visual impairment0USH1G CL E G H12459016356ORPHA:231169Usher syndrome type 178
HP:0000505HP:0000505Visual impairment0USH2A CL E G H739912601ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent777
HP:0000505HP:0000505Visual impairment0USH2A CL E G H739912601OMIM:613809Retinitis pigmentosa 39.777
HP:0000505HP:0000505Visual impairment0USH2A CL E G H739912601ORPHA:231178Usher syndrome type 2777
HP:0000505HP:0000505Visual impairment0USP45 CL E G H8501520080ORPHA:65Leber congenital amaurosis
HP:0000505HP:0000505Visual impairment0USP45 CL E G H8501520080OMIM:618513LEBER CONGENITAL AMAUROSIS 19; LCA19
HP:0000505HP:0000505Visual impairment0USP48 CL E G H8419618533ORPHA:96253Cushing diseaseHP:0040283 - Occasional1
HP:0000505HP:0000505Visual impairment0USP8 CL E G H910112631ORPHA:96253Cushing diseaseHP:0040283 - Occasional7
HP:0000505HP:0000505Visual impairment0VAMP2 CL E G H684412643OMIM:618760NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM
HP:0000505HP:0000505Visual impairment0VCAN CL E G H14622464OMIM:143200Wagner vitreoretinopathy180
HP:0000505HP:0000505Visual impairment0VHL CL E G H742812687ORPHA:892Von Hippel-Lindau disease490
HP:0000505HP:0000505Visual impairment0VPS11 CL E G H5582314583OMIM:616683Leukodystrophy, hypomyelinating, 121
HP:0000505HP:0000505Visual impairment0VPS11 CL E G H5582314583ORPHA:466934VPS11-related autosomal recessive hypomyelinating leukodystrophy1
HP:0000505HP:0000505Visual impairment0VPS13B CL E G H1576802183OMIM:216550Cohen syndrome.546
HP:0000505HP:0000505Visual impairment0VPS37D CL E G H15538218287ORPHA:904Williams syndromeHP:0040282 - Frequent
HP:0000505HP:0000505Visual impairment0VPS4A CL E G H2718313488OMIM:619273CIMDAG SYNDROME; CIMDAG1
HP:0000505HP:0000505Visual impairment0VPS51 CL E G H7381172OMIM:618606PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13
HP:0000505HP:0000505Visual impairment0VRK1 CL E G H744312718ORPHA:2254Pontocerebellar hypoplasia type 132
HP:0000505HP:0000505Visual impairment0VSX1 CL E G H3081312723OMIM:614195Craniofacial anomalies and anterior segment dysgenesis syndrome47
HP:0000505HP:0000505Visual impairment0VSX1 CL E G H3081312723ORPHA:98973Posterior polymorphous corneal dystrophy47
HP:0000505HP:0000505Visual impairment0WAC CL E G H5132217327ORPHA:284169Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletionHP:0040281 - Very frequent20
HP:0000505HP:0000505Visual impairment0WAC CL E G H5132217327ORPHA:466950Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation20
HP:0000505HP:0000505Visual impairment0WARS2 CL E G H1035212730OMIM:617710Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures2
HP:0000505HP:0000505Visual impairment0WARS2 CL E G H1035212730ORPHA:572798WARS2-related combined oxidative phosphorylation defect2
HP:0000505HP:0000505Visual impairment0WASF1 CL E G H893612732OMIM:618707NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS
HP:0000505HP:0000505Visual impairment0WDR11 CL E G H5571713831ORPHA:478Kallmann syndromeHP:0040283 - Occasional10
HP:0000505HP:0000505Visual impairment0WDR19 CL E G H5772818340OMIM:614378Cranioectodermal dysplasia 495
HP:0000505HP:0000505Visual impairment0WDR19 CL E G H5772818340ORPHA:3156Senior-Loken syndromeHP:0040281 - Very frequent95
HP:0000505HP:0000505Visual impairment0WDR19 CL E G H5772818340OMIM:616307Senior-Loken syndrome 8.95
HP:0000505HP:0000505Visual impairment0WDR26 CL E G H8023221208ORPHA:513456Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome8
HP:0000505HP:0000505Visual impairment0WDR26 CL E G H8023221208OMIM:617616Skraban-Deardorff syndrome8
HP:0000505HP:0000505Visual impairment0WDR45B CL E G H5627025072OMIM:617977Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures.1
HP:0000505HP:0000505Visual impairment0WFS1 CL E G H746612762OMIM:614296Wolfram-Like syndrome, autosomal dominant389
HP:0000505HP:0000505Visual impairment0WHRN CL E G H2586116361ORPHA:231178Usher syndrome type 2155
HP:0000505HP:0000505Visual impairment0WHRN CL E G H2586116361OMIM:611383Usher syndrome, type IID155
HP:0000505HP:0000505Visual impairment0WT1 CL E G H749012796ORPHA:893WAGR syndromeHP:0040282 - Frequent177
HP:0000505HP:0000505Visual impairment0XRCC2 CL E G H751612829ORPHA:84Fanconi anemiaHP:0040283 - Occasional125
HP:0000505HP:0000505Visual impairment0XRCC4 CL E G H751812831ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndrome9
HP:0000505HP:0000505Visual impairment0XYLT1 CL E G H6413115516OMIM:264800PSEUDOXANTHOMA ELASTICUM; PXE14
HP:0000505HP:0000505Visual impairment0XYLT2 CL E G H6413215517OMIM:264800PSEUDOXANTHOMA ELASTICUM; PXE5
HP:0000505HP:0000505Visual impairment0XYLT2 CL E G H6413215517ORPHA:85194Spondylo-ocular syndrome5
HP:0000505HP:0000505Visual impairment0XYLT2 CL E G H6413215517OMIM:605822Spondyloocular syndrome5
HP:0000505HP:0000505Visual impairment0YAP1 CL E G H1041316262ORPHA:1473Uveal coloboma-cleft lip and palate-intellectual disabilityHP:0040283 - Occasional2
HP:0000505HP:0000505Visual impairment0YARS1 CL E G H856512840OMIM:619418NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2
HP:0000505HP:0000505Visual impairment0YIF1B CL E G H9052230511OMIM:619125KAYA-BARAKAT-MASSON SYNDROME; KABAMAS
HP:0000505HP:0000505Visual impairment0YME1L1 CL E G H1073012843OMIM:617302Optic atrophy 11.2
HP:0000505HP:0000505Visual impairment0ZEB1 CL E G H693511642OMIM:613270Corneal dystrophy, fuchs endothelial, 68
HP:0000505HP:0000505Visual impairment0ZEB1 CL E G H693511642ORPHA:98974Fuchs endothelial corneal dystrophy8
HP:0000505HP:0000505Visual impairment0ZEB1 CL E G H693511642ORPHA:98973Posterior polymorphous corneal dystrophy8
HP:0000505HP:0000505Visual impairment0ZEB2 CL E G H983914881ORPHA:261552Mowat-Wilson syndrome due to a ZEB2 point mutationHP:0040283 - Occasional362
HP:0000505HP:0000505Visual impairment0ZFHX4 CL E G H7977630939ORPHA:91411Congenital ptosis
HP:0000505HP:0000505Visual impairment0ZFYVE26 CL E G H2350320761OMIM:270700Spastic paraplegia 15, autosomal recessive.189
HP:0000505HP:0000505Visual impairment0ZIC2 CL E G H754612873ORPHA:93925Alobar holoprosencephaly34
HP:0000505HP:0000505Visual impairment0ZIC2 CL E G H754612873ORPHA:93924Lobar holoprosencephaly34
HP:0000505HP:0000505Visual impairment0ZIC2 CL E G H754612873ORPHA:93926Midline interhemispheric variant of holoprosencephaly34
HP:0000505HP:0000505Visual impairment0ZIC2 CL E G H754612873ORPHA:220386Semilobar holoprosencephaly34
HP:0000505HP:0000505Visual impairment0ZMIZ1 CL E G H5717816493OMIM:618659NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA
HP:0000505HP:0000505Visual impairment0ZNF408 CL E G H7979720041OMIM:616468Exudative vitreoretinopathy 614
HP:0000505HP:0000505Visual impairment0ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathy14
HP:0000505HP:0000505Visual impairment0ZNF408 CL E G H7979720041ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent14
HP:0000505HP:0000505Visual impairment0ZNF408 CL E G H7979720041OMIM:616469Retinitis pigmentosa 7214
HP:0000505HP:0000505Visual impairment0ZNF423 CL E G H2309016762ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent49
HP:0000505HP:0000505Visual impairment0ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndrome397
HP:0000505HP:0000505Visual impairment0ZNF469 CL E G H8462723216OMIM:229200Brittle cornea syndrome397
HP:0000505HP:0000505Visual impairment0ZNF513 CL E G H13055726498ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent27
HP:0000505HP:0000505Visual impairment0ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 5827
HP:0000505HP:0000505Visual impairment0ZNHIT3 CL E G H932612309ORPHA:2836PEHO syndrome1
HP:0000505HP:0001123Visual field defect1AARS1 CL E G H1620OMIM:619661LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2
HP:0000505HP:0000572Visual loss1ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0001123Visual field defect1ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0007663Reduced visual acuity1ABCA4 CL E G H2434ORPHA:791Retinitis pigmentosa826
HP:0000505HP:0007663Reduced visual acuity1ABCA4 CL E G H2434OMIM:601718Retinitis pigmentosa 19.826
HP:0000505HP:0001123Visual field defect1ABCA4 CL E G H2434OMIM:601718Retinitis pigmentosa 19826
HP:0000505HP:0001123Visual field defect1ABCA4 CL E G H2434ORPHA:827Stargardt disease826
HP:0000505HP:0007663Reduced visual acuity1ABCA4 CL E G H2434ORPHA:827Stargardt diseaseHP:0040280 - Obligate826
HP:0000505HP:0007663Reduced visual acuity1ABCC6 CL E G H36857OMIM:177850Pseudoxanthoma elasticum, forme fruste.415
HP:0000505HP:0007663Reduced visual acuity1ABCC6 CL E G H36857OMIM:264800PSEUDOXANTHOMA ELASTICUM; PXE415
HP:0000505HP:0007663Reduced visual acuity1ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy135
HP:0000505HP:0000572Visual loss1ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy.135
HP:0000505HP:0007663Reduced visual acuity1ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophyHP:0040283 - Occasional135
HP:0000505HP:0001123Visual field defect1ACO2 CL E G H50118OMIM:616289Optic atrophy 960
HP:0000505HP:0007663Reduced visual acuity1ACO2 CL E G H50118OMIM:616289Optic atrophy 9.60
HP:0000505HP:0007663Reduced visual acuity1ACTB CL E G H60132ORPHA:79107Developmental malformations-deafness-dystonia syndrome72
HP:0000505HP:0007663Reduced visual acuity1ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasia178
HP:0000505HP:0001123Visual field defect1ADA2 CL E G H518161839ORPHA:820Sneddon syndromeHP:0040282 - Frequent22
HP:0000505HP:0000572Visual loss1ADAMTS10 CL E G H8179413201ORPHA:3449Weill-Marchesani syndromeHP:0040283 - Occasional63
HP:0000505HP:0007663Reduced visual acuity1ADAMTS10 CL E G H8179413201OMIM:277600Weill-Marchesani syndrome 163
HP:0000505HP:0007663Reduced visual acuity1ADAMTSL4 CL E G H5450719706ORPHA:1885Isolated ectopia lentis84
HP:0000505HP:0100704Cerebral visual impairment1ADARB1 CL E G H104226OMIM:618862NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS1
HP:0000505HP:0001123Visual field defect1ADGRV1 CL E G H8405917416ORPHA:231178Usher syndrome type 2530
HP:0000505HP:0000572Visual loss1ADGRV1 CL E G H8405917416ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent530
HP:0000505HP:0100704Cerebral visual impairment1ADNP CL E G H2339415766ORPHA:404448ADNP syndromeHP:0040283 - Occasional47
HP:0000505HP:0007663Reduced visual acuity1ADNP CL E G H2339415766ORPHA:404448ADNP syndrome47
HP:0000505HP:0100704Cerebral visual impairment1AFF3 CL E G H38996473OMIM:619297KINSSHIP SYNDROME; KINS1
HP:0000505HP:0007663Reduced visual acuity1AFF4 CL E G H2712517869ORPHA:444077Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome6
HP:0000505HP:0007663Reduced visual acuity1AFG3L2 CL E G H10939315OMIM:618977OPTIC ATROPHY 12; OPA1286
HP:0000505HP:0000572Visual loss1AGBL1 CL E G H12362426504ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000505HP:0007663Reduced visual acuity1AGBL1 CL E G H12362426504ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000505HP:0007663Reduced visual acuity1AGBL5 CL E G H6050926147ORPHA:791Retinitis pigmentosa2
HP:0000505HP:0001123Visual field defect1AGBL5 CL E G H6050926147OMIM:617023Retinitis pigmentosa 752
HP:0000505HP:0000572Visual loss1AGTPBP1 CL E G H2328717258ORPHA:2254Pontocerebellar hypoplasia type 11
HP:0000505HP:0100704Cerebral visual impairment1AHDC1 CL E G H2724525230ORPHA:412069AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndromeHP:0040283 - Occasional36
HP:0000505HP:0000572Visual loss1AHI1 CL E G H5480621575ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional175
HP:0000505HP:0007663Reduced visual acuity1AHI1 CL E G H5480621575ORPHA:791Retinitis pigmentosa175
HP:0000505HP:0007663Reduced visual acuity1AHR CL E G H196348ORPHA:791Retinitis pigmentosa2
HP:0000505HP:0007663Reduced visual acuity1AHR CL E G H196348OMIM:618345RETINITIS PIGMENTOSA 85; RP852
HP:0000505HP:0000572Visual loss1AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0000505HP:0007663Reduced visual acuity1AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0000505HP:0001123Visual field defect1AIP CL E G H9049358ORPHA:2965Prolactinoma95
HP:0000505HP:0007663Reduced visual acuity1AIPL1 CL E G H23746359ORPHA:65Leber congenital amaurosis114
HP:0000505HP:0007663Reduced visual acuity1AIPL1 CL E G H23746359OMIM:604393Leber congenital amaurosis 4.114
HP:0000505HP:0001123Visual field defect1AIPL1 CL E G H23746359OMIM:268000Retinitis pigmentosa114
HP:0000505HP:0001123Visual field defect1AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0000505HP:0007663Reduced visual acuity1AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0000505HP:0007663Reduced visual acuity1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0000572Visual loss1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0001123Visual field defect1AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0001123Visual field defect1AKT3 CL E G H10000393ORPHA:99802Hemimegalencephaly19
HP:0000505HP:0007663Reduced visual acuity1ALDH3A2 CL E G H224403OMIM:270200Sjogren-Larsson syndrome87
HP:0000505HP:0007663Reduced visual acuity1ALG3 CL E G H1019523056OMIM:601110Congenital disorder of glycosylation, type Id37
HP:0000505HP:0000572Visual loss1ALMS1 CL E G H7840428ORPHA:64Alström syndromeHP:0040281 - Very frequent404
HP:0000505HP:0001123Visual field defect1ALMS1 CL E G H7840428ORPHA:64Alström syndromeHP:0040283 - Occasional404
HP:0000505HP:0007663Reduced visual acuity1ALMS1 CL E G H7840428ORPHA:64Alström syndrome404
HP:0000505HP:0001123Visual field defect1ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome404
HP:0000505HP:0000572Visual loss1ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0000505HP:0007663Reduced visual acuity1ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome404
HP:0000505HP:0000572Visual loss1ALPK1 CL E G H8021620917OMIM:614979Splenomegaly, cytopenia, and vision loss.
HP:0000505HP:0001123Visual field defect1AMACR CL E G H23600451OMIM:614307Alpha-methylacyl-CoA racemase deficiency44
HP:0000505HP:0001123Visual field defect1AMACR CL E G H23600451ORPHA:79095Congenital bile acid synthesis defect type 444
HP:0000505HP:0100704Cerebral visual impairment1AMPD2 CL E G H271469OMIM:615809Pontocerebellar hypoplasia, type 9.21
HP:0000505HP:0001123Visual field defect1ANGPTL6 CL E G H8385423140ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent
HP:0000505HP:0000572Visual loss1ANKRD55 CL E G H7972225681ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000505HP:0007663Reduced visual acuity1ANKRD55 CL E G H7972225681ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000505HP:0007663Reduced visual acuity1AP1G1 CL E G H164555OMIM:619467USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD
HP:0000505HP:0007663Reduced visual acuity1AP3B1 CL E G H8546566OMIM:608233Hermansky-Pudlak syndrome 283
HP:0000505HP:0007663Reduced visual acuity1AP4B1 CL E G H10717572ORPHA:280763Severe intellectual disability and progressive spastic paraplegia49
HP:0000505HP:0007663Reduced visual acuity1AP4E1 CL E G H23431573ORPHA:280763Severe intellectual disability and progressive spastic paraplegia48
HP:0000505HP:0007663Reduced visual acuity1AP4M1 CL E G H9179574ORPHA:280763Severe intellectual disability and progressive spastic paraplegia41
HP:0000505HP:0007663Reduced visual acuity1AP4S1 CL E G H11154575ORPHA:280763Severe intellectual disability and progressive spastic paraplegia18
HP:0000505HP:0007663Reduced visual acuity1APC CL E G H324583ORPHA:99818Turcot syndrome with polyposis3179
HP:0000505HP:0000572Visual loss1APOE CL E G H348613OMIM:603075Macular degeneration, age-related, 139
HP:0000505HP:0100704Cerebral visual impairment1ARHGDIA CL E G H396678OMIM:615244Nephrotic syndrome, type 8.3
HP:0000505HP:0007663Reduced visual acuity1ARHGEF18 CL E G H2337017090ORPHA:791Retinitis pigmentosa6
HP:0000505HP:0007663Reduced visual acuity1ARHGEF18 CL E G H2337017090OMIM:617433Retinitis pigmentosa 78.6
HP:0000505HP:0001123Visual field defect1ARHGEF18 CL E G H2337017090OMIM:617433Retinitis pigmentosa 78.6
HP:0000505HP:0007663Reduced visual acuity1ARHGEF2 CL E G H9181682OMIM:617523Neurodevelopmental disorder with midbrain and hindbrain malformations1
HP:0000505HP:0007663Reduced visual acuity1ARL2 CL E G H402693OMIM:619082MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1; MRCS1
HP:0000505HP:0007663Reduced visual acuity1ARL2BP CL E G H2356817146ORPHA:791Retinitis pigmentosa3
HP:0000505HP:0007663Reduced visual acuity1ARL2BP CL E G H2356817146OMIM:615434Retinitis pigmentosa with or without situs inversus.3
HP:0000505HP:0000572Visual loss1ARL3 CL E G H403694OMIM:618161JOUBERT SYNDROME 35; JBTS351
HP:0000505HP:0007663Reduced visual acuity1ARL3 CL E G H403694ORPHA:791Retinitis pigmentosa1
HP:0000505HP:0001123Visual field defect1ARL3 CL E G H403694OMIM:618173RETINITIS PIGMENTOSA 83; RP831
HP:0000505HP:0007663Reduced visual acuity1ARL3 CL E G H403694OMIM:618173RETINITIS PIGMENTOSA 83; RP831
HP:0000505HP:0001123Visual field defect1ARL6 CL E G H8410013210OMIM:209900Bardet-Biedl syndrome 129
HP:0000505HP:0007663Reduced visual acuity1ARL6 CL E G H8410013210OMIM:209900Bardet-Biedl syndrome 129
HP:0000505HP:0007663Reduced visual acuity1ARL6 CL E G H8410013210ORPHA:791Retinitis pigmentosa29
HP:0000505HP:0001123Visual field defect1ARL6 CL E G H8410013210OMIM:268000Retinitis pigmentosa29
HP:0000505HP:0007663Reduced visual acuity1ARMC9 CL E G H8021020730OMIM:617622JOUBERT SYNDROME 30; JBTS30
HP:0000505HP:0007663Reduced visual acuity1ARNT2 CL E G H991516876OMIM:615926Webb-Dattani syndrome
HP:0000505HP:0100704Cerebral visual impairment1ARPC4 CL E G H10093707OMIM:620141
HP:0000505HP:0007663Reduced visual acuity1ARSA CL E G H410713ORPHA:309271Metachromatic leukodystrophy, adult formHP:0040283 - Occasional253
HP:0000505HP:0007663Reduced visual acuity1ARSA CL E G H410713ORPHA:309263Metachromatic leukodystrophy, juvenile formHP:0040283 - Occasional253
HP:0000505HP:0007663Reduced visual acuity1ARSA CL E G H410713ORPHA:309256Metachromatic leukodystrophy, late infantile formHP:0040283 - Occasional253
HP:0000505HP:0000572Visual loss1ARSG CL E G H2290124102ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0001123Visual field defect1ARSG CL E G H2290124102ORPHA:231183Usher syndrome type 3
HP:0000505HP:0001123Visual field defect1ARSG CL E G H2290124102OMIM:618144USHER SYNDROME, TYPE IV; USH4
HP:0000505HP:0001123Visual field defect1ASB10 CL E G H13637117185OMIM:603383GLAUCOMA 1, OPEN ANGLE, F; GLC1F54
HP:0000505HP:0100704Cerebral visual impairment1ASNS CL E G H440753OMIM:615574Asparagine synthetase deficiency.17
HP:0000505HP:0007663Reduced visual acuity1ASPA CL E G H443756OMIM:271900Canavan disease48
HP:0000505HP:0007663Reduced visual acuity1ASPA CL E G H443756ORPHA:314911Severe Canavan disease48
HP:0000505HP:0007663Reduced visual acuity1ASPH CL E G H444757OMIM:601552Facial dysmorphism, lens dislocation, anterior segment abnormalities, and spontaneous filtering blebs4
HP:0000505HP:0001123Visual field defect1ATF6 CL E G H22926791ORPHA:49382Achromatopsia10
HP:0000505HP:0007663Reduced visual acuity1ATF6 CL E G H22926791ORPHA:49382AchromatopsiaHP:0040282 - Frequent10
HP:0000505HP:0001123Visual field defect1ATF6 CL E G H22926791OMIM:616517ACHROMATOPSIA 7; ACHM710
HP:0000505HP:0007663Reduced visual acuity1ATF6 CL E G H22926791OMIM:616517ACHROMATOPSIA 7; ACHM710
HP:0000505HP:0007663Reduced visual acuity1ATIC CL E G H471794ORPHA:250977AICA-ribosiduria4
HP:0000505HP:0007663Reduced visual acuity1ATIC CL E G H471794OMIM:608688Aicar transformylase/imp cyclohydrolase deficiency4
HP:0000505HP:0100704Cerebral visual impairment1ATN1 CL E G H18223033OMIM:618494Congenital hypotonia, epilepsy, developmental delay, and digital anomalies.16
HP:0000505HP:0007663Reduced visual acuity1ATOH7 CL E G H22020213907ORPHA:91495Persistent hyperplastic primary vitreous4
HP:0000505HP:0007663Reduced visual acuity1ATOH7 CL E G H22020213907OMIM:221900Persistent hyperplastic primary vitreous, autosomal recessive4
HP:0000505HP:0001123Visual field defect1ATP1A2 CL E G H477800ORPHA:569Familial or sporadic hemiplegic migraine239
HP:0000505HP:0000572Visual loss1ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss.150
HP:0000505HP:0007663Reduced visual acuity1ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss150
HP:0000505HP:0001123Visual field defect1ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ATP6 CL E G H45087414OMIM:535000Leber optic atrophy.
HP:0000505HP:0001123Visual field defect1ATP6 CL E G H45087414OMIM:535000Leber optic atrophy
HP:0000505HP:0001123Visual field defect1ATP6 CL E G H45087414ORPHA:644NARP syndrome
HP:0000505HP:0007663Reduced visual acuity1ATP6 CL E G H45087414ORPHA:644NARP syndrome
HP:0000505HP:0007663Reduced visual acuity1ATP6 CL E G H45087414OMIM:551500Neuropathy, ataxia, and retinitis pigmentosa
HP:0000505HP:0007663Reduced visual acuity1ATRX CL E G H546886ORPHA:847Alpha-thalassemia-X-linked intellectual disability syndrome169
HP:0000505HP:0001123Visual field defect1ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0000505HP:0000572Visual loss1ATXN7 CL E G H631410560OMIM:164500Spinocerebellar ataxia 7 opca III opca with retinal degeneration opca with macular degeneration and external ophthalmoplegia autosomal dominant cerebellar ataxia, type II adca, type II8
HP:0000505HP:0000572Visual loss1ATXN7 CL E G H631410560ORPHA:94147Spinocerebellar ataxia type 7HP:0040282 - Frequent8
HP:0000505HP:0007663Reduced visual acuity1ATXN7 CL E G H631410560ORPHA:94147Spinocerebellar ataxia type 7HP:0040282 - Frequent8
HP:0000505HP:0007663Reduced visual acuity1B3GALNT2 CL E G H14878928596OMIM:615181MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1143
HP:0000505HP:0007663Reduced visual acuity1B3GAT3 CL E G H26229923OMIM:245600Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects5
HP:0000505HP:0007663Reduced visual acuity1B4GAT1 CL E G H1104115685OMIM:615287MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1317
HP:0000505HP:0001123Visual field defect1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0000572Visual loss1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0007663Reduced visual acuity1BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0000572Visual loss1BAP1 CL E G H8314950ORPHA:39044Uveal melanomaHP:0040281 - Very frequent184
HP:0000505HP:0001123Visual field defect1BBS1 CL E G H582966OMIM:209900Bardet-Biedl syndrome 1114
HP:0000505HP:0007663Reduced visual acuity1BBS1 CL E G H582966OMIM:209900Bardet-Biedl syndrome 1114
HP:0000505HP:0007663Reduced visual acuity1BBS1 CL E G H582966ORPHA:791Retinitis pigmentosa114
HP:0000505HP:0007663Reduced visual acuity1BBS2 CL E G H583967ORPHA:791Retinitis pigmentosa97
HP:0000505HP:0001123Visual field defect1BBS2 CL E G H583967OMIM:616562Retinitis pigmentosa 7497
HP:0000505HP:0007663Reduced visual acuity1BBS5 CL E G H129880970OMIM:615983Bardet-Biedl syndrome 525
HP:0000505HP:0007663Reduced visual acuity1BCOR CL E G H5488020893OMIM:309800Microphthalmia, syndromic 1101
HP:0000505HP:0000572Visual loss1BCOR CL E G H5488020893OMIM:300166Microphthalmia, syndromic 2.101
HP:0000505HP:0001123Visual field defect1BEST1 CL E G H743912703ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040282 - Frequent182
HP:0000505HP:0001123Visual field defect1BEST1 CL E G H743912703ORPHA:1243Best vitelliform macular dystrophyHP:0040283 - Occasional182
HP:0000505HP:0007663Reduced visual acuity1BEST1 CL E G H743912703OMIM:611809BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB182
HP:0000505HP:0007663Reduced visual acuity1BEST1 CL E G H743912703OMIM:153700Macular dystrophy, vitelliform, 2.182
HP:0000505HP:0007663Reduced visual acuity1BEST1 CL E G H743912703ORPHA:791Retinitis pigmentosa182
HP:0000505HP:0007663Reduced visual acuity1BEST1 CL E G H743912703OMIM:613194Retinitis pigmentosa-50182
HP:0000505HP:0007663Reduced visual acuity1BEST1 CL E G H743912703OMIM:193220VITREORETINOCHOROIDOPATHY182
HP:0000505HP:0007663Reduced visual acuity1BLOC1S3 CL E G H38855220914OMIM:614077Hermansky-Pudlak syndrome 8.42
HP:0000505HP:0007663Reduced visual acuity1BLOC1S5 CL E G H6391518561OMIM:619172HERMANSKY-PUDLAK SYNDROME 11; HPS11
HP:0000505HP:0007663Reduced visual acuity1BMP4 CL E G H6521071OMIM:607932Microphthalmia, syndromic 638
HP:0000505HP:0001123Visual field defect1BMPR1A CL E G H6571076ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional385
HP:0000505HP:0100704Cerebral visual impairment1BRAF CL E G H6731097OMIM:115150Cardiofaciocutaneous syndrome 1276
HP:0000505HP:0000572Visual loss1BRAF CL E G H6731097OMIM:115150Cardiofaciocutaneous syndrome 1276
HP:0000505HP:0001123Visual field defect1BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0007663Reduced visual acuity1BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0000572Visual loss1BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0001123Visual field defect1BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0000505HP:0100704Cerebral visual impairment1BRAT1 CL E G H22192721701OMIM:614498Rigidity and multifocal seizure syndrome, lethal neonatal20
HP:0000505HP:0000572Visual loss1BTD CL E G H6861122ORPHA:79241Biotinidase deficiency223
HP:0000505HP:0001123Visual field defect1BTD CL E G H6861122ORPHA:79241Biotinidase deficiency223
HP:0000505HP:0000572Visual loss1BTD CL E G H6861122OMIM:253260Biotinidase deficiencymultiple carboxylase deficiency, late-onset.223
HP:0000505HP:0007663Reduced visual acuity1BTNL2 CL E G H562441142ORPHA:797Sarcoidosis1
HP:0000505HP:0000572Visual loss1C19ORF12 CL E G H8363625443OMIM:614298Neurodegeneration with brain iron accumulation 4114
HP:0000505HP:0007663Reduced visual acuity1C1QBP CL E G H7081243OMIM:617713Combined oxidative phosphorylation deficiency 33
HP:0000505HP:0000572Visual loss1C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degenerationHP:0040282 - Frequent20
HP:0000505HP:0007663Reduced visual acuity1C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degeneration20
HP:0000505HP:0001123Visual field defect1C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration20
HP:0000505HP:0007663Reduced visual acuity1C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration20
HP:0000505HP:0000572Visual loss1C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration.20
HP:0000505HP:0007663Reduced visual acuity1C4A CL E G H7201323ORPHA:117Behçet disease1
HP:0000505HP:0000572Visual loss1CA2 CL E G H7601373OMIM:259730Osteopetrosis, autosomal recessive 3.29
HP:0000505HP:0007663Reduced visual acuity1CA4 CL E G H7621375ORPHA:791Retinitis pigmentosa23
HP:0000505HP:0007663Reduced visual acuity1CABP4 CL E G H570101386ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent94
HP:0000505HP:0001123Visual field defect1CACNA1A CL E G H7731388ORPHA:569Familial or sporadic hemiplegic migraine449
HP:0000505HP:0100704Cerebral visual impairment1CACNA1B CL E G H7741389OMIM:618497Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements.5
HP:0000505HP:0100704Cerebral visual impairment1CACNA1D CL E G H7761391OMIM:615474Primary aldosteronism, seizures, and neurologic abnormalitiesHP:0040283 - Occasional51
HP:0000505HP:0100704Cerebral visual impairment1CACNA1D CL E G H7761391ORPHA:369929Primary hyperaldosteronism-seizures-neurological abnormalities syndromeHP:0040282 - Frequent51
HP:0000505HP:0100704Cerebral visual impairment1CACNA1E CL E G H7771392OMIM:618285Developmental and epileptic encephalopathy 69.11
HP:0000505HP:0007663Reduced visual acuity1CACNA1F CL E G H7781393OMIM:300600Aland island eye disease58
HP:0000505HP:0007663Reduced visual acuity1CACNA1F CL E G H7781393ORPHA:178333Ã…land Islands eye diseaseHP:0040281 - Very frequent58
HP:0000505HP:0001123Visual field defect1CACNA1F CL E G H7781393OMIM:300476Cone-Rod dystrophy, X-linked, 358
HP:0000505HP:0007663Reduced visual acuity1CACNA1F CL E G H7781393OMIM:300476Cone-Rod dystrophy, X-linked, 3.58
HP:0000505HP:0007663Reduced visual acuity1CACNA1F CL E G H7781393ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent58
HP:0000505HP:0007663Reduced visual acuity1CACNA1F CL E G H7781393OMIM:300071Night blindness, congenital stationary, type 2A.58
HP:0000505HP:0007663Reduced visual acuity1CACNA2D4 CL E G H9358920202ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent129
HP:0000505HP:0007663Reduced visual acuity1CACNA2D4 CL E G H9358920202OMIM:610478Retinal cone dystrophy 4.129
HP:0000505HP:0001123Visual field defect1CACNA2D4 CL E G H9358920202OMIM:610478Retinal cone dystrophy 4129
HP:0000505HP:0007663Reduced visual acuity1CAPN5 CL E G H7261482OMIM:193235Vitreoretinopathy, neovascular inflammatory6
HP:0000505HP:0000572Visual loss1CARS2 CL E G H7958725695ORPHA:477774Combined oxidative phosphorylation defect type 2735
HP:0000505HP:0007663Reduced visual acuity1CBS CL E G H8751550ORPHA:394Classic homocystinuria242
HP:0000505HP:0100704Cerebral visual impairment1CC2D2A CL E G H5754529253OMIM:612285Joubert syndrome 9247
HP:0000505HP:0007663Reduced visual acuity1CC2D2A CL E G H5754529253ORPHA:2318Joubert syndrome with oculorenal defect247
HP:0000505HP:0001123Visual field defect1CC2D2A CL E G H5754529253OMIM:619845RETINITIS PIGMENTOSA 93; RP93247
HP:0000505HP:0007663Reduced visual acuity1CC2D2A CL E G H5754529253OMIM:619845RETINITIS PIGMENTOSA 93; RP93247
HP:0000505HP:0001123Visual field defect1CCDC28B CL E G H7914028163OMIM:209900Bardet-Biedl syndrome 14
HP:0000505HP:0007663Reduced visual acuity1CCDC28B CL E G H7914028163OMIM:209900Bardet-Biedl syndrome 14
HP:0000505HP:0100704Cerebral visual impairment1CCDC47 CL E G H5700324856OMIM:618268Trichohepatoneurodevelopmental syndrome.
HP:0000505HP:0000572Visual loss1CCND1 CL E G H5951582ORPHA:892Von Hippel-Lindau diseaseHP:0040283 - Occasional1
HP:0000505HP:0007663Reduced visual acuity1CCR1 CL E G H12301602ORPHA:117Behçet disease
HP:0000505HP:0007663Reduced visual acuity1CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopenia
HP:0000505HP:0007663Reduced visual acuity1CD247 CL E G H9191677ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional8
HP:0000505HP:0000572Visual loss1CD247 CL E G H9191677ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional8
HP:0000505HP:0007663Reduced visual acuity1CDC42 CL E G H9981736ORPHA:487796Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndromeHP:0040283 - Occasional6
HP:0000505HP:0007663Reduced visual acuity1CDC42BPB CL E G H95781738OMIM:619841
HP:0000505HP:0001123Visual field defect1CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0000505HP:0000572Visual loss1CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0000505HP:0001123Visual field defect1CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0000505HP:0007663Reduced visual acuity1CDH23 CL E G H6407213733ORPHA:2965Prolactinoma636
HP:0000505HP:0007663Reduced visual acuity1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0000505HP:0001123Visual field defect1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0000505HP:0000572Visual loss1CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenoma636
HP:0000505HP:0001123Visual field defect1CDH23 CL E G H6407213733ORPHA:231169Usher syndrome type 1636
HP:0000505HP:0000572Visual loss1CDH23 CL E G H6407213733ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent636
HP:0000505HP:0007663Reduced visual acuity1CDH3 CL E G H10011762ORPHA:1573Hypotrichosis with juvenile macular degeneration87
HP:0000505HP:0007663Reduced visual acuity1CDH3 CL E G H10011762OMIM:601553Hypotrichosis, congenital, with juvenile macular dystrophy87
HP:0000505HP:0001123Visual field defect1CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000505HP:0000572Visual loss1CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000505HP:0007663Reduced visual acuity1CDHR1 CL E G H9221114550ORPHA:791Retinitis pigmentosa147
HP:0000505HP:0100704Cerebral visual impairment1CDKL5 CL E G H679211411OMIM:300672Developmental and epileptic encephalopathy 2405
HP:0000505HP:0100704Cerebral visual impairment1CDON CL E G H5093717104ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent200
HP:0000505HP:0100704Cerebral visual impairment1CDON CL E G H5093717104ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional200
HP:0000505HP:0100704Cerebral visual impairment1CDON CL E G H5093717104ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent200
HP:0000505HP:0100704Cerebral visual impairment1CDON CL E G H5093717104ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent200
HP:0000505HP:0000572Visual loss1CEP120 CL E G H15324126690ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional7
HP:0000505HP:0007663Reduced visual acuity1CEP164 CL E G H2289729182OMIM:614845Nephronophthisis 1534
HP:0000505HP:0000572Visual loss1CEP164 CL E G H2289729182ORPHA:3156Senior-Loken syndrome34
HP:0000505HP:0007663Reduced visual acuity1CEP250 CL E G H111901859OMIM:618358CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2
HP:0000505HP:0007663Reduced visual acuity1CEP290 CL E G H8018429021OMIM:610188Joubert syndrome 5342
HP:0000505HP:0007663Reduced visual acuity1CEP290 CL E G H8018429021ORPHA:2318Joubert syndrome with oculorenal defect342
HP:0000505HP:0007663Reduced visual acuity1CEP290 CL E G H8018429021ORPHA:65Leber congenital amaurosis342
HP:0000505HP:0000572Visual loss1CEP290 CL E G H8018429021ORPHA:3156Senior-Loken syndrome342
HP:0000505HP:0007663Reduced visual acuity1CEP290 CL E G H8018429021OMIM:610189Senior-Loken syndrome 6.342
HP:0000505HP:0000572Visual loss1CEP41 CL E G H9568112370ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional90
HP:0000505HP:0001123Visual field defect1CEP78 CL E G H8413125740ORPHA:231183Usher syndrome type 39
HP:0000505HP:0000572Visual loss1CEP78 CL E G H8413125740ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent9
HP:0000505HP:0100704Cerebral visual impairment1CEP85L CL E G H38711921638OMIM:618873LISSENCEPHALY 10; LIS101
HP:0000505HP:0100704Cerebral visual impairment1CEP85L CL E G H38711921638ORPHA:572013Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome1
HP:0000505HP:0007663Reduced visual acuity1CERKL CL E G H37529821699ORPHA:791Retinitis pigmentosa71
HP:0000505HP:0001123Visual field defect1CERKL CL E G H37529821699OMIM:608380Retinitis pigmentosa 2671
HP:0000505HP:0100704Cerebral visual impairment1CERT1 CL E G H100872205OMIM:616351Mental retardation, autosomal dominant 34.
HP:0000505HP:0001123Visual field defect1CFAP410 CL E G H7551260OMIM:617547Retinal dystrophy with or without macular staphyloma
HP:0000505HP:0001123Visual field defect1CFAP418 CL E G H15765727232OMIM:617406Bardet-Biedl syndrome 21
HP:0000505HP:0007663Reduced visual acuity1CFAP418 CL E G H15765727232OMIM:617406Bardet-Biedl syndrome 21
HP:0000505HP:0007663Reduced visual acuity1CFAP418 CL E G H15765727232OMIM:614500Cone-Rod dystrophy 16
HP:0000505HP:0000572Visual loss1CFAP418 CL E G H15765727232OMIM:614500Cone-Rod dystrophy 16
HP:0000505HP:0007663Reduced visual acuity1CFAP418 CL E G H15765727232ORPHA:791Retinitis pigmentosa
HP:0000505HP:0001123Visual field defect1CFAP418 CL E G H15765727232OMIM:268000Retinitis pigmentosa
HP:0000505HP:0000572Visual loss1CFH CL E G H30754883OMIM:126700Basal laminar drusen86
HP:0000505HP:0001123Visual field defect1CFH CL E G H30754883ORPHA:75376Familial drusen86
HP:0000505HP:0000572Visual loss1CFH CL E G H30754883ORPHA:75376Familial drusenHP:0040281 - Very frequent86
HP:0000505HP:0000572Visual loss1CFHR1 CL E G H30784888OMIM:603075Macular degeneration, age-related, 1
HP:0000505HP:0000572Visual loss1CFHR3 CL E G H1087816980OMIM:603075Macular degeneration, age-related, 1
HP:0000505HP:0001123Visual field defect1CFI CL E G H34265394ORPHA:75376Familial drusen57
HP:0000505HP:0000572Visual loss1CFI CL E G H34265394ORPHA:75376Familial drusenHP:0040281 - Very frequent57
HP:0000505HP:0000572Visual loss1CFI CL E G H34265394OMIM:615439Macular degeneration, age-related, 1357
HP:0000505HP:0100704Cerebral visual impairment1CHD3 CL E G H11071918OMIM:618205Snijders blok-campeau syndromeHP:0040284 - Very rare2
HP:0000505HP:0100704Cerebral visual impairment1CHKA CL E G H11191937OMIM:620023
HP:0000505HP:0001123Visual field defect1CHM CL E G H11211940OMIM:303100CHOROIDEREMIA47
HP:0000505HP:0000572Visual loss1CHM CL E G H11211940ORPHA:180Choroideremia47
HP:0000505HP:0000572Visual loss1CHM CL E G H11211940OMIM:303100CHOROIDEREMIA47
HP:0000505HP:0100704Cerebral visual impairment1CHMP1A CL E G H51198740OMIM:614961Pontocerebellar hypoplasia, type 8HP:0040283 - Occasional19
HP:0000505HP:0007663Reduced visual acuity1CHN1 CL E G H11231943ORPHA:233Duane retraction syndrome35
HP:0000505HP:0007663Reduced visual acuity1CHN1 CL E G H11231943OMIM:604356DUANE RETRACTION SYNDROME 2; DURS235
HP:0000505HP:0007663Reduced visual acuity1CHP1 CL E G H1126117433OMIM:618438Spastic ataxia 9, autosomal recessive.
HP:0000505HP:0007663Reduced visual acuity1CHRDL1 CL E G H9185129861OMIM:309300MEGALOCORNEA9
HP:0000505HP:0007663Reduced visual acuity1CHST3 CL E G H94691971OMIM:245600Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects165
HP:0000505HP:0007663Reduced visual acuity1CHST6 CL E G H41666938ORPHA:98969Macular corneal dystrophy129
HP:0000505HP:0000572Visual loss1CIB2 CL E G H1051824579ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent15
HP:0000505HP:0001123Visual field defect1CIB2 CL E G H1051824579ORPHA:231169Usher syndrome type 115
HP:0000505HP:0007663Reduced visual acuity1CLCC1 CL E G H2315529675OMIM:609913RETINITIS PIGMENTOSA 32; RP32
HP:0000505HP:0001123Visual field defect1CLCN2 CL E G H11812020OMIM:615651Leukoencephalopathy with ataxiaHP:0040283 - Occasional44
HP:0000505HP:0100704Cerebral visual impairment1CLCN4 CL E G H11832022ORPHA:485350CLCN4-related X-linked intellectual disability syndromeHP:0040283 - Occasional45
HP:0000505HP:0100704Cerebral visual impairment1CLCN4 CL E G H11832022OMIM:300114Raynaud-Claes syndromeHP:0040284 - Very rare45
HP:0000505HP:0100704Cerebral visual impairment1CLCN6 CL E G H11852024OMIM:619173NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA
HP:0000505HP:0007663Reduced visual acuity1CLCN6 CL E G H11852024OMIM:619173NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA
HP:0000505HP:0007663Reduced visual acuity1CLCN7 CL E G H11862025ORPHA:53Albers-Schönberg osteopetrosis102
HP:0000505HP:0007663Reduced visual acuity1CLCN7 CL E G H11862025OMIM:618541Hypopigmentation, organomegaly, and delayed myelination and development.102
HP:0000505HP:0000572Visual loss1CLCN7 CL E G H11862025OMIM:166600Osteopetrosis, autosomal dominant 2.102
HP:0000505HP:0007663Reduced visual acuity1CLEC3B CL E G H712311891OMIM:619977
HP:0000505HP:0007663Reduced visual acuity1CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3216
HP:0000505HP:0000572Visual loss1CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3216
HP:0000505HP:0007663Reduced visual acuity1CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000505HP:0000572Visual loss1CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000505HP:0000572Visual loss1CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5141
HP:0000505HP:0000572Visual loss1CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6143
HP:0000505HP:0000572Visual loss1CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8111
HP:0000505HP:0000572Visual loss1CLN8 CL E G H20552079ORPHA:1947Progressive epilepsy-intellectual disability syndrome, Finnish type111
HP:0000505HP:0007663Reduced visual acuity1CLRN1 CL E G H740112605ORPHA:791Retinitis pigmentosa60
HP:0000505HP:0001123Visual field defect1CLRN1 CL E G H740112605OMIM:268000Retinitis pigmentosa60
HP:0000505HP:0001123Visual field defect1CLRN1 CL E G H740112605ORPHA:231183Usher syndrome type 360
HP:0000505HP:0000572Visual loss1CLRN1 CL E G H740112605ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent60
HP:0000505HP:0007663Reduced visual acuity1CLRN1 CL E G H740112605OMIM:276902Usher syndrome, type IIIA.60
HP:0000505HP:0001123Visual field defect1CLRN1 CL E G H740112605OMIM:276902Usher syndrome, type IIIAHP:0040282 - Frequent60
HP:0000505HP:0007663Reduced visual acuity1CNGA1 CL E G H12592148ORPHA:791Retinitis pigmentosa44
HP:0000505HP:0001123Visual field defect1CNGA1 CL E G H12592148OMIM:268000Retinitis pigmentosa44
HP:0000505HP:0007663Reduced visual acuity1CNGA1 CL E G H12592148OMIM:613756RETINITIS PIGMENTOSA 49; RP4944
HP:0000505HP:0001123Visual field defect1CNGA1 CL E G H12592148OMIM:613756RETINITIS PIGMENTOSA 49; RP4944
HP:0000505HP:0007663Reduced visual acuity1CNGA3 CL E G H12612150ORPHA:49382AchromatopsiaHP:0040282 - Frequent82
HP:0000505HP:0001123Visual field defect1CNGA3 CL E G H12612150ORPHA:49382Achromatopsia82
HP:0000505HP:0007663Reduced visual acuity1CNGA3 CL E G H12612150OMIM:216900Achromatopsia 282
HP:0000505HP:0007663Reduced visual acuity1CNGB1 CL E G H12582151ORPHA:791Retinitis pigmentosa164
HP:0000505HP:0001123Visual field defect1CNGB1 CL E G H12582151OMIM:613767Retinitis pigmentosa 45164
HP:0000505HP:0007663Reduced visual acuity1CNGB3 CL E G H547142153ORPHA:49382AchromatopsiaHP:0040282 - Frequent194
HP:0000505HP:0001123Visual field defect1CNGB3 CL E G H547142153ORPHA:49382Achromatopsia194
HP:0000505HP:0007663Reduced visual acuity1CNGB3 CL E G H547142153OMIM:262300Achromatopsia 3194
HP:0000505HP:0001123Visual field defect1CNGB3 CL E G H547142153ORPHA:827Stargardt disease194
HP:0000505HP:0007663Reduced visual acuity1CNGB3 CL E G H547142153ORPHA:827Stargardt diseaseHP:0040280 - Obligate194
HP:0000505HP:0001123Visual field defect1CNNM4 CL E G H26504105OMIM:217080Jalili syndrome61
HP:0000505HP:0100704Cerebral visual impairment1COG5 CL E G H1046614857ORPHA:263487COG5-CDGHP:0040283 - Occasional79
HP:0000505HP:0007663Reduced visual acuity1COL11A1 CL E G H13012186ORPHA:250984Autosomal recessive Stickler syndrome215
HP:0000505HP:0007663Reduced visual acuity1COL11A1 CL E G H13012186ORPHA:560Marshall syndrome215
HP:0000505HP:0000572Visual loss1COL17A1 CL E G H13082194ORPHA:293381Epithelial recurrent erosion dystrophy129
HP:0000505HP:0001123Visual field defect1COL18A1 CL E G H807812195OMIM:618880GLAUCOMA, PRIMARY CLOSED-ANGLE; GLCC177
HP:0000505HP:0000572Visual loss1COL18A1 CL E G H807812195ORPHA:1571Knobloch syndromeHP:0040282 - Frequent177
HP:0000505HP:0007663Reduced visual acuity1COL25A1 CL E G H8457018603ORPHA:91411Congenital ptosis3
HP:0000505HP:0000572Visual loss1COL2A1 CL E G H12802200ORPHA:90653Stickler syndrome type 1HP:0040283 - Occasional284
HP:0000505HP:0007663Reduced visual acuity1COL2A1 CL E G H12802200OMIM:108300Stickler syndrome, type I284
HP:0000505HP:0001123Visual field defect1COL3A1 CL E G H12812201ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent749
HP:0000505HP:0007663Reduced visual acuity1COL4A1 CL E G H12822202OMIM:175780Brain small vessel disease 1 with or without ocular anomaliesHP:0040284 - Very rare193
HP:0000505HP:0001123Visual field defect1COL4A1 CL E G H12822202OMIM:175780Brain small vessel disease 1 with or without ocular anomalies.193
HP:0000505HP:0000572Visual loss1COL7A1 CL E G H12942214ORPHA:89842Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate formHP:0040283 - Occasional263
HP:0000505HP:0000572Visual loss1COL7A1 CL E G H12942214ORPHA:79408Autosomal recessive generalized dystrophic epidermolysis bullosa, severe formHP:0040283 - Occasional263
HP:0000505HP:0007663Reduced visual acuity1COL8A2 CL E G H12962216ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000505HP:0000572Visual loss1COL8A2 CL E G H12962216ORPHA:98974Fuchs endothelial corneal dystrophy3
HP:0000505HP:0007663Reduced visual acuity1COL8A2 CL E G H12962216ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1COL9A1 CL E G H12972217ORPHA:250984Autosomal recessive Stickler syndrome110
HP:0000505HP:0007663Reduced visual acuity1COL9A2 CL E G H12982218ORPHA:250984Autosomal recessive Stickler syndrome110
HP:0000505HP:0007663Reduced visual acuity1COL9A3 CL E G H12992219ORPHA:250984Autosomal recessive Stickler syndrome137
HP:0000505HP:0100704Cerebral visual impairment1COPB2 CL E G H92762232OMIM:617800Microcephaly 19, primary, autosomal recessive.
HP:0000505HP:0000572Visual loss1COQ2 CL E G H2723525223OMIM:607426Coenzyme Q10 deficiency, primary, 1.54
HP:0000505HP:0100704Cerebral visual impairment1COQ2 CL E G H2723525223ORPHA:255249Leigh syndrome with nephrotic syndromeHP:0040283 - Occasional54
HP:0000505HP:0001123Visual field defect1COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1COX1 CL E G H45127419ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0100704Cerebral visual impairment1COX1 CL E G H45127419OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0001123Visual field defect1COX1 CL E G H45127419OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000572Visual loss1COX2 CL E G H45137421ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0100704Cerebral visual impairment1COX2 CL E G H45137421OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0001123Visual field defect1COX2 CL E G H45137421OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000572Visual loss1COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1COX3 CL E G H45147422OMIM:535000Leber optic atrophy
HP:0000505HP:0000572Visual loss1COX3 CL E G H45147422OMIM:535000Leber optic atrophy.
HP:0000505HP:0000572Visual loss1COX3 CL E G H45147422ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1COX3 CL E G H45147422OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1COX3 CL E G H45147422OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1COX6B1 CL E G H13402280OMIM:619051MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN710
HP:0000505HP:0100704Cerebral visual impairment1COX6B1 CL E G H13402280OMIM:619051MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN710
HP:0000505HP:0007663Reduced visual acuity1COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndrome6
HP:0000505HP:0000572Visual loss1COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional6
HP:0000505HP:0100704Cerebral visual impairment1CPSF3 CL E G H516922326OMIM:619876
HP:0000505HP:0007663Reduced visual acuity1CRB1 CL E G H234182343ORPHA:65Leber congenital amaurosis156
HP:0000505HP:0007663Reduced visual acuity1CRB1 CL E G H234182343OMIM:613835Leber congenital amaurosis 8.156
HP:0000505HP:0007663Reduced visual acuity1CRB1 CL E G H234182343ORPHA:791Retinitis pigmentosa156
HP:0000505HP:0007663Reduced visual acuity1CRB1 CL E G H234182343OMIM:600105Retinitis pigmentosa 12156
HP:0000505HP:0007663Reduced visual acuity1CREBBP CL E G H13872348OMIM:618332MENKE-HENNEKAM SYNDROME 1; MKHK1291
HP:0000505HP:0007663Reduced visual acuity1CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2158
HP:0000505HP:0001123Visual field defect1CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2158
HP:0000505HP:0007663Reduced visual acuity1CRX CL E G H14062383ORPHA:65Leber congenital amaurosis158
HP:0000505HP:0001123Visual field defect1CRX CL E G H14062383OMIM:268000Retinitis pigmentosa158
HP:0000505HP:0007663Reduced visual acuity1CRX CL E G H14062383ORPHA:791Retinitis pigmentosa158
HP:0000505HP:0007663Reduced visual acuity1CRYAA CL E G H14092388OMIM:604219Cataract 9, multiple types33
HP:0000505HP:0007663Reduced visual acuity1CRYBB1 CL E G H14142397OMIM:611544Cataract 17, multiple types.18
HP:0000505HP:0007663Reduced visual acuity1CRYGC CL E G H14202410OMIM:604307Cataract 2, multiple types11
HP:0000505HP:0000572Visual loss1CSPP1 CL E G H7984826193ORPHA:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophyHP:0040283 - Occasional57
HP:0000505HP:0007663Reduced visual acuity1CTC1 CL E G H8016926169OMIM:612199Cerebroretinal microangiopathy with calcifications and cysts160
HP:0000505HP:0001123Visual field defect1CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0000572Visual loss1CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0007663Reduced visual acuity1CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0007663Reduced visual acuity1CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathyHP:0040282 - Frequent88
HP:0000505HP:0007663Reduced visual acuity1CTNS CL E G H14972518OMIM:219800Cystinosis, nephropathic178
HP:0000505HP:0000572Visual loss1CTSD CL E G H15092529OMIM:610127Ceroid lipofuscinosis, neuronal, 10.159
HP:0000505HP:0001123Visual field defect1CWC27 CL E G H1028310664ORPHA:166035Brachydactyly-short stature-retinitis pigmentosa syndromeHP:0040283 - Occasional4
HP:0000505HP:0001123Visual field defect1CWC27 CL E G H1028310664OMIM:250410Retinitis pigmentosa with or without skeletal anomalies4
HP:0000505HP:0000572Visual loss1CYP1B1 CL E G H15452597ORPHA:98976Congenital glaucomaHP:0040283 - Occasional101
HP:0000505HP:0001123Visual field defect1CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucoma101
HP:0000505HP:0001123Visual field defect1CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy126
HP:0000505HP:0000572Visual loss1CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy126
HP:0000505HP:0007663Reduced visual acuity1CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophy126
HP:0000505HP:0001123Visual field defect1CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophy126
HP:0000505HP:0000572Visual loss1CYSLTR2 CL E G H5710518274ORPHA:39044Uveal melanomaHP:0040281 - Very frequent1
HP:0000505HP:0000572Visual loss1CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1CYTB CL E G H45197427OMIM:535000Leber optic atrophy.
HP:0000505HP:0001123Visual field defect1CYTB CL E G H45197427OMIM:535000Leber optic atrophy
HP:0000505HP:0001123Visual field defect1CYTB CL E G H45197427OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1CYTB CL E G H45197427OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0100704Cerebral visual impairment1D2HGDH CL E G H72829428358OMIM:600721D-2-Hydroxyglutaric aciduria 1102
HP:0000505HP:0000572Visual loss1DCN CL E G H16342705OMIM:610048Corneal dystrophy, congenital stromal31
HP:0000505HP:0007663Reduced visual acuity1DCT CL E G H16382709OMIM:619165OCULOCUTANEOUS ALBINISM, TYPE VIII; OCA8
HP:0000505HP:0007663Reduced visual acuity1DHDDS CL E G H7994720603ORPHA:791Retinitis pigmentosa47
HP:0000505HP:0007663Reduced visual acuity1DHDDS CL E G H7994720603OMIM:613861Retinitis pigmentosa 5947
HP:0000505HP:0001123Visual field defect1DHDDS CL E G H7994720603OMIM:613861Retinitis pigmentosa 5947
HP:0000505HP:0007663Reduced visual acuity1DHX37 CL E G H5764717210OMIM:618731NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC2
HP:0000505HP:0007663Reduced visual acuity1DHX38 CL E G H978517211ORPHA:791Retinitis pigmentosa1
HP:0000505HP:0100704Cerebral visual impairment1DIAPH1 CL E G H17292876OMIM:616632Seizures, cortical blindness, and microcephaly syndrome.118
HP:0000505HP:0100704Cerebral visual impairment1DISP1 CL E G H8497619711ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent22
HP:0000505HP:0100704Cerebral visual impairment1DISP1 CL E G H8497619711ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional22
HP:0000505HP:0100704Cerebral visual impairment1DISP1 CL E G H8497619711ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent22
HP:0000505HP:0100704Cerebral visual impairment1DISP1 CL E G H8497619711ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent22
HP:0000505HP:0001123Visual field defect1DLAT CL E G H17372896ORPHA:79244Pyruvate dehydrogenase E2 deficiency82
HP:0000505HP:0007663Reduced visual acuity1DLD CL E G H17382898ORPHA:2394Pyruvate dehydrogenase E3 deficiencyHP:0040283 - Occasional89
HP:0000505HP:0100704Cerebral visual impairment1DLL1 CL E G H285142908ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent3
HP:0000505HP:0100704Cerebral visual impairment1DLL1 CL E G H285142908ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional3
HP:0000505HP:0100704Cerebral visual impairment1DLL1 CL E G H285142908ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent3
HP:0000505HP:0100704Cerebral visual impairment1DLL1 CL E G H285142908ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent3
HP:0000505HP:0000572Visual loss1DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0000505HP:0007663Reduced visual acuity1DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0000505HP:0007663Reduced visual acuity1DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic form94
HP:0000505HP:0001123Visual field defect1DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic form94
HP:0000505HP:0000572Visual loss1DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000505HP:0001123Visual field defect1DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000505HP:0100704Cerebral visual impairment1DOCK7 CL E G H8544019190ORPHA:411986Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndromeHP:0040282 - Frequent11
HP:0000505HP:0100704Cerebral visual impairment1DOCK7 CL E G H8544019190OMIM:615859Epileptic encephalopathy, early infantile, 23.11
HP:0000505HP:0100704Cerebral visual impairment1DOHH CL E G H8347528662OMIM:620066
HP:0000505HP:0100704Cerebral visual impairment1DPM1 CL E G H88133005OMIM:608799Congenital disorder of glycosylation, type IE.27
HP:0000505HP:0100704Cerebral visual impairment1DPM1 CL E G H88133005ORPHA:79322DPM1-CDGHP:0040283 - Occasional27
HP:0000505HP:0007663Reduced visual acuity1DPP6 CL E G H18043010OMIM:616311MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD3318
HP:0000505HP:0007663Reduced visual acuity1DRAM2 CL E G H12833828769OMIM:616502Cone-Rod dystrophy 21.9
HP:0000505HP:0007663Reduced visual acuity1DTNBP1 CL E G H8406217328OMIM:614076Hermansky-Pudlak syndrome 7.46
HP:0000505HP:0100704Cerebral visual impairment1DTYMK CL E G H18413061OMIM:619847
HP:0000505HP:0007663Reduced visual acuity1DYRK1A CL E G H18593091ORPHA:464311Intellectual disability syndrome due to a DYRK1A point mutation134
HP:0000505HP:0001123Visual field defect1EFEMP1 CL E G H22023218ORPHA:75376Familial drusen54
HP:0000505HP:0000572Visual loss1EFEMP1 CL E G H22023218ORPHA:75376Familial drusenHP:0040281 - Very frequent54
HP:0000505HP:0001123Visual field defect1EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucoma54
HP:0000505HP:0007663Reduced visual acuity1EIF2B1 CL E G H19673257OMIM:603896Leukoencephalopathy with vanishing white matter42
HP:0000505HP:0007663Reduced visual acuity1EIF2B2 CL E G H88923258OMIM:603896Leukoencephalopathy with vanishing white matter24
HP:0000505HP:0007663Reduced visual acuity1EIF2B3 CL E G H88913259OMIM:603896Leukoencephalopathy with vanishing white matter32
HP:0000505HP:0007663Reduced visual acuity1EIF2B4 CL E G H88903260OMIM:603896Leukoencephalopathy with vanishing white matter38
HP:0000505HP:0007663Reduced visual acuity1EIF2B5 CL E G H88933261OMIM:603896Leukoencephalopathy with vanishing white matter48
HP:0000505HP:0000572Visual loss1ELMO2 CL E G H6391617233OMIM:606893Vascular malformation, primary intraosseous.3
HP:0000505HP:0007663Reduced visual acuity1ELN CL E G H20063327OMIM:194050Williams-Beuren syndrome172
HP:0000505HP:0001123Visual field defect1ELOVL1 CL E G H6483414418OMIM:618527Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features
HP:0000505HP:0007663Reduced visual acuity1ELOVL1 CL E G H6483414418OMIM:618527Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features.
HP:0000505HP:0007663Reduced visual acuity1ELOVL4 CL E G H678514415ORPHA:827Stargardt diseaseHP:0040280 - Obligate62
HP:0000505HP:0001123Visual field defect1ELOVL4 CL E G H678514415ORPHA:827Stargardt disease62
HP:0000505HP:0007663Reduced visual acuity1ELOVL4 CL E G H678514415OMIM:600110STARGARDT DISEASE 3; STGD362
HP:0000505HP:0007663Reduced visual acuity1ELP4 CL E G H266101171OMIM:617141Aniridia 24
HP:0000505HP:0100704Cerebral visual impairment1EMC1 CL E G H2306528957OMIM:616875Cerebellar atrophy, visual impairment, and psychomotor retardation5
HP:0000505HP:0100704Cerebral visual impairment1EMC1 CL E G H2306528957ORPHA:480898Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndromeHP:0040283 - Occasional5
HP:0000505HP:0001123Visual field defect1ENG CL E G H20223349ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent186
HP:0000505HP:0007663Reduced visual acuity1ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasia186
HP:0000505HP:0001123Visual field defect1EPCAM CL E G H407211529ORPHA:144Lynch syndromeHP:0040283 - Occasional170
HP:0000505HP:0000572Visual loss1EPM2A CL E G H79573413OMIM:254780Myoclonic epilepsy of lafora.83
HP:0000505HP:0007663Reduced visual acuity1EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15
HP:0000505HP:0000572Visual loss1EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15
HP:0000505HP:0007663Reduced visual acuity1ERAP1 CL E G H5175218173ORPHA:117Behçet disease1
HP:0000505HP:0007663Reduced visual acuity1ERCC4 CL E G H20723436OMIM:610965XFE progeroid syndrome158
HP:0000505HP:0007663Reduced visual acuity1ERF CL E G H20773444ORPHA:207Crouzon disease12
HP:0000505HP:0001123Visual field defect1ESPN CL E G H8371513281ORPHA:231169Usher syndrome type 133
HP:0000505HP:0000572Visual loss1ESPN CL E G H8371513281ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent33
HP:0000505HP:0000572Visual loss1EXOSC3 CL E G H5101017944ORPHA:2254Pontocerebellar hypoplasia type 138
HP:0000505HP:0000572Visual loss1EXOSC8 CL E G H1134017035ORPHA:2254Pontocerebellar hypoplasia type 14
HP:0000505HP:0000572Visual loss1EXOSC9 CL E G H53939137ORPHA:2254Pontocerebellar hypoplasia type 1
HP:0000505HP:0007663Reduced visual acuity1EYS CL E G H34600721555ORPHA:791Retinitis pigmentosa209
HP:0000505HP:0001123Visual field defect1EYS CL E G H34600721555OMIM:602772Retinitis pigmentosa 25209
HP:0000505HP:0000572Visual loss1FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegeneration76
HP:0000505HP:0001123Visual field defect1FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegenerationHP:0040282 - Frequent76
HP:0000505HP:0007663Reduced visual acuity1FAM161A CL E G H8414025808ORPHA:791Retinitis pigmentosa56
HP:0000505HP:0001123Visual field defect1FAM161A CL E G H8414025808OMIM:606068RETINITIS PIGMENTOSA 28; RP2856
HP:0000505HP:0001123Visual field defect1FAN1 CL E G H2290929170ORPHA:144Lynch syndromeHP:0040283 - Occasional15
HP:0000505HP:0007663Reduced visual acuity1FAS CL E G H35511920ORPHA:117Behçet disease59
HP:0000505HP:0007663Reduced visual acuity1FBN1 CL E G H22003603ORPHA:1885Isolated ectopia lentis1361
HP:0000505HP:0007663Reduced visual acuity1FBN1 CL E G H22003603OMIM:616914Marfan lipodystrophy syndrome1361
HP:0000505HP:0000572Visual loss1FBN1 CL E G H22003603ORPHA:3449Weill-Marchesani syndromeHP:0040283 - Occasional1361
HP:0000505HP:0007663Reduced visual acuity1FBN1 CL E G H22003603OMIM:608328Weill-Marchesani syndrome 2, dominant1361
HP:0000505HP:0007663Reduced visual acuity1FBN2 CL E G H22013604OMIM:616118MACULAR DEGENERATION, EARLY-ONSET; EOMD655
HP:0000505HP:0100704Cerebral visual impairment1FBXW7 CL E G H5529416712OMIM:62001222
HP:0000505HP:0100704Cerebral visual impairment1FCSK CL E G H19725829500OMIM:618324Congenital disorder of glycosylation with defective fucosylation 2.
HP:0000505HP:0100704Cerebral visual impairment1FDFT1 CL E G H22223629OMIM:618156SQUALENE SYNTHASE DEFICIENCY; SQSD
HP:0000505HP:0001123Visual field defect1FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome
HP:0000505HP:0007663Reduced visual acuity1FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome
HP:0000505HP:0100704Cerebral visual impairment1FGF12 CL E G H22573668OMIM:617166Epileptic encephalopathy, early infantile, 47HP:0040283 - Occasional3
HP:0000505HP:0100704Cerebral visual impairment1FGF8 CL E G H22533686ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent17
HP:0000505HP:0100704Cerebral visual impairment1FGF8 CL E G H22533686ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional17
HP:0000505HP:0100704Cerebral visual impairment1FGF8 CL E G H22533686ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent17
HP:0000505HP:0100704Cerebral visual impairment1FGF8 CL E G H22533686ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent17
HP:0000505HP:0100704Cerebral visual impairment1FGFR1 CL E G H22603688ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional172
HP:0000505HP:0100704Cerebral visual impairment1FGFR1 CL E G H22603688ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent172
HP:0000505HP:0007663Reduced visual acuity1FGFR2 CL E G H22633689ORPHA:207Crouzon disease175
HP:0000505HP:0000572Visual loss1FGFR2 CL E G H22633689ORPHA:93259Pfeiffer syndrome type 2HP:0040283 - Occasional175
HP:0000505HP:0007663Reduced visual acuity1FGFR2 CL E G H22633689ORPHA:93260Pfeiffer syndrome type 3175
HP:0000505HP:0007663Reduced visual acuity1FGFR2 CL E G H22633689ORPHA:794Saethre-Chotzen syndrome175
HP:0000505HP:0007663Reduced visual acuity1FGFR3 CL E G H22613690OMIM:602849Muenke syndrome145
HP:0000505HP:0007663Reduced visual acuity1FGFR3 CL E G H22613690ORPHA:794Saethre-Chotzen syndrome145
HP:0000505HP:0007663Reduced visual acuity1FKRP CL E G H7914717997ORPHA:370959Congenital muscular dystrophy with cerebellar involvement157
HP:0000505HP:0007663Reduced visual acuity1FKRP CL E G H7914717997OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1157
HP:0000505HP:0007663Reduced visual acuity1FKTN CL E G H22183622OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1184
HP:0000505HP:0007663Reduced visual acuity1FLNA CL E G H23163754ORPHA:1826Frontometaphyseal dysplasia493
HP:0000505HP:0007663Reduced visual acuity1FLVCR1 CL E G H2898224682OMIM:609033Ataxia, posterior column, with retinitis pigmentosa111
HP:0000505HP:0001123Visual field defect1FLVCR1 CL E G H2898224682OMIM:609033Ataxia, posterior column, with retinitis pigmentosa111
HP:0000505HP:0000572Visual loss1FLVCR1 CL E G H2898224682ORPHA:88628Posterior column ataxia-retinitis pigmentosa syndromeHP:0040282 - Frequent111
HP:0000505HP:0000572Visual loss1FOXC1 CL E G H22963800ORPHA:250923Isolated aniridiaHP:0040281 - Very frequent63
HP:0000505HP:0007663Reduced visual acuity1FOXE3 CL E G H23013808OMIM:610256Anterior segment dysgenesis 223
HP:0000505HP:0100704Cerebral visual impairment1FOXH1 CL E G H89283814ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent48
HP:0000505HP:0100704Cerebral visual impairment1FOXH1 CL E G H89283814ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional48
HP:0000505HP:0100704Cerebral visual impairment1FOXH1 CL E G H89283814ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent48
HP:0000505HP:0100704Cerebral visual impairment1FOXH1 CL E G H89283814ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent48
HP:0000505HP:0007663Reduced visual acuity1FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plus92
HP:0000505HP:0007663Reduced visual acuity1FOXRED1 CL E G H5557226927ORPHA:2609Isolated complex I deficiency61
HP:0000505HP:0100704Cerebral visual impairment1FOXRED1 CL E G H5557226927OMIM:618241Mitochondrial complex I deficiency, nuclear type 19HP:0040284 - Very rare61
HP:0000505HP:0007663Reduced visual acuity1FRAS1 CL E G H8014419185OMIM:219000Fraser syndrome353
HP:0000505HP:0007663Reduced visual acuity1FRAS1 CL E G H8014419185ORPHA:2052Fraser syndrome353
HP:0000505HP:0007663Reduced visual acuity1FREM2 CL E G H34164025396ORPHA:2052Fraser syndrome263
HP:0000505HP:0007663Reduced visual acuity1FRMD7 CL E G H901678079OMIM:310700Nystagmus 1, congenital, X-linked.38
HP:0000505HP:0007663Reduced visual acuity1FSCN2 CL E G H257943960ORPHA:791Retinitis pigmentosa26
HP:0000505HP:0007663Reduced visual acuity1FXN CL E G H23953951ORPHA:95Friedreich ataxiaHP:0040283 - Occasional18
HP:0000505HP:0007663Reduced visual acuity1FXN CL E G H23953951OMIM:229300Friedreich ataxia 1HP:0040283 - Occasional18
HP:0000505HP:0001123Visual field defect1FXN CL E G H23953951OMIM:229300Friedreich ataxia 1.18
HP:0000505HP:0007663Reduced visual acuity1FZD4 CL E G H83224042OMIM:133780Exudative vitreoretinopathy 1.109
HP:0000505HP:0007663Reduced visual acuity1FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathyHP:0040282 - Frequent109
HP:0000505HP:0007663Reduced visual acuity1FZD4 CL E G H83224042ORPHA:91495Persistent hyperplastic primary vitreous109
HP:0000505HP:0007663Reduced visual acuity1FZD4 CL E G H83224042ORPHA:90050Retinopathy of prematurity109
HP:0000505HP:0100704Cerebral visual impairment1GABRA2 CL E G H25554076OMIM:618557DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE784
HP:0000505HP:0100704Cerebral visual impairment1GABRB1 CL E G H25604081OMIM:617153Epileptic encephalopathy, early infantile, 45.3
HP:0000505HP:0100704Cerebral visual impairment1GABRB2 CL E G H25614082OMIM:617829Epileptic encephalopathy, infantile or early childhood, 2.44
HP:0000505HP:0000572Visual loss1GALC CL E G H25814115ORPHA:206448Adult Krabbe diseaseHP:0040283 - Occasional160
HP:0000505HP:0000572Visual loss1GALC CL E G H25814115ORPHA:206436Infantile Krabbe diseaseHP:0040283 - Occasional160
HP:0000505HP:0007663Reduced visual acuity1GALC CL E G H25814115ORPHA:206436Infantile Krabbe disease160
HP:0000505HP:0007663Reduced visual acuity1GALC CL E G H25814115OMIM:245200Krabbe disease160
HP:0000505HP:0000572Visual loss1GALC CL E G H25814115ORPHA:206443Late-infantile/juvenile Krabbe diseaseHP:0040282 - Frequent160
HP:0000505HP:0007663Reduced visual acuity1GALC CL E G H25814115ORPHA:206443Late-infantile/juvenile Krabbe disease160
HP:0000505HP:0100704Cerebral visual impairment1GAS1 CL E G H26194165ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent2
HP:0000505HP:0100704Cerebral visual impairment1GAS1 CL E G H26194165ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional2
HP:0000505HP:0100704Cerebral visual impairment1GAS1 CL E G H26194165ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent2
HP:0000505HP:0100704Cerebral visual impairment1GAS1 CL E G H26194165ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent2
HP:0000505HP:0007663Reduced visual acuity1GATA1 CL E G H26234170ORPHA:79277Congenital erythropoietic porphyria29
HP:0000505HP:0000572Visual loss1GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndromeHP:0040282 - Frequent137
HP:0000505HP:0007663Reduced visual acuity1GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasia8
HP:0000505HP:0007663Reduced visual acuity1GDF6 CL E G H3922554221ORPHA:65Leber congenital amaurosis64
HP:0000505HP:0007663Reduced visual acuity1GDF6 CL E G H3922554221OMIM:615360LEBER CONGENITAL AMAUROSIS 17; LCA1764
HP:0000505HP:0007663Reduced visual acuity1GJB2 CL E G H27064284OMIM:148210Keratitis-Ichthyosis-Deafness syndrome, autosomal dominant199
HP:0000505HP:0000572Visual loss1GJB2 CL E G H27064284ORPHA:477KID syndrome199
HP:0000505HP:0000572Visual loss1GJB6 CL E G H108044288ORPHA:477KID syndrome56
HP:0000505HP:0007663Reduced visual acuity1GLB1 CL E G H27204298ORPHA:79255GM1 gangliosidosis type 1120
HP:0000505HP:0100704Cerebral visual impairment1GLI2 CL E G H27364318ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent173
HP:0000505HP:0100704Cerebral visual impairment1GLI2 CL E G H27364318ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional173
HP:0000505HP:0100704Cerebral visual impairment1GLI2 CL E G H27364318ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent173
HP:0000505HP:0100704Cerebral visual impairment1GLI2 CL E G H27364318ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent173
HP:0000505HP:0100704Cerebral visual impairment1GLYCTK CL E G H13215824247ORPHA:941D-glyceric aciduriaHP:0040283 - Occasional6
HP:0000505HP:0007663Reduced visual acuity1GM2A CL E G H27604367OMIM:272750Gm2-Gangliosidosis, ab variant69
HP:0000505HP:0007663Reduced visual acuity1GMPPB CL E G H2992522932ORPHA:370959Congenital muscular dystrophy with cerebellar involvement34
HP:0000505HP:0000572Visual loss1GNA11 CL E G H27674379ORPHA:39044Uveal melanomaHP:0040281 - Very frequent16
HP:0000505HP:0001123Visual field defect1GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndrome7
HP:0000505HP:0007663Reduced visual acuity1GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndrome7
HP:0000505HP:0000572Visual loss1GNAQ CL E G H27764390ORPHA:39044Uveal melanomaHP:0040281 - Very frequent7
HP:0000505HP:0000572Visual loss1GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040284 - Very rare101
HP:0000505HP:0007663Reduced visual acuity1GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic101
HP:0000505HP:0007663Reduced visual acuity1GNAT1 CL E G H27794393ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent39
HP:0000505HP:0007663Reduced visual acuity1GNAT1 CL E G H27794393OMIM:610444Night blindness, congenital stationary, autosomal dominant 339
HP:0000505HP:0001123Visual field defect1GNAT1 CL E G H27794393OMIM:616389Night blindness, congenital stationary, type 1G39
HP:0000505HP:0007663Reduced visual acuity1GNAT2 CL E G H27804394ORPHA:49382AchromatopsiaHP:0040282 - Frequent19
HP:0000505HP:0001123Visual field defect1GNAT2 CL E G H27804394ORPHA:49382Achromatopsia19
HP:0000505HP:0100704Cerebral visual impairment1GNB1 CL E G H27824396ORPHA:488613Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndromeHP:0040283 - Occasional12
HP:0000505HP:0100704Cerebral visual impairment1GNB1 CL E G H27824396OMIM:616973Mental retardation, autosomal dominant 42HP:0040283 - Occasional12
HP:0000505HP:0007663Reduced visual acuity1GNB3 CL E G H27844400ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent5
HP:0000505HP:0007663Reduced visual acuity1GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopenia23
HP:0000505HP:0007663Reduced visual acuity1GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopenia8
HP:0000505HP:0001123Visual field defect1GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0000505HP:0007663Reduced visual acuity1GPR143 CL E G H493520145OMIM:300814Nystagmus 6, congenital, X-linked64
HP:0000505HP:0007663Reduced visual acuity1GPR179 CL E G H44043531371ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent124
HP:0000505HP:0007663Reduced visual acuity1GPR179 CL E G H44043531371OMIM:614565Night blindness, congenital stationary, type 1E.124
HP:0000505HP:0007663Reduced visual acuity1GRHL2 CL E G H799772799OMIM:618031Corneal dystrophy, posterior polymorphous, 4.33
HP:0000505HP:0007663Reduced visual acuity1GRHL2 CL E G H799772799ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional33
HP:0000505HP:0100704Cerebral visual impairment1GRIK2 CL E G H28984580OMIM:619580NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS32
HP:0000505HP:0100704Cerebral visual impairment1GRIN1 CL E G H29024584ORPHA:208447Bilateral generalized polymicrogyriaHP:0040282 - Frequent108
HP:0000505HP:0100704Cerebral visual impairment1GRIN1 CL E G H29024584OMIM:614254Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominantHP:0040284 - Very rare108
HP:0000505HP:0100704Cerebral visual impairment1GRIN2D CL E G H29064588OMIM:617162Epileptic encephalopathy, early infantile, 46.2
HP:0000505HP:0007663Reduced visual acuity1GRIP1 CL E G H2342618708ORPHA:2052Fraser syndrome80
HP:0000505HP:0007663Reduced visual acuity1GRK1 CL E G H601110013ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent4
HP:0000505HP:0007663Reduced visual acuity1GRM6 CL E G H29164598ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent63
HP:0000505HP:0100704Cerebral visual impairment1GRM7 CL E G H29174599OMIM:618922NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA5
HP:0000505HP:0007663Reduced visual acuity1GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent24
HP:0000505HP:0000572Visual loss1GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent24
HP:0000505HP:0000572Visual loss1GUCA1A CL E G H29784678OMIM:602093Cone dystrophy 324
HP:0000505HP:0007663Reduced visual acuity1GUCA1A CL E G H29784678OMIM:602093Cone dystrophy 3.24
HP:0000505HP:0007663Reduced visual acuity1GUCA1B CL E G H29794679ORPHA:791Retinitis pigmentosa36
HP:0000505HP:0000572Visual loss1GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent124
HP:0000505HP:0007663Reduced visual acuity1GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent124
HP:0000505HP:0007663Reduced visual acuity1GUCY2D CL E G H30004689OMIM:601777Cone-Rod dystrophy 6.124
HP:0000505HP:0001123Visual field defect1GUCY2D CL E G H30004689OMIM:601777Cone-Rod dystrophy 6124
HP:0000505HP:0007663Reduced visual acuity1GUCY2D CL E G H30004689ORPHA:65Leber congenital amaurosis124
HP:0000505HP:0007663Reduced visual acuity1GUCY2D CL E G H30004689OMIM:204000Leber congenital amaurosis, type I.124
HP:0000505HP:0007663Reduced visual acuity1H1-4 CL E G H30084718OMIM:617537Rahman syndrome
HP:0000505HP:0100704Cerebral visual impairment1H3-3A CL E G H30204764OMIM:619720BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1
HP:0000505HP:0007663Reduced visual acuity1H4C3 CL E G H83644787OMIM:619758TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1
HP:0000505HP:0007663Reduced visual acuity1H4C9 CL E G H82944793OMIM:619951
HP:0000505HP:0000572Visual loss1HADHA CL E G H30304801ORPHA:5Long chain 3-hydroxyacyl-CoA dehydrogenase deficiencyHP:0040282 - Frequent99
HP:0000505HP:0001123Visual field defect1HARS1 CL E G H30354816ORPHA:231183Usher syndrome type 3
HP:0000505HP:0000572Visual loss1HARS1 CL E G H30354816ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0007663Reduced visual acuity1HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndrome11
HP:0000505HP:0000572Visual loss1HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional11
HP:0000505HP:0007663Reduced visual acuity1HDAC4 CL E G H975914063OMIM:619797NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES; NEDCHF33
HP:0000505HP:0100704Cerebral visual impairment1HECW2 CL E G H5752029853OMIM:617268Neurodevelopmental disorder with hypotonia, seizures, and absent language11
HP:0000505HP:0007663Reduced visual acuity1HEXB CL E G H30744879OMIM:268800Sandhoff disease80
HP:0000505HP:0007663Reduced visual acuity1HGSNAT CL E G H13805026527ORPHA:791Retinitis pigmentosa86
HP:0000505HP:0001123Visual field defect1HGSNAT CL E G H13805026527OMIM:616544Retinitis pigmentosa 7386
HP:0000505HP:0100704Cerebral visual impairment1HK1 CL E G H30984922OMIM:618547NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA11
HP:0000505HP:0001123Visual field defect1HK1 CL E G H30984922OMIM:617460Retinitis pigmentosa 7911
HP:0000505HP:0007663Reduced visual acuity1HK1 CL E G H30984922OMIM:617460Retinitis pigmentosa 79.11
HP:0000505HP:0001123Visual field defect1HKDC1 CL E G H8020123302OMIM:619614RETINITIS PIGMENTOSA 92; RP922
HP:0000505HP:0000572Visual loss1HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathyHP:0040281 - Very frequent4
HP:0000505HP:0001123Visual field defect1HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathy4
HP:0000505HP:0007663Reduced visual acuity1HLA-B CL E G H31064932ORPHA:117Behçet disease4
HP:0000505HP:0000572Visual loss1HLA-B CL E G H31064932ORPHA:397Giant cell arteritisHP:0040283 - Occasional4
HP:0000505HP:0001123Visual field defect1HLA-B CL E G H31064932ORPHA:397Giant cell arteritisHP:0040283 - Occasional4
HP:0000505HP:0001123Visual field defect1HLA-DRB1 CL E G H31234948ORPHA:397Giant cell arteritisHP:0040283 - Occasional2
HP:0000505HP:0000572Visual loss1HLA-DRB1 CL E G H31234948ORPHA:397Giant cell arteritisHP:0040283 - Occasional2
HP:0000505HP:0007663Reduced visual acuity1HLA-DRB1 CL E G H31234948ORPHA:797Sarcoidosis2
HP:0000505HP:0000572Visual loss1HMCN1 CL E G H8387219194OMIM:603075Macular degeneration, age-related, 1262
HP:0000505HP:0007663Reduced visual acuity1HMX1 CL E G H31665017OMIM:612109Oculoauricular syndrome2
HP:0000505HP:0007663Reduced visual acuity1HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1121
HP:0000505HP:0007663Reduced visual acuity1HPS3 CL E G H8434315597OMIM:614072Hermansky-Pudlak syndrome 367
HP:0000505HP:0007663Reduced visual acuity1HPS4 CL E G H8978115844OMIM:614073Hermansky-Pudlak syndrome 4.123
HP:0000505HP:0007663Reduced visual acuity1HPS5 CL E G H1123417022OMIM:614074Hermansky-Pudlak syndrome 5.105
HP:0000505HP:0007663Reduced visual acuity1HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 6.45
HP:0000505HP:0007663Reduced visual acuity1HSD17B10 CL E G H30284800ORPHA:391428HSD10 disease, infantile type19
HP:0000505HP:0000572Visual loss1HSD17B10 CL E G H30284800ORPHA:391428HSD10 disease, infantile typeHP:0040283 - Occasional19
HP:0000505HP:0000572Visual loss1HSD17B10 CL E G H30284800OMIM:300438HSD10 mitochondrial disease.19
HP:0000505HP:0000572Visual loss1HSD17B4 CL E G H32955213OMIM:261515D-bifunctional protein deficiency98
HP:0000505HP:0001123Visual field defect1IBA57 CL E G H20020527302ORPHA:468661Autosomal recessive spastic paraplegia type 74HP:0040282 - Frequent16
HP:0000505HP:0001123Visual field defect1IBA57 CL E G H20020527302OMIM:616451Spastic paraplegia 74, autosomal recessive.16
HP:0000505HP:0007663Reduced visual acuity1IDH3A CL E G H34195384ORPHA:791Retinitis pigmentosa
HP:0000505HP:0007663Reduced visual acuity1IDH3A CL E G H34195384OMIM:619007RETINITIS PIGMENTOSA 90; RP90
HP:0000505HP:0001123Visual field defect1IDH3A CL E G H34195384OMIM:619007RETINITIS PIGMENTOSA 90; RP90
HP:0000505HP:0007663Reduced visual acuity1IDH3B CL E G H34205385ORPHA:791Retinitis pigmentosa30
HP:0000505HP:0001123Visual field defect1IDH3B CL E G H34205385OMIM:612572RETINITIS PIGMENTOSA 46; RP4630
HP:0000505HP:0001123Visual field defect1IDS CL E G H34235389ORPHA:217093Mucopolysaccharidosis type 2, attenuated form86
HP:0000505HP:0001123Visual field defect1IDS CL E G H34235389ORPHA:217085Mucopolysaccharidosis type 2, severe form86
HP:0000505HP:0007663Reduced visual acuity1IFNGR1 CL E G H34595439ORPHA:117Behçet disease60
HP:0000505HP:0007663Reduced visual acuity1IFT140 CL E G H974229077ORPHA:65Leber congenital amaurosis148
HP:0000505HP:0007663Reduced visual acuity1IFT140 CL E G H974229077ORPHA:791Retinitis pigmentosa148
HP:0000505HP:0000572Visual loss1IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80148
HP:0000505HP:0007663Reduced visual acuity1IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80148
HP:0000505HP:0001123Visual field defect1IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly148
HP:0000505HP:0000572Visual loss1IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly.148
HP:0000505HP:0001123Visual field defect1IFT172 CL E G H2616030391OMIM:619471BARDET-BIEDL SYNDROME 20; BBS2048
HP:0000505HP:0007663Reduced visual acuity1IFT172 CL E G H2616030391ORPHA:791Retinitis pigmentosa48
HP:0000505HP:0007663Reduced visual acuity1IFT88 CL E G H810020606ORPHA:791Retinitis pigmentosa3
HP:0000505HP:0007663Reduced visual acuity1IL10 CL E G H35865962ORPHA:117Behçet disease2
HP:0000505HP:0007663Reduced visual acuity1IL12A CL E G H35925969ORPHA:117Behçet disease
HP:0000505HP:0007663Reduced visual acuity1IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet disease
HP:0000505HP:0007663Reduced visual acuity1IL23R CL E G H14923319100ORPHA:117Behçet disease1
HP:0000505HP:0007663Reduced visual acuity1IL2RA CL E G H35596008ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional65
HP:0000505HP:0000572Visual loss1IL2RA CL E G H35596008ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional65
HP:0000505HP:0000572Visual loss1IL2RB CL E G H35606009ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000505HP:0007663Reduced visual acuity1IL2RB CL E G H35606009ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000505HP:0007663Reduced visual acuity1IMPDH1 CL E G H36146052ORPHA:65Leber congenital amaurosis52
HP:0000505HP:0007663Reduced visual acuity1IMPDH1 CL E G H36146052OMIM:613837Leber congenital amaurosis 11.52
HP:0000505HP:0007663Reduced visual acuity1IMPDH1 CL E G H36146052ORPHA:791Retinitis pigmentosa52
HP:0000505HP:0001123Visual field defect1IMPDH1 CL E G H36146052OMIM:180105Retinitis pigmentosa 1052
HP:0000505HP:0007663Reduced visual acuity1IMPDH1 CL E G H36146052OMIM:180105Retinitis pigmentosa 10HP:0040284 - Very rare52
HP:0000505HP:0001123Visual field defect1IMPG1 CL E G H36176055ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040282 - Frequent4
HP:0000505HP:0007663Reduced visual acuity1IMPG1 CL E G H36176055OMIM:616151Macular dystrophy, vitelliform, 4.4
HP:0000505HP:0007663Reduced visual acuity1IMPG1 CL E G H36176055ORPHA:791Retinitis pigmentosa4
HP:0000505HP:0001123Visual field defect1IMPG2 CL E G H5093918362ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040282 - Frequent120
HP:0000505HP:0007663Reduced visual acuity1IMPG2 CL E G H5093918362OMIM:616152Macular dystrophy, vitelliform, 5.120
HP:0000505HP:0001123Visual field defect1IMPG2 CL E G H5093918362OMIM:616152Macular dystrophy, vitelliform, 5120
HP:0000505HP:0007663Reduced visual acuity1IMPG2 CL E G H5093918362ORPHA:791Retinitis pigmentosa120
HP:0000505HP:0001123Visual field defect1IMPG2 CL E G H5093918362OMIM:613581RETINITIS PIGMENTOSA 56; RP56120
HP:0000505HP:0007663Reduced visual acuity1IMPG2 CL E G H5093918362OMIM:613581RETINITIS PIGMENTOSA 56; RP56120
HP:0000505HP:0000572Visual loss1INPP5E CL E G H5662321474ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional111
HP:0000505HP:0007663Reduced visual acuity1INPP5E CL E G H5662321474OMIM:610156Mental retardation, truncal obesity, retinal dystrophy, and micropenis syndrome.111
HP:0000505HP:0000572Visual loss1INVS CL E G H2713017870ORPHA:3156Senior-Loken syndrome106
HP:0000505HP:0007663Reduced visual acuity1IQCB1 CL E G H965728949ORPHA:65Leber congenital amaurosis61
HP:0000505HP:0000572Visual loss1IQCB1 CL E G H965728949ORPHA:3156Senior-Loken syndrome61
HP:0000505HP:0007663Reduced visual acuity1ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopenia119
HP:0000505HP:0007663Reduced visual acuity1ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopenia69
HP:0000505HP:0007663Reduced visual acuity1ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopenia80
HP:0000505HP:0001123Visual field defect1ITM2B CL E G H94456174OMIM:616079Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities3
HP:0000505HP:0007663Reduced visual acuity1ITM2B CL E G H94456174OMIM:616079Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities3
HP:0000505HP:0001123Visual field defect1JAK2 CL E G H37176192ORPHA:71493Familial thrombocytosisHP:0040283 - Occasional57
HP:0000505HP:0000572Visual loss1KARS1 CL E G H37356215OMIM:619196DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
HP:0000505HP:0100704Cerebral visual impairment1KAT6A CL E G H799413013OMIM:616268Arboleda-Tham syndrome.34
HP:0000505HP:0007663Reduced visual acuity1KAT6A CL E G H799413013OMIM:616268Arboleda-Tham syndrome34
HP:0000505HP:0100704Cerebral visual impairment1KAT6A CL E G H799413013ORPHA:457193Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndromeHP:0040282 - Frequent34
HP:0000505HP:0007663Reduced visual acuity1KCNJ13 CL E G H37696259ORPHA:65Leber congenital amaurosis42
HP:0000505HP:0007663Reduced visual acuity1KCNJ13 CL E G H37696259OMIM:614186Leber congenital amaurosis 16.42
HP:0000505HP:0007663Reduced visual acuity1KCNN2 CL E G H37816291OMIM:619724DYSTONIA 34, MYOCLONIC; DYT34
HP:0000505HP:0007663Reduced visual acuity1KCNV2 CL E G H16952219698OMIM:610356Retinal cone dystrophy 3B73
HP:0000505HP:0001123Visual field defect1KCNV2 CL E G H16952219698OMIM:610356Retinal cone dystrophy 3B73
HP:0000505HP:0000572Visual loss1KCTD7 CL E G H15488121957OMIM:611726Epilepsy, progressive myoclonic 3, with or without intracellular inclusionsHP:0040283 - Occasional106
HP:0000505HP:0007663Reduced visual acuity1KERA CL E G H110816309OMIM:217300Cornea plana 28
HP:0000505HP:0000572Visual loss1KIAA0586 CL E G H978619960ORPHA:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophyHP:0040283 - Occasional24
HP:0000505HP:0007663Reduced visual acuity1KIAA1549 CL E G H5767022219ORPHA:791Retinitis pigmentosa
HP:0000505HP:0000572Visual loss1KIAA1549 CL E G H5767022219OMIM:618613RETINITIS PIGMENTOSA 86; RP86
HP:0000505HP:0007663Reduced visual acuity1KIDINS220 CL E G H5749829508OMIM:617296SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO4
HP:0000505HP:0007663Reduced visual acuity1KIF11 CL E G H38326388OMIM:152950Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation.46
HP:0000505HP:0007663Reduced visual acuity1KIF11 CL E G H38326388ORPHA:2526Microcephaly-lymphedema-chorioretinopathy syndrome46
HP:0000505HP:0000572Visual loss1KIF11 CL E G H38326388ORPHA:2526Microcephaly-lymphedema-chorioretinopathy syndromeHP:0040283 - Occasional46
HP:0000505HP:0007663Reduced visual acuity1KIF14 CL E G H992819181OMIM:617914Microcephaly 20, primary, autosomal recessive9
HP:0000505HP:0100704Cerebral visual impairment1KIF1A CL E G H547888OMIM:614255Mental retardation, autosomal dominant 9HP:0040283 - Occasional276
HP:0000505HP:0000572Visual loss1KIF1A CL E G H547888ORPHA:2836PEHO syndromeHP:0040281 - Very frequent276
HP:0000505HP:0007663Reduced visual acuity1KIF1C CL E G H107496317ORPHA:397946Autosomal spastic paraplegia type 58HP:0040284 - Very rare38
HP:0000505HP:0001123Visual field defect1KIF3B CL E G H93716320OMIM:618955RETINITIS PIGMENTOSA 89; RP89
HP:0000505HP:0100704Cerebral visual impairment1KIF5A CL E G H37986323OMIM:617235Myoclonus, intractable, neonatal.93
HP:0000505HP:0007663Reduced visual acuity1KIZ CL E G H5585715865ORPHA:791Retinitis pigmentosa3
HP:0000505HP:0001123Visual field defect1KIZ CL E G H5585715865OMIM:615780Retinitis pigmentosa 693
HP:0000505HP:0007663Reduced visual acuity1KLHL7 CL E G H5597515646ORPHA:791Retinitis pigmentosa42
HP:0000505HP:0007663Reduced visual acuity1KLRC4 CL E G H83026377ORPHA:117Behçet disease
HP:0000505HP:0100704Cerebral visual impairment1KMT2B CL E G H975715840OMIM:61993411
HP:0000505HP:0001123Visual field defect1KRAS CL E G H38456407ORPHA:144Lynch syndromeHP:0040283 - Occasional196
HP:0000505HP:0007663Reduced visual acuity1KRT12 CL E G H38596414OMIM:122100Meesmann corneal dystrophy 1.22
HP:0000505HP:0007663Reduced visual acuity1LAMA1 CL E G H2842176481ORPHA:370022Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome35
HP:0000505HP:0007663Reduced visual acuity1LAMA1 CL E G H2842176481OMIM:615960Poretti-Boltshauser syndrome35
HP:0000505HP:0007663Reduced visual acuity1LAMB2 CL E G H39136487OMIM:609049Pierson syndrome92
HP:0000505HP:0000572Visual loss1LAMC3 CL E G H103196494OMIM:614115Cortical malformations, occipital.114
HP:0000505HP:0007663Reduced visual acuity1LARGE1 CL E G H92156511OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1136
HP:0000505HP:0007663Reduced visual acuity1LCA5 CL E G H16769131923ORPHA:65Leber congenital amaurosis70
HP:0000505HP:0000572Visual loss1LCA5 CL E G H16769131923OMIM:604537Leber congenital amaurosis 5.HP:0003577 - Congenital onset70
HP:0000505HP:0001123Visual field defect1LCA5 CL E G H16769131923ORPHA:364055Severe early-childhood-onset retinal dystrophy70
HP:0000505HP:0007663Reduced visual acuity1LCA5 CL E G H16769131923ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent70
HP:0000505HP:0007663Reduced visual acuity1LIM2 CL E G H39826610OMIM:615277Cataract 19, multiple types16
HP:0000505HP:0007663Reduced visual acuity1LMBRD2 CL E G H9225525287OMIM:619694DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES; DENBA
HP:0000505HP:0100704Cerebral visual impairment1LMNB1 CL E G H40016637OMIM:619179MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH2644
HP:0000505HP:0007663Reduced visual acuity1LOC111365204 CL E G H111365204OMIM:136550Macular dystrophy, retinal, 1, north Carolina type.
HP:0000505HP:0001123Visual field defect1LOC111365204 CL E G H111365204OMIM:136550Macular dystrophy, retinal, 1, north Carolina type
HP:0000505HP:0007663Reduced visual acuity1LONP1 CL E G H93619479ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiency8
HP:0000505HP:0007663Reduced visual acuity1LOXL3 CL E G H8469513869ORPHA:250984Autosomal recessive Stickler syndrome4
HP:0000505HP:0007663Reduced visual acuity1LRAT CL E G H92276685ORPHA:65Leber congenital amaurosis62
HP:0000505HP:0007663Reduced visual acuity1LRAT CL E G H92276685OMIM:613341Leber congenital amaurosis 14.62
HP:0000505HP:0001123Visual field defect1LRAT CL E G H92276685OMIM:268000Retinitis pigmentosa62
HP:0000505HP:0007663Reduced visual acuity1LRAT CL E G H92276685ORPHA:791Retinitis pigmentosa62
HP:0000505HP:0001123Visual field defect1LRAT CL E G H92276685ORPHA:364055Severe early-childhood-onset retinal dystrophy62
HP:0000505HP:0007663Reduced visual acuity1LRAT CL E G H92276685ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent62
HP:0000505HP:0007663Reduced visual acuity1LRIT3 CL E G H34519324783ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent54
HP:0000505HP:0000572Visual loss1LRP2 CL E G H40366694OMIM:222448Donnai-Barrow syndrome289
HP:0000505HP:0000572Visual loss1LRP2 CL E G H40366694ORPHA:2143Donnai-Barrow syndrome289
HP:0000505HP:0007663Reduced visual acuity1LRP5 CL E G H40416697OMIM:133780Exudative vitreoretinopathy 1.125
HP:0000505HP:0007663Reduced visual acuity1LRP5 CL E G H40416697OMIM:601813Exudative vitreoretinopathy 4.125
HP:0000505HP:0007663Reduced visual acuity1LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathyHP:0040282 - Frequent125
HP:0000505HP:0007663Reduced visual acuity1LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndrome125
HP:0000505HP:0007663Reduced visual acuity1LRP5 CL E G H40416697OMIM:259770Osteoporosis-Pseudoglioma syndrome125
HP:0000505HP:0007663Reduced visual acuity1LRP5 CL E G H40416697ORPHA:90050Retinopathy of prematurity125
HP:0000505HP:0007663Reduced visual acuity1LRPAP1 CL E G H40436701OMIM:615431Myopia 23, autosomal recessive.4
HP:0000505HP:0000572Visual loss1LSS CL E G H40476708OMIM:616509Cataract 44.2
HP:0000505HP:0000572Visual loss1LTBP2 CL E G H40536715ORPHA:98976Congenital glaucomaHP:0040283 - Occasional123
HP:0000505HP:0000572Visual loss1LTBP2 CL E G H40536715ORPHA:3449Weill-Marchesani syndromeHP:0040283 - Occasional123
HP:0000505HP:0007663Reduced visual acuity1LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndromeHP:0040282 - Frequent239
HP:0000505HP:0007663Reduced visual acuity1LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0000505HP:0100704Cerebral visual impairment1MACF1 CL E G H2349913664OMIM:618325Lissencephaly 9 with complex brainstem malformation2
HP:0000505HP:0100704Cerebral visual impairment1MACF1 CL E G H2349913664ORPHA:572013Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome2
HP:0000505HP:0007663Reduced visual acuity1MAFB CL E G H99356408ORPHA:233Duane retraction syndrome63
HP:0000505HP:0007663Reduced visual acuity1MAG CL E G H40996783OMIM:616680Spastic paraplegia 75, autosomal recessive.4
HP:0000505HP:0007663Reduced visual acuity1MAK CL E G H41176816ORPHA:791Retinitis pigmentosa53
HP:0000505HP:0007663Reduced visual acuity1MAK CL E G H41176816OMIM:614181Retinitis pigmentosa 6253
HP:0000505HP:0001123Visual field defect1MAK CL E G H41176816OMIM:614181Retinitis pigmentosa 62.53
HP:0000505HP:0007663Reduced visual acuity1MAP3K7 CL E G H68856859ORPHA:1826Frontometaphyseal dysplasia11
HP:0000505HP:0100704Cerebral visual impairment1MAPK8IP3 CL E G H231626884OMIM:618443Neurodevelopmental disorder with or without variable brain abnormalitiesHP:0040284 - Very rare
HP:0000505HP:0007663Reduced visual acuity1MAPKAPK3 CL E G H78676888OMIM:617111Macular dystrophy, patterned, 3.1
HP:0000505HP:0007663Reduced visual acuity1MARK3 CL E G H41406897OMIM:618283Visual impairment and progressive phthisis bulbi.
HP:0000505HP:0007663Reduced visual acuity1MC1R CL E G H41576929OMIM:203200Albinism, oculocutaneous, type II.124
HP:0000505HP:0007663Reduced visual acuity1MC1R CL E G H41576929ORPHA:79432Oculocutaneous albinism type 2HP:0040282 - Frequent124
HP:0000505HP:0007663Reduced visual acuity1MECR CL E G H5110219691OMIM:617282Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities6
HP:0000505HP:0007663Reduced visual acuity1MECR CL E G H5110219691ORPHA:508093MEPAN syndrome6
HP:0000505HP:0007663Reduced visual acuity1MED25 CL E G H8185728845ORPHA:464738Basel-Vanagaite-Smirin-Yosef syndrome43
HP:0000505HP:0007663Reduced visual acuity1MEFV CL E G H42106998ORPHA:117Behçet disease281
HP:0000505HP:0007663Reduced visual acuity1MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0000505HP:0001123Visual field defect1MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0000505HP:0000572Visual loss1MEN1 CL E G H42217010ORPHA:2965Prolactinoma462
HP:0000505HP:0007663Reduced visual acuity1MERTK CL E G H104617027ORPHA:791Retinitis pigmentosa75
HP:0000505HP:0001123Visual field defect1MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 3875
HP:0000505HP:0000572Visual loss1MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 3875
HP:0000505HP:0000572Visual loss1MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000505HP:0001123Visual field defect1MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000505HP:0007663Reduced visual acuity1MFRP CL E G H8355218121OMIM:611040Microphthalmia, isolated 5.26
HP:0000505HP:0000572Visual loss1MFSD8 CL E G H25647128486OMIM:610951Ceroid lipofuscinosis, neuronal, 7.120
HP:0000505HP:0007663Reduced visual acuity1MFSD8 CL E G H25647128486OMIM:610951Ceroid lipofuscinosis, neuronal, 7120
HP:0000505HP:0001123Visual field defect1MFSD8 CL E G H25647128486OMIM:616170Macular dystrophy with central cone involvement120
HP:0000505HP:0007663Reduced visual acuity1MFSD8 CL E G H25647128486OMIM:616170Macular dystrophy with central cone involvement.120
HP:0000505HP:0007663Reduced visual acuity1MICU1 CL E G H103671530OMIM:615673Myopathy with extrapyramidal signs14
HP:0000505HP:0007663Reduced visual acuity1MIR184 CL E G H40696031555OMIM:614303Edict syndrome.1
HP:0000505HP:0007663Reduced visual acuity1MIR204 CL E G H40698731582OMIM:616722Retinal dystrophy and iris coloboma with or without congenital cataract.1
HP:0000505HP:0000572Visual loss1MKS1 CL E G H549037121ORPHA:220493Joubert syndrome with ocular defectHP:0040283 - Occasional127
HP:0000505HP:0001123Visual field defect1MLH1 CL E G H42927127ORPHA:144Lynch syndromeHP:0040283 - Occasional1819
HP:0000505HP:0001123Visual field defect1MLH3 CL E G H270307128ORPHA:144Lynch syndromeHP:0040283 - Occasional131
HP:0000505HP:0007663Reduced visual acuity1MLXIPL CL E G H5108512744OMIM:194050Williams-Beuren syndrome1
HP:0000505HP:0007663Reduced visual acuity1MMACHC CL E G H2597424525OMIM:277400Methylmalonic aciduria and homocystinuria, Cblc type.101
HP:0000505HP:0000572Visual loss1MMP1 CL E G H43127155ORPHA:79408Autosomal recessive generalized dystrophic epidermolysis bullosa, severe formHP:0040283 - Occasional6
HP:0000505HP:0001123Visual field defect1MMP19 CL E G H43277165OMIM:611543Cavitary optic disc anomalies.2
HP:0000505HP:0007663Reduced visual acuity1MMP19 CL E G H43277165OMIM:611543Cavitary optic disc anomalies.2
HP:0000505HP:0001123Visual field defect1MPL CL E G H43527217ORPHA:71493Familial thrombocytosisHP:0040283 - Occasional97
HP:0000505HP:0001123Visual field defect1MSH2 CL E G H44367325ORPHA:144Lynch syndromeHP:0040283 - Occasional2162
HP:0000505HP:0001123Visual field defect1MSH6 CL E G H29567329ORPHA:144Lynch syndromeHP:0040283 - Occasional2232
HP:0000505HP:0001123Visual field defect1MSX2 CL E G H44887392OMIM:604757Craniosynostosis 2HP:0040283 - Occasional45
HP:0000505HP:0007663Reduced visual acuity1MTFMT CL E G H12326329666OMIM:614947Combined oxidative phosphorylation deficiency 15HP:0040283 - Occasional29
HP:0000505HP:0100704Cerebral visual impairment1MTHFS CL E G H105887437OMIM:618367Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelinationHP:0040284 - Very rare
HP:0000505HP:0001123Visual field defect1MTOR CL E G H24753942ORPHA:99802Hemimegalencephaly68
HP:0000505HP:0007663Reduced visual acuity1MTR CL E G H45487468OMIM:250940Homocystinuria-megaloblastic anemia, cblg Complementation type217
HP:0000505HP:0007663Reduced visual acuity1MTRFR CL E G H9157426784ORPHA:320375Autosomal recessive spastic paraplegia type 55HP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1MTRFR CL E G H9157426784ORPHA:254930Combined oxidative phosphorylation defect type 7HP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1MTRFR CL E G H9157426784OMIM:615035Spastic paraplegia 55, autosomal recessive
HP:0000505HP:0007663Reduced visual acuity1MTRFR CL E G H9157426784OMIM:615035Spastic paraplegia 55, autosomal recessiveHP:0040283 - Occasional
HP:0000505HP:0007663Reduced visual acuity1MTRR CL E G H45527473OMIM:236270Homocystinuria-megaloblastic anemia, cbl E type88
HP:0000505HP:0000572Visual loss1MTTP CL E G H45477467ORPHA:14Abetalipoproteinemia81
HP:0000505HP:0007663Reduced visual acuity1MTTP CL E G H45477467ORPHA:14Abetalipoproteinemia81
HP:0000505HP:0001123Visual field defect1MTTP CL E G H45477467ORPHA:14Abetalipoproteinemia81
HP:0000505HP:0001123Visual field defect1MYO7A CL E G H46477606ORPHA:231169Usher syndrome type 1516
HP:0000505HP:0000572Visual loss1MYO7A CL E G H46477606ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent516
HP:0000505HP:0001123Visual field defect1MYO7A CL E G H46477606ORPHA:231178Usher syndrome type 2516
HP:0000505HP:0000572Visual loss1MYO7A CL E G H46477606ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent516
HP:0000505HP:0000572Visual loss1MYO7A CL E G H46477606OMIM:276900Usher syndrome, type I.516
HP:0000505HP:0000572Visual loss1MYOC CL E G H46537610ORPHA:98976Congenital glaucomaHP:0040283 - Occasional47
HP:0000505HP:0001123Visual field defect1MYOC CL E G H46537610ORPHA:98977Juvenile glaucoma47
HP:0000505HP:0007663Reduced visual acuity1NAA10 CL E G H826018704OMIM:309800Microphthalmia, syndromic 123
HP:0000505HP:0100704Cerebral visual impairment1NADK2 CL E G H13368626404OMIM:6160342,4-Dienoyl-Coa reductase deficiency.14
HP:0000505HP:0100704Cerebral visual impairment1NADK2 CL E G H13368626404ORPHA:431361Progressive encephalopathy with leukodystrophy due to DECR deficiencyHP:0040282 - Frequent14
HP:0000505HP:0100704Cerebral visual impairment1NAGA CL E G H46687631ORPHA:79279Alpha-N-acetylgalactosaminidase deficiency type 1HP:0040281 - Very frequent47
HP:0000505HP:0100704Cerebral visual impairment1NAGA CL E G H46687631OMIM:609241Schindler disease, type I.47
HP:0000505HP:0100704Cerebral visual impairment1NARS2 CL E G H7973126274OMIM:616239Combined oxidative phosphorylation deficiency 24.34
HP:0000505HP:0007663Reduced visual acuity1NBAS CL E G H5159415625OMIM:614800Short stature, optic nerve atrophy, and pelger-huet anomaly.25
HP:0000505HP:0000572Visual loss1NBAS CL E G H5159415625OMIM:614800Short stature, optic nerve atrophy, and pelger-huet anomaly25
HP:0000505HP:0007663Reduced visual acuity1ND1 CL E G H45357455ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000572Visual loss1ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND1 CL E G H45357455OMIM:535000Leber optic atrophy
HP:0000505HP:0000572Visual loss1ND1 CL E G H45357455OMIM:535000Leber optic atrophy.
HP:0000505HP:0000572Visual loss1ND1 CL E G H45357455ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1ND1 CL E G H45357455OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1ND1 CL E G H45357455OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0007663Reduced visual acuity1ND2 CL E G H45367456ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0000572Visual loss1ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND2 CL E G H45367456OMIM:535000Leber optic atrophy
HP:0000505HP:0000572Visual loss1ND2 CL E G H45367456OMIM:535000Leber optic atrophy.
HP:0000505HP:0007663Reduced visual acuity1ND3 CL E G H45377458ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0001123Visual field defect1ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND4 CL E G H45387459OMIM:535000Leber optic atrophy
HP:0000505HP:0000572Visual loss1ND4 CL E G H45387459OMIM:535000Leber optic atrophy.
HP:0000505HP:0000572Visual loss1ND4 CL E G H45387459ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0000572Visual loss1ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ND4L CL E G H45397460OMIM:535000Leber optic atrophy.
HP:0000505HP:0001123Visual field defect1ND4L CL E G H45397460OMIM:535000Leber optic atrophy
HP:0000505HP:0001123Visual field defect1ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ND5 CL E G H45407461OMIM:535000Leber optic atrophy.
HP:0000505HP:0001123Visual field defect1ND5 CL E G H45407461OMIM:535000Leber optic atrophy
HP:0000505HP:0000572Visual loss1ND5 CL E G H45407461ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0100704Cerebral visual impairment1ND5 CL E G H45407461OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0001123Visual field defect1ND5 CL E G H45407461OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000572Visual loss1ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0001123Visual field defect1ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000572Visual loss1ND6 CL E G H45417462OMIM:535000Leber optic atrophy.
HP:0000505HP:0001123Visual field defect1ND6 CL E G H45417462OMIM:535000Leber optic atrophy
HP:0000505HP:0000572Visual loss1ND6 CL E G H45417462ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0100704Cerebral visual impairment1ND6 CL E G H45417462OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0001123Visual field defect1ND6 CL E G H45417462OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0007663Reduced visual acuity1NDE1 CL E G H5482017619ORPHA:2177Hydranencephaly96
HP:0000505HP:0007663Reduced visual acuity1NDP CL E G H46937678OMIM:305390Exudative vitreoretinopathy 2, X-linked.39
HP:0000505HP:0007663Reduced visual acuity1NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathyHP:0040282 - Frequent39
HP:0000505HP:0007663Reduced visual acuity1NDP CL E G H46937678OMIM:310600Norrie disease39
HP:0000505HP:0007663Reduced visual acuity1NDP CL E G H46937678ORPHA:649Norrie disease39
HP:0000505HP:0007663Reduced visual acuity1NDP CL E G H46937678ORPHA:91495Persistent hyperplastic primary vitreous39
HP:0000505HP:0007663Reduced visual acuity1NDP CL E G H46937678ORPHA:90050Retinopathy of prematurity39
HP:0000505HP:0007663Reduced visual acuity1NDUFA1 CL E G H46947683ORPHA:2609Isolated complex I deficiency7
HP:0000505HP:0007663Reduced visual acuity1NDUFA11 CL E G H12632820371ORPHA:2609Isolated complex I deficiency32
HP:0000505HP:0007663Reduced visual acuity1NDUFA6 CL E G H47007690ORPHA:2609Isolated complex I deficiency1
HP:0000505HP:0007663Reduced visual acuity1NDUFAF1 CL E G H5110318828ORPHA:2609Isolated complex I deficiency40
HP:0000505HP:0007663Reduced visual acuity1NDUFAF2 CL E G H9194228086ORPHA:2609Isolated complex I deficiency26
HP:0000505HP:0007663Reduced visual acuity1NDUFAF3 CL E G H2591529918ORPHA:2609Isolated complex I deficiency31
HP:0000505HP:0007663Reduced visual acuity1NDUFAF4 CL E G H2907821034ORPHA:2609Isolated complex I deficiency50
HP:0000505HP:0007663Reduced visual acuity1NDUFAF5 CL E G H7913315899ORPHA:2609Isolated complex I deficiency34
HP:0000505HP:0007663Reduced visual acuity1NDUFAF8 CL E G H28418433551ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0007663Reduced visual acuity1NDUFB10 CL E G H47167696ORPHA:2609Isolated complex I deficiency
HP:0000505HP:0007663Reduced visual acuity1NDUFB11 CL E G H5453920372ORPHA:2609Isolated complex I deficiency3
HP:0000505HP:0007663Reduced visual acuity1NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndrome3
HP:0000505HP:0000572Visual loss1NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1NDUFB3 CL E G H47097698ORPHA:2609Isolated complex I deficiency9
HP:0000505HP:0007663Reduced visual acuity1NDUFB9 CL E G H47157704ORPHA:2609Isolated complex I deficiency16
HP:0000505HP:0007663Reduced visual acuity1NDUFS1 CL E G H47197707ORPHA:2609Isolated complex I deficiency81
HP:0000505HP:0007663Reduced visual acuity1NDUFS2 CL E G H47207708ORPHA:2609Isolated complex I deficiency65
HP:0000505HP:0001123Visual field defect1NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000505HP:0000572Visual loss1NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000505HP:0007663Reduced visual acuity1NDUFS3 CL E G H47227710ORPHA:2609Isolated complex I deficiency22
HP:0000505HP:0007663Reduced visual acuity1NDUFS4 CL E G H47247711ORPHA:2609Isolated complex I deficiency27
HP:0000505HP:0007663Reduced visual acuity1NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 127
HP:0000505HP:0007663Reduced visual acuity1NDUFS6 CL E G H47267713ORPHA:2609Isolated complex I deficiency21
HP:0000505HP:0007663Reduced visual acuity1NDUFS7 CL E G H3742917714ORPHA:2609Isolated complex I deficiency38
HP:0000505HP:0007663Reduced visual acuity1NDUFS8 CL E G H47287715ORPHA:2609Isolated complex I deficiency42
HP:0000505HP:0007663Reduced visual acuity1NDUFV1 CL E G H47237716ORPHA:2609Isolated complex I deficiency74
HP:0000505HP:0007663Reduced visual acuity1NDUFV1 CL E G H47237716OMIM:618225Mitochondrial complex I deficiency, nuclear type 474
HP:0000505HP:0007663Reduced visual acuity1NDUFV2 CL E G H47297717ORPHA:2609Isolated complex I deficiency27
HP:0000505HP:0007663Reduced visual acuity1NEK2 CL E G H47517745ORPHA:791Retinitis pigmentosa5
HP:0000505HP:0000572Visual loss1NEU1 CL E G H47587758ORPHA:93400Congenital sialidosis type 2HP:0040283 - Occasional43
HP:0000505HP:0000572Visual loss1NEU1 CL E G H47587758ORPHA:93399Juvenile sialidosis type 2HP:0040283 - Occasional43
HP:0000505HP:0000572Visual loss1NEU1 CL E G H47587758OMIM:256550Neuraminidase deficiency43
HP:0000505HP:0000572Visual loss1NEU1 CL E G H47587758ORPHA:812Sialidosis type 143
HP:0000505HP:0100704Cerebral visual impairment1NEUROD2 CL E G H47617763OMIM:618374Epileptic encephalopathy, early infantile, 72.
HP:0000505HP:0007663Reduced visual acuity1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndrome1952
HP:0000505HP:0000572Visual loss1NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndrome1952
HP:0000505HP:0007663Reduced visual acuity1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0001123Visual field defect1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0000572Visual loss1NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0007663Reduced visual acuity1NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040282 - Frequent220
HP:0000505HP:0000572Visual loss1NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040283 - Occasional220
HP:0000505HP:0007663Reduced visual acuity1NFIX CL E G H47847788ORPHA:44798019p13.3 microduplication syndrome40
HP:0000505HP:0000572Visual loss1NHLRC1 CL E G H37888421576OMIM:254780Myoclonic epilepsy of lafora.77
HP:0000505HP:0007663Reduced visual acuity1NHS CL E G H48107820OMIM:302200Cataract, congenital total, with posterior sutural opacities in heterozygotes88
HP:0000505HP:0000572Visual loss1NHS CL E G H48107820OMIM:302350Nance-Horan syndrome.88
HP:0000505HP:0000572Visual loss1NHS CL E G H48107820ORPHA:627Nance-Horan syndromeHP:0040281 - Very frequent88
HP:0000505HP:0007663Reduced visual acuity1NLRP3 CL E G H11454816400ORPHA:1451CINCA syndrome217
HP:0000505HP:0007663Reduced visual acuity1NMNAT1 CL E G H6480217877ORPHA:65Leber congenital amaurosis15
HP:0000505HP:0007663Reduced visual acuity1NMNAT1 CL E G H6480217877OMIM:608553Leber congenital amaurosis 915
HP:0000505HP:0000572Visual loss1NOD2 CL E G H641275331ORPHA:90340Blau syndromeHP:0040283 - Occasional187
HP:0000505HP:0100704Cerebral visual impairment1NODAL CL E G H48387865ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent45
HP:0000505HP:0100704Cerebral visual impairment1NODAL CL E G H48387865ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional45
HP:0000505HP:0100704Cerebral visual impairment1NODAL CL E G H48387865ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent45
HP:0000505HP:0100704Cerebral visual impairment1NODAL CL E G H48387865ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent45
HP:0000505HP:0007663Reduced visual acuity1NOG CL E G H92417866OMIM:186500Multiple synostoses syndrome 122
HP:0000505HP:0000572Visual loss1NOTCH3 CL E G H48547883OMIM:125310Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathyHP:0040283 - Occasional144
HP:0000505HP:0000572Visual loss1NPHP1 CL E G H48677905ORPHA:3156Senior-Loken syndrome85
HP:0000505HP:0000572Visual loss1NPHP3 CL E G H270317907ORPHA:3156Senior-Loken syndrome157
HP:0000505HP:0000572Visual loss1NPHP4 CL E G H26173419104ORPHA:3156Senior-Loken syndrome220
HP:0000505HP:0007663Reduced visual acuity1NPHP4 CL E G H26173419104OMIM:606996Senior-Loken syndrome 4220
HP:0000505HP:0007663Reduced visual acuity1NR2E3 CL E G H100027974ORPHA:791Retinitis pigmentosa58
HP:0000505HP:0100704Cerebral visual impairment1NR2F1 CL E G H70257975OMIM:615722Bosch-Boonstra-Schaaf optic atrophy syndrome.37
HP:0000505HP:0007663Reduced visual acuity1NR2F1 CL E G H70257975OMIM:615722Bosch-Boonstra-Schaaf optic atrophy syndrome.37
HP:0000505HP:0001123Visual field defect1NR2F1 CL E G H70257975OMIM:615722Bosch-Boonstra-Schaaf optic atrophy syndrome.37
HP:0000505HP:0100704Cerebral visual impairment1NR2F1 CL E G H70257975ORPHA:401777Optic atrophy-intellectual disability syndromeHP:0040283 - Occasional37
HP:0000505HP:0007663Reduced visual acuity1NR2F1 CL E G H70257975ORPHA:401777Optic atrophy-intellectual disability syndromeHP:0040282 - Frequent37
HP:0000505HP:0001123Visual field defect1NR2F1 CL E G H70257975ORPHA:401777Optic atrophy-intellectual disability syndromeHP:0040283 - Occasional37
HP:0000505HP:0001123Visual field defect1NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0000505HP:0007663Reduced visual acuity1NRL CL E G H49018002ORPHA:791Retinitis pigmentosa30
HP:0000505HP:0007663Reduced visual acuity1NRL CL E G H49018002OMIM:613750Retinitis pigmentosa 2730
HP:0000505HP:0007663Reduced visual acuity1NSMCE2 CL E G H28605326513ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndrome2
HP:0000505HP:0007663Reduced visual acuity1NUBPL CL E G H8022420278ORPHA:2609Isolated complex I deficiency89
HP:0000505HP:0007663Reduced visual acuity1NYX CL E G H605068082ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent42
HP:0000505HP:0007663Reduced visual acuity1OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retina94
HP:0000505HP:0000572Visual loss1OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retina94
HP:0000505HP:0001123Visual field defect1OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retina94
HP:0000505HP:0007663Reduced visual acuity1OAT CL E G H49428091OMIM:258870Ornithine aminotransferase deficiency94
HP:0000505HP:0007663Reduced visual acuity1OCA2 CL E G H49488101OMIM:203200Albinism, oculocutaneous, type II.121
HP:0000505HP:0007663Reduced visual acuity1OCA2 CL E G H49488101ORPHA:79432Oculocutaneous albinism type 2HP:0040282 - Frequent121
HP:0000505HP:0007663Reduced visual acuity1OCRL CL E G H49528108OMIM:309000Lowe syndrome.88
HP:0000505HP:0007663Reduced visual acuity1OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of Lowe88
HP:0000505HP:0007663Reduced visual acuity1OFD1 CL E G H84812567ORPHA:791Retinitis pigmentosa201
HP:0000505HP:0001123Visual field defect1OFD1 CL E G H84812567OMIM:300424Retinitis pigmentosa 23201
HP:0000505HP:0007663Reduced visual acuity1OFD1 CL E G H84812567OMIM:300424Retinitis pigmentosa 23201
HP:0000505HP:0007663Reduced visual acuity1OGT CL E G H84738127OMIM:300997Mental retardation, X-linked 1064
HP:0000505HP:0000572Visual loss1OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndrome214
HP:0000505HP:0001123Visual field defect1OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndrome214
HP:0000505HP:0007663Reduced visual acuity1OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic form214
HP:0000505HP:0001123Visual field defect1OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic form214
HP:0000505HP:0000572Visual loss1OPA1 CL E G H49768140OMIM:210000Behr syndrome214
HP:0000505HP:0007663Reduced visual acuity1OPA1 CL E G H49768140OMIM:210000Behr syndrome214
HP:0000505HP:0007663Reduced visual acuity1OPA1 CL E G H49768140OMIM:165500Optic atrophy 1.214
HP:0000505HP:0001123Visual field defect1OPA1 CL E G H49768140OMIM:165500Optic atrophy 1214
HP:0000505HP:0001123Visual field defect1OPA1 CL E G H49768140OMIM:125250Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy214
HP:0000505HP:0007663Reduced visual acuity1OPA1 CL E G H49768140OMIM:125250Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy.214
HP:0000505HP:0007663Reduced visual acuity1OPA3 CL E G H802078142OMIM:2585013-methylglutaconic aciduria, type III.163
HP:0000505HP:0007663Reduced visual acuity1OPA3 CL E G H802078142ORPHA:67036Autosomal dominant optic atrophy and cataractHP:0040281 - Very frequent163
HP:0000505HP:0001123Visual field defect1OPA3 CL E G H802078142ORPHA:67036Autosomal dominant optic atrophy and cataract163
HP:0000505HP:0001123Visual field defect1OPA3 CL E G H802078142OMIM:165300OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3163
HP:0000505HP:0007663Reduced visual acuity1OPA3 CL E G H802078142OMIM:165300OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3163
HP:0000505HP:0007663Reduced visual acuity1OPN1LW CL E G H59569936OMIM:303700Blue cone monochromacy.7
HP:0000505HP:0007663Reduced visual acuity1OPN1MW CL E G H26524206OMIM:303700Blue cone monochromacy.5
HP:0000505HP:0007663Reduced visual acuity1OPN1SW CL E G H6111012ORPHA:88629TritanopiaHP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1OSTM1 CL E G H2896221652OMIM:259720Osteopetrosis, autosomal recessive 573
HP:0000505HP:0007663Reduced visual acuity1OVOL2 CL E G H5849515804ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional4
HP:0000505HP:0007663Reduced visual acuity1P3H2 CL E G H5521419317OMIM:614292Myopia, high, with cataract and vitreoretinal degeneration5
HP:0000505HP:0001123Visual field defect1P4HA2 CL E G H89748547ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0000505HP:0000572Visual loss1P4HA2 CL E G H89748547ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1P4HTM CL E G H5468128858OMIM:618493Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities
HP:0000505HP:0100704Cerebral visual impairment1P4HTM CL E G H5468128858OMIM:618493Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities.
HP:0000505HP:0000572Visual loss1PAK2 CL E G H50628591ORPHA:1571Knobloch syndromeHP:0040282 - Frequent
HP:0000505HP:0007663Reduced visual acuity1PANK2 CL E G H8002515894ORPHA:216873Atypical pantothenate kinase-associated neurodegeneration55
HP:0000505HP:0007663Reduced visual acuity1PANK2 CL E G H8002515894ORPHA:216866Classic pantothenate kinase-associated neurodegeneration55
HP:0000505HP:0007663Reduced visual acuity1PANK4 CL E G H5522919366OMIM:619593CATARACT 49; CTRCT49
HP:0000505HP:0100704Cerebral visual impairment1PARS2 CL E G H2597330563OMIM:618437Epileptic encephalopathy, early infantile, 75.14
HP:0000505HP:0007663Reduced visual acuity1PAX2 CL E G H50768616OMIM:120330Papillorenal syndrome39
HP:0000505HP:0007663Reduced visual acuity1PAX6 CL E G H50808620OMIM:604229Anterior segment dysgenesis 5, multiple subtypes.194
HP:0000505HP:0007663Reduced visual acuity1PAX6 CL E G H50808620ORPHA:2334Autosomal dominant keratitisHP:0040282 - Frequent194
HP:0000505HP:0007663Reduced visual acuity1PAX6 CL E G H50808620OMIM:120200COLOBOMA, OCULAR, AUTOSOMAL DOMINANT194
HP:0000505HP:0000572Visual loss1PAX6 CL E G H50808620ORPHA:250923Isolated aniridiaHP:0040281 - Very frequent194
HP:0000505HP:0007663Reduced visual acuity1PAX6 CL E G H50808620ORPHA:137902Isolated optic nerve hypoplasia/aplasiaHP:0040281 - Very frequent194
HP:0000505HP:0007663Reduced visual acuity1PAX6 CL E G H50808620ORPHA:35737Morning glory disc anomaly194
HP:0000505HP:0007663Reduced visual acuity1PAX6 CL E G H50808620OMIM:165550OPTIC NERVE HYPOPLASIA, BILATERAL194
HP:0000505HP:0007663Reduced visual acuity1PCARE CL E G H38893934383ORPHA:791Retinitis pigmentosa
HP:0000505HP:0001123Visual field defect1PCDH15 CL E G H6521714674ORPHA:231169Usher syndrome type 1352
HP:0000505HP:0000572Visual loss1PCDH15 CL E G H6521714674ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent352
HP:0000505HP:0007663Reduced visual acuity1PCYT1A CL E G H51308754ORPHA:65Leber congenital amaurosis11
HP:0000505HP:0000572Visual loss1PCYT1A CL E G H51308754OMIM:608940Spondylometaphyseal dysplasia with cone-rod dystrophy11
HP:0000505HP:0007663Reduced visual acuity1PCYT2 CL E G H58338756OMIM:618770SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82
HP:0000505HP:0007663Reduced visual acuity1PDE6A CL E G H51458785ORPHA:791Retinitis pigmentosa116
HP:0000505HP:0001123Visual field defect1PDE6A CL E G H51458785OMIM:613810RETINITIS PIGMENTOSA 43; RP43116
HP:0000505HP:0007663Reduced visual acuity1PDE6B CL E G H51588786ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent126
HP:0000505HP:0007663Reduced visual acuity1PDE6B CL E G H51588786ORPHA:791Retinitis pigmentosa126
HP:0000505HP:0001123Visual field defect1PDE6C CL E G H51468787ORPHA:49382Achromatopsia80
HP:0000505HP:0007663Reduced visual acuity1PDE6C CL E G H51468787ORPHA:49382AchromatopsiaHP:0040282 - Frequent80
HP:0000505HP:0007663Reduced visual acuity1PDE6C CL E G H51468787OMIM:613093Cone dystrophy 4.80
HP:0000505HP:0001123Visual field defect1PDE6G CL E G H51488789OMIM:268000Retinitis pigmentosa18
HP:0000505HP:0007663Reduced visual acuity1PDE6G CL E G H51488789ORPHA:791Retinitis pigmentosa18
HP:0000505HP:0007663Reduced visual acuity1PDE6G CL E G H51488789OMIM:613582Retinitis pigmentosa 5718
HP:0000505HP:0001123Visual field defect1PDE6G CL E G H51488789OMIM:613582Retinitis pigmentosa 5718
HP:0000505HP:0001123Visual field defect1PDE6H CL E G H51498790ORPHA:49382Achromatopsia14
HP:0000505HP:0007663Reduced visual acuity1PDE6H CL E G H51498790ORPHA:49382AchromatopsiaHP:0040282 - Frequent14
HP:0000505HP:0007663Reduced visual acuity1PDE6H CL E G H51498790OMIM:610024Retinal cone dystrophy 3A.14
HP:0000505HP:0000572Visual loss1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0007663Reduced visual acuity1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0001123Visual field defect1PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0007663Reduced visual acuity1PDHA1 CL E G H51608806ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiency88
HP:0000505HP:0100704Cerebral visual impairment1PDSS2 CL E G H5710723041OMIM:614652Coenzyme Q10 deficiency, primary, 3.54
HP:0000505HP:0100704Cerebral visual impairment1PDSS2 CL E G H5710723041ORPHA:255249Leigh syndrome with nephrotic syndromeHP:0040283 - Occasional54
HP:0000505HP:0001123Visual field defect1PDZD7 CL E G H7995526257ORPHA:231178Usher syndrome type 240
HP:0000505HP:0000572Visual loss1PDZD7 CL E G H7995526257ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent40
HP:0000505HP:0007663Reduced visual acuity1PDZD8 CL E G H11898726974OMIM:620021
HP:0000505HP:0100704Cerebral visual impairment1PET100 CL E G H10013180140038OMIM:619055MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN126
HP:0000505HP:0001123Visual field defect1PEX1 CL E G H51898850ORPHA:772Infantile Refsum disease169
HP:0000505HP:0001123Visual field defect1PEX10 CL E G H51928851ORPHA:772Infantile Refsum disease75
HP:0000505HP:0001123Visual field defect1PEX11B CL E G H87998853ORPHA:772Infantile Refsum disease4
HP:0000505HP:0001123Visual field defect1PEX12 CL E G H51938854ORPHA:772Infantile Refsum disease65
HP:0000505HP:0001123Visual field defect1PEX13 CL E G H51948855ORPHA:772Infantile Refsum disease66
HP:0000505HP:0000572Visual loss1PEX13 CL E G H51948855OMIM:614885Peroxisome biogenesis disorder 11B.66
HP:0000505HP:0001123Visual field defect1PEX14 CL E G H51958856ORPHA:772Infantile Refsum disease46
HP:0000505HP:0001123Visual field defect1PEX16 CL E G H94098857ORPHA:772Infantile Refsum disease59
HP:0000505HP:0001123Visual field defect1PEX19 CL E G H58249713ORPHA:772Infantile Refsum disease62
HP:0000505HP:0001123Visual field defect1PEX2 CL E G H58289717ORPHA:772Infantile Refsum disease82
HP:0000505HP:0001123Visual field defect1PEX26 CL E G H5567022965ORPHA:772Infantile Refsum disease106
HP:0000505HP:0001123Visual field defect1PEX3 CL E G H85048858ORPHA:772Infantile Refsum disease47
HP:0000505HP:0001123Visual field defect1PEX5 CL E G H58309719ORPHA:772Infantile Refsum disease99
HP:0000505HP:0007663Reduced visual acuity1PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome98
HP:0000505HP:0001123Visual field defect1PEX6 CL E G H51908859ORPHA:772Infantile Refsum disease98
HP:0000505HP:0000572Visual loss1PEX7 CL E G H51918860ORPHA:773Refsum disease72
HP:0000505HP:0100704Cerebral visual impairment1PGAP1 CL E G H8005525712OMIM:615802MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT4220
HP:0000505HP:0007663Reduced visual acuity1PGK1 CL E G H52308896ORPHA:713Glycogen storage disease due to phosphoglycerate kinase 1 deficiency21
HP:0000505HP:0000572Visual loss1PGK1 CL E G H52308896OMIM:300653Phosphoglycerate kinase 1 deficiencyHP:0040283 - Occasional21
HP:0000505HP:0100704Cerebral visual impairment1PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile formHP:0040283 - Occasional37
HP:0000505HP:0007663Reduced visual acuity1PHOX2A CL E G H401691OMIM:602078Fibrosis of extraocular muscles, congenital, 26
HP:0000505HP:0000572Visual loss1PHYH CL E G H52648940ORPHA:773Refsum disease45
HP:0000505HP:0007663Reduced visual acuity1PI4KA CL E G H52978983OMIM:619708GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2; GIDID211
HP:0000505HP:0100704Cerebral visual impairment1PIGA CL E G H52778957OMIM:300868Multiple congenital anomalies-hypotonia-seizures syndrome 2.46
HP:0000505HP:0100704Cerebral visual impairment1PIGA CL E G H52778957OMIM:301072NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH46
HP:0000505HP:0007663Reduced visual acuity1PIGN CL E G H235568967ORPHA:280633Multiple congenital anomalies-hypotonia-seizures syndrome37
HP:0000505HP:0007663Reduced visual acuity1PIGN CL E G H235568967OMIM:614080Multiple congenital anomalies-hypotonia-seizures syndrome 137
HP:0000505HP:0100704Cerebral visual impairment1PIGP CL E G H512273046OMIM:617599Epileptic encephalopathy, early infantile, 55.2
HP:0000505HP:0100704Cerebral visual impairment1PIGQ CL E G H909114135OMIM:618548MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4; MCAHS43
HP:0000505HP:0100704Cerebral visual impairment1PIGS CL E G H9400514937OMIM:618143GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18
HP:0000505HP:0100704Cerebral visual impairment1PIGT CL E G H5160414938ORPHA:369837Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndromeHP:0040281 - Very frequent12
HP:0000505HP:0100704Cerebral visual impairment1PIGT CL E G H5160414938OMIM:615398Multiple congenital anomalies-hypotonia-seizures syndrome 312
HP:0000505HP:0100704Cerebral visual impairment1PIGU CL E G H12886915791OMIM:618590NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS
HP:0000505HP:0100704Cerebral visual impairment1PIGY CL E G H8499228213OMIM:616809Hyperphosphatasia with mental retardation syndrome 6.2
HP:0000505HP:0001123Visual field defect1PIK3CA CL E G H52908975ORPHA:99802Hemimegalencephaly162
HP:0000505HP:0001123Visual field defect1PIK3CA CL E G H52908975ORPHA:144Lynch syndromeHP:0040283 - Occasional162
HP:0000505HP:0000572Visual loss1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0007663Reduced visual acuity1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0001123Visual field defect1PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0007663Reduced visual acuity1PIK3R2 CL E G H52968980OMIM:603387Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome12
HP:0000505HP:0007663Reduced visual acuity1PITPNM3 CL E G H8339421043OMIM:600977Cone-Rod dystrophy 5.135
HP:0000505HP:0001123Visual field defect1PITPNM3 CL E G H8339421043OMIM:600977Cone-Rod dystrophy 5135
HP:0000505HP:0007663Reduced visual acuity1PITX2 CL E G H53089005OMIM:180550Ring dermoid of cornea51
HP:0000505HP:0007663Reduced visual acuity1PITX3 CL E G H53099006OMIM:610623Cataract 11, multiple types6
HP:0000505HP:0007663Reduced visual acuity1PLA2G6 CL E G H83989039ORPHA:35069Infantile neuroaxonal dystrophy133
HP:0000505HP:0000572Visual loss1PLA2G6 CL E G H83989039OMIM:256600Neurodegeneration with brain iron accumulation 2A.133
HP:0000505HP:0100704Cerebral visual impairment1PLCH1 CL E G H2300729185ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent
HP:0000505HP:0007663Reduced visual acuity1PLG CL E G H53409071OMIM:217090Plasminogen deficiency, type iligneous conjunctivitis, included11
HP:0000505HP:0007663Reduced visual acuity1PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1105
HP:0000505HP:0000572Visual loss1PMPCB CL E G H95129119OMIM:617954Multiple mitochondrial dysfunctions syndrome 6HP:0040284 - Very rare
HP:0000505HP:0001123Visual field defect1PMS1 CL E G H53789121ORPHA:144Lynch syndromeHP:0040283 - Occasional56
HP:0000505HP:0001123Visual field defect1PMS2 CL E G H53959122ORPHA:144Lynch syndromeHP:0040283 - Occasional1121
HP:0000505HP:0000572Visual loss1PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0000505HP:0007663Reduced visual acuity1PNPT1 CL E G H8717823166OMIM:608703Spinocerebellar ataxia 25.60
HP:0000505HP:0007663Reduced visual acuity1PNPT1 CL E G H8717823166ORPHA:101111Spinocerebellar ataxia type 25HP:0040282 - Frequent60
HP:0000505HP:0001123Visual field defect1POC1B CL E G H28280930836OMIM:615973Cone-Rod dystrophy 203
HP:0000505HP:0007663Reduced visual acuity1POC1B CL E G H28280930836OMIM:615973Cone-Rod dystrophy 20.3
HP:0000505HP:0007663Reduced visual acuity1POGZ CL E G H2312618801ORPHA:468678White-Sutton syndrome35
HP:0000505HP:0000572Visual loss1POLA1 CL E G H54229173OMIM:301220PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR2
HP:0000505HP:0007663Reduced visual acuity1POLG CL E G H54289179ORPHA:726Alpers-Huttenlocher syndrome464
HP:0000505HP:0100704Cerebral visual impairment1POLG CL E G H54289179ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare464
HP:0000505HP:0100704Cerebral visual impairment1POLG CL E G H54289179OMIM:203700Mitochondrial DNA depletion syndrome 4A (Alpers type).464
HP:0000505HP:0000572Visual loss1POLG CL E G H54289179OMIM:203700Mitochondrial DNA depletion syndrome 4A (Alpers type).464
HP:0000505HP:0100704Cerebral visual impairment1POLG2 CL E G H112329180ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare45
HP:0000505HP:0000572Visual loss1POLG2 CL E G H112329180OMIM:619425MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE); MTDPS16B45
HP:0000505HP:0100704Cerebral visual impairment1POLG2 CL E G H112329180OMIM:610131Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4HP:0040283 - Occasional45
HP:0000505HP:0100704Cerebral visual impairment1POLR3GL CL E G H8426528466OMIM:619234SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM
HP:0000505HP:0007663Reduced visual acuity1POLR3GL CL E G H8426528466OMIM:619234SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM
HP:0000505HP:0007663Reduced visual acuity1POMGNT1 CL E G H5562419139ORPHA:370959Congenital muscular dystrophy with cerebellar involvement180
HP:0000505HP:0007663Reduced visual acuity1POMGNT1 CL E G H5562419139ORPHA:791Retinitis pigmentosa180
HP:0000505HP:0001123Visual field defect1POMGNT1 CL E G H5562419139OMIM:617123RETINITIS PIGMENTOSA 76; RP76180
HP:0000505HP:0007663Reduced visual acuity1POMGNT1 CL E G H5562419139OMIM:617123RETINITIS PIGMENTOSA 76; RP76180
HP:0000505HP:0007663Reduced visual acuity1POMK CL E G H8419726267ORPHA:370959Congenital muscular dystrophy with cerebellar involvement18
HP:0000505HP:0007663Reduced visual acuity1POMK CL E G H8419726267OMIM:615249MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12.18
HP:0000505HP:0007663Reduced visual acuity1POMT1 CL E G H105859202ORPHA:370959Congenital muscular dystrophy with cerebellar involvement213
HP:0000505HP:0007663Reduced visual acuity1POMT1 CL E G H105859202OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1213
HP:0000505HP:0007663Reduced visual acuity1POMT2 CL E G H2995419743ORPHA:370959Congenital muscular dystrophy with cerebellar involvement221
HP:0000505HP:0007663Reduced visual acuity1POMT2 CL E G H2995419743OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1221
HP:0000505HP:0007663Reduced visual acuity1PORCN CL E G H6484017652OMIM:305600Focal dermal hypoplasia.20
HP:0000505HP:0001123Visual field defect1POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndrome40
HP:0000505HP:0007663Reduced visual acuity1POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndromeHP:0040282 - Frequent40
HP:0000505HP:0100704Cerebral visual impairment1PPP2R1A CL E G H55189302OMIM:616362Mental retardation, autosomal dominant 3613
HP:0000505HP:0100704Cerebral visual impairment1PPP2R1A CL E G H55189302ORPHA:457284Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndromeHP:0040282 - Frequent13
HP:0000505HP:0100704Cerebral visual impairment1PPP3CA CL E G H55309314OMIM:617711Epileptic encephalopathy, infantile or early childhood, 1HP:0040284 - Very rare2
HP:0000505HP:0000572Visual loss1PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1172
HP:0000505HP:0007663Reduced visual acuity1PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1172
HP:0000505HP:0007663Reduced visual acuity1PQBP1 CL E G H100849330OMIM:309500Renpenning syndrome28
HP:0000505HP:0007663Reduced visual acuity1PRCD CL E G H76820632528ORPHA:791Retinitis pigmentosa39
HP:0000505HP:0000572Visual loss1PRDM5 CL E G H111079349ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent58
HP:0000505HP:0007663Reduced visual acuity1PRDX1 CL E G H50529352OMIM:277400Methylmalonic aciduria and homocystinuria, Cblc type.
HP:0000505HP:0007663Reduced visual acuity1PRIMPOL CL E G H20197326575OMIM:615420Myopia 22, autosomal dominant.1
HP:0000505HP:0001123Visual field defect1PROM1 CL E G H88429454OMIM:612657CONE-ROD DYSTROPHY 12; CORD12110
HP:0000505HP:0007663Reduced visual acuity1PROM1 CL E G H88429454OMIM:612657CONE-ROD DYSTROPHY 12; CORD12110
HP:0000505HP:0001123Visual field defect1PROM1 CL E G H88429454OMIM:608051Macular dystrophy, retinal, 2110
HP:0000505HP:0007663Reduced visual acuity1PROM1 CL E G H88429454OMIM:608051Macular dystrophy, retinal, 2.110
HP:0000505HP:0007663Reduced visual acuity1PROM1 CL E G H88429454ORPHA:791Retinitis pigmentosa110
HP:0000505HP:0001123Visual field defect1PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0000505HP:0007663Reduced visual acuity1PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0000505HP:0001123Visual field defect1PROM1 CL E G H88429454ORPHA:827Stargardt disease110
HP:0000505HP:0007663Reduced visual acuity1PROM1 CL E G H88429454ORPHA:827Stargardt diseaseHP:0040280 - Obligate110
HP:0000505HP:0007663Reduced visual acuity1PROM1 CL E G H88429454OMIM:603786Stargardt disease 4.110
HP:0000505HP:0001123Visual field defect1PRORP CL E G H969219958OMIM:619737COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54; COXPD54
HP:0000505HP:0007663Reduced visual acuity1PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive75
HP:0000505HP:0007663Reduced visual acuity1PRPF3 CL E G H912917348ORPHA:791Retinitis pigmentosa28
HP:0000505HP:0001123Visual field defect1PRPF3 CL E G H912917348OMIM:601414Retinitis pigmentosa 1828
HP:0000505HP:0007663Reduced visual acuity1PRPF31 CL E G H2612115446ORPHA:791Retinitis pigmentosa70
HP:0000505HP:0007663Reduced visual acuity1PRPF31 CL E G H2612115446OMIM:600138Retinitis pigmentosa 1170
HP:0000505HP:0001123Visual field defect1PRPF31 CL E G H2612115446OMIM:600138Retinitis pigmentosa 1170
HP:0000505HP:0007663Reduced visual acuity1PRPF4 CL E G H912817349ORPHA:791Retinitis pigmentosa2
HP:0000505HP:0007663Reduced visual acuity1PRPF6 CL E G H2414815860ORPHA:791Retinitis pigmentosa51
HP:0000505HP:0007663Reduced visual acuity1PRPF6 CL E G H2414815860OMIM:613983Retinitis pigmentosa 60.51
HP:0000505HP:0007663Reduced visual acuity1PRPF8 CL E G H1059417340ORPHA:791Retinitis pigmentosa94
HP:0000505HP:0001123Visual field defect1PRPF8 CL E G H1059417340OMIM:600059Retinitis pigmentosa 1394
HP:0000505HP:0001123Visual field defect1PRPH2 CL E G H59619942ORPHA:99000Adult-onset foveomacular vitelliform dystrophyHP:0040282 - Frequent159
HP:0000505HP:0000572Visual loss1PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent159
HP:0000505HP:0007663Reduced visual acuity1PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent159
HP:0000505HP:0007663Reduced visual acuity1PRPH2 CL E G H59619942OMIM:608161Macular dystrophy, vitelliform, 3.159
HP:0000505HP:0007663Reduced visual acuity1PRPH2 CL E G H59619942ORPHA:791Retinitis pigmentosa159
HP:0000505HP:0001123Visual field defect1PRPH2 CL E G H59619942OMIM:608133Retinitis pigmentosa 7159
HP:0000505HP:0001123Visual field defect1PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescens159
HP:0000505HP:0000572Visual loss1PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescens159
HP:0000505HP:0007663Reduced visual acuity1PRPH2 CL E G H59619942ORPHA:827Stargardt diseaseHP:0040280 - Obligate159
HP:0000505HP:0001123Visual field defect1PRPH2 CL E G H59619942ORPHA:827Stargardt disease159
HP:0000505HP:0000572Visual loss1PRPS1 CL E G H56319462OMIM:301835Arts syndrome.49
HP:0000505HP:0000572Visual loss1PRPS1 CL E G H56319462OMIM:311070Charcot-Marie-Tooth disease, X-linked recessive, 549
HP:0000505HP:0007663Reduced visual acuity1PRPS1 CL E G H56319462ORPHA:1187Lethal ataxia with deafness and optic atrophy49
HP:0000505HP:0007663Reduced visual acuity1PRR12 CL E G H5747929217OMIM:619539NEUROOCULAR SYNDROME; NOC1
HP:0000505HP:0001123Visual field defect1PRRT2 CL E G H11247630500ORPHA:569Familial or sporadic hemiplegic migraine94
HP:0000505HP:0100704Cerebral visual impairment1PRUNE1 CL E G H5849713420ORPHA:544469PRUNE1-related neurological syndrome8
HP:0000505HP:0007663Reduced visual acuity1PSAP CL E G H56609498ORPHA:206436Infantile Krabbe disease81
HP:0000505HP:0000572Visual loss1PSAP CL E G H56609498ORPHA:206436Infantile Krabbe diseaseHP:0040283 - Occasional81
HP:0000505HP:0007663Reduced visual acuity1PSAP CL E G H56609498ORPHA:309271Metachromatic leukodystrophy, adult formHP:0040283 - Occasional81
HP:0000505HP:0007663Reduced visual acuity1PSAP CL E G H56609498ORPHA:309263Metachromatic leukodystrophy, juvenile formHP:0040283 - Occasional81
HP:0000505HP:0007663Reduced visual acuity1PSAP CL E G H56609498ORPHA:309256Metachromatic leukodystrophy, late infantile formHP:0040283 - Occasional81
HP:0000505HP:0100704Cerebral visual impairment1PSMD12 CL E G H57189557OMIM:617516Stankiewicz-Isidor syndrome4
HP:0000505HP:0100704Cerebral visual impairment1PTCH1 CL E G H57279585ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent665
HP:0000505HP:0100704Cerebral visual impairment1PTCH1 CL E G H57279585ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional665
HP:0000505HP:0100704Cerebral visual impairment1PTCH1 CL E G H57279585ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent665
HP:0000505HP:0100704Cerebral visual impairment1PTCH1 CL E G H57279585ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent665
HP:0000505HP:0000572Visual loss1PTPN2 CL E G H57719650ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000505HP:0007663Reduced visual acuity1PTPN2 CL E G H57719650ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0000505HP:0000572Visual loss1PTPN22 CL E G H261919652ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0000505HP:0001123Visual field defect1PTPN22 CL E G H261919652ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1PTPN22 CL E G H261919652ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional3
HP:0000505HP:0000572Visual loss1PTPN22 CL E G H261919652ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1PUF60 CL E G H2282717042ORPHA:5084888q24.3 microdeletion syndromeHP:0040282 - Frequent19
HP:0000505HP:0007663Reduced visual acuity1PUF60 CL E G H2282717042ORPHA:508498Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome19
HP:0000505HP:0007663Reduced visual acuity1PXDN CL E G H783714966OMIM:269400Corneal opacification with other ocular anomalies22
HP:0000505HP:0100704Cerebral visual impairment1PYCR2 CL E G H2992030262ORPHA:481152PYCR2-related microcephaly-progressive leukoencephalopathyHP:0040283 - Occasional11
HP:0000505HP:0100704Cerebral visual impairment1RAB18 CL E G H2293114244ORPHA:2510Micro syndromeHP:0040281 - Very frequent85
HP:0000505HP:0100704Cerebral visual impairment1RAB18 CL E G H2293114244OMIM:614222Warburg micro syndrome 385
HP:0000505HP:0001123Visual field defect1RAB28 CL E G H93649768OMIM:615374Cone-Rod dystrophy 186
HP:0000505HP:0100704Cerebral visual impairment1RAB3GAP1 CL E G H2293017063ORPHA:2510Micro syndromeHP:0040281 - Very frequent90
HP:0000505HP:0100704Cerebral visual impairment1RAB3GAP2 CL E G H2578217168ORPHA:2510Micro syndromeHP:0040281 - Very frequent135
HP:0000505HP:0007663Reduced visual acuity1RAC1 CL E G H58799801ORPHA:500159Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom3
HP:0000505HP:0100704Cerebral visual impairment1RALGAPA1 CL E G H25395917770OMIM:618797NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT1
HP:0000505HP:0001123Visual field defect1RAX2 CL E G H8483918286OMIM:62010252
HP:0000505HP:0007663Reduced visual acuity1RAX2 CL E G H8483918286OMIM:62010252
HP:0000505HP:0000572Visual loss1RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 1152
HP:0000505HP:0001123Visual field defect1RBP3 CL E G H59499921OMIM:268000Retinitis pigmentosa108
HP:0000505HP:0007663Reduced visual acuity1RBP3 CL E G H59499921ORPHA:791Retinitis pigmentosa108
HP:0000505HP:0007663Reduced visual acuity1RBP3 CL E G H59499921OMIM:615233Retinitis pigmentosa 66.108
HP:0000505HP:0001123Visual field defect1RBP3 CL E G H59499921OMIM:615233Retinitis pigmentosa 66108
HP:0000505HP:0007663Reduced visual acuity1RBP4 CL E G H59509922OMIM:615147Retinal dystrophy, iris coloboma, and comedogenic acne syndrome.8
HP:0000505HP:0007663Reduced visual acuity1RCBTB1 CL E G H5521318243OMIM:617175RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA8
HP:0000505HP:0007663Reduced visual acuity1RD3 CL E G H34303519689ORPHA:65Leber congenital amaurosis95
HP:0000505HP:0007663Reduced visual acuity1RD3 CL E G H34303519689OMIM:610612Leber congenital amaurosis 1295
HP:0000505HP:0000572Visual loss1RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome2
HP:0000505HP:0001123Visual field defect1RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome2
HP:0000505HP:0007663Reduced visual acuity1RDH12 CL E G H14522619977ORPHA:65Leber congenital amaurosis45
HP:0000505HP:0007663Reduced visual acuity1RDH12 CL E G H14522619977OMIM:612712Leber congenital amaurosis 1345
HP:0000505HP:0007663Reduced visual acuity1RDH12 CL E G H14522619977ORPHA:791Retinitis pigmentosa45
HP:0000505HP:0000572Visual loss1RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescens32
HP:0000505HP:0001123Visual field defect1RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescens32
HP:0000505HP:0007663Reduced visual acuity1REEP6 CL E G H9284030078ORPHA:791Retinitis pigmentosa5
HP:0000505HP:0007663Reduced visual acuity1REEP6 CL E G H9284030078OMIM:617304Retinitis pigmentosa 77.5
HP:0000505HP:0100704Cerebral visual impairment1RERE CL E G H4739965ORPHA:494344RERE-related neurodevelopmental syndromeHP:0040283 - Occasional16
HP:0000505HP:0007663Reduced visual acuity1RFT1 CL E G H9186930220OMIM:612015Congenital disorder of glycosylation, type IN.92
HP:0000505HP:0007663Reduced visual acuity1RGR CL E G H59959990ORPHA:791Retinitis pigmentosa28
HP:0000505HP:0001123Visual field defect1RGR CL E G H59959990OMIM:613769RETINITIS PIGMENTOSA 44; RP4428
HP:0000505HP:0007663Reduced visual acuity1RHO CL E G H601010012ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent107
HP:0000505HP:0001123Visual field defect1RHO CL E G H601010012OMIM:610445Night blindness, congenital stationary, autosomal dominant 1.107
HP:0000505HP:0007663Reduced visual acuity1RHO CL E G H601010012ORPHA:791Retinitis pigmentosa107
HP:0000505HP:0001123Visual field defect1RHO CL E G H601010012OMIM:613731Retinitis pigmentosa 4.107
HP:0000505HP:0007663Reduced visual acuity1RHO CL E G H601010012OMIM:613731Retinitis pigmentosa 4107
HP:0000505HP:0000572Visual loss1RHO CL E G H601010012ORPHA:52427Retinitis punctata albescens107
HP:0000505HP:0001123Visual field defect1RHO CL E G H601010012ORPHA:52427Retinitis punctata albescens107
HP:0000505HP:0007663Reduced visual acuity1RHOA CL E G H387667OMIM:618727ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES; EDFAOB8
HP:0000505HP:0007663Reduced visual acuity1RIC1 CL E G H5758917686OMIM:618761CATIFA SYNDROME; CATIFA
HP:0000505HP:0007663Reduced visual acuity1RIMS2 CL E G H969917283OMIM:618970CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE; CRSDS2
HP:0000505HP:0000572Visual loss1RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophy47
HP:0000505HP:0001123Visual field defect1RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040281 - Very frequent47
HP:0000505HP:0001123Visual field defect1RLBP1 CL E G H601710024OMIM:607476NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD47
HP:0000505HP:0007663Reduced visual acuity1RLBP1 CL E G H601710024ORPHA:791Retinitis pigmentosa47
HP:0000505HP:0000572Visual loss1RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescens47
HP:0000505HP:0001123Visual field defect1RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescens47
HP:0000505HP:0100704Cerebral visual impairment1RNF13 CL E G H1134210057OMIM:618379DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73; DEE73
HP:0000505HP:0100704Cerebral visual impairment1RNF13 CL E G H1134210057ORPHA:544503RNF13-related severe early-onset epileptic encephalopathyHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1RNU4ATAC CL E G H10015168334016OMIM:226960EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS15
HP:0000505HP:0007663Reduced visual acuity1ROM1 CL E G H609410254ORPHA:791Retinitis pigmentosa38
HP:0000505HP:0001123Visual field defect1ROM1 CL E G H609410254OMIM:268000Retinitis pigmentosa38
HP:0000505HP:0001123Visual field defect1ROM1 CL E G H609410254OMIM:608133Retinitis pigmentosa 738
HP:0000505HP:0007663Reduced visual acuity1RORA CL E G H609510258OMIM:618060INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA1
HP:0000505HP:0007663Reduced visual acuity1RP1 CL E G H610110263ORPHA:791Retinitis pigmentosa111
HP:0000505HP:0007663Reduced visual acuity1RP1 CL E G H610110263OMIM:180100Retinitis pigmentosa 1111
HP:0000505HP:0001123Visual field defect1RP1 CL E G H610110263OMIM:180100Retinitis pigmentosa 1111
HP:0000505HP:0000572Visual loss1RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000505HP:0007663Reduced visual acuity1RP1L1 CL E G H9413715946ORPHA:791Retinitis pigmentosa284
HP:0000505HP:0007663Reduced visual acuity1RP1L1 CL E G H9413715946OMIM:618826RETINITIS PIGMENTOSA 88; RP88284
HP:0000505HP:0007663Reduced visual acuity1RP2 CL E G H610210274ORPHA:791Retinitis pigmentosa45
HP:0000505HP:0001123Visual field defect1RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked45
HP:0000505HP:0007663Reduced visual acuity1RP9 CL E G H610010288ORPHA:791Retinitis pigmentosa14
HP:0000505HP:0001123Visual field defect1RP9 CL E G H610010288OMIM:180104Retinitis pigmentosa 914
HP:0000505HP:0007663Reduced visual acuity1RPE65 CL E G H612110294ORPHA:65Leber congenital amaurosis129
HP:0000505HP:0007663Reduced visual acuity1RPE65 CL E G H612110294OMIM:204100Leber congenital amaurosis, type II.129
HP:0000505HP:0007663Reduced visual acuity1RPE65 CL E G H612110294ORPHA:791Retinitis pigmentosa129
HP:0000505HP:0007663Reduced visual acuity1RPE65 CL E G H612110294OMIM:613794Retinitis pigmentosa 20129
HP:0000505HP:0001123Visual field defect1RPE65 CL E G H612110294OMIM:618697RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87129
HP:0000505HP:0007663Reduced visual acuity1RPE65 CL E G H612110294ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent129
HP:0000505HP:0001123Visual field defect1RPE65 CL E G H612110294ORPHA:364055Severe early-childhood-onset retinal dystrophy129
HP:0000505HP:0001123Visual field defect1RPGR CL E G H610310295ORPHA:49382Achromatopsia200
HP:0000505HP:0007663Reduced visual acuity1RPGR CL E G H610310295ORPHA:49382AchromatopsiaHP:0040282 - Frequent200
HP:0000505HP:0007663Reduced visual acuity1RPGR CL E G H610310295OMIM:304020Cone-rod dystrophy, X-linked, 1200
HP:0000505HP:0007663Reduced visual acuity1RPGR CL E G H610310295OMIM:300834MACULAR DEGENERATION, X-LINKED ATROPHIC200
HP:0000505HP:0007663Reduced visual acuity1RPGR CL E G H610310295ORPHA:791Retinitis pigmentosa200
HP:0000505HP:0001123Visual field defect1RPGR CL E G H610310295OMIM:300029Retinitis pigmentosa 3200
HP:0000505HP:0007663Reduced visual acuity1RPGR CL E G H610310295OMIM:300029Retinitis pigmentosa 3200
HP:0000505HP:0007663Reduced visual acuity1RPGRIP1 CL E G H5709613436OMIM:608194CONE-ROD DYSTROPHY 13; CORD13109
HP:0000505HP:0007663Reduced visual acuity1RPGRIP1 CL E G H5709613436ORPHA:65Leber congenital amaurosis109
HP:0000505HP:0007663Reduced visual acuity1RPGRIP1 CL E G H5709613436OMIM:613826Leber congenital amaurosis 6109
HP:0000505HP:0001123Visual field defect1RPS20 CL E G H622410405ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional1
HP:0000505HP:0007663Reduced visual acuity1RRAS2 CL E G H2280017271OMIM:618624NOONAN SYNDROME 12; NS121
HP:0000505HP:0100704Cerebral visual impairment1RRM2B CL E G H5048417296ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare125
HP:0000505HP:0001123Visual field defect1RRM2B CL E G H5048417296OMIM:268315ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION125
HP:0000505HP:0000572Visual loss1RS1 CL E G H624710457OMIM:312700Retinoschisis 1, X-linked, juvenile148
HP:0000505HP:0001123Visual field defect1RTN4IP1 CL E G H8481618647OMIM:616732OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA102
HP:0000505HP:0007663Reduced visual acuity1RTN4IP1 CL E G H8481618647OMIM:616732OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA102
HP:0000505HP:0007663Reduced visual acuity1SAG CL E G H629510521ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent32
HP:0000505HP:0007663Reduced visual acuity1SAG CL E G H629510521ORPHA:791Retinitis pigmentosa32
HP:0000505HP:0007663Reduced visual acuity1SALL2 CL E G H629710526OMIM:216820COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE1
HP:0000505HP:0007663Reduced visual acuity1SALL4 CL E G H5716715924ORPHA:233Duane retraction syndrome86
HP:0000505HP:0007663Reduced visual acuity1SARDH CL E G H175710536ORPHA:3129Sarcosinemia4
HP:0000505HP:0007663Reduced visual acuity1SCAPER CL E G H4985513081OMIM:618195Intellectual developmental disorder and retinitis pigmentosa.
HP:0000505HP:0007663Reduced visual acuity1SCAPER CL E G H4985513081ORPHA:791Retinitis pigmentosa
HP:0000505HP:0100704Cerebral visual impairment1SCN1A CL E G H632310585OMIM:607208Epileptic encephalopathy, early infantile, 6 (Dravet syndrome).1053
HP:0000505HP:0001123Visual field defect1SCN1A CL E G H632310585ORPHA:569Familial or sporadic hemiplegic migraine1053
HP:0000505HP:0007663Reduced visual acuity1SCN1A CL E G H632310585OMIM:609634Migraine, familial hemiplegic, 31053
HP:0000505HP:0100704Cerebral visual impairment1SCN3A CL E G H632810590OMIM:617938EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE6270
HP:0000505HP:0007663Reduced visual acuity1SCN8A CL E G H633410596OMIM:614306Cognitive impairment with or without cerebellar ataxia357
HP:0000505HP:0000572Visual loss1SDCCAG8 CL E G H1080610671ORPHA:3156Senior-Loken syndrome61
HP:0000505HP:0007663Reduced visual acuity1SDHA CL E G H638910680ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent304
HP:0000505HP:0001123Visual field defect1SDHA CL E G H638910680OMIM:619259NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA304
HP:0000505HP:0007663Reduced visual acuity1SDHAF1 CL E G H64409633867ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent16
HP:0000505HP:0007663Reduced visual acuity1SDHB CL E G H639010681ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent237
HP:0000505HP:0007663Reduced visual acuity1SDHD CL E G H639210683ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent129
HP:0000505HP:0007663Reduced visual acuity1SELENOI CL E G H8546529361ORPHA:506353Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunctionHP:0040282 - Frequent
HP:0000505HP:0100704Cerebral visual impairment1SELENOI CL E G H8546529361OMIM:618768SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81
HP:0000505HP:0007663Reduced visual acuity1SELENOI CL E G H8546529361OMIM:618768SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81
HP:0000505HP:0001123Visual field defect1SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 1048
HP:0000505HP:0000572Visual loss1SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 1048
HP:0000505HP:0001123Visual field defect1SEMA4A CL E G H6421810729ORPHA:440437Familial colorectal cancer Type XHP:0040283 - Occasional48
HP:0000505HP:0007663Reduced visual acuity1SEMA4A CL E G H6421810729ORPHA:791Retinitis pigmentosa48
HP:0000505HP:0007663Reduced visual acuity1SEMA4A CL E G H6421810729OMIM:610282Retinitis pigmentosa 3548
HP:0000505HP:0100704Cerebral visual impairment1SEPSECS CL E G H5109130605ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040283 - Occasional66
HP:0000505HP:0007663Reduced visual acuity1SEPSECS CL E G H5109130605ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040282 - Frequent66
HP:0000505HP:0001123Visual field defect1SETD5 CL E G H5520925566ORPHA:404440Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency43
HP:0000505HP:0000572Visual loss1SF3B1 CL E G H2345110768ORPHA:39044Uveal melanomaHP:0040281 - Very frequent19
HP:0000505HP:0007663Reduced visual acuity1SF3B2 CL E G H1099210769OMIM:164210Hemifacial microsomia2
HP:0000505HP:0007663Reduced visual acuity1SH3BP2 CL E G H645210825OMIM:118400Cherubism177
HP:0000505HP:0000572Visual loss1SH3BP2 CL E G H645210825ORPHA:184Cherubism177
HP:0000505HP:0001123Visual field defect1SH3BP2 CL E G H645210825OMIM:118400Cherubism177
HP:0000505HP:0001123Visual field defect1SH3TC2 CL E G H7962829427ORPHA:99949Charcot-Marie-Tooth disease type 4C493
HP:0000505HP:0100704Cerebral visual impairment1SHANK3 CL E G H8535814294OMIM:606232Phelan-Mcdermid syndrome53
HP:0000505HP:0100704Cerebral visual impairment1SHH CL E G H646910848ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent67
HP:0000505HP:0100704Cerebral visual impairment1SHH CL E G H646910848ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional67
HP:0000505HP:0100704Cerebral visual impairment1SHH CL E G H646910848ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent67
HP:0000505HP:0100704Cerebral visual impairment1SHH CL E G H646910848ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent67
HP:0000505HP:0100704Cerebral visual impairment1SIX3 CL E G H649610889ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent32
HP:0000505HP:0100704Cerebral visual impairment1SIX3 CL E G H649610889ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional32
HP:0000505HP:0100704Cerebral visual impairment1SIX3 CL E G H649610889ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent32
HP:0000505HP:0100704Cerebral visual impairment1SIX3 CL E G H649610889ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent32
HP:0000505HP:0000572Visual loss1SLC19A2 CL E G H1056010938OMIM:249270Thiamine-Responsive megaloblastic anemia syndrome.55
HP:0000505HP:0000572Visual loss1SLC19A2 CL E G H1056010938ORPHA:49827Thiamine-responsive megaloblastic anemia syndromeHP:0040283 - Occasional55
HP:0000505HP:0007663Reduced visual acuity1SLC1A3 CL E G H650710941ORPHA:209967Episodic ataxia type 6HP:0040283 - Occasional63
HP:0000505HP:0007663Reduced visual acuity1SLC24A1 CL E G H918710975ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent66
HP:0000505HP:0007663Reduced visual acuity1SLC24A1 CL E G H918710975OMIM:613830Night blindness, congenital stationary, type 1D66
HP:0000505HP:0007663Reduced visual acuity1SLC24A5 CL E G H28365220611OMIM:113750Albinism, oculocutaneous, type VI.12
HP:0000505HP:0007663Reduced visual acuity1SLC24A5 CL E G H28365220611ORPHA:370097Oculocutaneous albinism type 6HP:0040281 - Very frequent12
HP:0000505HP:0100704Cerebral visual impairment1SLC25A1 CL E G H657610979OMIM:615182Combined d-2- and l-2-hydroxyglutaric aciduriaHP:0040283 - Occasional28
HP:0000505HP:0100704Cerebral visual impairment1SLC25A4 CL E G H29110990ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare68
HP:0000505HP:0001123Visual field defect1SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0000505HP:0000572Visual loss1SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0000505HP:0000572Visual loss1SLC25A46 CL E G H9113725198ORPHA:2254Pontocerebellar hypoplasia type 114
HP:0000505HP:0100704Cerebral visual impairment1SLC35A2 CL E G H735511022ORPHA:356961SLC35A2-CDGHP:0040282 - Frequent27
HP:0000505HP:0007663Reduced visual acuity1SLC38A8 CL E G H14616732434OMIM:609218Foveal hypoplasia 2.13
HP:0000505HP:0007663Reduced visual acuity1SLC39A14 CL E G H2351620858OMIM:144755Hyperostosis cranialis interna.5
HP:0000505HP:0007663Reduced visual acuity1SLC45A2 CL E G H5115116472ORPHA:79435Oculocutaneous albinism type 4HP:0040281 - Very frequent42
HP:0000505HP:0007663Reduced visual acuity1SLC4A11 CL E G H8395916438ORPHA:293603Congenital hereditary endothelial dystrophy type IIHP:0040282 - Frequent66
HP:0000505HP:0007663Reduced visual acuity1SLC4A11 CL E G H8395916438OMIM:217400Corneal endothelial dystrophy and perceptive deafness66
HP:0000505HP:0000572Visual loss1SLC4A11 CL E G H8395916438ORPHA:98974Fuchs endothelial corneal dystrophy66
HP:0000505HP:0007663Reduced visual acuity1SLC4A11 CL E G H8395916438ORPHA:98974Fuchs endothelial corneal dystrophy66
HP:0000505HP:0000572Visual loss1SLC52A2 CL E G H7958130224OMIM:614707Brown-Vialetto-Van laere syndrome 2HP:0040283 - Occasional47
HP:0000505HP:0001123Visual field defect1SLC6A6 CL E G H653311052OMIM:145350Hypotaurinemic retinal degeneration and cardiomyopathy
HP:0000505HP:0007663Reduced visual acuity1SLC7A14 CL E G H5770929326ORPHA:791Retinitis pigmentosa4
HP:0000505HP:0001123Visual field defect1SLC7A14 CL E G H5770929326OMIM:615725Retinitis pigmentosa 68.4
HP:0000505HP:0007663Reduced visual acuity1SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasia504
HP:0000505HP:0007663Reduced visual acuity1SMARCA2 CL E G H659511098ORPHA:2728Blepharophimosis-intellectual disability syndrome, Ohdo type146
HP:0000505HP:0000572Visual loss1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0007663Reduced visual acuity1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0001123Visual field defect1SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0007663Reduced visual acuity1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0001123Visual field defect1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0000572Visual loss1SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0100704Cerebral visual impairment1SMC1A CL E G H824311111ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent135
HP:0000505HP:0007663Reduced visual acuity1SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome174
HP:0000505HP:0000572Visual loss1SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeHP:0040282 - Frequent174
HP:0000505HP:0007663Reduced visual acuity1SMO CL E G H660811119OMIM:601707Curry-Jones syndrome22
HP:0000505HP:0000572Visual loss1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0007663Reduced visual acuity1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0001123Visual field defect1SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0007663Reduced visual acuity1SNRNP200 CL E G H2302030859ORPHA:791Retinitis pigmentosa83
HP:0000505HP:0100704Cerebral visual impairment1SNRPN CL E G H663811164ORPHA:177907Prader-Willi syndrome due to translocationHP:0040283 - Occasional37
HP:0000505HP:0007663Reduced visual acuity1SOBP CL E G H5508429256OMIM:613671Mental retardation, anterior maxillary protrusion, and strabismus29
HP:0000505HP:0100704Cerebral visual impairment1SON CL E G H665111183ORPHA:500150Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndromeHP:0040283 - Occasional12
HP:0000505HP:0000572Visual loss1SON CL E G H665111183ORPHA:500150Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome12
HP:0000505HP:0100704Cerebral visual impairment1SON CL E G H665111183OMIM:617140Zttk syndrome.12
HP:0000505HP:0000572Visual loss1SOST CL E G H5096413771OMIM:122860Craniodiaphyseal dysplasia, autosomal dominant26
HP:0000505HP:0001123Visual field defect1SOST CL E G H5096413771OMIM:269500Sclerosteosis 126
HP:0000505HP:0000572Visual loss1SOST CL E G H5096413771OMIM:269500Sclerosteosis 1.26
HP:0000505HP:0000572Visual loss1SOX2 CL E G H665711195ORPHA:77298Anophthalmia/microphthalmia-esophageal atresia syndromeHP:0040282 - Frequent33
HP:0000505HP:0100704Cerebral visual impairment1SPATA5 CL E G H16637818119OMIM:616577Epilepsy, hearing loss, and mental retardation syndromeHP:0040283 - Occasional19
HP:0000505HP:0100704Cerebral visual impairment1SPATA5 CL E G H16637818119ORPHA:457351Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndromeHP:0040282 - Frequent19
HP:0000505HP:0100704Cerebral visual impairment1SPATA5L1 CL E G H7902928762OMIM:619616NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS
HP:0000505HP:0007663Reduced visual acuity1SPATA7 CL E G H5581220423ORPHA:65Leber congenital amaurosis48
HP:0000505HP:0001123Visual field defect1SPATA7 CL E G H5581220423OMIM:604232LEBER CONGENITAL AMAUROSIS 3; LCA348
HP:0000505HP:0000572Visual loss1SPATA7 CL E G H5581220423OMIM:604232LEBER CONGENITAL AMAUROSIS 3; LCA348
HP:0000505HP:0007663Reduced visual acuity1SPATA7 CL E G H5581220423ORPHA:791Retinitis pigmentosa48
HP:0000505HP:0007663Reduced visual acuity1SPATA7 CL E G H5581220423ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent48
HP:0000505HP:0001123Visual field defect1SPATA7 CL E G H5581220423ORPHA:364055Severe early-childhood-onset retinal dystrophy48
HP:0000505HP:0000572Visual loss1SPTBN1 CL E G H671111275OMIM:619475DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA
HP:0000505HP:0100704Cerebral visual impairment1SPTBN4 CL E G H5773114896OMIM:617519Neurodevelopmental disorder with hypotonia, neuropathy, and deafness.3
HP:0000505HP:0000572Visual loss1SRD5A3 CL E G H7964425812OMIM:612379Congenital disorder of glycosylation, type IQHP:0040282 - Frequent80
HP:0000505HP:0000572Visual loss1SRD5A3 CL E G H7964425812ORPHA:324737SRD5A3-CDGHP:0040282 - Frequent80
HP:0000505HP:0007663Reduced visual acuity1SREBF1 CL E G H672011289OMIM:158310Mucoepithelial dysplasia, hereditary1
HP:0000505HP:0100704Cerebral visual impairment1ST3GAL5 CL E G H886910872OMIM:609056Salt and pepper developmental regression syndrome.47
HP:0000505HP:0000572Visual loss1ST3GAL5 CL E G H886910872OMIM:609056Salt and pepper developmental regression syndrome.47
HP:0000505HP:0100704Cerebral visual impairment1STAG2 CL E G H1073511355ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent1
HP:0000505HP:0100704Cerebral visual impairment1STAG2 CL E G H1073511355ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent1
HP:0000505HP:0007663Reduced visual acuity1STAT4 CL E G H677511365ORPHA:117Behçet disease2
HP:0000505HP:0000572Visual loss1STAT4 CL E G H677511365ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional2
HP:0000505HP:0007663Reduced visual acuity1STAT4 CL E G H677511365ORPHA:85410Oligoarticular juvenile idiopathic arthritisHP:0040283 - Occasional2
HP:0000505HP:0100704Cerebral visual impairment1STIL CL E G H649110879ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent99
HP:0000505HP:0100704Cerebral visual impairment1STIL CL E G H649110879ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional99
HP:0000505HP:0100704Cerebral visual impairment1STIL CL E G H649110879ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent99
HP:0000505HP:0100704Cerebral visual impairment1STIL CL E G H649110879ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent99
HP:0000505HP:0007663Reduced visual acuity1STX3 CL E G H680911438OMIM:619446RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE; RDMVID1
HP:0000505HP:0007663Reduced visual acuity1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0000572Visual loss1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0001123Visual field defect1SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0100704Cerebral visual impairment1SUOX CL E G H682111460OMIM:272300SULFOCYSTEINURIA40
HP:0000505HP:0007663Reduced visual acuity1TACSTD2 CL E G H407011530OMIM:204870Corneal dystrophy, gelatinous drop-like.42
HP:0000505HP:0100704Cerebral visual impairment1TANGO2 CL E G H12898925439ORPHA:480864Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndromeHP:0040283 - Occasional12
HP:0000505HP:0007663Reduced visual acuity1TANGO2 CL E G H12898925439ORPHA:480864Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome12
HP:0000505HP:0007663Reduced visual acuity1TASP1 CL E G H5561715859OMIM:618950SULEIMAN-EL-HATTAB SYNDROME; SULEHS
HP:0000505HP:0000572Visual loss1TAT CL E G H689811573ORPHA:28378Tyrosinemia type 2HP:0040283 - Occasional43
HP:0000505HP:0100704Cerebral visual impairment1TBC1D20 CL E G H12863716133ORPHA:2510Micro syndromeHP:0040281 - Very frequent15
HP:0000505HP:0007663Reduced visual acuity1TBC1D24 CL E G H5746529203OMIM:220500Doors syndrome271
HP:0000505HP:0000572Visual loss1TBC1D24 CL E G H5746529203OMIM:615338Epileptic encephalopathy, early infantile, 16.271
HP:0000505HP:0007663Reduced visual acuity1TBC1D2B CL E G H2310229183ORPHA:397973Intellectual disability-obesity-prognathism-eye and skin anomalies syndromeHP:0040283 - Occasional
HP:0000505HP:0100704Cerebral visual impairment1TBCK CL E G H9362728261OMIM:616900Hypotonia, infantile, with psychomotor retardation and characteristic facies 313
HP:0000505HP:0007663Reduced visual acuity1TBX1 CL E G H689911592OMIM:188400Digeorge syndrome32
HP:0000505HP:0000572Visual loss1TCF4 CL E G H692511634ORPHA:98974Fuchs endothelial corneal dystrophy241
HP:0000505HP:0007663Reduced visual acuity1TCF4 CL E G H692511634ORPHA:98974Fuchs endothelial corneal dystrophy241
HP:0000505HP:0007663Reduced visual acuity1TCIRG1 CL E G H1031211647OMIM:259700Osteopetrosis, autosomal recessive 182
HP:0000505HP:0000572Visual loss1TCOF1 CL E G H694911654OMIM:154500Treacher collins-franceschetti syndrome.140
HP:0000505HP:0100704Cerebral visual impairment1TDGF1 CL E G H699711701ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent1
HP:0000505HP:0100704Cerebral visual impairment1TDGF1 CL E G H699711701ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional1
HP:0000505HP:0100704Cerebral visual impairment1TDGF1 CL E G H699711701ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent1
HP:0000505HP:0100704Cerebral visual impairment1TDGF1 CL E G H699711701ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent1
HP:0000505HP:0000572Visual loss1TEK CL E G H701011724ORPHA:98976Congenital glaucomaHP:0040283 - Occasional78
HP:0000505HP:0100704Cerebral visual impairment1TELO2 CL E G H989429099ORPHA:488642TELO2-related intellectual disability-neurodevelopmental disorderHP:0040282 - Frequent12
HP:0000505HP:0100704Cerebral visual impairment1TELO2 CL E G H989429099OMIM:616954You-Hoover-Fong syndromeHP:0040283 - Occasional12
HP:0000505HP:0007663Reduced visual acuity1TENM3 CL E G H5571429944OMIM:615145Microphthalmia, isolated, with coloboma 9.12
HP:0000505HP:0000572Visual loss1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0007663Reduced visual acuity1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0001123Visual field defect1TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0007663Reduced visual acuity1TFE3 CL E G H703011752OMIM:301066INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES; MRXSPF
HP:0000505HP:0000572Visual loss1TFG CL E G H1034211758OMIM:615658Spastic paraplegia 57, autosomal recessive.18
HP:0000505HP:0007663Reduced visual acuity1TGFBI CL E G H704511771OMIM:607541Corneal dystrophy, Avellino type.58
HP:0000505HP:0007663Reduced visual acuity1TGFBI CL E G H704511771OMIM:121820Corneal dystrophy, epithelial basement membrane58
HP:0000505HP:0000572Visual loss1TGFBI CL E G H704511771OMIM:122200Corneal dystrophy, lattice type I58
HP:0000505HP:0007663Reduced visual acuity1TGFBI CL E G H704511771OMIM:608471Corneal dystrophy, lattice type IIIA.58
HP:0000505HP:0007663Reduced visual acuity1TGFBI CL E G H704511771OMIM:608470Corneal dystrophy, Reis-Bucklers type58
HP:0000505HP:0007663Reduced visual acuity1TGFBI CL E G H704511771ORPHA:98962Granular corneal dystrophy type I58
HP:0000505HP:0007663Reduced visual acuity1TGFBI CL E G H704511771ORPHA:98963Granular corneal dystrophy type II58
HP:0000505HP:0000572Visual loss1TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type IHP:0040281 - Very frequent58
HP:0000505HP:0000572Visual loss1TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophy58
HP:0000505HP:0001123Visual field defect1TGFBR2 CL E G H704811773ORPHA:144Lynch syndromeHP:0040283 - Occasional253
HP:0000505HP:0001123Visual field defect1TGFBR3 CL E G H704911774ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent1
HP:0000505HP:0100704Cerebral visual impairment1TGIF1 CL E G H705011776ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent32
HP:0000505HP:0100704Cerebral visual impairment1TGIF1 CL E G H705011776ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional32
HP:0000505HP:0100704Cerebral visual impairment1TGIF1 CL E G H705011776ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent32
HP:0000505HP:0100704Cerebral visual impairment1TGIF1 CL E G H705011776ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent32
HP:0000505HP:0001123Visual field defect1THPO CL E G H706611795ORPHA:71493Familial thrombocytosisHP:0040283 - Occasional23
HP:0000505HP:0001123Visual field defect1THSD1 CL E G H5590117754ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent2
HP:0000505HP:0001123Visual field defect1TIMM8A CL E G H167811817OMIM:304700Mohr-Tranebjaerg syndrome15
HP:0000505HP:0007663Reduced visual acuity1TIMM8A CL E G H167811817OMIM:304700Mohr-Tranebjaerg syndrome.15
HP:0000505HP:0001123Visual field defect1TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndrome15
HP:0000505HP:0100704Cerebral visual impairment1TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndromeHP:0040283 - Occasional15
HP:0000505HP:0000572Visual loss1TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndromeHP:0040283 - Occasional15
HP:0000505HP:0100704Cerebral visual impairment1TIMM8A CL E G H167811817OMIM:304700Mohr-Tranebjaerg syndrome.15
HP:0000505HP:0007663Reduced visual acuity1TIMMDC1 CL E G H513001321ORPHA:2609Isolated complex I deficiency1
HP:0000505HP:0007663Reduced visual acuity1TIMP3 CL E G H707811822OMIM:136900Sorsby fundus dystrophy95
HP:0000505HP:0000572Visual loss1TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophyHP:0040281 - Very frequent95
HP:0000505HP:0001123Visual field defect1TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophy95
HP:0000505HP:0007663Reduced visual acuity1TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophy95
HP:0000505HP:0007663Reduced visual acuity1TLCD3B CL E G H8372325295OMIM:619531CONE-ROD DYSTROPHY 22; CORD22
HP:0000505HP:0007663Reduced visual acuity1TLR4 CL E G H709911850ORPHA:117Behçet disease3
HP:0000505HP:0007663Reduced visual acuity1TMEM126A CL E G H8423325382OMIM:612989Optic atrophy 7 with or without auditory neuropathy.23
HP:0000505HP:0001123Visual field defect1TMEM126A CL E G H8423325382OMIM:612989Optic atrophy 7 with or without auditory neuropathy23
HP:0000505HP:0007663Reduced visual acuity1TMEM126B CL E G H5586330883ORPHA:2609Isolated complex I deficiency4
HP:0000505HP:0007663Reduced visual acuity1TMEM138 CL E G H5152426944ORPHA:2318Joubert syndrome with oculorenal defect39
HP:0000505HP:0007663Reduced visual acuity1TMEM216 CL E G H5125925018ORPHA:2318Joubert syndrome with oculorenal defect45
HP:0000505HP:0007663Reduced visual acuity1TMEM231 CL E G H7958337234ORPHA:2318Joubert syndrome with oculorenal defect33
HP:0000505HP:0007663Reduced visual acuity1TMEM237 CL E G H6506214432ORPHA:2318Joubert syndrome with oculorenal defect82
HP:0000505HP:0100704Cerebral visual impairment1TMEM53 CL E G H7963926186OMIM:619727CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE; CTDI
HP:0000505HP:0007663Reduced visual acuity1TMEM67 CL E G H9114728396OMIM:610688Joubert syndrome 6166
HP:0000505HP:0007663Reduced visual acuity1TMEM98 CL E G H2602224529OMIM:615972Nanophthalmos 4HP:0040283 - Occasional3
HP:0000505HP:0000572Visual loss1TNFRSF11A CL E G H879211908OMIM:612301OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB772
HP:0000505HP:0007663Reduced visual acuity1TNFSF11 CL E G H860011926OMIM:259710Osteopetrosis, autosomal recessive 244
HP:0000505HP:0007663Reduced visual acuity1TOPORS CL E G H1021021653ORPHA:791Retinitis pigmentosa61
HP:0000505HP:0001123Visual field defect1TOPORS CL E G H1021021653OMIM:609923Retinitis pigmentosa 3161
HP:0000505HP:0001123Visual field defect1TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0000505HP:0000572Visual loss1TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2203
HP:0000505HP:0000572Visual loss1TRAF3IP1 CL E G H2614617861ORPHA:3156Senior-Loken syndrome6
HP:0000505HP:0100704Cerebral visual impairment1TRAF7 CL E G H8423120456OMIM:618164Cardiac, facial, and digital anomalies with developmental delayHP:0040284 - Very rare
HP:0000505HP:0007663Reduced visual acuity1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0001123Visual field defect1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0000572Visual loss1TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0100704Cerebral visual impairment1TRAPPC12 CL E G H5111224284ORPHA:500144Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndromeHP:0040282 - Frequent2
HP:0000505HP:0100704Cerebral visual impairment1TRAPPC12 CL E G H5111224284OMIM:617669Encephalopathy, progressive, early-onset, with brain atrophy and spasticity.2
HP:0000505HP:0100704Cerebral visual impairment1TRAPPC2L CL E G H5169330887OMIM:618331Encephalopathy, progressive, early-onset, with episodic rhabdomyolysisHP:0040284 - Very rare
HP:0000505HP:0001123Visual field defect1TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040283 - Occasional56
HP:0000505HP:0000572Visual loss1TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy56
HP:0000505HP:0000572Visual loss1TRIM44 CL E G H5476519016OMIM:617142Aniridia 31
HP:0000505HP:0000572Visual loss1TRIM44 CL E G H5476519016ORPHA:250923Isolated aniridiaHP:0040281 - Very frequent1
HP:0000505HP:0007663Reduced visual acuity1TRIO CL E G H720412303ORPHA:476126Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome8
HP:0000505HP:0001123Visual field defect1TRNC CL E G H45117477OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNC CL E G H45117477OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNF CL E G H45587481ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1TRNF CL E G H45587481OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNF CL E G H45587481OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNH CL E G H45647487ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1TRNK CL E G H45667489OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNK CL E G H45667489OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNL1 CL E G H45677490ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0100704Cerebral visual impairment1TRNL1 CL E G H45677490OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0001123Visual field defect1TRNL1 CL E G H45677490OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0000572Visual loss1TRNQ CL E G H45727495ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1TRNQ CL E G H45727495OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNQ CL E G H45727495OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNS1 CL E G H45747497ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1TRNS1 CL E G H45747497OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNS1 CL E G H45747497OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNS2 CL E G H45757498ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1TRNS2 CL E G H45757498OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNS2 CL E G H45757498OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNS2 CL E G H45757498ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0001123Visual field defect1TRNS2 CL E G H45757498ORPHA:231183Usher syndrome type 3
HP:0000505HP:0001123Visual field defect1TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28
HP:0000505HP:0001123Visual field defect1TRNV CL E G H45777500OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNV CL E G H45777500OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000572Visual loss1TRNW CL E G H45787501ORPHA:550MELASHP:0040282 - Frequent
HP:0000505HP:0001123Visual field defect1TRNW CL E G H45787501OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
HP:0000505HP:0100704Cerebral visual impairment1TRNW CL E G H45787501OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0007663Reduced visual acuity1TRPM1 CL E G H43087146ORPHA:215Congenital stationary night blindnessHP:0040281 - Very frequent104
HP:0000505HP:0007663Reduced visual acuity1TRPM1 CL E G H43087146OMIM:613216NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C104
HP:0000505HP:0100704Cerebral visual impairment1TSEN15 CL E G H11646116791ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040283 - Occasional3
HP:0000505HP:0007663Reduced visual acuity1TSEN15 CL E G H11646116791ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040282 - Frequent3
HP:0000505HP:0007663Reduced visual acuity1TSEN2 CL E G H8074628422ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040282 - Frequent84
HP:0000505HP:0100704Cerebral visual impairment1TSEN2 CL E G H8074628422ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040283 - Occasional84
HP:0000505HP:0100704Cerebral visual impairment1TSEN2 CL E G H8074628422OMIM:612389Pontocerebellar hypoplasia, type 2B84
HP:0000505HP:0007663Reduced visual acuity1TSEN34 CL E G H7904215506ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040282 - Frequent57
HP:0000505HP:0100704Cerebral visual impairment1TSEN34 CL E G H7904215506ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040283 - Occasional57
HP:0000505HP:0100704Cerebral visual impairment1TSEN54 CL E G H28398927561ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040283 - Occasional102
HP:0000505HP:0007663Reduced visual acuity1TSEN54 CL E G H28398927561ORPHA:2524Pontocerebellar hypoplasia type 2HP:0040282 - Frequent102
HP:0000505HP:0007663Reduced visual acuity1TSPAN12 CL E G H2355421641OMIM:613310Exudative vitreoretinopathy 5HP:0040283 - Occasional39
HP:0000505HP:0007663Reduced visual acuity1TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathyHP:0040282 - Frequent39
HP:0000505HP:0007663Reduced visual acuity1TTC8 CL E G H12301620087ORPHA:791Retinitis pigmentosa41
HP:0000505HP:0007663Reduced visual acuity1TTC8 CL E G H12301620087OMIM:613464Retinitis pigmentosa 51.41
HP:0000505HP:0007663Reduced visual acuity1TTLL5 CL E G H2309319963OMIM:615860Cone-Rod dystrophy 199
HP:0000505HP:0007663Reduced visual acuity1TUB CL E G H727512406OMIM:616188Retinal dystrophy and obesity.1
HP:0000505HP:0007663Reduced visual acuity1TUB CL E G H727512406ORPHA:791Retinitis pigmentosa1
HP:0000505HP:0007663Reduced visual acuity1TUBA3D CL E G H11345724071OMIM:617928Keratoconus 9.
HP:0000505HP:0001123Visual field defect1TUBB2B CL E G H34773330829ORPHA:300573Polymicrogyria due to TUBB2B mutation39
HP:0000505HP:0000572Visual loss1TUBB3 CL E G H1038120772ORPHA:300570Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutationHP:0040283 - Occasional64
HP:0000505HP:0007663Reduced visual acuity1TUBB3 CL E G H1038120772ORPHA:300570Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation64
HP:0000505HP:0007663Reduced visual acuity1TUBB3 CL E G H1038120772OMIM:600638Fibrosis of extraocular muscles, congenital, 3A, with or without extraocularinvolvement64
HP:0000505HP:0007663Reduced visual acuity1TUBB4B CL E G H1038320771ORPHA:65Leber congenital amaurosis
HP:0000505HP:0007663Reduced visual acuity1TUBB4B CL E G H1038320771OMIM:617879Leber congenital amaurosis with early-onset deafness.
HP:0000505HP:0100704Cerebral visual impairment1TUBGCP2 CL E G H1084418599OMIM:618737PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS
HP:0000505HP:0007663Reduced visual acuity1TUBGCP4 CL E G H2722916691OMIM:616335Microcephaly and chorioretinopathy, autosomal recessive, 3.14
HP:0000505HP:0007663Reduced visual acuity1TULP1 CL E G H728712423ORPHA:65Leber congenital amaurosis66
HP:0000505HP:0001123Visual field defect1TULP1 CL E G H728712423OMIM:613843Leber congenital amaurosis 1566
HP:0000505HP:0007663Reduced visual acuity1TULP1 CL E G H728712423ORPHA:791Retinitis pigmentosa66
HP:0000505HP:0007663Reduced visual acuity1TULP1 CL E G H728712423OMIM:600132RETINITIS PIGMENTOSA 14; RP1466
HP:0000505HP:0001123Visual field defect1TULP1 CL E G H728712423OMIM:600132RETINITIS PIGMENTOSA 14; RP1466
HP:0000505HP:0007663Reduced visual acuity1TWIST1 CL E G H729112428ORPHA:794Saethre-Chotzen syndrome18
HP:0000505HP:0100704Cerebral visual impairment1TWNK CL E G H566521160ORPHA:254892Autosomal dominant progressive external ophthalmoplegiaHP:0040284 - Very rare113
HP:0000505HP:0007663Reduced visual acuity1TYR CL E G H729912442OMIM:203100Albinism, oculocutaneous, type IA.146
HP:0000505HP:0007663Reduced visual acuity1UBAC2 CL E G H33786720486ORPHA:117Behçet disease
HP:0000505HP:0007663Reduced visual acuity1UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive21
HP:0000505HP:0000572Visual loss1UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive.21
HP:0000505HP:0007663Reduced visual acuity1UFM1 CL E G H5156920597OMIM:617899Leukodystrophy, hypomyelinating, 14
HP:0000505HP:0007663Reduced visual acuity1UROD CL E G H738912591ORPHA:95159Hepatoerythropoietic porphyria31
HP:0000505HP:0007663Reduced visual acuity1UROS CL E G H739012592ORPHA:79277Congenital erythropoietic porphyria41
HP:0000505HP:0001123Visual field defect1USH1C CL E G H1008312597ORPHA:231169Usher syndrome type 1173
HP:0000505HP:0000572Visual loss1USH1C CL E G H1008312597ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent173
HP:0000505HP:0000572Visual loss1USH1C CL E G H1008312597OMIM:276900Usher syndrome, type I.173
HP:0000505HP:0001123Visual field defect1USH1G CL E G H12459016356ORPHA:231169Usher syndrome type 178
HP:0000505HP:0000572Visual loss1USH1G CL E G H12459016356ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent78
HP:0000505HP:0007663Reduced visual acuity1USH2A CL E G H739912601ORPHA:791Retinitis pigmentosa777
HP:0000505HP:0001123Visual field defect1USH2A CL E G H739912601OMIM:613809Retinitis pigmentosa 39.777
HP:0000505HP:0001123Visual field defect1USH2A CL E G H739912601ORPHA:231178Usher syndrome type 2777
HP:0000505HP:0000572Visual loss1USH2A CL E G H739912601ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent777
HP:0000505HP:0007663Reduced visual acuity1USP45 CL E G H8501520080ORPHA:65Leber congenital amaurosis
HP:0000505HP:0001123Visual field defect1USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0000505HP:0001123Visual field defect1USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0000505HP:0100704Cerebral visual impairment1VAMP2 CL E G H684412643OMIM:618760NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM
HP:0000505HP:0000572Visual loss1VCAN CL E G H14622464OMIM:143200Wagner vitreoretinopathy.180
HP:0000505HP:0001123Visual field defect1VCAN CL E G H14622464OMIM:143200Wagner vitreoretinopathy.180
HP:0000505HP:0000572Visual loss1VHL CL E G H742812687ORPHA:892Von Hippel-Lindau diseaseHP:0040283 - Occasional490
HP:0000505HP:0007663Reduced visual acuity1VPS11 CL E G H5582314583OMIM:616683Leukodystrophy, hypomyelinating, 121
HP:0000505HP:0100704Cerebral visual impairment1VPS11 CL E G H5582314583OMIM:616683Leukodystrophy, hypomyelinating, 12.1
HP:0000505HP:0100704Cerebral visual impairment1VPS11 CL E G H5582314583ORPHA:466934VPS11-related autosomal recessive hypomyelinating leukodystrophyHP:0040281 - Very frequent1
HP:0000505HP:0007663Reduced visual acuity1VPS13B CL E G H1576802183OMIM:216550Cohen syndrome.546
HP:0000505HP:0100704Cerebral visual impairment1VPS51 CL E G H7381172OMIM:618606PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13
HP:0000505HP:0000572Visual loss1VRK1 CL E G H744312718ORPHA:2254Pontocerebellar hypoplasia type 132
HP:0000505HP:0007663Reduced visual acuity1VSX1 CL E G H3081312723OMIM:614195Craniofacial anomalies and anterior segment dysgenesis syndrome47
HP:0000505HP:0007663Reduced visual acuity1VSX1 CL E G H3081312723ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0007663Reduced visual acuity1WAC CL E G H5132217327ORPHA:284169Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion20
HP:0000505HP:0000572Visual loss1WAC CL E G H5132217327ORPHA:466950Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutationHP:0040283 - Occasional20
HP:0000505HP:0007663Reduced visual acuity1WARS2 CL E G H1035212730OMIM:617710Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures2
HP:0000505HP:0007663Reduced visual acuity1WARS2 CL E G H1035212730ORPHA:572798WARS2-related combined oxidative phosphorylation defect2
HP:0000505HP:0007663Reduced visual acuity1WASF1 CL E G H893612732OMIM:618707NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS
HP:0000505HP:0000572Visual loss1WDR19 CL E G H5772818340ORPHA:3156Senior-Loken syndrome95
HP:0000505HP:0007663Reduced visual acuity1WDR19 CL E G H5772818340OMIM:616307Senior-Loken syndrome 8.95
HP:0000505HP:0007663Reduced visual acuity1WDR26 CL E G H8023221208ORPHA:513456Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome8
HP:0000505HP:0007663Reduced visual acuity1WDR26 CL E G H8023221208OMIM:617616Skraban-Deardorff syndrome8
HP:0000505HP:0001123Visual field defect1WFS1 CL E G H746612762OMIM:614296Wolfram-Like syndrome, autosomal dominant389
HP:0000505HP:0007663Reduced visual acuity1WFS1 CL E G H746612762OMIM:614296Wolfram-Like syndrome, autosomal dominant389
HP:0000505HP:0000572Visual loss1WHRN CL E G H2586116361ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent155
HP:0000505HP:0001123Visual field defect1WHRN CL E G H2586116361ORPHA:231178Usher syndrome type 2155
HP:0000505HP:0007663Reduced visual acuity1WHRN CL E G H2586116361OMIM:611383Usher syndrome, type IID155
HP:0000505HP:0007663Reduced visual acuity1XRCC4 CL E G H751812831ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndrome9
HP:0000505HP:0007663Reduced visual acuity1XYLT1 CL E G H6413115516OMIM:264800PSEUDOXANTHOMA ELASTICUM; PXE14
HP:0000505HP:0007663Reduced visual acuity1XYLT2 CL E G H6413215517OMIM:264800PSEUDOXANTHOMA ELASTICUM; PXE5
HP:0000505HP:0000572Visual loss1XYLT2 CL E G H6413215517ORPHA:85194Spondylo-ocular syndromeHP:0040281 - Very frequent5
HP:0000505HP:0007663Reduced visual acuity1XYLT2 CL E G H6413215517OMIM:605822Spondyloocular syndrome5
HP:0000505HP:0001123Visual field defect1YARS1 CL E G H856512840OMIM:619418NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2
HP:0000505HP:0100704Cerebral visual impairment1YIF1B CL E G H9052230511OMIM:619125KAYA-BARAKAT-MASSON SYNDROME; KABAMAS
HP:0000505HP:0007663Reduced visual acuity1YME1L1 CL E G H1073012843OMIM:617302Optic atrophy 112
HP:0000505HP:0007663Reduced visual acuity1ZEB1 CL E G H693511642OMIM:613270Corneal dystrophy, fuchs endothelial, 68
HP:0000505HP:0007663Reduced visual acuity1ZEB1 CL E G H693511642ORPHA:98974Fuchs endothelial corneal dystrophy8
HP:0000505HP:0000572Visual loss1ZEB1 CL E G H693511642ORPHA:98974Fuchs endothelial corneal dystrophy8
HP:0000505HP:0007663Reduced visual acuity1ZEB1 CL E G H693511642ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional8
HP:0000505HP:0007663Reduced visual acuity1ZFHX4 CL E G H7977630939ORPHA:91411Congenital ptosis
HP:0000505HP:0007663Reduced visual acuity1ZFYVE26 CL E G H2350320761OMIM:270700Spastic paraplegia 15, autosomal recessive.189
HP:0000505HP:0100704Cerebral visual impairment1ZIC2 CL E G H754612873ORPHA:93925Alobar holoprosencephalyHP:0040282 - Frequent34
HP:0000505HP:0100704Cerebral visual impairment1ZIC2 CL E G H754612873ORPHA:93924Lobar holoprosencephalyHP:0040283 - Occasional34
HP:0000505HP:0100704Cerebral visual impairment1ZIC2 CL E G H754612873ORPHA:93926Midline interhemispheric variant of holoprosencephalyHP:0040282 - Frequent34
HP:0000505HP:0100704Cerebral visual impairment1ZIC2 CL E G H754612873ORPHA:220386Semilobar holoprosencephalyHP:0040282 - Frequent34
HP:0000505HP:0007663Reduced visual acuity1ZMIZ1 CL E G H5717816493OMIM:618659NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA
HP:0000505HP:0000572Visual loss1ZNF408 CL E G H7979720041OMIM:616468Exudative vitreoretinopathy 614
HP:0000505HP:0007663Reduced visual acuity1ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathyHP:0040282 - Frequent14
HP:0000505HP:0007663Reduced visual acuity1ZNF408 CL E G H7979720041ORPHA:791Retinitis pigmentosa14
HP:0000505HP:0001123Visual field defect1ZNF408 CL E G H7979720041OMIM:616469Retinitis pigmentosa 7214
HP:0000505HP:0007663Reduced visual acuity1ZNF408 CL E G H7979720041OMIM:616469Retinitis pigmentosa 72.14
HP:0000505HP:0007663Reduced visual acuity1ZNF423 CL E G H2309016762ORPHA:2318Joubert syndrome with oculorenal defect49
HP:0000505HP:0000572Visual loss1ZNF469 CL E G H8462723216OMIM:229200Brittle cornea syndrome.397
HP:0000505HP:0000572Visual loss1ZNF469 CL E G H8462723216ORPHA:90354Brittle cornea syndromeHP:0040282 - Frequent397
HP:0000505HP:0007663Reduced visual acuity1ZNF513 CL E G H13055726498ORPHA:791Retinitis pigmentosa27
HP:0000505HP:0001123Visual field defect1ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 5827
HP:0000505HP:0007663Reduced visual acuity1ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 5827
HP:0000505HP:0000572Visual loss1ZNHIT3 CL E G H932612309ORPHA:2836PEHO syndromeHP:0040281 - Very frequent1
HP:0000505HP:0030531Altitudinal visual field defect2 CL E G H
HP:0000505HP:0012377Hemianopia2AARS1 CL E G H1620OMIM:619661LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2
HP:0000505HP:0001133Constriction of peripheral visual field2ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0000575Scotoma2ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0000618Blindness2ABCA4 CL E G H2434ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent826
HP:0000505HP:0001133Constriction of peripheral visual field2ABCA4 CL E G H2434OMIM:601718Retinitis pigmentosa 19826
HP:0000505HP:0000575Scotoma2ABCA4 CL E G H2434ORPHA:827Stargardt disease826
HP:0000505HP:0000618Blindness2ABCD1 CL E G H21561OMIM:300100Adrenoleukodystrophy.135
HP:0000505HP:0000618Blindness2ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophyHP:0040284 - Very rare135
HP:0000505HP:0000575Scotoma2ACO2 CL E G H50118OMIM:616289Optic atrophy 960
HP:0000505HP:0000618Blindness2ACTB CL E G H60132ORPHA:79107Developmental malformations-deafness-dystonia syndromeHP:0040282 - Frequent72
HP:0000505HP:0000646Amblyopia2ACVRL1 CL E G H94175ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional178
HP:0000505HP:0000618Blindness2ADAMTS10 CL E G H8179413201OMIM:277600Weill-Marchesani syndrome 1.63
HP:0000505HP:0000646Amblyopia2ADAMTSL4 CL E G H5450719706ORPHA:1885Isolated ectopia lentisHP:0040283 - Occasional84
HP:0000505HP:0000575Scotoma2ADGRV1 CL E G H8405917416ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent530
HP:0000505HP:0012377Hemianopia2ADGRV1 CL E G H8405917416ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent530
HP:0000505HP:0000646Amblyopia2ADNP CL E G H2339415766ORPHA:404448ADNP syndromeHP:0040284 - Very rare47
HP:0000505HP:0000646Amblyopia2AFF4 CL E G H2712517869ORPHA:444077Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndromeHP:0040283 - Occasional6
HP:0000505HP:0000618Blindness2AGBL5 CL E G H6050926147ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent2
HP:0000505HP:0001133Constriction of peripheral visual field2AGBL5 CL E G H6050926147OMIM:617023Retinitis pigmentosa 752
HP:0000505HP:0000529Progressive visual loss2AGTPBP1 CL E G H2328717258ORPHA:2254Pontocerebellar hypoplasia type 11
HP:0000505HP:0000618Blindness2AHI1 CL E G H5480621575ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent175
HP:0000505HP:0000618Blindness2AHR CL E G H196348ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent2
HP:0000505HP:0000618Blindness2AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0000505HP:0001117Sudden loss of visual acuity2AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0000505HP:0012377Hemianopia2AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0000505HP:0000529Progressive visual loss2AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040282 - Frequent95
HP:0000505HP:0001141Severely reduced visual acuity2AIPL1 CL E G H23746359ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent114
HP:0000505HP:0000618Blindness2AIPL1 CL E G H23746359OMIM:604393Leber congenital amaurosis 4.114
HP:0000505HP:0001133Constriction of peripheral visual field2AIPL1 CL E G H23746359OMIM:268000Retinitis pigmentosa.114
HP:0000505HP:0001133Constriction of peripheral visual field2AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0000505HP:0000618Blindness2AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040284 - Very rare54
HP:0000505HP:0012377Hemianopia2AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0030532Visual acuity test abnormality2AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040283 - Occasional54
HP:0000505HP:0030588Abnormal visual field test2AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0000529Progressive visual loss2AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0012377Hemianopia2AKT3 CL E G H10000393ORPHA:99802HemimegalencephalyHP:0040283 - Occasional19
HP:0000505HP:0001141Severely reduced visual acuity2ALG3 CL E G H1019523056OMIM:601110Congenital disorder of glycosylation, type Id.37
HP:0000505HP:0000618Blindness2ALMS1 CL E G H7840428ORPHA:64Alström syndromeHP:0040281 - Very frequent404
HP:0000505HP:0000618Blindness2ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0000505HP:0001133Constriction of peripheral visual field2ALMS1 CL E G H7840428OMIM:203800Alstrom syndrome.404
HP:0000505HP:0001133Constriction of peripheral visual field2AMACR CL E G H23600451OMIM:614307Alpha-methylacyl-CoA racemase deficiency44
HP:0000505HP:0012377Hemianopia2AMACR CL E G H23600451ORPHA:79095Congenital bile acid synthesis defect type 444
HP:0000505HP:0000646Amblyopia2AP1G1 CL E G H164555OMIM:619467USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD
HP:0000505HP:0000646Amblyopia2AP4B1 CL E G H10717572ORPHA:280763Severe intellectual disability and progressive spastic paraplegiaHP:0040284 - Very rare49
HP:0000505HP:0000646Amblyopia2AP4E1 CL E G H23431573ORPHA:280763Severe intellectual disability and progressive spastic paraplegiaHP:0040284 - Very rare48
HP:0000505HP:0000646Amblyopia2AP4M1 CL E G H9179574ORPHA:280763Severe intellectual disability and progressive spastic paraplegiaHP:0040284 - Very rare41
HP:0000505HP:0000646Amblyopia2AP4S1 CL E G H11154575ORPHA:280763Severe intellectual disability and progressive spastic paraplegiaHP:0040284 - Very rare18
HP:0000505HP:0030532Visual acuity test abnormality2APC CL E G H324583ORPHA:99818Turcot syndrome with polyposis3179
HP:0000505HP:0000529Progressive visual loss2APOE CL E G H348613OMIM:603075Macular degeneration, age-related, 139
HP:0000505HP:0000618Blindness2ARHGEF18 CL E G H2337017090ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent6
HP:0000505HP:0000646Amblyopia2ARHGEF2 CL E G H9181682OMIM:617523Neurodevelopmental disorder with midbrain and hindbrain malformations.1
HP:0000505HP:0000618Blindness2ARL2BP CL E G H2356817146ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent3
HP:0000505HP:0000529Progressive visual loss2ARL3 CL E G H403694OMIM:618161JOUBERT SYNDROME 35; JBTS351
HP:0000505HP:0000618Blindness2ARL3 CL E G H403694ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent1
HP:0000505HP:0001133Constriction of peripheral visual field2ARL3 CL E G H403694OMIM:618173RETINITIS PIGMENTOSA 83; RP831
HP:0000505HP:0001133Constriction of peripheral visual field2ARL6 CL E G H8410013210OMIM:209900Bardet-Biedl syndrome 129
HP:0000505HP:0000618Blindness2ARL6 CL E G H8410013210ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent29
HP:0000505HP:0001133Constriction of peripheral visual field2ARL6 CL E G H8410013210OMIM:268000Retinitis pigmentosa.29
HP:0000505HP:0000618Blindness2ARNT2 CL E G H991516876OMIM:615926Webb-Dattani syndrome.
HP:0000505HP:0012377Hemianopia2ARSG CL E G H2290124102ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2ARSG CL E G H2290124102ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2ARSG CL E G H2290124102OMIM:618144USHER SYNDROME, TYPE IV; USH4
HP:0000505HP:0001133Constriction of peripheral visual field2ARSG CL E G H2290124102OMIM:618144USHER SYNDROME, TYPE IV; USH4
HP:0000505HP:0007854Glaucomatous visual field defect2ASB10 CL E G H13637117185OMIM:603383GLAUCOMA 1, OPEN ANGLE, F; GLC1F54
HP:0000505HP:0000618Blindness2ASPA CL E G H443756OMIM:271900Canavan disease48
HP:0000505HP:0000618Blindness2ASPA CL E G H443756ORPHA:314911Severe Canavan diseaseHP:0040283 - Occasional48
HP:0000505HP:0000575Scotoma2ATF6 CL E G H22926791ORPHA:49382Achromatopsia10
HP:0000505HP:0000575Scotoma2ATF6 CL E G H22926791OMIM:616517ACHROMATOPSIA 7; ACHM710
HP:0000505HP:0000618Blindness2ATIC CL E G H471794ORPHA:250977AICA-ribosiduria4
HP:0000505HP:0000618Blindness2ATIC CL E G H471794OMIM:608688Aicar transformylase/imp cyclohydrolase deficiency4
HP:0000505HP:0000618Blindness2ATOH7 CL E G H22020213907ORPHA:91495Persistent hyperplastic primary vitreous4
HP:0000505HP:0000646Amblyopia2ATOH7 CL E G H22020213907ORPHA:91495Persistent hyperplastic primary vitreous4
HP:0000505HP:0032123Ultra-low vision2ATOH7 CL E G H22020213907OMIM:221900Persistent hyperplastic primary vitreous, autosomal recessive4
HP:0000505HP:0000575Scotoma2ATP1A2 CL E G H477800ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent239
HP:0000505HP:0000618Blindness2ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss.150
HP:0000505HP:0000529Progressive visual loss2ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss.150
HP:0000505HP:0000575Scotoma2ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000529Progressive visual loss2ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ATP6 CL E G H45087414OMIM:535000Leber optic atrophy
HP:0000505HP:0030588Abnormal visual field test2ATP6 CL E G H45087414ORPHA:644NARP syndromeHP:0040282 - Frequent
HP:0000505HP:0000618Blindness2ATP6 CL E G H45087414ORPHA:644NARP syndromeHP:0040282 - Frequent
HP:0000505HP:0001133Constriction of peripheral visual field2ATP6 CL E G H45087414ORPHA:644NARP syndromeHP:0040282 - Frequent
HP:0000505HP:0000618Blindness2ATP6 CL E G H45087414OMIM:551500Neuropathy, ataxia, and retinitis pigmentosa.
HP:0000505HP:0000618Blindness2ATRX CL E G H546886ORPHA:847Alpha-thalassemia-X-linked intellectual disability syndromeHP:0040283 - Occasional169
HP:0000505HP:0000529Progressive visual loss2ATXN7 CL E G H631410560OMIM:164500Spinocerebellar ataxia 7 opca III opca with retinal degeneration opca with macular degeneration and external ophthalmoplegia autosomal dominant cerebellar ataxia, type II adca, type II.8
HP:0000505HP:0000618Blindness2ATXN7 CL E G H631410560ORPHA:94147Spinocerebellar ataxia type 7HP:0040283 - Occasional8
HP:0000505HP:0000618Blindness2B3GALNT2 CL E G H14878928596OMIM:615181MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11.43
HP:0000505HP:0000646Amblyopia2B3GAT3 CL E G H26229923OMIM:245600Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects.5
HP:0000505HP:0000618Blindness2B4GAT1 CL E G H1104115685OMIM:615287MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13.17
HP:0000505HP:0000529Progressive visual loss2BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0000618Blindness2BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040284 - Very rare184
HP:0000505HP:0030588Abnormal visual field test2BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0012377Hemianopia2BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0030532Visual acuity test abnormality2BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040283 - Occasional184
HP:0000505HP:0001133Constriction of peripheral visual field2BBS1 CL E G H582966OMIM:209900Bardet-Biedl syndrome 1114
HP:0000505HP:0000618Blindness2BBS1 CL E G H582966ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent114
HP:0000505HP:0000618Blindness2BBS2 CL E G H583967ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent97
HP:0000505HP:0001133Constriction of peripheral visual field2BBS2 CL E G H583967OMIM:616562Retinitis pigmentosa 74.97
HP:0000505HP:0000618Blindness2BCOR CL E G H5488020893OMIM:309800Microphthalmia, syndromic 1.101
HP:0000505HP:0000618Blindness2BEST1 CL E G H743912703ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent182
HP:0000505HP:0000618Blindness2BEST1 CL E G H743912703OMIM:193220VITREORETINOCHOROIDOPATHY.182
HP:0000505HP:0000618Blindness2BMP4 CL E G H6521071OMIM:607932Microphthalmia, syndromic 638
HP:0000505HP:0000529Progressive visual loss2BRAF CL E G H6731097OMIM:115150Cardiofaciocutaneous syndrome 1.276
HP:0000505HP:0001117Sudden loss of visual acuity2BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040284 - Very rare276
HP:0000505HP:0007987Progressive visual field defects2BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent276
HP:0000505HP:0030588Abnormal visual field test2BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent276
HP:0000505HP:0000529Progressive visual loss2BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0012377Hemianopia2BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0200068Nonprogressive visual loss2BTD CL E G H6861122ORPHA:79241Biotinidase deficiencyHP:0040283 - Occasional223
HP:0000505HP:0000575Scotoma2BTD CL E G H6861122ORPHA:79241Biotinidase deficiencyHP:0040283 - Occasional223
HP:0000505HP:0000618Blindness2BTNL2 CL E G H562441142ORPHA:797SarcoidosisHP:0040283 - Occasional1
HP:0000505HP:0000529Progressive visual loss2C19ORF12 CL E G H8363625443OMIM:614298Neurodegeneration with brain iron accumulation 4.114
HP:0000505HP:0000646Amblyopia2C1QBP CL E G H7081243OMIM:617713Combined oxidative phosphorylation deficiency 33.
HP:0000505HP:0030532Visual acuity test abnormality2C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degeneration20
HP:0000505HP:0000575Scotoma2C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration.20
HP:0000505HP:0000618Blindness2C1QTNF5 CL E G H11490214344OMIM:605670Late-Onset retinal degeneration.20
HP:0000505HP:0001141Severely reduced visual acuity2C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degenerationHP:0040282 - Frequent20
HP:0000505HP:0000618Blindness2C4A CL E G H7201323ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0000505HP:0000618Blindness2CA4 CL E G H7621375ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent23
HP:0000505HP:0000575Scotoma2CACNA1A CL E G H7731388ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent449
HP:0000505HP:0001141Severely reduced visual acuity2CACNA1F CL E G H7781393OMIM:300600Aland island eye disease.58
HP:0000505HP:0000575Scotoma2CACNA1F CL E G H7781393OMIM:300476Cone-Rod dystrophy, X-linked, 358
HP:0000505HP:0001133Constriction of peripheral visual field2CACNA2D4 CL E G H9358920202OMIM:610478Retinal cone dystrophy 4.129
HP:0000505HP:0000618Blindness2CAPN5 CL E G H7261482OMIM:193235Vitreoretinopathy, neovascular inflammatory6
HP:0000505HP:0000529Progressive visual loss2CARS2 CL E G H7958725695ORPHA:477774Combined oxidative phosphorylation defect type 27HP:0040282 - Frequent35
HP:0000505HP:0000646Amblyopia2CBS CL E G H8751550ORPHA:394Classic homocystinuriaHP:0040282 - Frequent242
HP:0000505HP:0000618Blindness2CC2D2A CL E G H5754529253ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent247
HP:0000505HP:0001133Constriction of peripheral visual field2CC2D2A CL E G H5754529253OMIM:619845RETINITIS PIGMENTOSA 93; RP93247
HP:0000505HP:0001133Constriction of peripheral visual field2CCDC28B CL E G H7914028163OMIM:209900Bardet-Biedl syndrome 14
HP:0000505HP:0000618Blindness2CCR1 CL E G H12301602ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0000505HP:0000618Blindness2CD109 CL E G H13522821685ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040284 - Very rare
HP:0000505HP:0000646Amblyopia2CDC42BPB CL E G H95781738OMIM:619841
HP:0000505HP:0000618Blindness2CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0000505HP:0000529Progressive visual loss2CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040282 - Frequent636
HP:0000505HP:0001117Sudden loss of visual acuity2CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0000505HP:0012377Hemianopia2CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0000505HP:0012377Hemianopia2CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000505HP:0030588Abnormal visual field test2CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000505HP:0000618Blindness2CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000505HP:0001117Sudden loss of visual acuity2CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000505HP:0000529Progressive visual loss2CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0000505HP:0012377Hemianopia2CDH23 CL E G H6407213733ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent636
HP:0000505HP:0000575Scotoma2CDH23 CL E G H6407213733ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent636
HP:0000505HP:0000618Blindness2CDH3 CL E G H10011762ORPHA:1573Hypotrichosis with juvenile macular degenerationHP:0040281 - Very frequent87
HP:0000505HP:0000618Blindness2CDH3 CL E G H10011762OMIM:601553Hypotrichosis, congenital, with juvenile macular dystrophy87
HP:0000505HP:0000529Progressive visual loss2CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000505HP:0001133Constriction of peripheral visual field2CDHR1 CL E G H9221114550OMIM:613660CONE-ROD DYSTROPHY 15; CORD15147
HP:0000505HP:0000618Blindness2CDHR1 CL E G H9221114550ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent147
HP:0000505HP:0000618Blindness2CEP164 CL E G H2289729182OMIM:614845Nephronophthisis 15HP:0040283 - Occasional34
HP:0000505HP:0000529Progressive visual loss2CEP164 CL E G H2289729182ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent34
HP:0000505HP:0000618Blindness2CEP290 CL E G H8018429021OMIM:610188Joubert syndrome 5342
HP:0000505HP:0000618Blindness2CEP290 CL E G H8018429021ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent342
HP:0000505HP:0001141Severely reduced visual acuity2CEP290 CL E G H8018429021ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent342
HP:0000505HP:0000529Progressive visual loss2CEP290 CL E G H8018429021ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent342
HP:0000505HP:0000575Scotoma2CEP78 CL E G H8413125740ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent9
HP:0000505HP:0012377Hemianopia2CEP78 CL E G H8413125740ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent9
HP:0000505HP:0000618Blindness2CERKL CL E G H37529821699ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent71
HP:0000505HP:0001133Constriction of peripheral visual field2CERKL CL E G H37529821699OMIM:608380Retinitis pigmentosa 2671
HP:0000505HP:0000575Scotoma2CFAP410 CL E G H7551260OMIM:617547Retinal dystrophy with or without macular staphyloma
HP:0000505HP:0001133Constriction of peripheral visual field2CFAP418 CL E G H15765727232OMIM:617406Bardet-Biedl syndrome 21
HP:0000505HP:0000618Blindness2CFAP418 CL E G H15765727232OMIM:617406Bardet-Biedl syndrome 21
HP:0000505HP:0000529Progressive visual loss2CFAP418 CL E G H15765727232OMIM:614500Cone-Rod dystrophy 16
HP:0000505HP:0001133Constriction of peripheral visual field2CFAP418 CL E G H15765727232OMIM:268000Retinitis pigmentosa.
HP:0000505HP:0000618Blindness2CFAP418 CL E G H15765727232ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000529Progressive visual loss2CFH CL E G H30754883OMIM:126700Basal laminar drusen.86
HP:0000505HP:0000575Scotoma2CFH CL E G H30754883ORPHA:75376Familial drusen86
HP:0000505HP:0000529Progressive visual loss2CFHR1 CL E G H30784888OMIM:603075Macular degeneration, age-related, 1
HP:0000505HP:0000529Progressive visual loss2CFHR3 CL E G H1087816980OMIM:603075Macular degeneration, age-related, 1
HP:0000505HP:0000575Scotoma2CFI CL E G H34265394ORPHA:75376Familial drusen57
HP:0000505HP:0000529Progressive visual loss2CFI CL E G H34265394OMIM:615439Macular degeneration, age-related, 13.57
HP:0000505HP:0000529Progressive visual loss2CHM CL E G H11211940ORPHA:180ChoroideremiaHP:0040282 - Frequent47
HP:0000505HP:0000529Progressive visual loss2CHM CL E G H11211940OMIM:303100CHOROIDEREMIA.47
HP:0000505HP:0001133Constriction of peripheral visual field2CHM CL E G H11211940OMIM:303100CHOROIDEREMIA.47
HP:0000505HP:0000646Amblyopia2CHN1 CL E G H11231943ORPHA:233Duane retraction syndromeHP:0040283 - Occasional35
HP:0000505HP:0000646Amblyopia2CHN1 CL E G H11231943OMIM:604356DUANE RETRACTION SYNDROME 2; DURS235
HP:0000505HP:0000646Amblyopia2CHST3 CL E G H94691971OMIM:245600Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects.165
HP:0000505HP:0001141Severely reduced visual acuity2CHST6 CL E G H41666938ORPHA:98969Macular corneal dystrophyHP:0040282 - Frequent129
HP:0000505HP:0012377Hemianopia2CIB2 CL E G H1051824579ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent15
HP:0000505HP:0000575Scotoma2CIB2 CL E G H1051824579ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent15
HP:0000505HP:0000646Amblyopia2CLCN6 CL E G H11852024OMIM:619173NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA
HP:0000505HP:0000618Blindness2CLCN7 CL E G H11862025ORPHA:53Albers-Schönberg osteopetrosisHP:0040283 - Occasional102
HP:0000505HP:0000618Blindness2CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3.216
HP:0000505HP:0000529Progressive visual loss2CLN3 CL E G H12012074OMIM:204200Ceroid lipofuscinosis, neuronal, 3.216
HP:0000505HP:0000618Blindness2CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000505HP:0000646Amblyopia2CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000505HP:0000529Progressive visual loss2CLN3 CL E G H12012074ORPHA:228346CLN3 disease216
HP:0000505HP:0000529Progressive visual loss2CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5.141
HP:0000505HP:0000529Progressive visual loss2CLN6 CL E G H549822077OMIM:601780Ceroid lipofuscinosis, neuronal, 6.143
HP:0000505HP:0000529Progressive visual loss2CLN8 CL E G H20552079OMIM:600143Ceroid lipofuscinosis, neuronal, 8.111
HP:0000505HP:0000529Progressive visual loss2CLN8 CL E G H20552079ORPHA:1947Progressive epilepsy-intellectual disability syndrome, Finnish typeHP:0040282 - Frequent111
HP:0000505HP:0001133Constriction of peripheral visual field2CLRN1 CL E G H740112605OMIM:268000Retinitis pigmentosa.60
HP:0000505HP:0000618Blindness2CLRN1 CL E G H740112605ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent60
HP:0000505HP:0012377Hemianopia2CLRN1 CL E G H740112605ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent60
HP:0000505HP:0000575Scotoma2CLRN1 CL E G H740112605ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent60
HP:0000505HP:0000618Blindness2CNGA1 CL E G H12592148ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent44
HP:0000505HP:0001133Constriction of peripheral visual field2CNGA1 CL E G H12592148OMIM:268000Retinitis pigmentosa.44
HP:0000505HP:0001133Constriction of peripheral visual field2CNGA1 CL E G H12592148OMIM:613756RETINITIS PIGMENTOSA 49; RP4944
HP:0000505HP:0000575Scotoma2CNGA3 CL E G H12612150ORPHA:49382Achromatopsia82
HP:0000505HP:0000618Blindness2CNGB1 CL E G H12582151ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent164
HP:0000505HP:0001133Constriction of peripheral visual field2CNGB1 CL E G H12582151OMIM:613767Retinitis pigmentosa 45164
HP:0000505HP:0000575Scotoma2CNGB3 CL E G H547142153ORPHA:49382Achromatopsia194
HP:0000505HP:0001141Severely reduced visual acuity2CNGB3 CL E G H547142153OMIM:262300Achromatopsia 3.194
HP:0000505HP:0000575Scotoma2CNGB3 CL E G H547142153ORPHA:827Stargardt disease194
HP:0000505HP:0000575Scotoma2CNNM4 CL E G H26504105OMIM:217080Jalili syndrome61
HP:0000505HP:0000646Amblyopia2COL11A1 CL E G H13012186ORPHA:250984Autosomal recessive Stickler syndromeHP:0040282 - Frequent215
HP:0000505HP:0000646Amblyopia2COL11A1 CL E G H13012186ORPHA:560Marshall syndromeHP:0040282 - Frequent215
HP:0000505HP:0000529Progressive visual loss2COL17A1 CL E G H13082194ORPHA:293381Epithelial recurrent erosion dystrophyHP:0040281 - Very frequent129
HP:0000505HP:0000529Progressive visual loss2COL18A1 CL E G H807812195ORPHA:1571Knobloch syndromeHP:0040282 - Frequent177
HP:0000505HP:0000646Amblyopia2COL25A1 CL E G H8457018603ORPHA:91411Congenital ptosis3
HP:0000505HP:0000618Blindness2COL2A1 CL E G H12802200OMIM:108300Stickler syndrome, type I.284
HP:0000505HP:0000646Amblyopia2COL4A1 CL E G H12822202OMIM:175780Brain small vessel disease 1 with or without ocular anomalies.193
HP:0000505HP:0032122Very low visual acuity2COL8A2 CL E G H12962216ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional3
HP:0000505HP:0000646Amblyopia2COL8A2 CL E G H12962216ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional3
HP:0000505HP:0000646Amblyopia2COL9A1 CL E G H12972217ORPHA:250984Autosomal recessive Stickler syndromeHP:0040282 - Frequent110
HP:0000505HP:0000646Amblyopia2COL9A2 CL E G H12982218ORPHA:250984Autosomal recessive Stickler syndromeHP:0040282 - Frequent110
HP:0000505HP:0000646Amblyopia2COL9A3 CL E G H12992219ORPHA:250984Autosomal recessive Stickler syndromeHP:0040282 - Frequent137
HP:0000505HP:0000529Progressive visual loss2COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0012377Hemianopia2COX1 CL E G H45127419OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2COX2 CL E G H45137421OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000529Progressive visual loss2COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2COX3 CL E G H45147422OMIM:535000Leber optic atrophy
HP:0000505HP:0012377Hemianopia2COX3 CL E G H45147422OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000618Blindness2COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional6
HP:0000505HP:0000646Amblyopia2COX7B CL E G H13492291ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional6
HP:0000505HP:0001141Severely reduced visual acuity2CRB1 CL E G H234182343ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent156
HP:0000505HP:0000618Blindness2CRB1 CL E G H234182343ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent156
HP:0000505HP:0000618Blindness2CREBBP CL E G H13872348OMIM:618332MENKE-HENNEKAM SYNDROME 1; MKHK1291
HP:0000505HP:0000618Blindness2CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2.158
HP:0000505HP:0001133Constriction of peripheral visual field2CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2158
HP:0000505HP:0000575Scotoma2CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2158
HP:0000505HP:0001141Severely reduced visual acuity2CRX CL E G H14062383ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent158
HP:0000505HP:0001133Constriction of peripheral visual field2CRX CL E G H14062383OMIM:268000Retinitis pigmentosa.158
HP:0000505HP:0000618Blindness2CRX CL E G H14062383ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent158
HP:0000505HP:0000646Amblyopia2CRYAA CL E G H14092388OMIM:604219Cataract 9, multiple types.33
HP:0000505HP:0000646Amblyopia2CRYBB1 CL E G H14142397OMIM:611544Cataract 17, multiple typesHP:0040283 - Occasional18
HP:0000505HP:0000646Amblyopia2CRYGC CL E G H14202410OMIM:604307Cataract 2, multiple types.11
HP:0000505HP:0000618Blindness2CTC1 CL E G H8016926169OMIM:612199Cerebroretinal microangiopathy with calcifications and cysts.160
HP:0000505HP:0030588Abnormal visual field test2CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent88
HP:0000505HP:0001117Sudden loss of visual acuity2CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040284 - Very rare88
HP:0000505HP:0007987Progressive visual field defects2CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent88
HP:0000505HP:0012377Hemianopia2CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0000529Progressive visual loss2CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0000618Blindness2CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional88
HP:0000505HP:0001141Severely reduced visual acuity2CTNNB1 CL E G H14992514ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional88
HP:0000505HP:0000618Blindness2CTNS CL E G H14972518OMIM:219800Cystinosis, nephropathic178
HP:0000505HP:0001133Constriction of peripheral visual field2CWC27 CL E G H1028310664OMIM:250410Retinitis pigmentosa with or without skeletal anomalies4
HP:0000505HP:0000575Scotoma2CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucoma101
HP:0000505HP:0007854Glaucomatous visual field defect2CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent101
HP:0000505HP:0001133Constriction of peripheral visual field2CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucoma101
HP:0000505HP:0001133Constriction of peripheral visual field2CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy.126
HP:0000505HP:0000575Scotoma2CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy126
HP:0000505HP:0000529Progressive visual loss2CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy.126
HP:0000505HP:0001141Severely reduced visual acuity2CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040283 - Occasional126
HP:0000505HP:0001133Constriction of peripheral visual field2CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040282 - Frequent126
HP:0000505HP:0000575Scotoma2CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophy126
HP:0000505HP:0000618Blindness2CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040283 - Occasional126
HP:0000505HP:0001129Large central visual field defect2CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040283 - Occasional126
HP:0000505HP:0000575Scotoma2CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000529Progressive visual loss2CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2CYTB CL E G H45197427OMIM:535000Leber optic atrophy
HP:0000505HP:0012377Hemianopia2CYTB CL E G H45197427OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000529Progressive visual loss2DCN CL E G H16342705OMIM:610048Corneal dystrophy, congenital stromal.31
HP:0000505HP:0000618Blindness2DHDDS CL E G H7994720603ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent47
HP:0000505HP:0001133Constriction of peripheral visual field2DHDDS CL E G H7994720603OMIM:613861Retinitis pigmentosa 5947
HP:0000505HP:0000618Blindness2DHX37 CL E G H5764717210OMIM:618731NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC2
HP:0000505HP:0000618Blindness2DHX38 CL E G H978517211ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent1
HP:0000505HP:0001133Constriction of peripheral visual field2DLAT CL E G H17372896ORPHA:79244Pyruvate dehydrogenase E2 deficiency82
HP:0000505HP:0000575Scotoma2DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000529Progressive visual loss2DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0000505HP:0000575Scotoma2DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic form94
HP:0000505HP:0030515Moderately reduced visual acuity2DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040282 - Frequent94
HP:0000505HP:0000575Scotoma2DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000505HP:0000529Progressive visual loss2DNM1L CL E G H100592973OMIM:610708Optic atrophy 594
HP:0000505HP:0000646Amblyopia2DPP6 CL E G H18043010OMIM:616311MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD3318
HP:0000505HP:0000646Amblyopia2DYRK1A CL E G H18593091ORPHA:464311Intellectual disability syndrome due to a DYRK1A point mutationHP:0040283 - Occasional134
HP:0000505HP:0000575Scotoma2EFEMP1 CL E G H22023218ORPHA:75376Familial drusen54
HP:0000505HP:0000575Scotoma2EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucoma54
HP:0000505HP:0001133Constriction of peripheral visual field2EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucoma54
HP:0000505HP:0007854Glaucomatous visual field defect2EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent54
HP:0000505HP:0000618Blindness2EIF2B1 CL E G H19673257OMIM:603896Leukoencephalopathy with vanishing white matterHP:0040283 - Occasional42
HP:0000505HP:0000618Blindness2EIF2B2 CL E G H88923258OMIM:603896Leukoencephalopathy with vanishing white matterHP:0040283 - Occasional24
HP:0000505HP:0000618Blindness2EIF2B3 CL E G H88913259OMIM:603896Leukoencephalopathy with vanishing white matterHP:0040283 - Occasional32
HP:0000505HP:0000618Blindness2EIF2B4 CL E G H88903260OMIM:603896Leukoencephalopathy with vanishing white matterHP:0040283 - Occasional38
HP:0000505HP:0000618Blindness2EIF2B5 CL E G H88933261OMIM:603896Leukoencephalopathy with vanishing white matterHP:0040283 - Occasional48
HP:0000505HP:0000646Amblyopia2ELN CL E G H20063327OMIM:194050Williams-Beuren syndrome172
HP:0000505HP:0001133Constriction of peripheral visual field2ELOVL1 CL E G H6483414418OMIM:618527Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features
HP:0000505HP:0000575Scotoma2ELOVL4 CL E G H678514415ORPHA:827Stargardt disease62
HP:0000505HP:0000646Amblyopia2ELP4 CL E G H266101171OMIM:617141Aniridia 24
HP:0000505HP:0000646Amblyopia2ENG CL E G H20223349ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional186
HP:0000505HP:0000646Amblyopia2EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15.
HP:0000505HP:0000529Progressive visual loss2EPRS1 CL E G H20583418OMIM:617951Leukodystrophy, hypomyelinating, 15.
HP:0000505HP:0000618Blindness2ERAP1 CL E G H5175218173ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0000505HP:0000618Blindness2ERCC4 CL E G H20723436OMIM:610965XFE progeroid syndrome158
HP:0000505HP:0000646Amblyopia2ERF CL E G H20773444ORPHA:207Crouzon diseaseHP:0040283 - Occasional12
HP:0000505HP:0012377Hemianopia2ESPN CL E G H8371513281ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent33
HP:0000505HP:0000575Scotoma2ESPN CL E G H8371513281ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent33
HP:0000505HP:0000529Progressive visual loss2EXOSC3 CL E G H5101017944ORPHA:2254Pontocerebellar hypoplasia type 138
HP:0000505HP:0000529Progressive visual loss2EXOSC8 CL E G H1134017035ORPHA:2254Pontocerebellar hypoplasia type 14
HP:0000505HP:0000529Progressive visual loss2EXOSC9 CL E G H53939137ORPHA:2254Pontocerebellar hypoplasia type 1
HP:0000505HP:0000618Blindness2EYS CL E G H34600721555ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent209
HP:0000505HP:0001133Constriction of peripheral visual field2EYS CL E G H34600721555OMIM:602772Retinitis pigmentosa 25209
HP:0000505HP:0000529Progressive visual loss2FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegeneration76
HP:0000505HP:0000618Blindness2FAM161A CL E G H8414025808ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent56
HP:0000505HP:0001133Constriction of peripheral visual field2FAM161A CL E G H8414025808OMIM:606068RETINITIS PIGMENTOSA 28; RP2856
HP:0000505HP:0000618Blindness2FAS CL E G H35511920ORPHA:117Behçet diseaseHP:0040283 - Occasional59
HP:0000505HP:0000646Amblyopia2FBN1 CL E G H22003603ORPHA:1885Isolated ectopia lentisHP:0040283 - Occasional1361
HP:0000505HP:0000618Blindness2FBN1 CL E G H22003603OMIM:608328Weill-Marchesani syndrome 2, dominant.1361
HP:0000505HP:0000618Blindness2FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndromeHP:0040283 - Occasional
HP:0000505HP:0000575Scotoma2FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome
HP:0000505HP:0000646Amblyopia2FGFR2 CL E G H22633689ORPHA:207Crouzon diseaseHP:0040283 - Occasional175
HP:0000505HP:0000646Amblyopia2FGFR2 CL E G H22633689ORPHA:93260Pfeiffer syndrome type 3HP:0040283 - Occasional175
HP:0000505HP:0000646Amblyopia2FGFR2 CL E G H22633689ORPHA:794Saethre-Chotzen syndromeHP:0040283 - Occasional175
HP:0000505HP:0000646Amblyopia2FGFR3 CL E G H22613690OMIM:602849Muenke syndrome145
HP:0000505HP:0000646Amblyopia2FGFR3 CL E G H22613690ORPHA:794Saethre-Chotzen syndromeHP:0040283 - Occasional145
HP:0000505HP:0000618Blindness2FKRP CL E G H7914717997ORPHA:370959Congenital muscular dystrophy with cerebellar involvementHP:0040284 - Very rare157
HP:0000505HP:0000618Blindness2FKRP CL E G H7914717997OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.157
HP:0000505HP:0000618Blindness2FKTN CL E G H22183622OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.184
HP:0000505HP:0000646Amblyopia2FLNA CL E G H23163754ORPHA:1826Frontometaphyseal dysplasiaHP:0040283 - Occasional493
HP:0000505HP:0000575Scotoma2FLVCR1 CL E G H2898224682OMIM:609033Ataxia, posterior column, with retinitis pigmentosa111
HP:0000505HP:0000618Blindness2FLVCR1 CL E G H2898224682OMIM:609033Ataxia, posterior column, with retinitis pigmentosa.HP:0003581 - Adult onset111
HP:0000505HP:0000646Amblyopia2FOXL2 CL E G H6681092ORPHA:572333Blepharophimosis-ptosis-epicanthus inversus syndrome plusHP:0040282 - Frequent92
HP:0000505HP:0000618Blindness2FOXRED1 CL E G H5557226927ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional61
HP:0000505HP:0000618Blindness2FRAS1 CL E G H8014419185OMIM:219000Fraser syndrome.353
HP:0000505HP:0000618Blindness2FRAS1 CL E G H8014419185ORPHA:2052Fraser syndromeHP:0040281 - Very frequent353
HP:0000505HP:0000618Blindness2FREM2 CL E G H34164025396ORPHA:2052Fraser syndromeHP:0040281 - Very frequent263
HP:0000505HP:0032037Mildly reduced visual acuity2FRMD7 CL E G H901678079OMIM:310700Nystagmus 1, congenital, X-linked.38
HP:0000505HP:0000618Blindness2FSCN2 CL E G H257943960ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent26
HP:0000505HP:0000618Blindness2FZD4 CL E G H83224042OMIM:133780Exudative vitreoretinopathy 1.109
HP:0000505HP:0001141Severely reduced visual acuity2FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional109
HP:0000505HP:0000618Blindness2FZD4 CL E G H83224042ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional109
HP:0000505HP:0000646Amblyopia2FZD4 CL E G H83224042ORPHA:91495Persistent hyperplastic primary vitreous109
HP:0000505HP:0000618Blindness2FZD4 CL E G H83224042ORPHA:91495Persistent hyperplastic primary vitreous109
HP:0000505HP:0000618Blindness2FZD4 CL E G H83224042ORPHA:90050Retinopathy of prematurityHP:0040283 - Occasional109
HP:0000505HP:0000618Blindness2GALC CL E G H25814115ORPHA:206436Infantile Krabbe diseaseHP:0040283 - Occasional160
HP:0000505HP:0000618Blindness2GALC CL E G H25814115OMIM:245200Krabbe disease.160
HP:0000505HP:0000618Blindness2GALC CL E G H25814115ORPHA:206443Late-infantile/juvenile Krabbe diseaseHP:0040283 - Occasional160
HP:0000505HP:0000618Blindness2GATA1 CL E G H26234170ORPHA:79277Congenital erythropoietic porphyriaHP:0040284 - Very rare29
HP:0000505HP:0000646Amblyopia2GDF2 CL E G H26584217ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional8
HP:0000505HP:0001141Severely reduced visual acuity2GDF6 CL E G H3922554221ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent64
HP:0000505HP:0032123Ultra-low vision2GDF6 CL E G H3922554221OMIM:615360LEBER CONGENITAL AMAUROSIS 17; LCA1764
HP:0000505HP:0000618Blindness2GJB2 CL E G H27064284OMIM:148210Keratitis-Ichthyosis-Deafness syndrome, autosomal dominant.199
HP:0000505HP:0000618Blindness2GLB1 CL E G H27204298ORPHA:79255GM1 gangliosidosis type 1HP:0040281 - Very frequent120
HP:0000505HP:0000618Blindness2GM2A CL E G H27604367OMIM:272750Gm2-Gangliosidosis, ab variant.69
HP:0000505HP:0000618Blindness2GMPPB CL E G H2992522932ORPHA:370959Congenital muscular dystrophy with cerebellar involvementHP:0040284 - Very rare34
HP:0000505HP:0000618Blindness2GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndromeHP:0040283 - Occasional7
HP:0000505HP:0012377Hemianopia2GNAQ CL E G H27764390ORPHA:3205Sturge-Weber syndromeHP:0040283 - Occasional7
HP:0000505HP:0000618Blindness2GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0000505HP:0000618Blindness2GNAT1 CL E G H27794393OMIM:610444Night blindness, congenital stationary, autosomal dominant 3.39
HP:0000505HP:0001133Constriction of peripheral visual field2GNAT1 CL E G H27794393OMIM:616389Night blindness, congenital stationary, type 1G39
HP:0000505HP:0000575Scotoma2GNAT2 CL E G H27804394ORPHA:49382Achromatopsia19
HP:0000505HP:0000618Blindness2GP1BA CL E G H28114439ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040284 - Very rare23
HP:0000505HP:0000618Blindness2GP1BB CL E G H28124440ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040284 - Very rare8
HP:0000505HP:0012377Hemianopia2GPR101 CL E G H8355014963OMIM:300942Chromosome Xq26.3 duplication syndrome5
HP:0000505HP:0000646Amblyopia2GPR143 CL E G H493520145OMIM:300814Nystagmus 6, congenital, X-linked.64
HP:0000505HP:0000646Amblyopia2GRHL2 CL E G H799772799ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional33
HP:0000505HP:0032122Very low visual acuity2GRHL2 CL E G H799772799ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional33
HP:0000505HP:0000618Blindness2GRIP1 CL E G H2342618708ORPHA:2052Fraser syndromeHP:0040281 - Very frequent80
HP:0000505HP:0000529Progressive visual loss2GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophy24
HP:0000505HP:0000529Progressive visual loss2GUCA1A CL E G H29784678OMIM:602093Cone dystrophy 3.24
HP:0000505HP:0000618Blindness2GUCA1B CL E G H29794679ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent36
HP:0000505HP:0000529Progressive visual loss2GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophy124
HP:0000505HP:0001133Constriction of peripheral visual field2GUCY2D CL E G H30004689OMIM:601777Cone-Rod dystrophy 6124
HP:0000505HP:0001141Severely reduced visual acuity2GUCY2D CL E G H30004689ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent124
HP:0000505HP:0000618Blindness2GUCY2D CL E G H30004689OMIM:204000Leber congenital amaurosis, type I.124
HP:0000505HP:0000646Amblyopia2H1-4 CL E G H30084718OMIM:617537Rahman syndrome.
HP:0000505HP:0000646Amblyopia2H4C3 CL E G H83644787OMIM:619758TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1
HP:0000505HP:0012377Hemianopia2HARS1 CL E G H30354816ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2HARS1 CL E G H30354816ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0000646Amblyopia2HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional11
HP:0000505HP:0000618Blindness2HCCS CL E G H30524837ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional11
HP:0000505HP:0000646Amblyopia2HDAC4 CL E G H975914063OMIM:619797NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES; NEDCHF33
HP:0000505HP:0000618Blindness2HEXB CL E G H30744879OMIM:268800Sandhoff disease80
HP:0000505HP:0000618Blindness2HGSNAT CL E G H13805026527ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent86
HP:0000505HP:0001133Constriction of peripheral visual field2HGSNAT CL E G H13805026527OMIM:616544Retinitis pigmentosa 73.86
HP:0000505HP:0001133Constriction of peripheral visual field2HK1 CL E G H30984922OMIM:617460Retinitis pigmentosa 79.11
HP:0000505HP:0001133Constriction of peripheral visual field2HKDC1 CL E G H8020123302OMIM:619614RETINITIS PIGMENTOSA 92; RP922
HP:0000505HP:0000575Scotoma2HKDC1 CL E G H8020123302OMIM:619614RETINITIS PIGMENTOSA 92; RP922
HP:0000505HP:0030644Blind-spot enlargment2HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathyHP:0040282 - Frequent4
HP:0000505HP:0000575Scotoma2HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathy4
HP:0000505HP:0000618Blindness2HLA-B CL E G H31064932ORPHA:117Behçet diseaseHP:0040283 - Occasional4
HP:0000505HP:0000618Blindness2HLA-DRB1 CL E G H31234948ORPHA:797SarcoidosisHP:0040283 - Occasional2
HP:0000505HP:0000529Progressive visual loss2HMCN1 CL E G H8387219194OMIM:603075Macular degeneration, age-related, 1262
HP:0000505HP:0032123Ultra-low vision2HMX1 CL E G H31665017OMIM:612109Oculoauricular syndrome2
HP:0000505HP:0001141Severely reduced visual acuity2HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1.121
HP:0000505HP:0000618Blindness2HPS1 CL E G H32575163OMIM:203300Hermansky-Pudlak syndrome 1.121
HP:0000505HP:0000646Amblyopia2HPS6 CL E G H7980318817OMIM:614075Hermansky-Pudlak syndrome 645
HP:0000505HP:0000618Blindness2HSD17B10 CL E G H30284800ORPHA:391428HSD10 disease, infantile typeHP:0040282 - Frequent19
HP:0000505HP:0000618Blindness2IDH3A CL E G H34195384ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0001133Constriction of peripheral visual field2IDH3A CL E G H34195384OMIM:619007RETINITIS PIGMENTOSA 90; RP90
HP:0000505HP:0000618Blindness2IDH3B CL E G H34205385ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent30
HP:0000505HP:0001133Constriction of peripheral visual field2IDH3B CL E G H34205385OMIM:612572RETINITIS PIGMENTOSA 46; RP4630
HP:0000505HP:0001133Constriction of peripheral visual field2IDS CL E G H34235389ORPHA:217093Mucopolysaccharidosis type 2, attenuated form86
HP:0000505HP:0001133Constriction of peripheral visual field2IDS CL E G H34235389ORPHA:217085Mucopolysaccharidosis type 2, severe form86
HP:0000505HP:0000618Blindness2IFNGR1 CL E G H34595439ORPHA:117Behçet diseaseHP:0040283 - Occasional60
HP:0000505HP:0001141Severely reduced visual acuity2IFT140 CL E G H974229077ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent148
HP:0000505HP:0000618Blindness2IFT140 CL E G H974229077ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent148
HP:0000505HP:0000529Progressive visual loss2IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80.148
HP:0000505HP:0000618Blindness2IFT140 CL E G H974229077OMIM:617781Retinitis pigmentosa 80.148
HP:0000505HP:0001133Constriction of peripheral visual field2IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly148
HP:0000505HP:0001133Constriction of peripheral visual field2IFT172 CL E G H2616030391OMIM:619471BARDET-BIEDL SYNDROME 20; BBS2048
HP:0000505HP:0000618Blindness2IFT172 CL E G H2616030391ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent48
HP:0000505HP:0000618Blindness2IFT88 CL E G H810020606ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent3
HP:0000505HP:0000618Blindness2IL10 CL E G H35865962ORPHA:117Behçet diseaseHP:0040283 - Occasional2
HP:0000505HP:0000618Blindness2IL12A CL E G H35925969ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0000505HP:0000618Blindness2IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0000505HP:0000618Blindness2IL23R CL E G H14923319100ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0000505HP:0001141Severely reduced visual acuity2IMPDH1 CL E G H36146052ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent52
HP:0000505HP:0000618Blindness2IMPDH1 CL E G H36146052ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent52
HP:0000505HP:0001133Constriction of peripheral visual field2IMPDH1 CL E G H36146052OMIM:180105Retinitis pigmentosa 10.52
HP:0000505HP:0030515Moderately reduced visual acuity2IMPG1 CL E G H36176055OMIM:616151Macular dystrophy, vitelliform, 4.4
HP:0000505HP:0000618Blindness2IMPG1 CL E G H36176055ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent4
HP:0000505HP:0030515Moderately reduced visual acuity2IMPG2 CL E G H5093918362OMIM:616152Macular dystrophy, vitelliform, 5.120
HP:0000505HP:0000575Scotoma2IMPG2 CL E G H5093918362OMIM:616152Macular dystrophy, vitelliform, 5120
HP:0000505HP:0000618Blindness2IMPG2 CL E G H5093918362ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent120
HP:0000505HP:0000529Progressive visual loss2INVS CL E G H2713017870ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent106
HP:0000505HP:0001141Severely reduced visual acuity2IQCB1 CL E G H965728949ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent61
HP:0000505HP:0000529Progressive visual loss2IQCB1 CL E G H965728949ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent61
HP:0000505HP:0000618Blindness2ITGA2 CL E G H36736137ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040284 - Very rare119
HP:0000505HP:0000618Blindness2ITGA2B CL E G H36746138ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040284 - Very rare69
HP:0000505HP:0000618Blindness2ITGB3 CL E G H36906156ORPHA:853Fetal and neonatal alloimmune thrombocytopeniaHP:0040284 - Very rare80
HP:0000505HP:0000575Scotoma2ITM2B CL E G H94456174OMIM:616079Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities3
HP:0000505HP:0000529Progressive visual loss2KARS1 CL E G H37356215OMIM:619196DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
HP:0000505HP:0000646Amblyopia2KAT6A CL E G H799413013OMIM:616268Arboleda-Tham syndrome34
HP:0000505HP:0001141Severely reduced visual acuity2KCNJ13 CL E G H37696259ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent42
HP:0000505HP:0000646Amblyopia2KCNN2 CL E G H37816291OMIM:619724DYSTONIA 34, MYOCLONIC; DYT34
HP:0000505HP:0000575Scotoma2KCNV2 CL E G H16952219698OMIM:610356Retinal cone dystrophy 3B.73
HP:0000505HP:0000618Blindness2KIAA1549 CL E G H5767022219ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000529Progressive visual loss2KIAA1549 CL E G H5767022219OMIM:618613RETINITIS PIGMENTOSA 86; RP86
HP:0000505HP:0000618Blindness2KIF11 CL E G H38326388ORPHA:2526Microcephaly-lymphedema-chorioretinopathy syndromeHP:0040283 - Occasional46
HP:0000505HP:0000646Amblyopia2KIF11 CL E G H38326388ORPHA:2526Microcephaly-lymphedema-chorioretinopathy syndromeHP:0040283 - Occasional46
HP:0000505HP:0000618Blindness2KIF14 CL E G H992819181OMIM:617914Microcephaly 20, primary, autosomal recessive.9
HP:0000505HP:0001133Constriction of peripheral visual field2KIF3B CL E G H93716320OMIM:618955RETINITIS PIGMENTOSA 89; RP89
HP:0000505HP:0000618Blindness2KIZ CL E G H5585715865ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent3
HP:0000505HP:0001133Constriction of peripheral visual field2KIZ CL E G H5585715865OMIM:615780Retinitis pigmentosa 69.3
HP:0000505HP:0000618Blindness2KLHL7 CL E G H5597515646ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent42
HP:0000505HP:0000618Blindness2KLRC4 CL E G H83026377ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0000505HP:0000646Amblyopia2LAMA1 CL E G H2842176481ORPHA:370022Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndromeHP:0040282 - Frequent35
HP:0000505HP:0000646Amblyopia2LAMA1 CL E G H2842176481OMIM:615960Poretti-Boltshauser syndrome.35
HP:0000505HP:0000618Blindness2LAMB2 CL E G H39136487OMIM:609049Pierson syndrome.92
HP:0000505HP:0000618Blindness2LARGE1 CL E G H92156511OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.136
HP:0000505HP:0001141Severely reduced visual acuity2LCA5 CL E G H16769131923ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent70
HP:0000505HP:0001133Constriction of peripheral visual field2LCA5 CL E G H16769131923ORPHA:364055Severe early-childhood-onset retinal dystrophy70
HP:0000505HP:0000646Amblyopia2LIM2 CL E G H39826610OMIM:615277Cataract 19, multiple types.16
HP:0000505HP:0000646Amblyopia2LMBRD2 CL E G H9225525287OMIM:619694DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES; DENBA
HP:0000505HP:0000575Scotoma2LOC111365204 CL E G H111365204OMIM:136550Macular dystrophy, retinal, 1, north Carolina type
HP:0000505HP:0000618Blindness2LONP1 CL E G H93619479ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040283 - Occasional8
HP:0000505HP:0000646Amblyopia2LOXL3 CL E G H8469513869ORPHA:250984Autosomal recessive Stickler syndromeHP:0040282 - Frequent4
HP:0000505HP:0001141Severely reduced visual acuity2LRAT CL E G H92276685ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent62
HP:0000505HP:0000618Blindness2LRAT CL E G H92276685OMIM:613341Leber congenital amaurosis 1462
HP:0000505HP:0001133Constriction of peripheral visual field2LRAT CL E G H92276685OMIM:268000Retinitis pigmentosa.62
HP:0000505HP:0000618Blindness2LRAT CL E G H92276685ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent62
HP:0000505HP:0001133Constriction of peripheral visual field2LRAT CL E G H92276685ORPHA:364055Severe early-childhood-onset retinal dystrophy62
HP:0000505HP:0000529Progressive visual loss2LRP2 CL E G H40366694OMIM:222448Donnai-Barrow syndrome289
HP:0000505HP:0000529Progressive visual loss2LRP2 CL E G H40366694ORPHA:2143Donnai-Barrow syndromeHP:0040282 - Frequent289
HP:0000505HP:0000618Blindness2LRP5 CL E G H40416697OMIM:133780Exudative vitreoretinopathy 1.125
HP:0000505HP:0000618Blindness2LRP5 CL E G H40416697OMIM:601813Exudative vitreoretinopathy 4.125
HP:0000505HP:0000618Blindness2LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional125
HP:0000505HP:0001141Severely reduced visual acuity2LRP5 CL E G H40416697ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional125
HP:0000505HP:0030515Moderately reduced visual acuity2LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndromeHP:0040284 - Very rare125
HP:0000505HP:0030532Visual acuity test abnormality2LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndrome125
HP:0000505HP:0001141Severely reduced visual acuity2LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndromeHP:0040282 - Frequent125
HP:0000505HP:0000618Blindness2LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndrome125
HP:0000505HP:0000618Blindness2LRP5 CL E G H40416697OMIM:259770Osteoporosis-Pseudoglioma syndrome.125
HP:0000505HP:0000618Blindness2LRP5 CL E G H40416697ORPHA:90050Retinopathy of prematurityHP:0040283 - Occasional125
HP:0000505HP:0000646Amblyopia2MAFB CL E G H99356408ORPHA:233Duane retraction syndromeHP:0040283 - Occasional63
HP:0000505HP:0000618Blindness2MAK CL E G H41176816ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent53
HP:0000505HP:0000646Amblyopia2MAP3K7 CL E G H68856859ORPHA:1826Frontometaphyseal dysplasiaHP:0040283 - Occasional11
HP:0000505HP:0000646Amblyopia2MED25 CL E G H8185728845ORPHA:464738Basel-Vanagaite-Smirin-Yosef syndromeHP:0040283 - Occasional43
HP:0000505HP:0000618Blindness2MEFV CL E G H42106998ORPHA:117Behçet diseaseHP:0040283 - Occasional281
HP:0000505HP:0000529Progressive visual loss2MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040282 - Frequent462
HP:0000505HP:0000618Blindness2MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0000505HP:0001117Sudden loss of visual acuity2MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0000505HP:0012377Hemianopia2MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0000505HP:0000618Blindness2MERTK CL E G H104617027ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent75
HP:0000505HP:0000529Progressive visual loss2MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 38.75
HP:0000505HP:0001133Constriction of peripheral visual field2MERTK CL E G H104617027OMIM:613862Retinitis pigmentosa 3875
HP:0000505HP:0000575Scotoma2MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000505HP:0000529Progressive visual loss2MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI203
HP:0000505HP:0000618Blindness2MFSD8 CL E G H25647128486OMIM:610951Ceroid lipofuscinosis, neuronal, 7.120
HP:0000505HP:0000575Scotoma2MFSD8 CL E G H25647128486OMIM:616170Macular dystrophy with central cone involvement120
HP:0000505HP:0000646Amblyopia2MICU1 CL E G H103671530OMIM:615673Myopathy with extrapyramidal signs14
HP:0000505HP:0000646Amblyopia2MLXIPL CL E G H5108512744OMIM:194050Williams-Beuren syndrome1
HP:0000505HP:0012377Hemianopia2MTOR CL E G H24753942ORPHA:99802HemimegalencephalyHP:0040283 - Occasional68
HP:0000505HP:0000618Blindness2MTR CL E G H45487468OMIM:250940Homocystinuria-megaloblastic anemia, cblg Complementation typeHP:0040283 - Occasional217
HP:0000505HP:0000575Scotoma2MTRFR CL E G H9157426784OMIM:615035Spastic paraplegia 55, autosomal recessive
HP:0000505HP:0000618Blindness2MTRR CL E G H45527473OMIM:236270Homocystinuria-megaloblastic anemia, cbl E typeHP:0040283 - Occasional88
HP:0000505HP:0000575Scotoma2MTTP CL E G H45477467ORPHA:14AbetalipoproteinemiaHP:0040283 - Occasional81
HP:0000505HP:0000529Progressive visual loss2MTTP CL E G H45477467ORPHA:14AbetalipoproteinemiaHP:0040282 - Frequent81
HP:0000505HP:0000618Blindness2MTTP CL E G H45477467ORPHA:14AbetalipoproteinemiaHP:0040284 - Very rare81
HP:0000505HP:0000575Scotoma2MYO7A CL E G H46477606ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent516
HP:0000505HP:0012377Hemianopia2MYO7A CL E G H46477606ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent516
HP:0000505HP:0000575Scotoma2MYO7A CL E G H46477606ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent516
HP:0000505HP:0012377Hemianopia2MYO7A CL E G H46477606ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent516
HP:0000505HP:0000575Scotoma2MYOC CL E G H46537610ORPHA:98977Juvenile glaucoma47
HP:0000505HP:0001133Constriction of peripheral visual field2MYOC CL E G H46537610ORPHA:98977Juvenile glaucoma47
HP:0000505HP:0007854Glaucomatous visual field defect2MYOC CL E G H46537610ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent47
HP:0000505HP:0000618Blindness2NAA10 CL E G H826018704OMIM:309800Microphthalmia, syndromic 1.23
HP:0000505HP:0200068Nonprogressive visual loss2NBAS CL E G H5159415625OMIM:614800Short stature, optic nerve atrophy, and pelger-huet anomaly.25
HP:0000505HP:0000618Blindness2ND1 CL E G H45357455ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional
HP:0000505HP:0000529Progressive visual loss2ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND1 CL E G H45357455OMIM:535000Leber optic atrophy
HP:0000505HP:0012377Hemianopia2ND1 CL E G H45357455OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000618Blindness2ND2 CL E G H45367456ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional
HP:0000505HP:0000529Progressive visual loss2ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND2 CL E G H45367456OMIM:535000Leber optic atrophy
HP:0000505HP:0000618Blindness2ND3 CL E G H45377458ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional
HP:0000505HP:0000575Scotoma2ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000529Progressive visual loss2ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND4 CL E G H45387459OMIM:535000Leber optic atrophy
HP:0000505HP:0000529Progressive visual loss2ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND4L CL E G H45397460OMIM:535000Leber optic atrophy
HP:0000505HP:0000529Progressive visual loss2ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND5 CL E G H45407461OMIM:535000Leber optic atrophy
HP:0000505HP:0012377Hemianopia2ND5 CL E G H45407461OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000529Progressive visual loss2ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathy
HP:0000505HP:0000575Scotoma2ND6 CL E G H45417462OMIM:535000Leber optic atrophy
HP:0000505HP:0012377Hemianopia2ND6 CL E G H45417462OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0000618Blindness2NDE1 CL E G H5482017619ORPHA:2177HydranencephalyHP:0040281 - Very frequent96
HP:0000505HP:0000618Blindness2NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional39
HP:0000505HP:0001141Severely reduced visual acuity2NDP CL E G H46937678ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional39
HP:0000505HP:0000618Blindness2NDP CL E G H46937678OMIM:310600Norrie disease.HP:0003593 - Infantile onset39
HP:0000505HP:0000618Blindness2NDP CL E G H46937678ORPHA:649Norrie diseaseHP:0040281 - Very frequent39
HP:0000505HP:0000646Amblyopia2NDP CL E G H46937678ORPHA:91495Persistent hyperplastic primary vitreous39
HP:0000505HP:0000618Blindness2NDP CL E G H46937678ORPHA:91495Persistent hyperplastic primary vitreous39
HP:0000505HP:0000618Blindness2NDP CL E G H46937678ORPHA:90050Retinopathy of prematurityHP:0040283 - Occasional39
HP:0000505HP:0000618Blindness2NDUFA1 CL E G H46947683ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional7
HP:0000505HP:0000618Blindness2NDUFA11 CL E G H12632820371ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional32
HP:0000505HP:0000618Blindness2NDUFA6 CL E G H47007690ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional1
HP:0000505HP:0000618Blindness2NDUFAF1 CL E G H5110318828ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional40
HP:0000505HP:0000618Blindness2NDUFAF2 CL E G H9194228086ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional26
HP:0000505HP:0000618Blindness2NDUFAF3 CL E G H2591529918ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional31
HP:0000505HP:0000618Blindness2NDUFAF4 CL E G H2907821034ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional50
HP:0000505HP:0000618Blindness2NDUFAF5 CL E G H7913315899ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional34
HP:0000505HP:0000618Blindness2NDUFAF8 CL E G H28418433551ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional
HP:0000505HP:0000618Blindness2NDUFB10 CL E G H47167696ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional
HP:0000505HP:0000618Blindness2NDUFB11 CL E G H5453920372ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional3
HP:0000505HP:0000646Amblyopia2NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional3
HP:0000505HP:0000618Blindness2NDUFB11 CL E G H5453920372ORPHA:2556Microphthalmia with linear skin defects syndromeHP:0040283 - Occasional3
HP:0000505HP:0000618Blindness2NDUFB3 CL E G H47097698ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional9
HP:0000505HP:0000618Blindness2NDUFB9 CL E G H47157704ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional16
HP:0000505HP:0000618Blindness2NDUFS1 CL E G H47197707ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional81
HP:0000505HP:0000618Blindness2NDUFS2 CL E G H47207708ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional65
HP:0000505HP:0000529Progressive visual loss2NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000505HP:0000575Scotoma2NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathy65
HP:0000505HP:0000618Blindness2NDUFS3 CL E G H47227710ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional22
HP:0000505HP:0000618Blindness2NDUFS4 CL E G H47247711ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional27
HP:0000505HP:0000618Blindness2NDUFS4 CL E G H47247711OMIM:252010Mitochondrial complex I deficiency, nuclear type 1.27
HP:0000505HP:0000618Blindness2NDUFS6 CL E G H47267713ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional21
HP:0000505HP:0000618Blindness2NDUFS7 CL E G H3742917714ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional38
HP:0000505HP:0000618Blindness2NDUFS8 CL E G H47287715ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional42
HP:0000505HP:0000618Blindness2NDUFV1 CL E G H47237716ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional74
HP:0000505HP:0000618Blindness2NDUFV1 CL E G H47237716OMIM:618225Mitochondrial complex I deficiency, nuclear type 474
HP:0000505HP:0000618Blindness2NDUFV2 CL E G H47297717ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional27
HP:0000505HP:0000618Blindness2NEK2 CL E G H47517745ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent5
HP:0000505HP:0000529Progressive visual loss2NEU1 CL E G H47587758OMIM:256550Neuraminidase deficiency.43
HP:0000505HP:0000529Progressive visual loss2NEU1 CL E G H47587758ORPHA:812Sialidosis type 1HP:0040281 - Very frequent43
HP:0000505HP:0000529Progressive visual loss2NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040282 - Frequent1952
HP:0000505HP:0000618Blindness2NF1 CL E G H47637765ORPHA:9768517q11 microdeletion syndromeHP:0040283 - Occasional1952
HP:0000505HP:0030532Visual acuity test abnormality2NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040283 - Occasional220
HP:0000505HP:0000529Progressive visual loss2NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0012377Hemianopia2NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0000618Blindness2NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040284 - Very rare220
HP:0000505HP:0030588Abnormal visual field test2NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0000646Amblyopia2NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040283 - Occasional220
HP:0000505HP:0000618Blindness2NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040283 - Occasional220
HP:0000505HP:0000646Amblyopia2NFIX CL E G H47847788ORPHA:44798019p13.3 microduplication syndromeHP:0040283 - Occasional40
HP:0000505HP:0001141Severely reduced visual acuity2NHS CL E G H48107820OMIM:302200Cataract, congenital total, with posterior sutural opacities in heterozygotes.88
HP:0000505HP:0000618Blindness2NLRP3 CL E G H11454816400ORPHA:1451CINCA syndromeHP:0040283 - Occasional217
HP:0000505HP:0001141Severely reduced visual acuity2NMNAT1 CL E G H6480217877ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent15
HP:0000505HP:0032123Ultra-low vision2NMNAT1 CL E G H6480217877OMIM:608553Leber congenital amaurosis 915
HP:0000505HP:0000646Amblyopia2NOG CL E G H92417866OMIM:186500Multiple synostoses syndrome 122
HP:0000505HP:0000529Progressive visual loss2NPHP1 CL E G H48677905ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent85
HP:0000505HP:0000529Progressive visual loss2NPHP3 CL E G H270317907ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent157
HP:0000505HP:0000529Progressive visual loss2NPHP4 CL E G H26173419104ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent220
HP:0000505HP:0001141Severely reduced visual acuity2NPHP4 CL E G H26173419104OMIM:606996Senior-Loken syndrome 4.220
HP:0000505HP:0000646Amblyopia2NPHP4 CL E G H26173419104OMIM:606996Senior-Loken syndrome 4.220
HP:0000505HP:0000618Blindness2NR2E3 CL E G H100027974ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent58
HP:0000505HP:0000646Amblyopia2NR2F1 CL E G H70257975ORPHA:401777Optic atrophy-intellectual disability syndromeHP:0040283 - Occasional37
HP:0000505HP:0000618Blindness2NRL CL E G H49018002ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent30
HP:0000505HP:0000618Blindness2NRL CL E G H49018002OMIM:613750Retinitis pigmentosa 27.30
HP:0000505HP:0000618Blindness2NSMCE2 CL E G H28605326513ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndrome2
HP:0000505HP:0000618Blindness2NUBPL CL E G H8022420278ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional89
HP:0000505HP:0000618Blindness2OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retinaHP:0040282 - Frequent94
HP:0000505HP:0000529Progressive visual loss2OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retinaHP:0040281 - Very frequent94
HP:0000505HP:0001133Constriction of peripheral visual field2OAT CL E G H49428091ORPHA:414Gyrate atrophy of choroid and retinaHP:0040282 - Frequent94
HP:0000505HP:0000618Blindness2OAT CL E G H49428091OMIM:258870Ornithine aminotransferase deficiency.94
HP:0000505HP:0000646Amblyopia2OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of LoweHP:0040281 - Very frequent88
HP:0000505HP:0000618Blindness2OFD1 CL E G H84812567ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent201
HP:0000505HP:0001141Severely reduced visual acuity2OFD1 CL E G H84812567OMIM:300424Retinitis pigmentosa 23201
HP:0000505HP:0001133Constriction of peripheral visual field2OFD1 CL E G H84812567OMIM:300424Retinitis pigmentosa 23201
HP:0000505HP:0000646Amblyopia2OGT CL E G H84738127OMIM:300997Mental retardation, X-linked 1064
HP:0000505HP:0001133Constriction of peripheral visual field2OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndromeHP:0040283 - Occasional214
HP:0000505HP:0000529Progressive visual loss2OPA1 CL E G H49768140ORPHA:1215Autosomal dominant optic atrophy plus syndromeHP:0040281 - Very frequent214
HP:0000505HP:0000575Scotoma2OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic form214
HP:0000505HP:0030515Moderately reduced visual acuity2OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040282 - Frequent214
HP:0000505HP:0000529Progressive visual loss2OPA1 CL E G H49768140OMIM:210000Behr syndrome.214
HP:0000505HP:0000618Blindness2OPA1 CL E G H49768140OMIM:210000Behr syndrome214
HP:0000505HP:0000575Scotoma2OPA1 CL E G H49768140OMIM:165500Optic atrophy 1214
HP:0000505HP:0000575Scotoma2OPA1 CL E G H49768140OMIM:125250Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy214
HP:0000505HP:0000575Scotoma2OPA3 CL E G H802078142ORPHA:67036Autosomal dominant optic atrophy and cataract163
HP:0000505HP:0000618Blindness2OPA3 CL E G H802078142ORPHA:67036Autosomal dominant optic atrophy and cataractHP:0040283 - Occasional163
HP:0000505HP:0000575Scotoma2OPA3 CL E G H802078142OMIM:165300OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3163
HP:0000505HP:0001141Severely reduced visual acuity2OSTM1 CL E G H2896221652OMIM:259720Osteopetrosis, autosomal recessive 573
HP:0000505HP:0032122Very low visual acuity2OVOL2 CL E G H5849515804ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional4
HP:0000505HP:0000646Amblyopia2OVOL2 CL E G H5849515804ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional4
HP:0000505HP:0032037Mildly reduced visual acuity2P3H2 CL E G H5521419317OMIM:614292Myopia, high, with cataract and vitreoretinal degeneration5
HP:0000505HP:0000646Amblyopia2P4HTM CL E G H5468128858OMIM:618493Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities.
HP:0000505HP:0000529Progressive visual loss2PAK2 CL E G H50628591ORPHA:1571Knobloch syndromeHP:0040282 - Frequent
HP:0000505HP:0000618Blindness2PANK2 CL E G H8002515894ORPHA:216873Atypical pantothenate kinase-associated neurodegenerationHP:0040284 - Very rare55
HP:0000505HP:0000618Blindness2PANK2 CL E G H8002515894ORPHA:216866Classic pantothenate kinase-associated neurodegenerationHP:0040284 - Very rare55
HP:0000505HP:0030532Visual acuity test abnormality2PAX6 CL E G H50808620ORPHA:137902Isolated optic nerve hypoplasia/aplasia194
HP:0000505HP:0000646Amblyopia2PAX6 CL E G H50808620ORPHA:35737Morning glory disc anomalyHP:0040281 - Very frequent194
HP:0000505HP:0000618Blindness2PCARE CL E G H38893934383ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2PCDH15 CL E G H6521714674ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent352
HP:0000505HP:0012377Hemianopia2PCDH15 CL E G H6521714674ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent352
HP:0000505HP:0001141Severely reduced visual acuity2PCYT1A CL E G H51308754ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent11
HP:0000505HP:0000529Progressive visual loss2PCYT1A CL E G H51308754OMIM:608940Spondylometaphyseal dysplasia with cone-rod dystrophy.11
HP:0000505HP:0000618Blindness2PDE6A CL E G H51458785ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent116
HP:0000505HP:0001133Constriction of peripheral visual field2PDE6A CL E G H51458785OMIM:613810RETINITIS PIGMENTOSA 43; RP43116
HP:0000505HP:0000618Blindness2PDE6B CL E G H51588786ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent126
HP:0000505HP:0000575Scotoma2PDE6C CL E G H51468787ORPHA:49382Achromatopsia80
HP:0000505HP:0001133Constriction of peripheral visual field2PDE6G CL E G H51488789OMIM:268000Retinitis pigmentosa.18
HP:0000505HP:0000618Blindness2PDE6G CL E G H51488789ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent18
HP:0000505HP:0001133Constriction of peripheral visual field2PDE6G CL E G H51488789OMIM:613582Retinitis pigmentosa 5718
HP:0000505HP:0000575Scotoma2PDE6H CL E G H51498790ORPHA:49382Achromatopsia14
HP:0000505HP:0030532Visual acuity test abnormality2PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040283 - Occasional9
HP:0000505HP:0012377Hemianopia2PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0000529Progressive visual loss2PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0030588Abnormal visual field test2PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0000618Blindness2PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040284 - Very rare9
HP:0000505HP:0000618Blindness2PDHA1 CL E G H51608806ORPHA:79243Pyruvate dehydrogenase E1-alpha deficiencyHP:0040283 - Occasional88
HP:0000505HP:0012377Hemianopia2PDZD7 CL E G H7995526257ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent40
HP:0000505HP:0000575Scotoma2PDZD7 CL E G H7995526257ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent40
HP:0000505HP:0000646Amblyopia2PDZD8 CL E G H11898726974OMIM:620021
HP:0000505HP:0001133Constriction of peripheral visual field2PEX1 CL E G H51898850ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent169
HP:0000505HP:0001133Constriction of peripheral visual field2PEX10 CL E G H51928851ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent75
HP:0000505HP:0001133Constriction of peripheral visual field2PEX11B CL E G H87998853ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent4
HP:0000505HP:0001133Constriction of peripheral visual field2PEX12 CL E G H51938854ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent65
HP:0000505HP:0001133Constriction of peripheral visual field2PEX13 CL E G H51948855ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent66
HP:0000505HP:0001133Constriction of peripheral visual field2PEX14 CL E G H51958856ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent46
HP:0000505HP:0001133Constriction of peripheral visual field2PEX16 CL E G H94098857ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent59
HP:0000505HP:0001133Constriction of peripheral visual field2PEX19 CL E G H58249713ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent62
HP:0000505HP:0001133Constriction of peripheral visual field2PEX2 CL E G H58289717ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent82
HP:0000505HP:0001133Constriction of peripheral visual field2PEX26 CL E G H5567022965ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent106
HP:0000505HP:0001133Constriction of peripheral visual field2PEX3 CL E G H85048858ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent47
HP:0000505HP:0001133Constriction of peripheral visual field2PEX5 CL E G H58309719ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent99
HP:0000505HP:0000618Blindness2PEX6 CL E G H51908859ORPHA:95433Autosomal recessive spinocerebellar ataxia-blindness-deafness syndromeHP:0040282 - Frequent98
HP:0000505HP:0001133Constriction of peripheral visual field2PEX6 CL E G H51908859ORPHA:772Infantile Refsum diseaseHP:0040281 - Very frequent98
HP:0000505HP:0000529Progressive visual loss2PEX7 CL E G H51918860ORPHA:773Refsum diseaseHP:0040283 - Occasional72
HP:0000505HP:0000618Blindness2PGK1 CL E G H52308896ORPHA:713Glycogen storage disease due to phosphoglycerate kinase 1 deficiencyHP:0040284 - Very rare21
HP:0000505HP:0000646Amblyopia2PHOX2A CL E G H401691OMIM:602078Fibrosis of extraocular muscles, congenital, 2.6
HP:0000505HP:0000529Progressive visual loss2PHYH CL E G H52648940ORPHA:773Refsum diseaseHP:0040283 - Occasional45
HP:0000505HP:0000646Amblyopia2PIGN CL E G H235568967ORPHA:280633Multiple congenital anomalies-hypotonia-seizures syndromeHP:0040283 - Occasional37
HP:0000505HP:0000646Amblyopia2PIGN CL E G H235568967OMIM:614080Multiple congenital anomalies-hypotonia-seizures syndrome 137
HP:0000505HP:0012377Hemianopia2PIK3CA CL E G H52908975ORPHA:99802HemimegalencephalyHP:0040283 - Occasional162
HP:0000505HP:0012377Hemianopia2PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0000529Progressive visual loss2PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0000618Blindness2PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040284 - Very rare162
HP:0000505HP:0030532Visual acuity test abnormality2PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040283 - Occasional162
HP:0000505HP:0030588Abnormal visual field test2PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0000618Blindness2PIK3R2 CL E G H52968980OMIM:603387Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus syndrome.12
HP:0000505HP:0000575Scotoma2PITPNM3 CL E G H8339421043OMIM:600977Cone-Rod dystrophy 5135
HP:0000505HP:0000646Amblyopia2PITX2 CL E G H53089005OMIM:180550Ring dermoid of cornea51
HP:0000505HP:0000618Blindness2PITX3 CL E G H53099006OMIM:610623Cataract 11, multiple types.6
HP:0000505HP:0000618Blindness2PLA2G6 CL E G H83989039ORPHA:35069Infantile neuroaxonal dystrophyHP:0040283 - Occasional133
HP:0000505HP:0000618Blindness2PLG CL E G H53409071OMIM:217090Plasminogen deficiency, type iligneous conjunctivitis, included.11
HP:0000505HP:0000618Blindness2PLOD1 CL E G H53519081OMIM:225400Ehlers-Danlos syndrome, kyphoscoliotic type, 1.105
HP:0000505HP:0000529Progressive visual loss2PNPLA6 CL E G H1090816268OMIM:215470Boucher-Neuhauser syndrome103
HP:0000505HP:0000575Scotoma2POC1B CL E G H28280930836OMIM:615973Cone-Rod dystrophy 203
HP:0000505HP:0001133Constriction of peripheral visual field2POC1B CL E G H28280930836OMIM:615973Cone-Rod dystrophy 20.3
HP:0000505HP:0000618Blindness2POGZ CL E G H2312618801ORPHA:468678White-Sutton syndromeHP:0040284 - Very rare35
HP:0000505HP:0000618Blindness2POLG CL E G H54289179ORPHA:726Alpers-Huttenlocher syndromeHP:0040283 - Occasional464
HP:0000505HP:0000646Amblyopia2POLR3GL CL E G H8426528466OMIM:619234SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM
HP:0000505HP:0000618Blindness2POMGNT1 CL E G H5562419139ORPHA:370959Congenital muscular dystrophy with cerebellar involvementHP:0040284 - Very rare180
HP:0000505HP:0000618Blindness2POMGNT1 CL E G H5562419139ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent180
HP:0000505HP:0001133Constriction of peripheral visual field2POMGNT1 CL E G H5562419139OMIM:617123RETINITIS PIGMENTOSA 76; RP76180
HP:0000505HP:0000618Blindness2POMK CL E G H8419726267ORPHA:370959Congenital muscular dystrophy with cerebellar involvementHP:0040284 - Very rare18
HP:0000505HP:0000618Blindness2POMT1 CL E G H105859202ORPHA:370959Congenital muscular dystrophy with cerebellar involvementHP:0040284 - Very rare213
HP:0000505HP:0000618Blindness2POMT1 CL E G H105859202OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.213
HP:0000505HP:0000618Blindness2POMT2 CL E G H2995419743ORPHA:370959Congenital muscular dystrophy with cerebellar involvementHP:0040284 - Very rare221
HP:0000505HP:0000618Blindness2POMT2 CL E G H2995419743OMIM:236670Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1.221
HP:0000505HP:0030532Visual acuity test abnormality2POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndromeHP:0040282 - Frequent40
HP:0000505HP:0001133Constriction of peripheral visual field2POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndrome40
HP:0000505HP:0000529Progressive visual loss2PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1.172
HP:0000505HP:0000618Blindness2PPT1 CL E G H55389325OMIM:256730Ceroid lipofuscinosis, neuronal, 1.HP:0011463 - Childhood onset172
HP:0000505HP:0000618Blindness2PQBP1 CL E G H100849330OMIM:309500Renpenning syndrome28
HP:0000505HP:0000618Blindness2PRCD CL E G H76820632528ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent39
HP:0000505HP:0000575Scotoma2PROM1 CL E G H88429454OMIM:612657CONE-ROD DYSTROPHY 12; CORD12110
HP:0000505HP:0000575Scotoma2PROM1 CL E G H88429454OMIM:608051Macular dystrophy, retinal, 2110
HP:0000505HP:0000618Blindness2PROM1 CL E G H88429454ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent110
HP:0000505HP:0001141Severely reduced visual acuity2PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0000505HP:0001133Constriction of peripheral visual field2PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0000505HP:0000575Scotoma2PROM1 CL E G H88429454ORPHA:827Stargardt disease110
HP:0000505HP:0012377Hemianopia2PRORP CL E G H969219958OMIM:619737COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54; COXPD54
HP:0000505HP:0000618Blindness2PROS1 CL E G H56279456OMIM:614514Thrombophilia due to protein S deficiency, autosomal recessive.75
HP:0000505HP:0000618Blindness2PRPF3 CL E G H912917348ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent28
HP:0000505HP:0007987Progressive visual field defects2PRPF3 CL E G H912917348OMIM:601414Retinitis pigmentosa 18.28
HP:0000505HP:0000575Scotoma2PRPF3 CL E G H912917348OMIM:601414Retinitis pigmentosa 18.28
HP:0000505HP:0000618Blindness2PRPF31 CL E G H2612115446ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent70
HP:0000505HP:0001133Constriction of peripheral visual field2PRPF31 CL E G H2612115446OMIM:600138Retinitis pigmentosa 1170
HP:0000505HP:0000618Blindness2PRPF31 CL E G H2612115446OMIM:600138Retinitis pigmentosa 11.70
HP:0000505HP:0000618Blindness2PRPF4 CL E G H912817349ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent2
HP:0000505HP:0000618Blindness2PRPF6 CL E G H2414815860ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent51
HP:0000505HP:0000618Blindness2PRPF8 CL E G H1059417340ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent94
HP:0000505HP:0001133Constriction of peripheral visual field2PRPF8 CL E G H1059417340OMIM:600059Retinitis pigmentosa 13.94
HP:0000505HP:0000529Progressive visual loss2PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophy159
HP:0000505HP:0000618Blindness2PRPH2 CL E G H59619942ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent159
HP:0000505HP:0001133Constriction of peripheral visual field2PRPH2 CL E G H59619942OMIM:608133Retinitis pigmentosa 7.159
HP:0000505HP:0007987Progressive visual field defects2PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent159
HP:0000505HP:0000575Scotoma2PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescens159
HP:0000505HP:0000529Progressive visual loss2PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent159
HP:0000505HP:0001133Constriction of peripheral visual field2PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescens159
HP:0000505HP:0000575Scotoma2PRPH2 CL E G H59619942ORPHA:827Stargardt disease159
HP:0000505HP:0000529Progressive visual loss2PRPS1 CL E G H56319462OMIM:311070Charcot-Marie-Tooth disease, X-linked recessive, 549
HP:0000505HP:0000618Blindness2PRPS1 CL E G H56319462ORPHA:1187Lethal ataxia with deafness and optic atrophyHP:0040281 - Very frequent49
HP:0000505HP:0000646Amblyopia2PRR12 CL E G H5747929217OMIM:619539NEUROOCULAR SYNDROME; NOC1
HP:0000505HP:0000575Scotoma2PRRT2 CL E G H11247630500ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent94
HP:0000505HP:0000618Blindness2PSAP CL E G H56609498ORPHA:206436Infantile Krabbe diseaseHP:0040283 - Occasional81
HP:0000505HP:0000646Amblyopia2PUF60 CL E G H2282717042ORPHA:508498Intellectual disability-cardiac anomalies-short stature-joint laxity syndromeHP:0040283 - Occasional19
HP:0000505HP:0000575Scotoma2RAB28 CL E G H93649768OMIM:615374Cone-Rod dystrophy 186
HP:0000505HP:0030515Moderately reduced visual acuity2RAC1 CL E G H58799801ORPHA:500159Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndromHP:0040283 - Occasional3
HP:0000505HP:0001133Constriction of peripheral visual field2RAX2 CL E G H8483918286OMIM:62010252
HP:0000505HP:0000529Progressive visual loss2RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 1152
HP:0000505HP:0001133Constriction of peripheral visual field2RBP3 CL E G H59499921OMIM:268000Retinitis pigmentosa.108
HP:0000505HP:0000618Blindness2RBP3 CL E G H59499921ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent108
HP:0000505HP:0000575Scotoma2RBP3 CL E G H59499921OMIM:615233Retinitis pigmentosa 66108
HP:0000505HP:0001133Constriction of peripheral visual field2RBP3 CL E G H59499921OMIM:615233Retinitis pigmentosa 66.108
HP:0000505HP:0001141Severely reduced visual acuity2RD3 CL E G H34303519689ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent95
HP:0000505HP:0000618Blindness2RD3 CL E G H34303519689OMIM:610612Leber congenital amaurosis 1295
HP:0000505HP:0000529Progressive visual loss2RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndromeHP:0040281 - Very frequent2
HP:0000505HP:0001133Constriction of peripheral visual field2RDH11 CL E G H5110917964ORPHA:436245Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndromeHP:0040282 - Frequent2
HP:0000505HP:0001141Severely reduced visual acuity2RDH12 CL E G H14522619977ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent45
HP:0000505HP:0000618Blindness2RDH12 CL E G H14522619977ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent45
HP:0000505HP:0000575Scotoma2RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescens32
HP:0000505HP:0007987Progressive visual field defects2RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent32
HP:0000505HP:0000529Progressive visual loss2RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent32
HP:0000505HP:0001133Constriction of peripheral visual field2RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescens32
HP:0000505HP:0000618Blindness2REEP6 CL E G H9284030078ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent5
HP:0000505HP:0000618Blindness2RGR CL E G H59959990ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent28
HP:0000505HP:0001133Constriction of peripheral visual field2RGR CL E G H59959990OMIM:613769RETINITIS PIGMENTOSA 44; RP4428
HP:0000505HP:0000618Blindness2RHO CL E G H601010012ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent107
HP:0000505HP:0000618Blindness2RHO CL E G H601010012OMIM:613731Retinitis pigmentosa 4.107
HP:0000505HP:0000529Progressive visual loss2RHO CL E G H601010012ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent107
HP:0000505HP:0001133Constriction of peripheral visual field2RHO CL E G H601010012ORPHA:52427Retinitis punctata albescens107
HP:0000505HP:0000575Scotoma2RHO CL E G H601010012ORPHA:52427Retinitis punctata albescens107
HP:0000505HP:0007987Progressive visual field defects2RHO CL E G H601010012ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent107
HP:0000505HP:0000646Amblyopia2RIC1 CL E G H5758917686OMIM:618761CATIFA SYNDROME; CATIFA
HP:0000505HP:0001129Large central visual field defect2RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0000529Progressive visual loss2RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040281 - Very frequent47
HP:0000505HP:0000575Scotoma2RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophy47
HP:0000505HP:0000575Scotoma2RLBP1 CL E G H601710024OMIM:607476NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD47
HP:0000505HP:0000618Blindness2RLBP1 CL E G H601710024ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent47
HP:0000505HP:0000575Scotoma2RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescens47
HP:0000505HP:0001133Constriction of peripheral visual field2RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescens47
HP:0000505HP:0000529Progressive visual loss2RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescensHP:0040281 - Very frequent47
HP:0000505HP:0007987Progressive visual field defects2RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent47
HP:0000505HP:0001133Constriction of peripheral visual field2RNU4ATAC CL E G H10015168334016OMIM:226960EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS15
HP:0000505HP:0001133Constriction of peripheral visual field2ROM1 CL E G H609410254OMIM:268000Retinitis pigmentosa.38
HP:0000505HP:0000618Blindness2ROM1 CL E G H609410254ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent38
HP:0000505HP:0001133Constriction of peripheral visual field2ROM1 CL E G H609410254OMIM:608133Retinitis pigmentosa 7.38
HP:0000505HP:0000646Amblyopia2RORA CL E G H609510258OMIM:618060INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA1
HP:0000505HP:0000618Blindness2RP1 CL E G H610110263ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent111
HP:0000505HP:0001133Constriction of peripheral visual field2RP1 CL E G H610110263OMIM:180100Retinitis pigmentosa 1.111
HP:0000505HP:0000575Scotoma2RP1 CL E G H610110263OMIM:180100Retinitis pigmentosa 1111
HP:0000505HP:0000529Progressive visual loss2RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000505HP:0000618Blindness2RP1L1 CL E G H9413715946ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent284
HP:0000505HP:0000618Blindness2RP2 CL E G H610210274ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent45
HP:0000505HP:0001133Constriction of peripheral visual field2RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked.45
HP:0000505HP:0000575Scotoma2RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked45
HP:0000505HP:0000618Blindness2RP9 CL E G H610010288ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent14
HP:0000505HP:0001133Constriction of peripheral visual field2RP9 CL E G H610010288OMIM:180104Retinitis pigmentosa 9.14
HP:0000505HP:0001141Severely reduced visual acuity2RPE65 CL E G H612110294ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent129
HP:0000505HP:0000618Blindness2RPE65 CL E G H612110294OMIM:204100Leber congenital amaurosis, type II.129
HP:0000505HP:0000618Blindness2RPE65 CL E G H612110294ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent129
HP:0000505HP:0001141Severely reduced visual acuity2RPE65 CL E G H612110294OMIM:613794Retinitis pigmentosa 20.129
HP:0000505HP:0001133Constriction of peripheral visual field2RPE65 CL E G H612110294OMIM:618697RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87129
HP:0000505HP:0001133Constriction of peripheral visual field2RPE65 CL E G H612110294ORPHA:364055Severe early-childhood-onset retinal dystrophy129
HP:0000505HP:0000575Scotoma2RPGR CL E G H610310295ORPHA:49382Achromatopsia200
HP:0000505HP:0000618Blindness2RPGR CL E G H610310295ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent200
HP:0000505HP:0001133Constriction of peripheral visual field2RPGR CL E G H610310295OMIM:300029Retinitis pigmentosa 3200
HP:0000505HP:0000575Scotoma2RPGR CL E G H610310295OMIM:300029Retinitis pigmentosa 3200
HP:0000505HP:0001141Severely reduced visual acuity2RPGRIP1 CL E G H5709613436ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent109
HP:0000505HP:0001141Severely reduced visual acuity2RPGRIP1 CL E G H5709613436OMIM:613826Leber congenital amaurosis 6.109
HP:0000505HP:0000646Amblyopia2RRAS2 CL E G H2280017271OMIM:618624NOONAN SYNDROME 12; NS121
HP:0000505HP:0001133Constriction of peripheral visual field2RRM2B CL E G H5048417296OMIM:268315ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION125
HP:0000505HP:0000529Progressive visual loss2RS1 CL E G H624710457OMIM:312700Retinoschisis 1, X-linked, juvenile148
HP:0000505HP:0000575Scotoma2RTN4IP1 CL E G H8481618647OMIM:616732OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA102
HP:0000505HP:0030644Blind-spot enlargment2RTN4IP1 CL E G H8481618647OMIM:616732OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA102
HP:0000505HP:0000618Blindness2SAG CL E G H629510521ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent32
HP:0000505HP:0000646Amblyopia2SALL4 CL E G H5716715924ORPHA:233Duane retraction syndromeHP:0040283 - Occasional86
HP:0000505HP:0000618Blindness2SARDH CL E G H175710536ORPHA:3129Sarcosinemia4
HP:0000505HP:0000618Blindness2SCAPER CL E G H4985513081ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2SCN1A CL E G H632310585ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent1053
HP:0000505HP:0000618Blindness2SCN1A CL E G H632310585OMIM:609634Migraine, familial hemiplegic, 3.1053
HP:0000505HP:0000646Amblyopia2SCN8A CL E G H633410596OMIM:614306Cognitive impairment with or without cerebellar ataxiaHP:0040283 - Occasional357
HP:0000505HP:0000529Progressive visual loss2SDCCAG8 CL E G H1080610671ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent61
HP:0000505HP:0000618Blindness2SDHA CL E G H638910680ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040284 - Very rare304
HP:0000505HP:0001133Constriction of peripheral visual field2SDHA CL E G H638910680OMIM:619259NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA304
HP:0000505HP:0000618Blindness2SDHAF1 CL E G H64409633867ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040284 - Very rare16
HP:0000505HP:0000618Blindness2SDHB CL E G H639010681ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040284 - Very rare237
HP:0000505HP:0000618Blindness2SDHD CL E G H639210683ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040284 - Very rare129
HP:0000505HP:0000529Progressive visual loss2SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 10.48
HP:0000505HP:0001133Constriction of peripheral visual field2SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 1048
HP:0000505HP:0000618Blindness2SEMA4A CL E G H6421810729ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent48
HP:0000505HP:0000618Blindness2SEMA4A CL E G H6421810729OMIM:610282Retinitis pigmentosa 35.48
HP:0000505HP:0012377Hemianopia2SETD5 CL E G H5520925566ORPHA:404440Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiencyHP:0040283 - Occasional43
HP:0000505HP:0000646Amblyopia2SF3B2 CL E G H1099210769OMIM:164210Hemifacial microsomia2
HP:0000505HP:0001133Constriction of peripheral visual field2SH3BP2 CL E G H645210825OMIM:118400Cherubism177
HP:0000505HP:0000529Progressive visual loss2SH3BP2 CL E G H645210825ORPHA:184CherubismHP:0040283 - Occasional177
HP:0000505HP:0001133Constriction of peripheral visual field2SH3TC2 CL E G H7962829427ORPHA:99949Charcot-Marie-Tooth disease type 4C493
HP:0000505HP:0000618Blindness2SLC24A1 CL E G H918710975OMIM:613830Night blindness, congenital stationary, type 1D.66
HP:0000505HP:0000575Scotoma2SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0000505HP:0000529Progressive visual loss2SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB.14
HP:0000505HP:0000529Progressive visual loss2SLC25A46 CL E G H9113725198ORPHA:2254Pontocerebellar hypoplasia type 114
HP:0000505HP:0001133Constriction of peripheral visual field2SLC6A6 CL E G H653311052OMIM:145350Hypotaurinemic retinal degeneration and cardiomyopathy
HP:0000505HP:0000618Blindness2SLC7A14 CL E G H5770929326ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent4
HP:0000505HP:0000646Amblyopia2SMAD4 CL E G H40896770ORPHA:774Hereditary hemorrhagic telangiectasiaHP:0040283 - Occasional504
HP:0000505HP:0000646Amblyopia2SMARCA2 CL E G H659511098ORPHA:2728Blepharophimosis-intellectual disability syndrome, Ohdo typeHP:0040281 - Very frequent146
HP:0000505HP:0000529Progressive visual loss2SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0000618Blindness2SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040284 - Very rare87
HP:0000505HP:0030588Abnormal visual field test2SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0012377Hemianopia2SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0030532Visual acuity test abnormality2SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040283 - Occasional87
HP:0000505HP:0030588Abnormal visual field test2SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0000618Blindness2SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040284 - Very rare47
HP:0000505HP:0000529Progressive visual loss2SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0030532Visual acuity test abnormality2SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040283 - Occasional47
HP:0000505HP:0012377Hemianopia2SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0000618Blindness2SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeHP:0040282 - Frequent174
HP:0000505HP:0000646Amblyopia2SMCHD1 CL E G H2334729090ORPHA:2250Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndromeHP:0040282 - Frequent174
HP:0000505HP:0000646Amblyopia2SMO CL E G H660811119OMIM:601707Curry-Jones syndrome22
HP:0000505HP:0000529Progressive visual loss2SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0030588Abnormal visual field test2SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0012377Hemianopia2SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0030532Visual acuity test abnormality2SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040283 - Occasional22
HP:0000505HP:0000618Blindness2SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040284 - Very rare22
HP:0000505HP:0000618Blindness2SNRNP200 CL E G H2302030859ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent83
HP:0000505HP:0000646Amblyopia2SOBP CL E G H5508429256OMIM:613671Mental retardation, anterior maxillary protrusion, and strabismusHP:0040283 - Occasional29
HP:0000505HP:0000529Progressive visual loss2SON CL E G H665111183ORPHA:500150Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndromeHP:0040283 - Occasional12
HP:0000505HP:0000529Progressive visual loss2SOST CL E G H5096413771OMIM:122860Craniodiaphyseal dysplasia, autosomal dominant.26
HP:0000505HP:0001133Constriction of peripheral visual field2SOST CL E G H5096413771OMIM:269500Sclerosteosis 1.26
HP:0000505HP:0001141Severely reduced visual acuity2SPATA7 CL E G H5581220423ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent48
HP:0000505HP:0001133Constriction of peripheral visual field2SPATA7 CL E G H5581220423OMIM:604232LEBER CONGENITAL AMAUROSIS 3; LCA348
HP:0000505HP:0000618Blindness2SPATA7 CL E G H5581220423ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent48
HP:0000505HP:0001133Constriction of peripheral visual field2SPATA7 CL E G H5581220423ORPHA:364055Severe early-childhood-onset retinal dystrophy48
HP:0000505HP:0000618Blindness2SREBF1 CL E G H672011289OMIM:158310Mucoepithelial dysplasia, hereditary.1
HP:0000505HP:0000618Blindness2STAT4 CL E G H677511365ORPHA:117Behçet diseaseHP:0040283 - Occasional2
HP:0000505HP:0001141Severely reduced visual acuity2STX3 CL E G H680911438OMIM:619446RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE; RDMVID1
HP:0000505HP:0012377Hemianopia2SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0030588Abnormal visual field test2SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0000618Blindness2SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040284 - Very rare124
HP:0000505HP:0030532Visual acuity test abnormality2SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040283 - Occasional124
HP:0000505HP:0000529Progressive visual loss2SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0000646Amblyopia2TANGO2 CL E G H12898925439ORPHA:480864Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndromeHP:0040283 - Occasional12
HP:0000505HP:0000646Amblyopia2TASP1 CL E G H5561715859OMIM:618950SULEIMAN-EL-HATTAB SYNDROME; SULEHS
HP:0000505HP:0000618Blindness2TBC1D24 CL E G H5746529203OMIM:220500Doors syndrome.271
HP:0000505HP:0000646Amblyopia2TBX1 CL E G H689911592OMIM:188400Digeorge syndrome.32
HP:0000505HP:0000618Blindness2TCIRG1 CL E G H1031211647OMIM:259700Osteopetrosis, autosomal recessive 1.82
HP:0000505HP:0000529Progressive visual loss2TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0012377Hemianopia2TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0030588Abnormal visual field test2TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0030532Visual acuity test abnormality2TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040283 - Occasional238
HP:0000505HP:0000618Blindness2TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040284 - Very rare238
HP:0000505HP:0000646Amblyopia2TFE3 CL E G H703011752OMIM:301066INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES; MRXSPF
HP:0000505HP:0000529Progressive visual loss2TGFBI CL E G H704511771OMIM:122200Corneal dystrophy, lattice type I.58
HP:0000505HP:0000529Progressive visual loss2TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type I58
HP:0000505HP:0000529Progressive visual loss2TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophy58
HP:0000505HP:0001133Constriction of peripheral visual field2TIMM8A CL E G H167811817OMIM:304700Mohr-Tranebjaerg syndrome.15
HP:0000505HP:0000575Scotoma2TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndrome15
HP:0000505HP:0000618Blindness2TIMMDC1 CL E G H513001321ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional1
HP:0000505HP:0000618Blindness2TIMP3 CL E G H707811822OMIM:136900Sorsby fundus dystrophy.95
HP:0000505HP:0001129Large central visual field defect2TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophyHP:0040282 - Frequent95
HP:0000505HP:0001141Severely reduced visual acuity2TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophyHP:0040283 - Occasional95
HP:0000505HP:0000618Blindness2TIMP3 CL E G H707811822ORPHA:59181Sorsby pseudoinflammatory fundus dystrophyHP:0040283 - Occasional95
HP:0000505HP:0000618Blindness2TLR4 CL E G H709911850ORPHA:117Behçet diseaseHP:0040283 - Occasional3
HP:0000505HP:0000575Scotoma2TMEM126A CL E G H8423325382OMIM:612989Optic atrophy 7 with or without auditory neuropathy23
HP:0000505HP:0001133Constriction of peripheral visual field2TMEM126A CL E G H8423325382OMIM:612989Optic atrophy 7 with or without auditory neuropathy.23
HP:0000505HP:0000618Blindness2TMEM126B CL E G H5586330883ORPHA:2609Isolated complex I deficiencyHP:0040283 - Occasional4
HP:0000505HP:0000618Blindness2TMEM138 CL E G H5152426944ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent39
HP:0000505HP:0000618Blindness2TMEM216 CL E G H5125925018ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent45
HP:0000505HP:0000618Blindness2TMEM231 CL E G H7958337234ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent33
HP:0000505HP:0000618Blindness2TMEM237 CL E G H6506214432ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent82
HP:0000505HP:0000618Blindness2TMEM67 CL E G H9114728396OMIM:610688Joubert syndrome 6.166
HP:0000505HP:0000529Progressive visual loss2TNFRSF11A CL E G H879211908OMIM:612301OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB772
HP:0000505HP:0000618Blindness2TNFSF11 CL E G H860011926OMIM:259710Osteopetrosis, autosomal recessive 2.44
HP:0000505HP:0000618Blindness2TOPORS CL E G H1021021653ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent61
HP:0000505HP:0000529Progressive visual loss2TPP1 CL E G H12002073OMIM:204500Ceroid lipofuscinosis, neuronal, 2.203
HP:0000505HP:0000529Progressive visual loss2TRAF3IP1 CL E G H2614617861ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent6
HP:0000505HP:0012377Hemianopia2TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0030588Abnormal visual field test2TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0000618Blindness2TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040284 - Very rare
HP:0000505HP:0030532Visual acuity test abnormality2TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040283 - Occasional
HP:0000505HP:0000529Progressive visual loss2TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0012377Hemianopia2TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040283 - Occasional56
HP:0000505HP:0000529Progressive visual loss2TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0000505HP:0000529Progressive visual loss2TRIM44 CL E G H5476519016OMIM:617142Aniridia 3.1
HP:0000505HP:0000646Amblyopia2TRIO CL E G H720412303ORPHA:476126Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndromeHP:0040283 - Occasional8
HP:0000505HP:0012377Hemianopia2TRNC CL E G H45117477OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNF CL E G H45587481OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNK CL E G H45667489OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNL1 CL E G H45677490OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNQ CL E G H45727495OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNS1 CL E G H45747497OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNS2 CL E G H45757498OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNS2 CL E G H45757498ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2TRNS2 CL E G H45757498ORPHA:231183Usher syndrome type 3HP:0040281 - Very frequent
HP:0000505HP:0000575Scotoma2TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28
HP:0000505HP:0012377Hemianopia2TRNV CL E G H45777500OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0012377Hemianopia2TRNW CL E G H45787501OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0000505HP:0001141Severely reduced visual acuity2TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional39
HP:0000505HP:0000618Blindness2TSPAN12 CL E G H2355421641ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional39
HP:0000505HP:0000618Blindness2TTC8 CL E G H12301620087ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent41
HP:0000505HP:0000618Blindness2TUB CL E G H727512406ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent1
HP:0000505HP:0012377Hemianopia2TUBB2B CL E G H34773330829ORPHA:300573Polymicrogyria due to TUBB2B mutationHP:0040283 - Occasional39
HP:0000505HP:0030532Visual acuity test abnormality2TUBB3 CL E G H1038120772ORPHA:300570Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation64
HP:0000505HP:0000646Amblyopia2TUBB3 CL E G H1038120772OMIM:600638Fibrosis of extraocular muscles, congenital, 3A, with or without extraocularinvolvement.64
HP:0000505HP:0001141Severely reduced visual acuity2TUBB4B CL E G H1038320771ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent
HP:0000505HP:0001141Severely reduced visual acuity2TULP1 CL E G H728712423ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent66
HP:0000505HP:0001133Constriction of peripheral visual field2TULP1 CL E G H728712423OMIM:613843Leber congenital amaurosis 15.66
HP:0000505HP:0000618Blindness2TULP1 CL E G H728712423ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent66
HP:0000505HP:0001133Constriction of peripheral visual field2TULP1 CL E G H728712423OMIM:600132RETINITIS PIGMENTOSA 14; RP1466
HP:0000505HP:0000646Amblyopia2TWIST1 CL E G H729112428ORPHA:794Saethre-Chotzen syndromeHP:0040283 - Occasional18
HP:0000505HP:0000618Blindness2UBAC2 CL E G H33786720486ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0000505HP:0000529Progressive visual loss2UCHL1 CL E G H734512513OMIM:615491Spastic paraplegia 79, autosomal recessive.21
HP:0000505HP:0000618Blindness2UFM1 CL E G H5156920597OMIM:617899Leukodystrophy, hypomyelinating, 14HP:0040284 - Very rare
HP:0000505HP:0000618Blindness2UROD CL E G H738912591ORPHA:95159Hepatoerythropoietic porphyriaHP:0040284 - Very rare31
HP:0000505HP:0000618Blindness2UROS CL E G H739012592ORPHA:79277Congenital erythropoietic porphyriaHP:0040284 - Very rare41
HP:0000505HP:0012377Hemianopia2USH1C CL E G H1008312597ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent173
HP:0000505HP:0000575Scotoma2USH1C CL E G H1008312597ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent173
HP:0000505HP:0012377Hemianopia2USH1G CL E G H12459016356ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent78
HP:0000505HP:0000575Scotoma2USH1G CL E G H12459016356ORPHA:231169Usher syndrome type 1HP:0040281 - Very frequent78
HP:0000505HP:0000618Blindness2USH2A CL E G H739912601ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent777
HP:0000505HP:0000575Scotoma2USH2A CL E G H739912601ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent777
HP:0000505HP:0012377Hemianopia2USH2A CL E G H739912601ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent777
HP:0000505HP:0001141Severely reduced visual acuity2USP45 CL E G H8501520080ORPHA:65Leber congenital amaurosisHP:0040281 - Very frequent
HP:0000505HP:0000529Progressive visual loss2VRK1 CL E G H744312718ORPHA:2254Pontocerebellar hypoplasia type 132
HP:0000505HP:0000646Amblyopia2VSX1 CL E G H3081312723ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0032122Very low visual acuity2VSX1 CL E G H3081312723ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0000646Amblyopia2WAC CL E G H5132217327ORPHA:284169Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletionHP:0040283 - Occasional20
HP:0000505HP:0000646Amblyopia2WARS2 CL E G H1035212730OMIM:617710Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures.2
HP:0000505HP:0000646Amblyopia2WARS2 CL E G H1035212730ORPHA:572798WARS2-related combined oxidative phosphorylation defectHP:0040283 - Occasional2
HP:0000505HP:0000529Progressive visual loss2WDR19 CL E G H5772818340ORPHA:3156Senior-Loken syndromeHP:0040282 - Frequent95
HP:0000505HP:0000646Amblyopia2WDR26 CL E G H8023221208ORPHA:513456Intellectual disability-seizures-abnormal gait-facial dysmorphism syndromeHP:0040283 - Occasional8
HP:0000505HP:0000646Amblyopia2WDR26 CL E G H8023221208OMIM:617616Skraban-Deardorff syndrome.8
HP:0000505HP:0001141Severely reduced visual acuity2WFS1 CL E G H746612762OMIM:614296Wolfram-Like syndrome, autosomal dominant389
HP:0000505HP:0030644Blind-spot enlargment2WFS1 CL E G H746612762OMIM:614296Wolfram-Like syndrome, autosomal dominant389
HP:0000505HP:0012377Hemianopia2WHRN CL E G H2586116361ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent155
HP:0000505HP:0000575Scotoma2WHRN CL E G H2586116361ORPHA:231178Usher syndrome type 2HP:0040281 - Very frequent155
HP:0000505HP:0000618Blindness2WHRN CL E G H2586116361OMIM:611383Usher syndrome, type IID.155
HP:0000505HP:0000618Blindness2XRCC4 CL E G H751812831ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndrome9
HP:0000505HP:0000646Amblyopia2XYLT2 CL E G H6413215517OMIM:605822Spondyloocular syndrome.5
HP:0000505HP:0001133Constriction of peripheral visual field2YARS1 CL E G H856512840OMIM:619418NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2
HP:0000505HP:0000646Amblyopia2YME1L1 CL E G H1073012843OMIM:617302Optic atrophy 11.2
HP:0000505HP:0032122Very low visual acuity2ZEB1 CL E G H693511642ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional8
HP:0000505HP:0000646Amblyopia2ZEB1 CL E G H693511642ORPHA:98973Posterior polymorphous corneal dystrophyHP:0040283 - Occasional8
HP:0000505HP:0000646Amblyopia2ZFHX4 CL E G H7977630939ORPHA:91411Congenital ptosis
HP:0000505HP:0000646Amblyopia2ZMIZ1 CL E G H5717816493OMIM:618659NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA
HP:0000505HP:0000529Progressive visual loss2ZNF408 CL E G H7979720041OMIM:616468Exudative vitreoretinopathy 6.14
HP:0000505HP:0000618Blindness2ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional14
HP:0000505HP:0001141Severely reduced visual acuity2ZNF408 CL E G H7979720041ORPHA:891Familial exudative vitreoretinopathyHP:0040283 - Occasional14
HP:0000505HP:0000618Blindness2ZNF408 CL E G H7979720041ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent14
HP:0000505HP:0001133Constriction of peripheral visual field2ZNF408 CL E G H7979720041OMIM:616469Retinitis pigmentosa 72.14
HP:0000505HP:0000618Blindness2ZNF423 CL E G H2309016762ORPHA:2318Joubert syndrome with oculorenal defectHP:0040282 - Frequent49
HP:0000505HP:0000618Blindness2ZNF513 CL E G H13055726498ORPHA:791Retinitis pigmentosaHP:0040281 - Very frequent27
HP:0000505HP:0001133Constriction of peripheral visual field2ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 5827
HP:0000505HP:0001141Severely reduced visual acuity2ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 58.27
HP:0000505HP:0030533Abnormal unaided visual acuity test3 CL E G H
HP:0000505HP:0030592Abnormal static perimetry test3 CL E G H
HP:0000505HP:0030527Very severe constriction of peripheral visual field3 CL E G H
HP:0000505HP:0030590Abnormal Amsler grid test3 CL E G H
HP:0000505HP:0030552Visual acuity light perception without projection3 CL E G H
HP:0000505HP:0010822Scintillating scotoma3 CL E G H
HP:0000505HP:0030526Severe constriction of peripheral visual field3 CL E G H
HP:0000505HP:0030589Abnormal confrontational visual field test3 CL E G H
HP:0000505HP:0030525Moderate constriction of peripheral visual field3 CL E G H
HP:0000505HP:0030522Mild constriction of peripheral visual field3 CL E G H
HP:0000505HP:0030535Abnormal pinhole visual acuity test3 CL E G H
HP:0000505HP:0032285Ultra-low vision with retained light projection3 CL E G H
HP:0000505HP:0000603Central scotoma3ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0007994Peripheral visual field loss3ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0000505HP:0000603Central scotoma3ABCA4 CL E G H2434ORPHA:827Stargardt diseaseHP:0040281 - Very frequent826
HP:0000505HP:0030528Paracentral scotoma3ACO2 CL E G H50118OMIM:616289Optic atrophy 9.60
HP:0000505HP:0007994Peripheral visual field loss3AGBL5 CL E G H6050926147OMIM:617023Retinitis pigmentosa 75.2
HP:0000505HP:0030517Heteronymous hemianopia3AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0000505HP:0030591Abnormal kinetic perimetry test3AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040283 - Occasional54
HP:0000505HP:0007924Slow decrease in visual acuity3AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040283 - Occasional54
HP:0000505HP:0030517Heteronymous hemianopia3AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0000505HP:0030516Homonymous hemianopia3AMACR CL E G H23600451ORPHA:79095Congenital bile acid synthesis defect type 444
HP:0000505HP:0030553Visual acuity no light perception3APC CL E G H324583ORPHA:99818Turcot syndrome with polyposisHP:0040284 - Very rare3179
HP:0000505HP:0007994Peripheral visual field loss3ARL6 CL E G H8410013210OMIM:209900Bardet-Biedl syndrome 129
HP:0000505HP:0030529Ring scotoma3ARSG CL E G H2290124102OMIM:618144USHER SYNDROME, TYPE IV; USH4
HP:0000505HP:0000603Central scotoma3ATF6 CL E G H22926791ORPHA:49382AchromatopsiaHP:0040282 - Frequent10
HP:0000505HP:0000603Central scotoma3ATF6 CL E G H22926791OMIM:616517ACHROMATOPSIA 7; ACHM710
HP:0000505HP:0007875Congenital blindness3ATIC CL E G H471794ORPHA:250977AICA-ribosiduriaHP:0040281 - Very frequent4
HP:0000505HP:0007875Congenital blindness3ATIC CL E G H471794OMIM:608688Aicar transformylase/imp cyclohydrolase deficiency.4
HP:0000505HP:0032287Ultra-low vision with no light perception3ATOH7 CL E G H22020213907OMIM:221900Persistent hyperplastic primary vitreous, autosomal recessive4
HP:0000505HP:0000603Central scotoma3ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3ATP6 CL E G H45087414ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3ATP6 CL E G H45087414OMIM:535000Leber optic atrophy.
HP:0000505HP:0007924Slow decrease in visual acuity3BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040283 - Occasional184
HP:0000505HP:0030517Heteronymous hemianopia3BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0000505HP:0030591Abnormal kinetic perimetry test3BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040283 - Occasional184
HP:0000505HP:0007994Peripheral visual field loss3BBS1 CL E G H582966OMIM:209900Bardet-Biedl syndrome 1114
HP:0000505HP:0030517Heteronymous hemianopia3BRAF CL E G H6731097ORPHA:54595Craniopharyngioma276
HP:0000505HP:0007924Slow decrease in visual acuity3BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent276
HP:0000505HP:0030534Abnormal best corrected visual acuity test3C1QTNF5 CL E G H11490214344ORPHA:67042Late-onset retinal degenerationHP:0040281 - Very frequent20
HP:0000505HP:0000603Central scotoma3CACNA1F CL E G H7781393OMIM:300476Cone-Rod dystrophy, X-linked, 358
HP:0000505HP:0007994Peripheral visual field loss3CCDC28B CL E G H7914028163OMIM:209900Bardet-Biedl syndrome 14
HP:0000505HP:0030517Heteronymous hemianopia3CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0000505HP:0030517Heteronymous hemianopia3CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000505HP:0007875Congenital blindness3CEP290 CL E G H8018429021OMIM:610188Joubert syndrome 5.342
HP:0000505HP:0000603Central scotoma3CFAP410 CL E G H7551260OMIM:617547Retinal dystrophy with or without macular staphyloma.
HP:0000505HP:0030528Paracentral scotoma3CFH CL E G H30754883ORPHA:75376Familial drusenHP:0040283 - Occasional86
HP:0000505HP:0030528Paracentral scotoma3CFI CL E G H34265394ORPHA:75376Familial drusenHP:0040283 - Occasional57
HP:0000505HP:0007994Peripheral visual field loss3CNGA1 CL E G H12592148OMIM:613756RETINITIS PIGMENTOSA 49; RP4944
HP:0000505HP:0000603Central scotoma3CNGA3 CL E G H12612150ORPHA:49382AchromatopsiaHP:0040282 - Frequent82
HP:0000505HP:0007994Peripheral visual field loss3CNGB1 CL E G H12582151OMIM:613767Retinitis pigmentosa 45.164
HP:0000505HP:0000603Central scotoma3CNGB3 CL E G H547142153ORPHA:49382AchromatopsiaHP:0040282 - Frequent194
HP:0000505HP:0000603Central scotoma3CNGB3 CL E G H547142153ORPHA:827Stargardt diseaseHP:0040281 - Very frequent194
HP:0000505HP:0000603Central scotoma3COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3COX1 CL E G H45127419ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000603Central scotoma3COX3 CL E G H45147422ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3COX3 CL E G H45147422OMIM:535000Leber optic atrophy.
HP:0000505HP:0007994Peripheral visual field loss3CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2.158
HP:0000505HP:0000603Central scotoma3CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2158
HP:0000505HP:0030517Heteronymous hemianopia3CTNNB1 CL E G H14992514ORPHA:54595Craniopharyngioma88
HP:0000505HP:0007924Slow decrease in visual acuity3CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent88
HP:0000505HP:0007994Peripheral visual field loss3CWC27 CL E G H1028310664OMIM:250410Retinitis pigmentosa with or without skeletal anomalies4
HP:0000505HP:0007994Peripheral visual field loss3CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent101
HP:0000505HP:0000603Central scotoma3CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucomaHP:0040284 - Very rare101
HP:0000505HP:0030528Paracentral scotoma3CYP4V2 CL E G H28544023198OMIM:210370Bietti crystalline corneoretinal dystrophy.126
HP:0000505HP:0000603Central scotoma3CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040283 - Occasional126
HP:0000505HP:0030528Paracentral scotoma3CYP4V2 CL E G H28544023198ORPHA:41751Bietti crystalline dystrophyHP:0040283 - Occasional126
HP:0000505HP:0000603Central scotoma3CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3CYTB CL E G H45197427ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3CYTB CL E G H45197427OMIM:535000Leber optic atrophy.
HP:0000505HP:0007994Peripheral visual field loss3DLAT CL E G H17372896ORPHA:79244Pyruvate dehydrogenase E2 deficiencyHP:0040283 - Occasional82
HP:0000505HP:0000576Centrocecal scotoma3DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000603Central scotoma3DNAJC30 CL E G H8427716410ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000603Central scotoma3DNAJC30 CL E G H8427716410OMIM:619382LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR
HP:0000505HP:0000603Central scotoma3DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040283 - Occasional94
HP:0000505HP:0007924Slow decrease in visual acuity3DNM1L CL E G H100592973OMIM:610708Optic atrophy 5.94
HP:0000505HP:0000603Central scotoma3DNM1L CL E G H100592973OMIM:610708Optic atrophy 5.94
HP:0000505HP:0030528Paracentral scotoma3EFEMP1 CL E G H22023218ORPHA:75376Familial drusenHP:0040283 - Occasional54
HP:0000505HP:0000603Central scotoma3EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucomaHP:0040284 - Very rare54
HP:0000505HP:0007994Peripheral visual field loss3EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent54
HP:0000505HP:0000603Central scotoma3ELOVL4 CL E G H678514415ORPHA:827Stargardt diseaseHP:0040281 - Very frequent62
HP:0000505HP:0007924Slow decrease in visual acuity3FA2H CL E G H7915221197ORPHA:329308Fatty acid hydroxylase-associated neurodegenerationHP:0040282 - Frequent76
HP:0000505HP:0000603Central scotoma3FDXR CL E G H22323642ORPHA:543470Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndromeHP:0040283 - Occasional
HP:0000505HP:0030529Ring scotoma3FLVCR1 CL E G H2898224682OMIM:609033Ataxia, posterior column, with retinitis pigmentosa111
HP:0000505HP:0032284Ultra-low vision with retained motion projection3GDF6 CL E G H3922554221OMIM:615360LEBER CONGENITAL AMAUROSIS 17; LCA1764
HP:0000505HP:0000603Central scotoma3GNAT2 CL E G H27804394ORPHA:49382AchromatopsiaHP:0040282 - Frequent19
HP:0000505HP:0007924Slow decrease in visual acuity3GUCA1A CL E G H29784678ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent24
HP:0000505HP:0007924Slow decrease in visual acuity3GUCY2D CL E G H30004689ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent124
HP:0000505HP:0007994Peripheral visual field loss3GUCY2D CL E G H30004689OMIM:601777Cone-Rod dystrophy 6.124
HP:0000505HP:0030528Paracentral scotoma3HKDC1 CL E G H8020123302OMIM:619614RETINITIS PIGMENTOSA 92; RP922
HP:0000505HP:0030530Arcuate scotoma3HLA-A CL E G H31054931ORPHA:179Birdshot chorioretinopathyHP:0040283 - Occasional4
HP:0000505HP:0032286Ultra-low vision with retained light perception3HMX1 CL E G H31665017OMIM:612109Oculoauricular syndrome2
HP:0000505HP:0007994Peripheral visual field loss3IDS CL E G H34235389ORPHA:217093Mucopolysaccharidosis type 2, attenuated formHP:0040283 - Occasional86
HP:0000505HP:0007994Peripheral visual field loss3IDS CL E G H34235389ORPHA:217085Mucopolysaccharidosis type 2, severe formHP:0040283 - Occasional86
HP:0000505HP:0007994Peripheral visual field loss3IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly148
HP:0000505HP:0000603Central scotoma3IMPG2 CL E G H5093918362OMIM:616152Macular dystrophy, vitelliform, 5.120
HP:0000505HP:0000603Central scotoma3ITM2B CL E G H94456174OMIM:616079Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities.3
HP:0000505HP:0007994Peripheral visual field loss3LCA5 CL E G H16769131923ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent70
HP:0000505HP:0000603Central scotoma3LOC111365204 CL E G H111365204OMIM:136550Macular dystrophy, retinal, 1, north Carolina type.
HP:0000505HP:0007875Congenital blindness3LRAT CL E G H92276685OMIM:613341Leber congenital amaurosis 14.62
HP:0000505HP:0007994Peripheral visual field loss3LRAT CL E G H92276685ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent62
HP:0000505HP:0007875Congenital blindness3LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndromeHP:0040282 - Frequent125
HP:0000505HP:0030551Visual acuity light perception with projection3LRP5 CL E G H40416697ORPHA:2788Osteoporosis-pseudoglioma syndromeHP:0040283 - Occasional125
HP:0000505HP:0030517Heteronymous hemianopia3MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0000505HP:0000603Central scotoma3MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI.203
HP:0000505HP:0007924Slow decrease in visual acuity3MFN2 CL E G H992716877OMIM:601152Hereditary motor and sensory neuropathy VI.203
HP:0000505HP:0000603Central scotoma3MFSD8 CL E G H25647128486OMIM:616170Macular dystrophy with central cone involvement.120
HP:0000505HP:0000603Central scotoma3MTRFR CL E G H9157426784OMIM:615035Spastic paraplegia 55, autosomal recessive.
HP:0000505HP:0007994Peripheral visual field loss3MYOC CL E G H46537610ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent47
HP:0000505HP:0000603Central scotoma3MYOC CL E G H46537610ORPHA:98977Juvenile glaucomaHP:0040284 - Very rare47
HP:0000505HP:0000576Centrocecal scotoma3ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000603Central scotoma3ND1 CL E G H45357455ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3ND1 CL E G H45357455OMIM:535000Leber optic atrophy.
HP:0000505HP:0007924Slow decrease in visual acuity3ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000603Central scotoma3ND2 CL E G H45367456ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3ND2 CL E G H45367456OMIM:535000Leber optic atrophy.
HP:0000505HP:0000603Central scotoma3ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3ND4 CL E G H45387459ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3ND4 CL E G H45387459OMIM:535000Leber optic atrophy.
HP:0000505HP:0007924Slow decrease in visual acuity3ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000603Central scotoma3ND4L CL E G H45397460ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3ND4L CL E G H45397460OMIM:535000Leber optic atrophy.
HP:0000505HP:0000576Centrocecal scotoma3ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000603Central scotoma3ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3ND5 CL E G H45407461ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3ND5 CL E G H45407461OMIM:535000Leber optic atrophy.
HP:0000505HP:0000603Central scotoma3ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0007924Slow decrease in visual acuity3ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent
HP:0000505HP:0000576Centrocecal scotoma3ND6 CL E G H45417462ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent
HP:0000505HP:0000576Centrocecal scotoma3ND6 CL E G H45417462OMIM:535000Leber optic atrophy.
HP:0000505HP:0000576Centrocecal scotoma3NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent65
HP:0000505HP:0000603Central scotoma3NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathyHP:0040282 - Frequent65
HP:0000505HP:0007924Slow decrease in visual acuity3NDUFS2 CL E G H47207708ORPHA:104Leber hereditary optic neuropathyHP:0040281 - Very frequent65
HP:0000505HP:0007924Slow decrease in visual acuity3NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040283 - Occasional220
HP:0000505HP:0030591Abnormal kinetic perimetry test3NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040283 - Occasional220
HP:0000505HP:0030517Heteronymous hemianopia3NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0000505HP:0032286Ultra-low vision with retained light perception3NMNAT1 CL E G H6480217877OMIM:608553Leber congenital amaurosis 915
HP:0000505HP:0007875Congenital blindness3NSMCE2 CL E G H28605326513ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndromeHP:0040283 - Occasional2
HP:0000505HP:0000603Central scotoma3OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040283 - Occasional214
HP:0000505HP:0000603Central scotoma3OPA1 CL E G H49768140OMIM:165500Optic atrophy 1.214
HP:0000505HP:0000576Centrocecal scotoma3OPA1 CL E G H49768140OMIM:165500Optic atrophy 1.214
HP:0000505HP:0000603Central scotoma3OPA1 CL E G H49768140OMIM:125250Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy.214
HP:0000505HP:0000576Centrocecal scotoma3OPA1 CL E G H49768140OMIM:125250Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy.214
HP:0000505HP:0000603Central scotoma3OPA3 CL E G H802078142ORPHA:67036Autosomal dominant optic atrophy and cataractHP:0040282 - Frequent163
HP:0000505HP:0030534Abnormal best corrected visual acuity test3PAX6 CL E G H50808620ORPHA:137902Isolated optic nerve hypoplasia/aplasiaHP:0040281 - Very frequent194
HP:0000505HP:0007994Peripheral visual field loss3PDE6A CL E G H51458785OMIM:613810RETINITIS PIGMENTOSA 43; RP43116
HP:0000505HP:0000603Central scotoma3PDE6C CL E G H51468787ORPHA:49382AchromatopsiaHP:0040282 - Frequent80
HP:0000505HP:0000603Central scotoma3PDE6H CL E G H51498790ORPHA:49382AchromatopsiaHP:0040282 - Frequent14
HP:0000505HP:0030591Abnormal kinetic perimetry test3PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040283 - Occasional9
HP:0000505HP:0007924Slow decrease in visual acuity3PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040283 - Occasional9
HP:0000505HP:0030517Heteronymous hemianopia3PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0000505HP:0030517Heteronymous hemianopia3PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0000505HP:0030591Abnormal kinetic perimetry test3PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040283 - Occasional162
HP:0000505HP:0007924Slow decrease in visual acuity3PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040283 - Occasional162
HP:0000505HP:0000603Central scotoma3PITPNM3 CL E G H8339421043OMIM:600977Cone-Rod dystrophy 5135
HP:0000505HP:0000603Central scotoma3POC1B CL E G H28280930836OMIM:615973Cone-Rod dystrophy 20.3
HP:0000505HP:0007994Peripheral visual field loss3POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndromeHP:0040282 - Frequent40
HP:0000505HP:0000603Central scotoma3PROM1 CL E G H88429454OMIM:612657CONE-ROD DYSTROPHY 12; CORD12110
HP:0000505HP:0000603Central scotoma3PROM1 CL E G H88429454OMIM:608051Macular dystrophy, retinal, 2.110
HP:0000505HP:0007994Peripheral visual field loss3PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0000505HP:0000603Central scotoma3PROM1 CL E G H88429454ORPHA:827Stargardt diseaseHP:0040281 - Very frequent110
HP:0000505HP:0007924Slow decrease in visual acuity3PRPH2 CL E G H59619942ORPHA:75377Central areolar choroidal dystrophyHP:0040282 - Frequent159
HP:0000505HP:0007994Peripheral visual field loss3PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent159
HP:0000505HP:0000603Central scotoma3PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent159
HP:0000505HP:0000603Central scotoma3PRPH2 CL E G H59619942ORPHA:827Stargardt diseaseHP:0040281 - Very frequent159
HP:0000505HP:0000603Central scotoma3RAB28 CL E G H93649768OMIM:615374Cone-Rod dystrophy 18.6
HP:0000505HP:0007924Slow decrease in visual acuity3RAX2 CL E G H8483918286OMIM:610381Cone-Rod dystrophy 11.52
HP:0000505HP:0000603Central scotoma3RBP3 CL E G H59499921OMIM:615233Retinitis pigmentosa 66.108
HP:0000505HP:0007875Congenital blindness3RD3 CL E G H34303519689OMIM:610612Leber congenital amaurosis 12.HP:0003577 - Congenital onset95
HP:0000505HP:0007994Peripheral visual field loss3RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent32
HP:0000505HP:0000603Central scotoma3RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent32
HP:0000505HP:0000603Central scotoma3RHO CL E G H601010012ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent107
HP:0000505HP:0007994Peripheral visual field loss3RHO CL E G H601010012ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent107
HP:0000505HP:0030528Paracentral scotoma3RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0030529Ring scotoma3RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0000603Central scotoma3RLBP1 CL E G H601710024ORPHA:85128Bothnia retinal dystrophyHP:0040283 - Occasional47
HP:0000505HP:0000603Central scotoma3RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent47
HP:0000505HP:0007994Peripheral visual field loss3RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent47
HP:0000505HP:0007994Peripheral visual field loss3RNU4ATAC CL E G H10015168334016OMIM:226960EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS15
HP:0000505HP:0007924Slow decrease in visual acuity3RP1L1 CL E G H9413715946OMIM:613587OCCULT MACULAR DYSTROPHY; OCMD284
HP:0000505HP:0007761Pericentral scotoma3RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked45
HP:0000505HP:0000603Central scotoma3RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked45
HP:0000505HP:0030529Ring scotoma3RP2 CL E G H610210274OMIM:312600Retinitis pigmentosa 2, X-linked45
HP:0000505HP:0007994Peripheral visual field loss3RPE65 CL E G H612110294OMIM:618697RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87129
HP:0000505HP:0007994Peripheral visual field loss3RPE65 CL E G H612110294ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent129
HP:0000505HP:0000603Central scotoma3RPGR CL E G H610310295ORPHA:49382AchromatopsiaHP:0040282 - Frequent200
HP:0000505HP:0030529Ring scotoma3RPGR CL E G H610310295OMIM:300029Retinitis pigmentosa 3200
HP:0000505HP:0007994Peripheral visual field loss3RRM2B CL E G H5048417296OMIM:268315ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION125
HP:0000505HP:0000603Central scotoma3RTN4IP1 CL E G H8481618647OMIM:616732OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA102
HP:0000505HP:0007875Congenital blindness3SARDH CL E G H175710536ORPHA:3129SarcosinemiaHP:0040283 - Occasional4
HP:0000505HP:0007994Peripheral visual field loss3SDHA CL E G H638910680OMIM:619259NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA304
HP:0000505HP:0007994Peripheral visual field loss3SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 10.48
HP:0000505HP:0007994Peripheral visual field loss3SH3TC2 CL E G H7962829427ORPHA:99949Charcot-Marie-Tooth disease type 4CHP:0040284 - Very rare493
HP:0000505HP:0007994Peripheral visual field loss3SLC6A6 CL E G H653311052OMIM:145350Hypotaurinemic retinal degeneration and cardiomyopathy
HP:0000505HP:0030517Heteronymous hemianopia3SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0000505HP:0007924Slow decrease in visual acuity3SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040283 - Occasional87
HP:0000505HP:0030591Abnormal kinetic perimetry test3SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040283 - Occasional87
HP:0000505HP:0030517Heteronymous hemianopia3SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0000505HP:0007924Slow decrease in visual acuity3SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040283 - Occasional47
HP:0000505HP:0030591Abnormal kinetic perimetry test3SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040283 - Occasional47
HP:0000505HP:0030517Heteronymous hemianopia3SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0000505HP:0007924Slow decrease in visual acuity3SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040283 - Occasional22
HP:0000505HP:0030591Abnormal kinetic perimetry test3SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040283 - Occasional22
HP:0000505HP:0007994Peripheral visual field loss3SPATA7 CL E G H5581220423ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent48
HP:0000505HP:0007924Slow decrease in visual acuity3SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040283 - Occasional124
HP:0000505HP:0030517Heteronymous hemianopia3SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0000505HP:0030591Abnormal kinetic perimetry test3SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040283 - Occasional124
HP:0000505HP:0030591Abnormal kinetic perimetry test3TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040283 - Occasional238
HP:0000505HP:0007924Slow decrease in visual acuity3TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040283 - Occasional238
HP:0000505HP:0030517Heteronymous hemianopia3TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0000505HP:0007924Slow decrease in visual acuity3TGFBI CL E G H704511771ORPHA:98964Lattice corneal dystrophy type IHP:0040283 - Occasional58
HP:0000505HP:0007924Slow decrease in visual acuity3TGFBI CL E G H704511771ORPHA:98960Thiel-Behnke corneal dystrophyHP:0040281 - Very frequent58
HP:0000505HP:0000603Central scotoma3TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndromeHP:0040283 - Occasional15
HP:0000505HP:0000603Central scotoma3TMEM126A CL E G H8423325382OMIM:612989Optic atrophy 7 with or without auditory neuropathy23
HP:0000505HP:0007924Slow decrease in visual acuity3TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040283 - Occasional
HP:0000505HP:0030517Heteronymous hemianopia3TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0000505HP:0030591Abnormal kinetic perimetry test3TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040283 - Occasional
HP:0000505HP:0030529Ring scotoma3TRNT1 CL E G H5109517341OMIM:616959Retinitis pigmentosa and erythrocytic microcytosis28
HP:0000505HP:0030534Abnormal best corrected visual acuity test3TUBB3 CL E G H1038120772ORPHA:300570Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutationHP:0040283 - Occasional64
HP:0000505HP:0007875Congenital blindness3XRCC4 CL E G H751812831ORPHA:436182Microcephalic primordial dwarfism-insulin resistance syndromeHP:0040283 - Occasional9
HP:0000505HP:0007994Peripheral visual field loss3ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 58.27
HP:0000505HP:0030581Pinhole visual acuity 1.3 LogMAR4 CL E G H
HP:0000505HP:0030547Unaided visual acuity 1.2 LogMAR4 CL E G H
HP:0000505HP:0030568Best corrected visual acuity 3.0 LogMAR4 CL E G H
HP:0000505HP:0030593Abnormal manual kinetic perimetry test4 CL E G H
HP:0000505HP:0030555Best corrected visual acuity 0.2 LogMAR4 CL E G H
HP:0000505HP:0030574Pinhole visual acuity 0.6 LogMAR4 CL E G H
HP:0000505HP:0030540Unaided visual acuity 0.5 LogMAR4 CL E G H
HP:0000505HP:0030561Best corrected visual acuity 0.8 LogMAR4 CL E G H
HP:0000505HP:0030519Congruous heteronymous hemianopia4 CL E G H
HP:0000505HP:0030580Pinhole visual acuity 1.2 LogMAR4 CL E G H
HP:0000505HP:0030546Unaided visual acuity 1.1 LogMAR4 CL E G H
HP:0000505HP:0030567Best corrected visual acuity 2.0 LogMAR4 CL E G H
HP:0000505HP:0030554Best corrected visual acuity 0.1 LogMAR4 CL E G H
HP:0000505HP:0030539Unaided visual acuity 0.4 LogMAR4 CL E G H
HP:0000505HP:0030573Pinhole visual acuity 0.5 LogMAR4 CL E G H
HP:0000505HP:0030560Best corrected visual acuity 0.6 LogMAR4 CL E G H
HP:0000505HP:0030518Congruous homonymous hemianopia4 CL E G H
HP:0000505HP:0030579Pinhole visual acuity 1.1 LogMAR4 CL E G H
HP:0000505HP:0030545Unaided visual acuity 1.0 LogMAR4 CL E G H
HP:0000505HP:0030566Best corrected visual acuity 1.3 LogMAR4 CL E G H
HP:0000505HP:0030538Unaided visual acuity 0.3 LogMAR4 CL E G H
HP:0000505HP:0030572Pinhole visual acuity 0.4 LogMAR4 CL E G H
HP:0000505HP:0030559Best corrected visual acuity 0.7 LogMAR4 CL E G H
HP:0000505HP:0030578Pinhole visual acuity 1.0 LogMAR4 CL E G H
HP:0000505HP:0030544Unaided visual acuity 0.9 LogMAR4 CL E G H
HP:0000505HP:0030565Best corrected visual acuity 1.2 LogMAR4 CL E G H
HP:0000505HP:0030550Unaided visual acuity 3.0 LogMAR4 CL E G H
HP:0000505HP:0030571Pinhole visual acuity 0.3 LogMAR4 CL E G H
HP:0000505HP:0030537Unaided visual acuity 0.2 LogMAR4 CL E G H
HP:0000505HP:0030558Best corrected visual acuity 0.5 LogMAR4 CL E G H
HP:0000505HP:0030577Pinhole visual acuity 0.9 LogMAR4 CL E G H
HP:0000505HP:0030543Unaided visual acuity 0.8 LogMAR4 CL E G H
HP:0000505HP:0030564Best corrected visual acuity 1.1 LogMAR4 CL E G H
HP:0000505HP:0030583Pinhole visual acuity 3.0 LogMAR4 CL E G H
HP:0000505HP:0030549Unaided visual acuity 2.0 LogMAR4 CL E G H
HP:0000505HP:0030570Pinhole visual acuity 0.2 LogMAR4 CL E G H
HP:0000505HP:0030536Unaided visual acuity 0.1 LogMAR4 CL E G H
HP:0000505HP:0030557Best corrected visual acuity 0.4 LogMAR4 CL E G H
HP:0000505HP:0030595Abnormal static automated perimetry test4 CL E G H
HP:0000505HP:0030576Pinhole visual acuity 0.8 LogMAR4 CL E G H
HP:0000505HP:0030542Unaided visual acuity 0.7 LogMAR4 CL E G H
HP:0000505HP:0030563Best corrected visual acuity 1.0 LogMAR4 CL E G H
HP:0000505HP:0030582Pinhole visual acuity 2.0 LogMAR4 CL E G H
HP:0000505HP:0030548Unaided visual acuity 1.3 LogMAR4 CL E G H
HP:0000505HP:0030569Pinhole visual acuity 0.1 LogMAR4 CL E G H
HP:0000505HP:0030594Abnormal automated kinetic perimetry test4 CL E G H
HP:0000505HP:0030556Best corrected visual acuity 0.3 LogMAR4 CL E G H
HP:0000505HP:0030575Pinhole visual acuity 0.7 LogMAR4 CL E G H
HP:0000505HP:0030541Unaided visual acuity 0.6 LogMAR4 CL E G H
HP:0000505HP:0030562Best corrected visual acuity 0.9 LogMAR4 CL E G H
HP:0000505HP:0030520Binasal hemianopia4 CL E G H
HP:0000505HP:0030521Bitemporal hemianopia4AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040283 - Occasional95
HP:0000505HP:0030521Bitemporal hemianopia4AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0000505HP:0030521Bitemporal hemianopia4BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0000505HP:0030521Bitemporal hemianopia4BRAF CL E G H6731097ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent276
HP:0000505HP:0030521Bitemporal hemianopia4CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040283 - Occasional636
HP:0000505HP:0030521Bitemporal hemianopia4CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0000505HP:0030521Bitemporal hemianopia4CTNNB1 CL E G H14992514ORPHA:54595CraniopharyngiomaHP:0040282 - Frequent88
HP:0000505HP:0030521Bitemporal hemianopia4MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040283 - Occasional462
HP:0000505HP:0030521Bitemporal hemianopia4NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0000505HP:0030521Bitemporal hemianopia4PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0000505HP:0030521Bitemporal hemianopia4PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0000505HP:0030521Bitemporal hemianopia4SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0000505HP:0030521Bitemporal hemianopia4SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0000505HP:0030521Bitemporal hemianopia4SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0000505HP:0030521Bitemporal hemianopia4SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0000505HP:0030521Bitemporal hemianopia4TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0000505HP:0030521Bitemporal hemianopia4TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0000505HP:0030599Abnormal Estermann grid perimetry test5 CL E G H
HP:0000505HP:0030598Abnormal Humphrey SITA 10-2 perimetry test5 CL E G H
HP:0000505HP:0030597Abnormal Humphrey SITA 24-2 perimetry test5 CL E G H
HP:0000505HP:0030596Abnormal Humphrey SITA 30-2 perimetry test5 CL E G H


Genes (1078) :AAAS AARS1 ABCA1 ABCA4 ABCC6 ABCD1 ACO2 ACTB ACVRL1 ADA2 ADAM9 ADAMTS10 ADAMTSL4 ADARB1 ADGRV1 ADNP AFF3 AFF4 AFG3L2 AGBL1 AGBL5 AGO2 AGTPBP1 AHDC1 AHI1 AHR AIFM1 AIMP1 AIP AIPL1 AIRE AKT1 AKT3 ALDH3A2 ALG2 ALG3 ALMS1 ALPK1 AMACR AMPD2 ANGPTL6 ANKH ANKRD11 ANKRD55 ANOS1 ANTXR1 AP1G1 AP3B1 AP3D1 AP4B1 AP4E1 AP4M1 AP4S1 APC APOE ARHGDIA ARHGEF18 ARHGEF2 ARID1A ARID1B ARID2 ARL2 ARL2BP ARL3 ARL6 ARMC9 ARNT2 ARPC4 ARSA ARSG ARX ASB10 ASNS ASPA ASPH ATF6 ATIC ATN1 ATOH7 ATP1A2 ATP1A3 ATP6 ATP6V0A1 ATRX ATXN7 B3GALNT2 B3GAT3 B3GLCT B4GAT1 BAP1 BAZ1B BBS1 BBS2 BBS5 BCL10 BCL7B BCOR BDNF BEST1 BIRC3 BLOC1S3 BLOC1S5 BMP4 BMPR1A BOLA3 BRAF BRAT1 BRCA1 BRCA2 BRIP1 BTD BTNL2 BUD23 C19ORF12 C1QBP C1QTNF5 C4A CA2 CA4 CABP4 CACNA1A CACNA1B CACNA1D CACNA1E CACNA1F CACNA2D4 CAMK2B CAPN5 CARS2 CASK CASZ1 CBS CC2D2A CCDC141 CCDC28B CCDC47 CCND1 CCR1 CD109 CD247 CDC42 CDC42BPB CDH23 CDH3 CDHR1 CDK8 CDKL5 CDON CEP120 CEP164 CEP250 CEP290 CEP41 CEP78 CEP85L CERKL CERT1 CFAP410 CFAP418 CFH CFHR1 CFHR3 CFI CHD3 CHD7 CHKA CHM CHMP1A CHN1 CHP1 CHRDL1 CHST3 CHST6 CIB2 CKAP2L CLCC1 CLCN2 CLCN4 CLCN6 CLCN7 CLEC3B CLIP2 CLN3 CLN5 CLN6 CLN8 CLP1 CLRN1 CLTC CNGA1 CNGA3 CNGB1 CNGB3 CNNM4 CNTNAP1 COG5 COL11A1 COL17A1 COL18A1 COL25A1 COL2A1 COL3A1 COL4A1 COL7A1 COL8A2 COL9A1 COL9A2 COL9A3 COPB2 COQ2 COQ7 COX1 COX2 COX3 COX6B1 COX7B CPSF3 CRB1 CREBBP CRX CRYAA CRYBB1 CRYGC CSF1R CSPP1 CTC1 CTLA4 CTNNB1 CTNS CTSD CWC27 CYP1B1 CYP27A1 CYP4V2 CYSLTR2 CYTB D2HGDH DCC DCN DCT DDR2 DDX3X DHDDS DHX37 DHX38 DIAPH1 DISP1 DLAT DLD DLL1 DNAJC30 DNM1L DOCK7 DOHH DOLK DPF2 DPM1 DPP6 DRAM2 DTNBP1 DTYMK DUSP6 DYRK1A EARS2 EFEMP1 EIF2B1 EIF2B2 EIF2B3 EIF2B4 EIF2B5 EIF4H ELMO2 ELN ELOVL1 ELOVL4 ELP4 EMC1 ENG ENPP1 EPCAM EPM2A EPRS1 ERAP1 ERCC1 ERCC2 ERCC4 ERCC5 ERCC6 ERCC8 ERF ESPN EXOSC3 EXOSC8 EXOSC9 EYS FA2H FAM161A FAN1 FANCA FANCB FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM FARS2 FAS FBN1 FBN2 FBXW7 FCSK FDFT1 FDX2 FDXR FEZF1 FGF12 FGF17 FGF8 FGFR1 FGFR2 FGFR3 FH FIG4 FKBP6 FKRP FKTN FLNA FLRT3 FLVCR1 FN1 FOXC1 FOXE3 FOXH1 FOXL2 FOXP1 FOXRED1 FRAS1 FREM2 FRMD7 FSCN2 FXN FZD4 GABRA2 GABRB1 GABRB2 GABRD GALC GAS1 GATA1 GATA2 GDF2 GDF3 GDF6 GJA1 GJB2 GJB6 GLB1 GLI2 GLRX5 GLYCTK GM2A GMPPA GMPPB GNA11 GNAQ GNAS GNAT1 GNAT2 GNB1 GNB3 GNS GP1BA GP1BB GPAA1 GPR101 GPR143 GPR179 GRHL2 GRIK2 GRIN1 GRIN2D GRIP1 GRK1 GRM6 GRM7 GRN GSN GTF2I GTF2IRD1 GTF2IRD2 GTPBP2 GTPBP3 GUCA1A GUCA1B GUCY2D GUSB H1-4 H3-3A H4C3 H4C9 HADHA HARS1 HCCS HDAC4 HECW2 HESX1 HEXB HGSNAT HIKESHI HK1 HKDC1 HLA-A HLA-B HLA-DPA1 HLA-DPB1 HLA-DQB1 HLA-DRB1 HMCN1 HMX1 HPDL HPS1 HPS3 HPS4 HPS5 HPS6 HS6ST1 HSD17B10 HSD17B4 HSPG2 IBA57 IDH3A IDH3B IDS IFNGR1 IFT140 IFT172 IFT74 IFT88 IGBP1 IGH IKBKG IKZF1 IL10 IL12A IL12A-AS1 IL17RD IL23R IL2RA IL2RB IMPDH1 IMPG1 IMPG2 INPP5E INVS IQCB1 IQSEC1 ISCA2 ITGA2 ITGA2B ITGB3 ITM2B ITPR1 JAK2 KANSL1 KARS1 KAT6A KCNAB2 KCNJ13 KCNN2 KCNV2 KCTD7 KERA KIAA0586 KIAA1549 KIDINS220 KIF11 KIF14 KIF1A KIF1C KIF3B KIF5A KIZ KLHL7 KLRC4 KMT2B KRAS KRT12 LAMA1 LAMB2 LAMC3 LAMP2 LARGE1 LCA5 LCAT LEMD3 LETM1 LIM2 LIMK1 LMBRD2 LMNB1 LOC111365204 LONP1 LOXL3 LRAT LRIT3 LRP2 LRP5 LRPAP1 LSS LTBP2 LUZP1 LYRM7 LYST LZTFL1 MAB21L1 MACF1 MAD2L2 MAF MAFB MAG MAK MALT1 MAP3K7 MAPK8IP3 MAPKAPK3 MARK3 MBD5 MC1R MCOLN1 MECR MED25 MEFV MEN1 MERTK METTL27 MFF MFN2 MFRP MFSD8 MICOS13 MICU1 MIR184 MIR204 MKS1 MLH1 MLH3 MLXIPL MMACHC MMP1 MMP19 MMP23B MPL MSH2 MSH6 MSX2 MTFMT MTHFS MTOR MTR MTRFR MTRR MTTP MYO7A MYOC NAA10 NADK2 NAGA NAPB NARS2 NBAS NCAPG2 NCF1 ND1 ND2 ND3 ND4 ND4L ND5 ND6 NDE1 NDNF NDP NDUFA1 NDUFA11 NDUFA6 NDUFAF1 NDUFAF2 NDUFAF3 NDUFAF4 NDUFAF5 NDUFAF8 NDUFB10 NDUFB11 NDUFB3 NDUFB8 NDUFB9 NDUFS1 NDUFS2 NDUFS3 NDUFS4 NDUFS6 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NEK2 NEU1 NEUROD2 NF1 NF2 NFIX NHLRC1 NHLRC2 NHS NLRP3 NMNAT1 NOD2 NODAL NOG NOTCH3 NPHP1 NPHP3 NPHP4 NR2E3 NR2F1 NR3C1 NRL NSMCE2 NTRK2 NUBPL NUS1 NYX OAT OCA2 OCRL OFD1 OGDHL OGT OPA1 OPA3 OPN1LW OPN1MW OPN1SW OSGEP OSTM1 OTX2 OVOL2 P3H2 P4HA2 P4HTM PAK2 PALB2 PANK2 PANK4 PARS2 PAX2 PAX6 PCARE PCDH12 PCDH15 PCYT1A PCYT2 PDE4D PDE6A PDE6B PDE6C PDE6G PDE6H PDGFB PDHA1 PDPN PDSS2 PDXK PDZD7 PDZD8 PEPD PET100 PEX1 PEX10 PEX11B PEX12 PEX13 PEX14 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PEX7 PGAP1 PGK1 PHF6 PHGDH PHOX2A PHYH PI4KA PIEZO2 PIGA PIGB PIGN PIGP PIGQ PIGS PIGT PIGU PIGY PIK3CA PIK3R2 PITPNM3 PITX2 PITX3 PLA2G6 PLCH1 PLEKHM1 PLG PLK4 PLOD1 PLXND1 PMPCB PMS1 PMS2 PNPLA6 PNPT1 POC1B POGZ POLA1 POLG POLG2 POLR1B POLR1C POLR1D POLR2A POLR3GL POMGNT1 POMK POMT1 POMT2 PORCN POU3F4 PPP1R12A PPP2CA PPP2R1A PPP3CA PPT1 PQBP1 PRCD PRDM16 PRDM5 PRDX1 PRIMPOL PRKCZ PRKDC PRNP PROK2 PROKR2 PROM1 PRORP PROS1 PRPF3 PRPF31 PRPF4 PRPF6 PRPF8 PRPH2 PRPS1 PRR12 PRRT2 PRTN3 PRUNE1 PSAP PSMD12 PTCH1 PTPN2 PTPN22 PUF60 PUS3 PXDN PYCR2 RAB11B RAB18 RAB28 RAB3GAP1 RAB3GAP2 RAC1 RAD51 RAD51C RALGAPA1 RAX2 RBP3 RBP4 RCBTB1 RD3 RDH11 RDH12 RDH5 REEP6 RERE REV3L RFC2 RFT1 RFWD3 RGR RGS9 RGS9BP RHO RHOA RIC1 RIMS1 RIMS2 RLBP1 RMRP RNF13 RNU4ATAC ROM1 RORA RP1 RP1L1 RP2 RP9 RPE65 RPGR RPGRIP1 RPGRIP1L RPS20 RRAS2 RRM2B RS1 RTN4IP1 SAG SALL2 SALL4 SAR1B SARDH SCAPER SCN1A SCN3A SCN8A SCO2 SDCCAG8 SDHA SDHAF1 SDHB SDHD SELENOI SEMA3A SEMA4A SEPSECS SETBP1 SETD1A SETD5 SF3B1 SF3B2 SFXN4 SH3BP2 SH3TC2 SHANK3 SHH SIX3 SKI SLC19A2 SLC1A3 SLC24A1 SLC24A5 SLC25A1 SLC25A4 SLC25A46 SLC35A2 SLC38A3 SLC38A8 SLC39A14 SLC39A4 SLC45A2 SLC4A11 SLC52A2 SLC6A6 SLC7A14 SLX4 SMAD4 SMARCA2 SMARCA4 SMARCB1 SMARCC2 SMARCD1 SMARCE1 SMC1A SMCHD1 SMG9 SMO SNRNP200 SNRPN SNX10 SOBP SON SOST SOX10 SOX11 SOX2 SOX3 SOX4 SPATA5 SPATA5L1 SPATA7 SPEN SPG11 SPRY4 SPTBN1 SPTBN4 SRD5A3 SREBF1 SRY ST3GAL5 STAG2 STAT4 STIL STX1A STX3 SUCLA2 SUFU SUMF1 SUOX SURF1 SYNJ1 SYT1 TACR3 TACSTD2 TANGO2 TAOK1 TASP1 TAT TBC1D20 TBC1D24 TBC1D2B TBCK TBL2 TBX1 TCF4 TCIRG1 TCOF1 TDGF1 TEK TELO2 TENM3 TERT TFE3 TFG TGFBI TGFBR2 TGFBR3 TGIF1 THOC2 THPO THSD1 TIMM8A TIMMDC1 TIMP3 TK2 TLCD3B TLR4 TMEM126A TMEM126B TMEM138 TMEM216 TMEM231 TMEM237 TMEM270 TMEM53 TMEM67 TMEM98 TNFRSF11A TNFSF11 TOPORS TP53 TP53RK TPP1 TRAF3IP1 TRAF7 TRAPPC11 TRAPPC12 TRAPPC2L TREX1 TRIM44 TRIO TRNC TRNE TRNF TRNH TRNK TRNL1 TRNQ TRNS1 TRNS2 TRNT1 TRNV TRNW TRPM1 TRRAP TSEN15 TSEN2 TSEN34 TSEN54 TSFM TSPAN12 TTC8 TTLL5 TTPA TTR TUB TUBA3D TUBB2B TUBB3 TUBB4A TUBB4B TUBGCP2 TUBGCP4 TUBGCP6 TULP1 TWIST1 TWIST2 TWNK TYR UBAC2 UBE2T UBE4B UCHL1 UFM1 UNC119 UROD UROS USH1C USH1G USH2A USP45 USP48 USP8 VAMP2 VCAN VHL VPS11 VPS13B VPS37D VPS4A VPS51 VRK1 VSX1 WAC WARS2 WASF1 WDR11 WDR19 WDR26 WDR45B WFS1 WHRN WT1 XRCC2 XRCC4 XYLT1 XYLT2 YAP1 YARS1 YIF1B YME1L1 ZEB1 ZEB2 ZFHX4 ZFYVE26 ZIC2 ZMIZ1 ZNF408 ZNF423 ZNF469 ZNF513 ZNHIT3

Diseases (1028) :ORPHA:869 OMIM:619661 OMIM:205400 ORPHA:1872 OMIM:604116 ORPHA:791 OMIM:601718 ORPHA:827 ORPHA:758 OMIM:177850 OMIM:264800 OMIM:300100 ORPHA:139396 OMIM:616289 ORPHA:79107 ORPHA:774 ORPHA:820 OMIM:612775 ORPHA:3449 OMIM:277600 ORPHA:1885 OMIM:618862 ORPHA:231178 ORPHA:404448 OMIM:615873 OMIM:619297 ORPHA:444077 OMIM:618977 ORPHA:98974 OMIM:617023 OMIM:619149 ORPHA:2254 ORPHA:412069 OMIM:608629 ORPHA:220493 OMIM:618345 ORPHA:83629 OMIM:260600 ORPHA:2965 ORPHA:65 OMIM:604393 OMIM:268000 OMIM:240300 ORPHA:3453 ORPHA:2495 ORPHA:99802 OMIM:270200 OMIM:607906 OMIM:601110 ORPHA:64 OMIM:203800 OMIM:614979 OMIM:614307 ORPHA:79095 OMIM:615809 ORPHA:231160 ORPHA:1522 ORPHA:261250 ORPHA:85410 ORPHA:478 ORPHA:2067 OMIM:619467 OMIM:608233 ORPHA:1000 ORPHA:54 ORPHA:280763 ORPHA:99818 OMIM:603075 OMIM:615244 OMIM:617433 OMIM:617523 ORPHA:1465 OMIM:614607 OMIM:135900 OMIM:619082 OMIM:615434 OMIM:618161 OMIM:618173 OMIM:209900 OMIM:600151 OMIM:617622 ORPHA:3157 OMIM:615926 OMIM:620141 ORPHA:309271 ORPHA:309263 ORPHA:309256 ORPHA:231183 OMIM:618144 OMIM:300004 OMIM:603383 OMIM:615574 OMIM:271900 ORPHA:314911 OMIM:601552 ORPHA:49382 OMIM:616517 ORPHA:250977 OMIM:608688 OMIM:618494 ORPHA:91495 OMIM:221900 ORPHA:569 OMIM:601338 ORPHA:104 OMIM:535000 ORPHA:644 OMIM:551500 OMIM:619970 ORPHA:847 ORPHA:96253 OMIM:164500 ORPHA:94147 ORPHA:588 OMIM:615181 OMIM:245600 ORPHA:709 OMIM:615287 ORPHA:39044 ORPHA:904 OMIM:616562 OMIM:615983 ORPHA:52417 ORPHA:568 OMIM:309800 OMIM:300166 ORPHA:893 ORPHA:99000 ORPHA:1243 OMIM:611809 OMIM:153700 OMIM:613194 OMIM:193220 OMIM:614077 OMIM:619172 OMIM:607932 ORPHA:440437 OMIM:614299 OMIM:115150 ORPHA:54595 OMIM:618056 OMIM:614498 ORPHA:84 ORPHA:79241 OMIM:253260 ORPHA:797 OMIM:614298 OMIM:617713 OMIM:605670 ORPHA:67042 ORPHA:117 OMIM:259730 OMIM:610427 ORPHA:215 OMIM:618497 OMIM:615474 ORPHA:369929 OMIM:618285 OMIM:300600 ORPHA:178333 OMIM:300476 OMIM:300071 OMIM:610478 OMIM:617799 OMIM:193235 ORPHA:477774 OMIM:616672 ORPHA:163937 ORPHA:1606 ORPHA:394 OMIM:236200 OMIM:612285 ORPHA:1454 ORPHA:2318 OMIM:619845 OMIM:618268 ORPHA:892 ORPHA:853 ORPHA:487796 OMIM:619841 ORPHA:91347 ORPHA:231169 ORPHA:1573 OMIM:601553 OMIM:613660 OMIM:618748 OMIM:300672 ORPHA:93925 ORPHA:93924 ORPHA:93926 ORPHA:220386 OMIM:614845 ORPHA:3156 OMIM:618358 OMIM:610188 OMIM:611755 OMIM:610189 OMIM:617236 OMIM:618873 ORPHA:572013 OMIM:608380 OMIM:616351 OMIM:617547 OMIM:617406 OMIM:614500 OMIM:126700 ORPHA:75376 OMIM:615439 OMIM:618205 OMIM:620023 OMIM:303100 ORPHA:180 OMIM:614961 ORPHA:233 OMIM:604356 OMIM:618438 OMIM:309300 ORPHA:98969 OMIM:272440 OMIM:609913 OMIM:615651 ORPHA:485350 OMIM:300114 OMIM:619173 ORPHA:53 ORPHA:667 OMIM:618541 ORPHA:210110 OMIM:166600 OMIM:611490 OMIM:619977 OMIM:204200 ORPHA:228346 OMIM:256731 ORPHA:228360 OMIM:601780 OMIM:600143 ORPHA:1947 ORPHA:411493 OMIM:614180 OMIM:276902 OMIM:617854 OMIM:613756 OMIM:216900 OMIM:613767 OMIM:262300 ORPHA:1871 OMIM:217080 ORPHA:1873 OMIM:618186 ORPHA:263487 ORPHA:250984 ORPHA:560 OMIM:122400 ORPHA:293381 OMIM:618880 ORPHA:1571 OMIM:267750 ORPHA:91411 ORPHA:93315 ORPHA:90653 OMIM:108300 OMIM:175780 ORPHA:89842 ORPHA:79408 ORPHA:98973 OMIM:617800 OMIM:607426 ORPHA:255249 OMIM:616733 ORPHA:550 OMIM:540000 OMIM:619051 OMIM:300887 ORPHA:2556 OMIM:619876 OMIM:613835 OMIM:600105 OMIM:618332 OMIM:120970 OMIM:613829 OMIM:604219 OMIM:611544 OMIM:604307 OMIM:618476 ORPHA:397715 OMIM:612199 ORPHA:900 ORPHA:891 OMIM:219800 ORPHA:411641 OMIM:610127 ORPHA:166035 OMIM:250410 ORPHA:98976 ORPHA:98977 ORPHA:909 OMIM:210370 ORPHA:41751 OMIM:600721 OMIM:610048 OMIM:619165 OMIM:618175 ORPHA:457260 OMIM:613861 OMIM:618731 OMIM:616632 ORPHA:79244 ORPHA:2394 OMIM:619382 ORPHA:98673 OMIM:610708 ORPHA:411986 OMIM:615859 OMIM:620066 ORPHA:91131 OMIM:608799 ORPHA:79322 OMIM:616311 OMIM:616502 OMIM:614076 OMIM:619847 ORPHA:464311 OMIM:614924 OMIM:126600 OMIM:603896 OMIM:606893 OMIM:194050 OMIM:618527 OMIM:600110 OMIM:617141 OMIM:616875 ORPHA:480898 ORPHA:144 OMIM:254780 OMIM:617951 ORPHA:90322 ORPHA:1466 ORPHA:90321 OMIM:610965 ORPHA:207 OMIM:616081 OMIM:602772 ORPHA:329308 OMIM:606068 OMIM:614946 ORPHA:3437 OMIM:616914 OMIM:608328 OMIM:616118 OMIM:620012 OMIM:618324 OMIM:618156 OMIM:251900 OMIM:617717 ORPHA:543470 OMIM:617166 ORPHA:87 OMIM:123500 ORPHA:93259 ORPHA:93260 ORPHA:794 ORPHA:93262 OMIM:602849 OMIM:606812 ORPHA:208441 ORPHA:370959 OMIM:236670 ORPHA:272 ORPHA:1826 OMIM:609033 ORPHA:88628 ORPHA:250923 OMIM:610256 ORPHA:572333 ORPHA:2609 OMIM:618241 ORPHA:2052 OMIM:219000 OMIM:310700 OMIM:607921 ORPHA:95 OMIM:229300 OMIM:133780 ORPHA:90050 OMIM:618557 OMIM:617153 OMIM:617829 ORPHA:206448 ORPHA:206436 OMIM:245200 ORPHA:206443 ORPHA:79277 ORPHA:3226 OMIM:613703 OMIM:615360 ORPHA:2710 OMIM:148210 ORPHA:477 ORPHA:79255 ORPHA:401866 OMIM:616859 ORPHA:941 OMIM:272750 ORPHA:3205 ORPHA:562 OMIM:174800 OMIM:610444 OMIM:616389 OMIM:613856 ORPHA:488613 OMIM:616973 OMIM:252940 OMIM:617810 ORPHA:529665 OMIM:300942 OMIM:300500 OMIM:300814 OMIM:614565 OMIM:618031 OMIM:619580 ORPHA:208447 OMIM:614254 OMIM:617162 ORPHA:75382 OMIM:618922 OMIM:614706 ORPHA:85448 OMIM:617988 ORPHA:444013 OMIM:616198 ORPHA:75377 OMIM:602093 OMIM:613827 OMIM:601777 OMIM:204000 OMIM:253220 OMIM:617537 OMIM:619720 OMIM:619758 OMIM:619951 ORPHA:5 OMIM:614504 OMIM:619797 OMIM:617268 OMIM:268800 OMIM:616544 OMIM:616881 OMIM:618547 OMIM:617460 OMIM:619614 ORPHA:179 ORPHA:397 ORPHA:36426 OMIM:123400 OMIM:612109 OMIM:619026 OMIM:203300 OMIM:614072 OMIM:614073 OMIM:614074 OMIM:614075 ORPHA:391428 OMIM:300438 OMIM:261515 ORPHA:800 ORPHA:468661 OMIM:615330 OMIM:616451 OMIM:619007 OMIM:612572 ORPHA:217093 ORPHA:217085 OMIM:617781 OMIM:266920 OMIM:619471 OMIM:617119 OMIM:300472 ORPHA:464 OMIM:613837 OMIM:180105 OMIM:616151 OMIM:616152 OMIM:613581 OMIM:610156 ORPHA:75858 OMIM:618687 OMIM:616370 OMIM:616079 OMIM:206700 ORPHA:71493 ORPHA:363958 ORPHA:363965 OMIM:619196 OMIM:616268 ORPHA:457193 OMIM:614186 OMIM:619724 OMIM:610356 OMIM:611726 OMIM:217300 OMIM:618613 OMIM:617296 OMIM:152950 ORPHA:2526 OMIM:617914 OMIM:614255 ORPHA:2836 ORPHA:397946 OMIM:618955 OMIM:617235 OMIM:615780 OMIM:619934 OMIM:122100 ORPHA:370022 OMIM:615960 OMIM:609049 OMIM:614115 OMIM:300257 OMIM:604537 ORPHA:364055 ORPHA:79292 ORPHA:1306 OMIM:620089 OMIM:615277 OMIM:619694 OMIM:619179 OMIM:600790 OMIM:136550 ORPHA:79243 OMIM:613341 OMIM:222448 ORPHA:2143 OMIM:601813 ORPHA:2788 OMIM:259770 ORPHA:178377 OMIM:615431 OMIM:616509 OMIM:615838 ORPHA:167 OMIM:214500 OMIM:615994 OMIM:618479 OMIM:618325 ORPHA:1272 OMIM:616680 OMIM:614181 OMIM:618443 OMIM:617111 OMIM:618283 OMIM:156200 OMIM:203200 ORPHA:79432 OMIM:252650 OMIM:617282 ORPHA:508093 ORPHA:464738 OMIM:613862 OMIM:617086 ORPHA:485421 OMIM:601152 OMIM:611040 OMIM:610951 OMIM:616170 ORPHA:67047 OMIM:618329 OMIM:615673 OMIM:614303 OMIM:616722 ORPHA:79282 OMIM:277400 OMIM:611543 OMIM:604757 OMIM:614947 OMIM:618367 OMIM:250940 ORPHA:320375 ORPHA:254930 OMIM:613559 OMIM:615035 OMIM:236270 ORPHA:2169 ORPHA:14 OMIM:276900 OMIM:616034 ORPHA:431361 ORPHA:79279 OMIM:609241 OMIM:620033 OMIM:616239 OMIM:614800 OMIM:618460 ORPHA:2177 OMIM:305390 OMIM:310600 ORPHA:649 ORPHA:70474 OMIM:252010 OMIM:618225 ORPHA:93400 ORPHA:93399 OMIM:256550 ORPHA:812 OMIM:618374 ORPHA:97685 ORPHA:637 ORPHA:447980 OMIM:618278 OMIM:302200 OMIM:302350 ORPHA:627 ORPHA:1451 OMIM:608553 OMIM:619260 ORPHA:90340 OMIM:186500 OMIM:125310 OMIM:606996 OMIM:615722 ORPHA:401777 OMIM:613750 ORPHA:436182 OMIM:617830 OMIM:617082 ORPHA:414 OMIM:258870 OMIM:309000 ORPHA:534 OMIM:300424 OMIM:619701 OMIM:300997 ORPHA:1215 OMIM:210000 OMIM:165500 OMIM:125250 OMIM:258501 ORPHA:67036 OMIM:165300 OMIM:303700 ORPHA:16 ORPHA:88629 OMIM:617729 OMIM:259720 OMIM:614292 OMIM:618493 ORPHA:216873 ORPHA:216866 OMIM:619593 OMIM:618437 OMIM:120330 ORPHA:1475 OMIM:604229 ORPHA:2334 OMIM:120200 OMIM:136520 ORPHA:137902 ORPHA:35737 OMIM:165550 OMIM:613428 OMIM:251280 OMIM:608940 ORPHA:85167 OMIM:618770 ORPHA:439822 OMIM:613810 OMIM:613093 OMIM:613582 OMIM:610024 OMIM:614652 OMIM:618511 OMIM:620021 ORPHA:742 OMIM:619055 ORPHA:772 ORPHA:44 ORPHA:912 OMIM:614871 OMIM:614885 OMIM:614877 OMIM:614867 OMIM:614873 ORPHA:95433 OMIM:614863 ORPHA:773 OMIM:615802 ORPHA:713 OMIM:300653 OMIM:301900 ORPHA:79351 OMIM:602078 OMIM:619708 ORPHA:1154 OMIM:300868 OMIM:301072 OMIM:618580 ORPHA:280633 OMIM:614080 OMIM:617599 OMIM:618548 OMIM:618143 ORPHA:369837 OMIM:615398 OMIM:618590 OMIM:616809 OMIM:603387 OMIM:600977 OMIM:180550 OMIM:610623 ORPHA:35069 OMIM:256600 OMIM:217090 ORPHA:2518 OMIM:616171 OMIM:225400 ORPHA:570 OMIM:617954 OMIM:215470 OMIM:608703 ORPHA:101111 OMIM:615973 ORPHA:468678 OMIM:616364 OMIM:301220 ORPHA:726 ORPHA:254892 ORPHA:254886 OMIM:203700 OMIM:258450 OMIM:619425 OMIM:610131 ORPHA:861 OMIM:618603 OMIM:619234 OMIM:617123 OMIM:615249 OMIM:305600 ORPHA:1435 OMIM:618820 OMIM:618354 OMIM:616362 ORPHA:457284 OMIM:617711 OMIM:256730 OMIM:309500 ORPHA:90354 OMIM:615420 OMIM:615966 OMIM:612657 OMIM:608051 OMIM:612095 OMIM:603786 OMIM:619737 OMIM:614514 OMIM:601414 OMIM:600138 OMIM:613983 OMIM:600059 OMIM:608161 OMIM:608133 ORPHA:52427 OMIM:301835 OMIM:311070 ORPHA:1187 OMIM:619539 ORPHA:544469 OMIM:617516 ORPHA:508488 ORPHA:508498 ORPHA:488627 OMIM:269400 ORPHA:481152 OMIM:617807 ORPHA:2510 OMIM:614222 OMIM:615374 ORPHA:500159 OMIM:618797 OMIM:620102 OMIM:610381 OMIM:615233 OMIM:615147 OMIM:617175 OMIM:610612 ORPHA:436245 OMIM:612712 OMIM:617304 ORPHA:494344 OMIM:612015 ORPHA:244310 OMIM:613769 ORPHA:75374 OMIM:610445 OMIM:613731 OMIM:618727 OMIM:618761 OMIM:603649 OMIM:618970 ORPHA:85128 OMIM:607476 ORPHA:175 OMIM:618379 ORPHA:544503 OMIM:226960 ORPHA:1824 OMIM:618060 OMIM:180100 OMIM:613587 OMIM:618826 OMIM:312600 OMIM:180104 OMIM:204100 OMIM:613794 OMIM:618697 OMIM:304020 OMIM:300834 OMIM:300029 OMIM:608194 OMIM:613826 OMIM:618624 OMIM:268315 OMIM:312700 OMIM:616732 OMIM:613758 OMIM:216820 ORPHA:959 ORPHA:71 ORPHA:3129 OMIM:618195 OMIM:607208 OMIM:609634 OMIM:617938 OMIM:614306 ORPHA:3208 OMIM:252011 OMIM:619259 OMIM:619167 ORPHA:506353 OMIM:618768 OMIM:610283 OMIM:610282 ORPHA:2524 OMIM:616078 ORPHA:798 OMIM:619056 ORPHA:404440 OMIM:164210 OMIM:615578 ORPHA:184 OMIM:118400 ORPHA:99949 OMIM:606232 ORPHA:49827 OMIM:249270 ORPHA:209967 OMIM:613830 OMIM:113750 ORPHA:370097 OMIM:615182 OMIM:616505 ORPHA:356961 OMIM:619881 OMIM:609218 OMIM:144755 ORPHA:37 OMIM:606574 ORPHA:79435 ORPHA:293603 OMIM:613268 ORPHA:1490 OMIM:217400 OMIM:614707 OMIM:145350 OMIM:615725 ORPHA:2728 OMIM:614609 OMIM:614608 ORPHA:2250 OMIM:616920 OMIM:601707 OMIM:610359 ORPHA:177907 OMIM:613671 ORPHA:500150 OMIM:617140 OMIM:122860 OMIM:269500 ORPHA:77298 OMIM:616577 ORPHA:457351 OMIM:619616 OMIM:604232 ORPHA:2822 OMIM:604360 OMIM:619475 OMIM:617519 OMIM:612379 ORPHA:324737 OMIM:158310 ORPHA:1772 OMIM:609056 OMIM:619446 ORPHA:1933 ORPHA:585 OMIM:272300 OMIM:617389 OMIM:618218 OMIM:204870 ORPHA:480864 OMIM:619575 OMIM:618950 ORPHA:28378 OMIM:615663 OMIM:220500 OMIM:615338 ORPHA:397973 OMIM:616900 OMIM:188400 OMIM:259700 OMIM:154500 ORPHA:488642 OMIM:616954 OMIM:615145 OMIM:301066 OMIM:615658 OMIM:607541 OMIM:121820 OMIM:122200 OMIM:608471 OMIM:608470 ORPHA:98962 ORPHA:98963 ORPHA:98964 ORPHA:98960 OMIM:300957 OMIM:304700 ORPHA:52368 OMIM:136900 ORPHA:59181 OMIM:619531 OMIM:612989 OMIM:608091 OMIM:619727 OMIM:610688 OMIM:615972 OMIM:612301 OMIM:259710 OMIM:609923 ORPHA:2807 OMIM:617730 OMIM:204500 OMIM:618164 ORPHA:500144 OMIM:617669 OMIM:618331 ORPHA:247691 OMIM:192315 OMIM:617142 ORPHA:476126 ORPHA:225 OMIM:616959 OMIM:613216 OMIM:618454 OMIM:612389 OMIM:612390 OMIM:277470 OMIM:610505 OMIM:613310 OMIM:613464 OMIM:615860 ORPHA:96 OMIM:105210 OMIM:616188 OMIM:617928 ORPHA:300573 ORPHA:300570 OMIM:600638 OMIM:612438 OMIM:617879 OMIM:618737 OMIM:616335 OMIM:251270 OMIM:613843 OMIM:600132 ORPHA:920 OMIM:203100 OMIM:606952 ORPHA:79431 ORPHA:79434 OMIM:615491 OMIM:617899 ORPHA:95159 OMIM:613809 OMIM:618513 OMIM:618760 OMIM:143200 OMIM:616683 ORPHA:466934 OMIM:216550 OMIM:619273 OMIM:618606 OMIM:614195 ORPHA:284169 ORPHA:466950 OMIM:617710 ORPHA:572798 OMIM:618707 OMIM:614378 OMIM:616307 ORPHA:513456 OMIM:617616 OMIM:617977 OMIM:614296 OMIM:611383 ORPHA:85194 OMIM:605822 ORPHA:1473 OMIM:619418 OMIM:619125 OMIM:617302 OMIM:613270 ORPHA:261552 OMIM:270700 OMIM:618659 OMIM:616468 OMIM:616469 OMIM:229200 OMIM:613617
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.